WorldWideScience
1

Baclofen in the management of cannabis dependence syndrome  

OpenAIRE

Cannabis is the most commonly used illicit drug in the world. However, only few studies have shown the efficacy of pharmacologic agents in targeting cannabis withdrawal symptoms or reducing the reinforcing effects of cannabis. Baclofen has been shown to reduce cannabis withdrawal symptoms and the subjective effects of cannabis. We think that the clinical utility of baclofen for cannabis dependence is a reasonable approach. A case report using baclofen is presented and provides preliminary sup...

Imbert, Bruce; Labrune, Nathalie; Lancon, Christophe; Simon, Nicolas

2014-01-01

2

Pharmacological Treatment of Cannabis Dependence  

OpenAIRE

Cannabis is the most frequently used illegal psychoactive substance in the world. There is a significant increase in the number of treatment admissions for cannabis use disorders in the past few years, and the majority of cannabis-dependent individuals who enter treatment have difficulty in achieving and maintaining abstinence. Thus, there is increased need for medications that can be used to treat this population. So far, no medication has been shown broadly and consistently effective; none ...

Weinstein, A. M.; Gorelick, David A.

2011-01-01

3

Cannabis Withdrawal is Common among Treatment-Seeking Adolescents with Cannabis Dependence and Major Depression, and is Associated with Rapid Relapse to Dependence  

Science.gov (United States)

Recently, reports have suggested that cannabis withdrawal occurs commonly in adults with cannabis dependence, though it is unclear whether this extends to those with comorbid depression or to comorbid adolescents. We hypothesized that cannabis withdrawal would be common among our sample of comorbid adolescents and young adults, and that the presence of cannabis withdrawal symptoms would be associated with a self-reported past history of rapid reinstatement of cannabis dependence symptoms (rapid relapse). The participants in this study included 170 adolescents and young adults, including 104 with cannabis dependence, 32 with cannabis abuse, and 34 with cannabis use without dependence or abuse. All of these subjects demonstrated current depressive symptoms and cannabis use, and most demonstrated current DSM-IV major depressive disorder and current comorbid cannabis dependence. These subjects had presented for treatment for either of two double-blind, placebo-controlled trials involving fluoxetine. Cannabis withdrawal was the most commonly reported cannabis dependence criterion among the 104 subjects in our sample with cannabis dependence, being noted in 92% of subjects, using a two-symptom cutoff for determination of cannabis withdrawal. The most common withdrawal symptoms among those with cannabis dependence were craving (82%), irritability (76%), restlessness (58%), anxiety (55%), and depression (52%). Cannabis withdrawal symptoms (in the N=170 sample) were reported to have been associated with rapid reinstatement of cannabis dependence symptoms (rapid relapse). These findings suggest that cannabis withdrawal should be included as a diagnosis in the upcoming DSM-V, and should be listed in the upcoming criteria list for the DSM-V diagnostic category of cannabis dependence. PMID:18313860

Cornelius, Jack R.; Chung, Tammy; Martin, Christopher; Wood, D. Scott; Clark, Duncan B.

2008-01-01

4

Sintomas depressivos e uso de Cannabis em adolescentes / Depressive symptoms in young Cannabis users / Síntomas depresivos en adolescentes usuarios de Cannabis  

Scientific Electronic Library Online (English)

Full Text Available SciELO Brazil | Language: Portuguese Abstract in portuguese A depressão é um dos transtornos psiquiátricos mais comuns na adolescência. Os quadros depressivos costumam apresentar elevadas taxas de comorbidades psiquiátricas, sendo freqüente o abuso de substâncias psicoativas. O artigo investiga a associação dos sintomas depressivos e o uso da cannabis. MÉTOD [...] O: Revisão sistemática, análise dos artigos indexados no Medline, PsycInfo, ProQuest, Web of Science e Lilacs, entre 2000 e 2005, descritores: depressive symptoms, depressive, adolescence, teenager e cannabis. RESULTADOS: Revisados 36 artigos completos, resultando no estudo de 9 artigos, que tratam de sintomas depressivos ou depressão e o uso ou dependência de cannabis em adolescentes. Os estudos confirmam a associação entre sintomas depressivos e o uso de cannabis na adolescência, sendo esta associação mais freqüente no uso precoce e regular de cannabis. CONCLUSÃO: Os sintomas depressivos/depressão estão relacionados ao uso/abuso e dependência de cannabis na adolescência. A investigação clínica e os programas de prevenção devem abordar estes transtornos na adolescência. Abstract in spanish Este artículo busca investigar la asociación de los síntomas depresivos y el uso de cannabis en la adolescencia. MÉTODO: Ha sido realizado, a través de revisión sistemática, el análisis de los artículos indexados localizados en los sistemas Medline, PsycInfo, ProQuest, Web of Science y Lilacs, entre [...] 2000 y 2005, utilizando los descriptores: depressive symptoms, depressive, adolescence, teenager y cannabis. RESULTADOS: La mayoría de los estudios confirma existir una asociación entre síntomas depresivos y el uso de cannabis en la adolescencia, cabe destacar que esta asociación es más frecuente en el uso precoz y regular de cañabais. CONCLUSIÓN: Los síntomas depresivos/Depresión están relacionados al uso/abuso y dependencia de cañabais en la adolescencia, siendo entonces importante que estas variables puedan ser investigadas en la práctica clínica como también en programas de prevención que aborden de forma simultánea estos síntomas/trastornos en este período de la vida. Abstract in english The association between depressive symptoms and cannabis use is investigated. Due to the fact that depression has been a common psyquiatric disorder in adolescence, depressive cases usually present high rates of psychiatric comorbidities and the abuse of psychoactive substances is frequent. Systemat [...] ic review, studies at PsycInfo, ProQuest, Web of Science and Lilacs databases analyzed between 2000 and 2005 are discussed. Results show that nine out of the thirty-six studies discuss depression and cannabis use or addiction in adolescents. Whereas the association between depressive symptoms and the use of cannabis during adolescence is confirmed, it is more frequent in an early and continuous cannabis use. Research shows that depressive symptoms are related to cannabis use, abuse and dependence during adolescence. Abovementioned variables must be investigated in clinical practice and in prevention programs that simultaneously focus on these disorders.

Tânia Moraes Ramos, Andrade; Irani Iracema de Lima, Argimon.

2008-09-01

5

Cross-sectional and prospective relation of cannabis potency, dosing and smoking behaviour with cannabis dependence: an ecological study  

OpenAIRE

Background and Aims Increased delta-9-tetrahydrocannabinol (THC) concentrations in cannabis may lead to higher THC exposure, cannabis dependence and treatment need, but users may also adapt the actual intake of THC through reduced inhalation of THC containing smoke (titration). We investigated whether consumers of stronger cannabis use less cannabis per joint or inhale less smoke than those using less potent cannabis and whether these factors predict cannabis dependence severity. Method...

Pol, P.; Liebregts, N.; Brunt, T.; Amsterdam, J.; Graaf, R.; Korf, D. J.; Brink, W. Den; Laar, M.

2014-01-01

6

A proof-of-concept randomized controlled study of gabapentin: effects on cannabis use, withdrawal and executive function deficits in cannabis-dependent adults.  

Science.gov (United States)

There are no FDA-approved pharmacotherapies for cannabis dependence. Cannabis is the most widely used illicit drug in the world, and patients seeking treatment for primary cannabis dependence represent 25% of all substance use admissions. We conducted a phase IIa proof-of-concept pilot study to examine the safety and efficacy of a calcium channel/GABA modulating drug, gabapentin, for the treatment of cannabis dependence. A 12-week, randomized, double-blind, placebo-controlled clinical trial was conducted in 50 unpaid treatment-seeking male and female outpatients, aged 18-65 years, diagnosed with current cannabis dependence. Subjects received either gabapentin (1200?mg/day) or matched placebo. Manual-guided, abstinence-oriented individual counseling was provided weekly to all participants. Cannabis use was measured by weekly urine toxicology and by self-report using the Timeline Followback Interview. Cannabis withdrawal symptoms were assessed using the Marijuana Withdrawal Checklist. Executive function was measured using subtests from the Delis-Kaplan Executive Function System. Relative to placebo, gabapentin significantly reduced cannabis use as measured both by urine toxicology (p=0.001) and by the Timeline Followback Interview (p=0.004), and significantly decreased withdrawal symptoms as measured by the Marijuana Withdrawal Checklist (p<0.001). Gabapentin was also associated with significantly greater improvement in overall performance on tests of executive function (p=0.029). This POC pilot study provides preliminary support for the safety and efficacy of gabapentin for treatment of cannabis dependence that merits further study, and provides an alternative conceptual framework for treatment of addiction aimed at restoring homeostasis in brain stress systems that are dysregulated in drug dependence and withdrawal. PMID:22373942

Mason, Barbara J; Crean, Rebecca; Goodell, Vivian; Light, John M; Quello, Susan; Shadan, Farhad; Buffkins, Kimberly; Kyle, Mark; Adusumalli, Murali; Begovic, Adnan; Rao, Santosh

2012-06-01

7

Dependence on cannabis--an ever lasting issue.  

Science.gov (United States)

In this paper the dependence syndrome on cannabis as it is defined in International Classification Systems (e.g., DSM-IV) will be examined from a theoretical and a technical point of view. Therefore, both the conceptualization and the operationalization of the dependence syndrome are the focus of interest. It is shown that dependence on cannabis should deal with only psychic dependence. Analyzing criteria of psychic dependence via DSM-IV points to the need of conceptual reformulation. Deficiencies concerning variable validity and measurement conditions are pointed out. It is suggested, that the dependence syndrome on cannabis via international classification systems (e.g. DSM-IV) should be revised. PMID:15974145

Soellner, Renate

2005-01-01

8

Cannabis use and childhood trauma interact additively to increase the risk of psychotic symptoms in adolescence.  

LENUS (Irish Health Repository)

Adolescent cannabis use has been shown in many studies to increase the risk of later psychosis. Childhood trauma is associated with both substance misuse and risk for psychosis. In this study our aim was to investigate whether there is a significant interaction between cannabis use and childhood trauma in increasing the risk for experiencing psychotic symptoms during adolescence.

Harley, M

2010-10-01

9

Testing bidirectional effects between cannabis use and depressive symptoms: moderation by the serotonin transporter gene.  

Science.gov (United States)

Evidence for the assumption that cannabis use is associated with depression and depressive symptoms is inconsistent and mostly weak. It is likely that the mixed results are due to the fact that prior studies ignored the moderating effects of an individual's genetic vulnerability. The present study takes a first step in scrutinizing the relationship between cannabis use and depressive symptoms by taking a developmental molecular-genetic perspective. Specifically, we concentrated on changes in cannabis use and depressive symptoms over time in a simultaneous manner and differences herein for individuals with and without the short allele of the 5-hydroxytryptamine (serotonin) transporter gene-linked polymorphic region (5-HTTLPR) genotype. Data were from 310 adolescents over a period of 4 years. We used a parallel-process growth model, which allows co-development of cannabis use and depressive symptoms throughout adolescence, and the possible role of the 5-HTTLPR genotype in this process. We used data from the younger siblings of these adolescents in an attempt to replicate potential findings. The parallel-process growth model shows that cannabis use increases the risk for an increase in depressive symptoms over time but only in the presence of the short allele of the 5-HTTLPR genotype. This effect remained significant after controlling for covariates. We did not find conclusive support for the idea that depressive symptoms affect cannabis use. These findings were replicated in the sample of the younger siblings. The findings of the present study show first evidence that the links between cannabis use and depressive symptoms are conditional on the individual's genetic makeup. PMID:21967091

Otten, Roy; Engels, Rutger C M E

2013-09-01

10

Polysubstance Use in Cannabis Users Referred for Treatment: Drug Use Profiles, Psychiatric Comorbidity and Cannabis-Related Beliefs  

OpenAIRE

Background: Population-based surveys demonstrate cannabis users are more likely to use both illicit and licit substances, compared with non-cannabis users. Few studies have examined the substance use profiles of cannabis users referred for treatment. Coexisting mental health symptoms and underlying cannabis-related beliefs associated with these profiles remains unexplored. Methods: Comprehensive drug use and dependence severity (Severity of Dependence Scale- Cannabis [SDS-C]) data were col...

JasonPaulConnor; RossMcDonaldYoung; Feeney, Geraldf X.

2013-01-01

11

The role of study and work in cannabis use and dependence trajectories among young adult frequent cannabis users  

Directory of Open Access Journals (Sweden)

Full Text Available Life course theory considers events in study and work as potential turning points in deviance, including illicit drug use. This qualitative study explores the role of occupational life in cannabis use and dependence in young adults. Two and three years after the initial structured interview, 47 at baseline frequent cannabis users were interviewed in-depth about the dynamics underlying changes in their cannabis use and dependence. Overall, cannabis use and dependence declined, including interviewees who quit using cannabis completely, in particular with students, both during their study and after they got employed. Life course theory appeared to be a useful framework to explore how and why occupational life is related to cannabis use and dependence over time. Our study showed that life events in this realm are rather common in young adults and can have a strong impact on cannabis use. While sometimes changes in use are temporary, turning points can evolve from changes in educational and employment situations; an effect that seems to be related to the consequences of these changes in terms of amount of leisure time and agency (i.e. feelings of being in control.

NienkeLiebregts

2013-08-01

12

A Proof-of-Concept Randomized Controlled Study of Gabapentin: Effects on Cannabis Use, Withdrawal and Executive Function Deficits in Cannabis-Dependent Adults  

OpenAIRE

There are no FDA-approved pharmacotherapies for cannabis dependence. Cannabis is the most widely used illicit drug in the world, and patients seeking treatment for primary cannabis dependence represent 25% of all substance use admissions. We conducted a phase IIa proof-of-concept pilot study to examine the safety and efficacy of a calcium channel/GABA modulating drug, gabapentin, for the treatment of cannabis dependence. A 12-week, randomized, double-blind, placebo-controlled clinical trial w...

Mason, Barbara J.; Crean, Rebecca; Goodell, Vivian; Light, John M.; Quello, Susan; Shadan, Farhad; Buffkins, Kimberly; Kyle, Mark; Adusumalli, Murali; Begovic, Adnan; Rao, Santosh

2012-01-01

13

Actions of delta-9-tetrahydrocannabinol in cannabis: Relation to use, abuse, dependence  

OpenAIRE

Cannabis use disorders have been recently identified as a relevant clinical issue: a subset of cannabis smokers seeks treatment for their cannabis use, yet few succeed in maintaining long-term abstinence. The rewarding and positive reinforcing effects of the primary psychoactive component of smoked cannabis, delta-9-tetrahydrocannabinol (THC) are mediated by the cannabinoid CB1 receptor. The CB1 receptor has also been shown to mediate cannabinoid dependence and expression of withdrawal upon c...

Cooper, Ziva D.; Haney, Margaret

2009-01-01

14

Potential use of Magnolia officinalis bark polyphenols in the treatment of cannabis dependence.  

Science.gov (United States)

In recent years, epidemiological data confirm that cannabis-related emergencies, cannabis-use disorders and dependence are significantly increased. Cannabis is generally considered a little dangerous substances of abuse, however, chronic consumption has been associated to the development of mental disorders, cognitive deficits, chronic bronchitis, emphysema, increased risk of myocardial infarction in the hour after use, increased mortality after myocardial infarction, liver inflammation and steatosis in patients affected by hepatitis C. In this article we described the pharmacological characteristics of Magnolia officinalis bark active principles suggesting a potential application in the treatment of both cannabis dependence and cannabis-related disorders. PMID:25459131

Coppola, Maurizio; Mondola, Raffaella

2014-12-01

15

Reliability and validity of the Marijuana Motives Measure among young adult frequent cannabis users and associations with cannabis dependence.  

Science.gov (United States)

The Marijuana Motives Measure (MMM) has so far been examined mainly in student populations, often with relatively limited involvement in cannabis use. This study evaluated the factor structure of the MMM in a demographically mixed sample of 600 young adult (18-30years) frequent (?3days per week) cannabis users in the Netherlands. Analysis confirmed a five-factor solution, denoting coping, enhancement, social, conformity and expansion motives. Additionally, the original MMM was extended with two items (boredom and habit), which formed a distinct, internally consistent sixth factor labelled routine motives. In a multivariable logistic regression analysis, coping and routine motives showed significant associations with 12-month DSM-IV cannabis dependence. The results suggest general reliability and validity of the MMM in a heterogeneous population of experienced cannabis users. PMID:25240105

Benschop, Annemieke; Liebregts, Nienke; van der Pol, Peggy; Schaap, Rick; Buisman, Renate; van Laar, Margriet; van den Brink, Wim; de Graaf, Ron; Korf, Dirk J

2015-01-01

16

Cue-Reactivity in Cannabis-Dependent Adolescents  

OpenAIRE

We measured event-related potentials (ERPs) with a craving manipulation to investigate the neural correlates of drug cue-reactivity in 13 cannabis-dependent (CD) adolescents (ages 14–17). The P300 responses to marijuana (MJ) pictures (MJ-P300) and control pictures (C-P300) were assessed after handling neutral objects and again after handling MJ paraphernalia (MJP). Self-reported drug craving and heart rates also were measured. MJ-P300 were larger than C-P300 (p<0.001) and both the MJ-P300 a...

Nickerson, Lisa D.; Ravichandran, Caitlin; Lundahl, Leslie H.; Rodolico, John; Dunlap, Steven; Trksak, George H.; Lukas, Scott E.

2011-01-01

17

Adolescent Cannabis Use Increases Risk for Cocaine-Induced Paranoia  

OpenAIRE

Cannabis can produce and/or exacerbate psychotic symptoms in vulnerable individuals. Early exposure to cannabis, particularly in combination with genetic factors, increases the risk of a subsequent, primary, psychotic disorder. Because paranoia is a common feature of stimulant abuse and cocaine dependent individuals frequently endorse a history of cannabis abuse, we examined whether early cannabis exposure, in conjunction with polymorphic variation in the catechol-O-methyl transferase gene (C...

Kalayasiri, Rasmon; Gelernter, Joel; Farrer, Lindsay; Weiss, Roger; Brady, Kathleen; Gueorguieva, Ralitza; Kranzler, Henry R.; Malison, Robert T.

2010-01-01

18

Cannabis e humor / Cannabis and mood  

Scientific Electronic Library Online (English)

Full Text Available SciELO Brazil | Language: Portuguese Abstract in portuguese OBJETIVO: Avaliar as relações entre o uso agudo e crônico de cannabis e alterações do humor. MÉTODO: Os artigos foram selecionados por meio de busca eletrônica no indexador PubMed. Capítulos de livros e as listas de referências dos artigos selecionados também foram revisados. RESULTADOS: Observam-se [...] elevados índices de comorbidade entre abuso/dependência de cannabis e transtornos afetivos em estudos transversais e em amostras clínicas. Estudos longitudinais indicam que, em longo prazo, o uso mais intenso de cannabis está relacionado com um risco maior de desenvolvimento de doença bipolar e, talvez, depressão maior em indivíduos inicialmente sem quadros afetivos; porém, os mesmos não encontraram maior risco de uso de cannabis entre aqueles com mania ou depressão sem esta comorbidade. Outra importante observação é que o uso de substâncias psicoativas em bipolares pode estar associado a uma série de características negativas, como dificuldade na recuperação dos sintomas afetivos, maior número de internações, piora na adesão ao tratamento, risco aumentado de suicídio, agressividade e a uma pobre resposta ao lítio. Tratamentos psicossociais e farmacológicos são indicados para o manejo da comorbidade entre cannabis e transtornos afetivos. CONCLUSÃO: As relações entre o uso de cannabis e alterações do humor são observadas tanto epidemiologicamente quanto nos contextos clínicos. Abstract in english OBJECTIVE: Evaluate the relationship between acute and chronic use of cannabis and mood changes. METHOD: Articles were selected by electronic search in PubMed. Chapters in books and reference lists of selected articles were also reviewed. As the research did not involve humans, there was no evaluati [...] on by a Research Ethics Committee. RESULTS: High rates of comorbidity between use/abuse/dependence of cannabis and affective disorders in longitudinal studies and in clinical samples were observed. Longitudinal studies indicate that, in long-term, the higher use of cannabis is associated with an increased risk of developing bipolar disorder, and probably, major depression in subjects initially without affective disorder, but was not found increased risk of cannabis use among those initially only with mania or depression. Another important observation is that substance abuse in bipolar patients may be associated with a number of negative characteristics, such as difficulty in recovering the affective symptoms, more hospitalizations, poor compliance with treatment, increased risk of suicide, aggression and a poor response to lithium. Psychosocial and pharmacological treatments are indicated for the management of comorbidity between cannabis and affective disorders. CONCLUSION: The relationship between cannabis use and mood changes are observed both in the epidemiological research and in the clinical settings.

Rafael Faria, Sanches; João Mazzoncini de Azevedo, Marques.

2010-06-01

19

Brief Treatments for Cannabis Dependence: Findings From a Randomized Multisite Trial  

Science.gov (United States)

This study evaluated the efficacy of 2 brief interventions for cannabis-dependent adults. A multisite randomized controlled trial compared cannabis use outcomes across 3 study conditions: (a) 2 sessions of motivational enhancement therapy (MET); (b) 9 sessions of multicomponent therapy that included MET, cognitive-behavioral therapy, and case…

Babor, Thomas F.

2004-01-01

20

Total exposure duration and proximity of cessation of cannabis use predict severity of sub-clinical psychotic symptoms among former users.  

Science.gov (United States)

In a non-clinical military enrolment setting, former cannabis users (N=81), compared to substance-naïve controls (N=132), endorsed markedly elevated rates of schizotypy subscale scores on the Schizotypal Personality Questionnaire (SPQ). Total duration of exposure and proximity of cessation of cannabis use also had an important impact on the severity of psychosis-like symptoms. PMID:22436347

Baskak, Bora; Munir, Kerim; Ozguven, Halise Devrimci; Koc, Ersin; Gedik, Gulumser; Erkan, Derya; Atbasoglu, Cem E

2012-07-30

21

A multi-center, randomized controlled trial of a group psychological intervention for psychosis with comorbid cannabis dependence over the early course of illness.  

LENUS (Irish Health Repository)

Patients who experience the onset of psychotic illness with a comorbid diagnosis of cannabis dependence experience poor clinical outcomes. Few studies have identified interventions that reduce cannabis use and improve clinical outcome in this population.

Madigan, Kevin

2013-01-01

22

The role of parents, peers and partners in cannabis use and dependence trajectories among young adult frequent users  

OpenAIRE

In a 3-year qualitative longitudinal study the role of social relationships in cannabis use and dependence in young adults (all frequent users at baseline) was explored. Overall, cannabis use and dependence declined. Changes in use were, for a considerable part, attributable to processes and life events in social relationships with peers and partners, while parents had little influence. Negatively experienced events often triggered increased use and positively experienced events decreased use...

Liebregts, N.; Pol, P.; Laar, M.; Graaf, R.; Brink, W. Den; Korf, D. J.

2013-01-01

23

Psychosis and cannabis  

Scientific Electronic Library Online (English)

Full Text Available SciELO Brazil | Language: English Abstract in english Alcohol and cannabis misuse is currently the most frequent co-morbidity disorder of schizophrenia. The following four issues will be dealt with: 1) the neurobiological basis of the psychosis-inducing, pathogenic effects of THC, the agent contained in cannabis products. 2) Can cannabis use - and for [...] comparison alcohol abuse - prematurely trigger or even cause schizophrenia? 3) Are persons genetically liable to schizophrenia, psychosis-prone individuals or young persons before completion of brain development at an increased risk? 4) What consequences does cannabis use have on the symptomatology and further course of schizophrenia? Results from recent literature and the ABC Schizophrenia Study show that the risk for cannabis use in schizophrenia is about twice the size in healthy controls. In most cases cannabis use starts before first admission, in a third of cases before schizophrenia onset. There is an increased affinity to misuse already at the prodromal stage. Cannabis can prematurely trigger schizophrenia onset - on average eight years earlier than in non-use - and cause the illness partly in interaction with predisposing factors. Cannabis use in the course of schizophrenia increases positive symptoms and reduces affective flattening, thus leading to dysfunctional coping in some cases.

Heinz, Häfner.

24

Burnout among High-School Students and Cannabis Use, Consumption Frequencies, Abuse and Dependence  

Science.gov (United States)

Background: Cannabis is a substance frequently consumed by adolescents, which is a risk factor for many psychopathological disorders. At the same time, adolescents in high-schools are likely to be exposed to significant stress from school that can sometimes lead to a burnout syndrome. Objective: The purpose of this study is to explore the impact…

Walburg, Vera; Moncla, Dany; Mialhes, Aurélie

2015-01-01

25

The Global Epidemiology and Contribution of Cannabis Use and Dependence to the Global Burden of Disease: Results from the GBD 2010 Study  

Science.gov (United States)

Aims Estimate the prevalence of cannabis dependence and its contribution to the global burden of disease. Methods Systematic reviews of epidemiological data on cannabis dependence (1990-2008) were conducted in line with PRISMA and meta-analysis of Observational Studies in Epidemiology (MOOSE) guidelines. Culling and data extraction followed protocols, with cross-checking and consistency checks. DisMod-MR, the latest version of generic disease modelling system, redesigned as a Bayesian meta-regression tool, imputed prevalence by age, year and sex for 187 countries and 21 regions. The disability weight associated with cannabis dependence was estimated through population surveys and multiplied by prevalence data to calculate the years of life lived with disability (YLDs) and disability-adjusted life years (DALYs). YLDs and DALYs attributed to regular cannabis use as a risk factor for schizophrenia were also estimated. Results There were an estimated 13.1 million cannabis dependent people globally in 2010 (point prevalence0.19% (95% uncertainty: 0.17-0.21%)). Prevalence peaked between 20-24 yrs, was higher in males (0.23% (0.2-0.27%)) than females (0.14% (0.12-0.16%)) and in high income regions. Cannabis dependence accounted for 2 million DALYs globally (0.08%; 0.05-0.12%) in 2010; a 22% increase in crude DALYs since 1990 largely due to population growth. Countries with statistically higher age-standardised DALY rates included the United States, Canada, Australia, New Zealand and Western European countries such as the United Kingdom; those with lower DALY rates were from Sub-Saharan Africa-West and Latin America. Regular cannabis use as a risk factor for schizophrenia accounted for an estimated 7,000 DALYs globally. Conclusion Cannabis dependence is a disorder primarily experienced by young adults, especially in higher income countries. It has not been shown to increase mortality as opioid and other forms of illicit drug dependence do. Our estimates suggest that cannabis use as a risk factor for schizophrenia is not a major contributor to population-level disease burden. PMID:24204649

Degenhardt, Louisa; Ferrari, Alize J.; Calabria, Bianca; Hall, Wayne D.; Norman, Rosana E.; McGrath, John; Flaxman, Abraham D.; Engell, Rebecca E.; Freedman, Greg D.; Whiteford, Harvey A.; Vos, Theo

2013-01-01

26

Strain dependence of adolescent Cannabis influence on heroin reward and mesolimbic dopamine transmission in adult Lewis and Fischer 344 rats.  

Science.gov (United States)

Adolescent Cannabis exposure has been hypothesized to act as a gateway to opiate abuse. In order to investigate the role of genetic background in cannabinoid-opiate interactions, we studied the effect of ?(9) -tetrahydrocannabinol (THC) exposure of adolescent Lewis and Fischer 344 rats on the responsiveness of accumbens shell and core dopamine (DA), as monitored by microdialysis, to THC and heroin at adulthood. Heroin reward and reinstatement by heroin priming were studied by conditioned place preference (CPP) and cognitive and emotional functions by object recognition, Y maze and elevated plus maze paradigms. THC stimulated shell DA in Lewis but not in Fischer 344 rats. Adolescent THC exposure potentiated DA stimulant effects of heroin in the shell and core of Lewis and only in the core of Fischer 344 rats. Control Lewis rats developed stronger CPP to heroin and resistance to extinction compared with Fischer 344 strain. In Lewis rats, THC exposure did not affect heroin CPP but potentiated the effect of heroin priming. In Fischer 344 rats, THC exposure increased heroin CPP and made it resistant to extinction. Lewis rats showed seeking reactions during extinction and hedonic reactions in response to heroin priming. Moreover, adolescent THC exposure affected emotional function only in Lewis rats. These observations suggest that long-term effects of Cannabis exposure on heroin addictive liability and emotionality are dependent on individual genetic background. PMID:23957273

Cadoni, Cristina; Simola, Nicola; Espa, Elena; Fenu, Sandro; Di Chiara, Gaetano

2015-01-01

27

In vivo measurement of neuronal dopamine transporter in tobacco and cannabis dependents subjects with positron tomography and [11C]P E 2 I  

International Nuclear Information System (INIS)

Modifications of dopamine neurotransmission are classically involved in addictive behaviors and drug reinforcement. However, to date no data are available concerning the effects of cannabis addiction on dopaminergic neurotransmission in Human. The neuronal dopamine transporter (D.A.T.) is essential for the maintenance of normal dopamine homeostasis in the brain by ensuring the re-uptake of extracellular dopamine. Therefore, observation of D.A.T. availability abnormalities in cannabis-dependents subjects could provide further evidence for the implication of dopaminergic dysfunction in this addiction. Thus, as the cannabis dependent subjects are also most of time tobacco-dependents, this work aims studying the D.A.T. availability in age-paired control, tobacco-dependent and cannabis-dependent male subjects using Positron Emission Tomography (PET). Subjects are scanned on High Resolution Research Tomograph (H.R.R.T.) for one hour after injection of a selective D.A.T. radioligand ([11C]P.E. 2 I.) [1]. The binding potential (B.P.) is calculated in order to obtained the specific binding of [11C]P.E. 2 I. to the D.A.T. using the simplified reference tissue model of Lammertsma (S.R.T.M.) [2] and B.P. maps were generated according to Gunn model [3]. Comparison of mean B.P. obtained in Region Of Interest and voxel to voxel comparison of B.P. maps using S.P.M.5 were performed with M.A.N.C.O.V.A. controlled for age between control, tobacco-dependent and cannetween control, tobacco-dependent and cannabis-dependent groups. Preliminary results are concordant between both approaches and shown significant decreases of the D.A.T. availability in the both groups of addicted subjects in comparison to controls at the level of dorsal and ventral striatum and the dorsal midbrain including substantia nigra and ventral tegmental area. However, no difference in D.A.T. binding between tobacco and cannabis dependents subjects was observed. These widespread modifications of D.A.T. availability in the dependents subjects might reflect a modification of dopamine neurotransmission in cannabis and/or tobacco addictions. (authors)

28

Abuso de cannabis em pacientes com transtornos psiquiátricos: atualização para uma antiga evidência Cannabis abuse in patients with psychiatric disorders: an update to old evidence  

Directory of Open Access Journals (Sweden)

Full Text Available OBJETIVO: Realizar uma atualização sobre o abuso de cannabis em pacientes com transtornos psiquiátricos. MÉTODO: Busca de artigos nas bases de dados eletrônicas Medline, The Cochrane Library Database, Lilacs, PubMed e SciELO, utilizando os descritores "marijuana abuse", "cannabis abuse", "psychiatric disorders" AND "mental disorders"; incluindo artigos que avaliaram ambas as exposições para abuso e dependência de cannabis e qualquer outro transtorno psiquiátrico. Foi considerado o período até dezembro de 2009. RESULTADOS: Observou-se que o abuso frequente de cannabis pode aumentar o risco para o desenvolvimento de esquizofrenia e de sintomas psicóticos crônicos, embora estes achados ainda careçam de comprovação. A cannabis parece ser uma das drogas de escolha de portadores de transtorno afetivo bipolar, sendo que é descrito que estados maníacos podem ser induzidos pelo seu consumo. O abuso de maconha também frequentemente co-ocorre em indivíduos com transtornos ansiosos, sendo que a relação de cronicidade destas condições e o consumo de maconha ainda é incerta. Para depressão ainda não existem evidências claras que apontem que o consumo de cannabis ocorre como forma de automedicação. Em indivíduos com transtornos psiquiátricos, há relatos de que o uso da cannabis pode exacerbar sintomas positivos, somar efeitos negativos no curso do transtorno, contribuir para pior adesão ao tratamento e levar a maior número de hospitalizações. CONCLUSÃO: O abuso de cannabis em pacientes com transtornos psiquiátricos como esquizofrenia, transtornos do humor e ansiosos tem impacto negativo tanto na fase aguda quanto em fases mais avançadas destas condições, embora futuros estudos avaliando estas associações ainda sejam necessários.OBJECTIVE: To perform an update on cannabis abuse by patients with psychiatric disorders. METHOD: A search was performed in the electronic databases Medline, The Cochrane Library Database, Lilacs, PubMed, and SciELO, using the keywords 'marijuana abuse', 'cannabis abuse', 'psychiatric disorders', and 'mental disorders'. Articles published until December 2009, dealing with cannabis abuse and dependence in association with other psychiatric disorders were included. RESULTS: Cannabis abuse was found to be associated with increased risk for the onset of schizophrenia and chronic psychotic symptoms, although these findings require confirmation from additional research. Cannabis seems to be one of the drugs of choice of individuals with bipolar disorder, despite evidence that manic states can be induced by its use. Cannabis abuse also occurs frequently in individuals with anxiety disorders, but the relationship between the chronic nature of these conditions and the use of marijuana remains uncertain. In respect to depression, there is no clear evidence to date that depressive patients use cannabis as a form of self-medication. In individuals with psychiatric disorders, the use of cannabis has been associated with increased positive symptoms, additional negative symptoms in the course of illness, impaired treatment compliance, and more hospitalizations. CONCLUSION: The abuse of cannabis by patients with psychiatric disorders such as schizophrenia and mood and anxious disorders has a negative impact both in the acute and advanced stages of these conditions, although further investigation on this association is still necessary.

Alessandra Diehl

2010-05-01

29

Abuso de cannabis em pacientes com transtornos psiquiátricos: atualização para uma antiga evidência / Cannabis abuse in patients with psychiatric disorders: an update to old evidence  

Scientific Electronic Library Online (English)

Full Text Available SciELO Brazil | Language: Portuguese Abstract in portuguese OBJETIVO: Realizar uma atualização sobre o abuso de cannabis em pacientes com transtornos psiquiátricos. MÉTODO: Busca de artigos nas bases de dados eletrônicas Medline, The Cochrane Library Database, Lilacs, PubMed e SciELO, utilizando os descritores "marijuana abuse", "cannabis abuse", "psychiatri [...] c disorders" AND "mental disorders"; incluindo artigos que avaliaram ambas as exposições para abuso e dependência de cannabis e qualquer outro transtorno psiquiátrico. Foi considerado o período até dezembro de 2009. RESULTADOS: Observou-se que o abuso frequente de cannabis pode aumentar o risco para o desenvolvimento de esquizofrenia e de sintomas psicóticos crônicos, embora estes achados ainda careçam de comprovação. A cannabis parece ser uma das drogas de escolha de portadores de transtorno afetivo bipolar, sendo que é descrito que estados maníacos podem ser induzidos pelo seu consumo. O abuso de maconha também frequentemente co-ocorre em indivíduos com transtornos ansiosos, sendo que a relação de cronicidade destas condições e o consumo de maconha ainda é incerta. Para depressão ainda não existem evidências claras que apontem que o consumo de cannabis ocorre como forma de automedicação. Em indivíduos com transtornos psiquiátricos, há relatos de que o uso da cannabis pode exacerbar sintomas positivos, somar efeitos negativos no curso do transtorno, contribuir para pior adesão ao tratamento e levar a maior número de hospitalizações. CONCLUSÃO: O abuso de cannabis em pacientes com transtornos psiquiátricos como esquizofrenia, transtornos do humor e ansiosos tem impacto negativo tanto na fase aguda quanto em fases mais avançadas destas condições, embora futuros estudos avaliando estas associações ainda sejam necessários. Abstract in english OBJECTIVE: To perform an update on cannabis abuse by patients with psychiatric disorders. METHOD: A search was performed in the electronic databases Medline, The Cochrane Library Database, Lilacs, PubMed, and SciELO, using the keywords 'marijuana abuse', 'cannabis abuse', 'psychiatric disorders', an [...] d 'mental disorders'. Articles published until December 2009, dealing with cannabis abuse and dependence in association with other psychiatric disorders were included. RESULTS: Cannabis abuse was found to be associated with increased risk for the onset of schizophrenia and chronic psychotic symptoms, although these findings require confirmation from additional research. Cannabis seems to be one of the drugs of choice of individuals with bipolar disorder, despite evidence that manic states can be induced by its use. Cannabis abuse also occurs frequently in individuals with anxiety disorders, but the relationship between the chronic nature of these conditions and the use of marijuana remains uncertain. In respect to depression, there is no clear evidence to date that depressive patients use cannabis as a form of self-medication. In individuals with psychiatric disorders, the use of cannabis has been associated with increased positive symptoms, additional negative symptoms in the course of illness, impaired treatment compliance, and more hospitalizations. CONCLUSION: The abuse of cannabis by patients with psychiatric disorders such as schizophrenia and mood and anxious disorders has a negative impact both in the acute and advanced stages of these conditions, although further investigation on this association is still necessary.

Alessandra, Diehl; Daniel Cruz, Cordeiro; Ronaldo, Laranjeira.

2010-05-01

30

Cannabis cue-induced brain activation correlates with drug craving in limbic and visual salience regions: Preliminary results  

OpenAIRE

Craving is a major motivator underlying drug use and relapse but the neural correlates of cannabis craving are not well understood. This study sought to determine whether visual cannabis cues increase cannabis craving and whether cue-induced craving is associated with regional brain activation in cannabis-dependent individuals. Cannabis craving was assessed in 16 cannabis-dependent adult volunteers while they viewed cannabis cues during a functional MRI (fMRI) scan. The Marijuana Craving Ques...

Charboneau, Evonne J.; Dietrich, Mary S.; Park, Sohee; Cao, Aize; Watkins, Tristan J.; Blackford, Jennifer U.; Benningfield, Margaret M.; Martin, Peter R.; Buchowski, Maciej S.; Cowan, Ronald L.

2013-01-01

31

Applying a Social Determinants of Health Perspective to Early Adolescent Cannabis Use--An Overview  

Science.gov (United States)

Cannabis is the most widely used illicit drug in the world. Although the risk of problematic cannabis use is relatively low, the lifetime prevalence of dependence is greater than for all other illicit drugs. As such, the population burden of problematic cannabis use warrants attention. Many health and psychosocial risks associated with cannabis

Hyshka, Elaine

2013-01-01

32

Associations Between Depressive Symptom Dimensions and Smoking Dependence Motives  

OpenAIRE

Depressive symptoms are heterogeneous and can be parsed into four subdimensions (i.e., positive affect [PA], negative affect [NA], somatic features [SF], and interpersonal problems [IP]) that may have unique associations with the motivation to smoke. This study explored associations between depressive symptom dimensions and 13 theoretically distinct domains of smoking dependence motivation in current cigarette smokers (N = 212; 53% female, mean [M] age = 24 years). Results demonstrated substa...

Mickens, Lavonda; Greenberg, Jodie; Ameringer, Katherine J.; Brightman, Molly; Sun, Ping; Leventhal, Adam M.

2011-01-01

33

Cannabidiol, a Cannabis sativa constituent, as an antipsychotic drug  

OpenAIRE

A high dose of delta9-tetrahydrocannabinol, the main Cannabis sativa (cannabis) component, induces anxiety and psychotic-like symptoms in healthy volunteers. These effects of delta9-tetrahydrocannabinol are significantly reduced by cannabidiol (CBD), a cannabis constituent which is devoid of the typical effects of the plant. This observation led us to suspect that CBD could have anxiolytic and/or antipsychotic actions. Studies in animal models and in healthy volunteers clearly suggest an anxi...

Zuardi A.W.; Crippa J.A.S.; Hallak J.E.C.; Moreira F.A.; Guimarães F.S.

2006-01-01

34

Developmental Pathways to Adolescent Cannabis Abuse and Dependence: Child Maltreatment, Emerging Personality, and Internalizing versus Externalizing Psychopathology  

OpenAIRE

Child maltreatment is strongly associated with adolescent psychopathology and substance abuse and dependence (Clark, Thatcher, & Martin, 2010; Ellis & Wolfe, 2009). However, developmental processes unfolding from childhood into adolescence that delineate this trajectory are not well understood. The current study uses path analysis in a structural equation modeling framework to examine multiple mediator models, including ego control, ego resiliency, and internalizing and externalizing symptoms...

Oshri, Assaf; Rogosch, Fred A.; Burnette, Mandi; Cicchetti, Dante

2011-01-01

35

Does liberalizing cannabis laws increase cannabis use?  

Science.gov (United States)

A key question in the ongoing policy debate over cannabis' legal status is whether liberalizing cannabis laws leads to an increase in cannabis use. This paper provides new evidence on the impact of a specific type of liberalization, decriminalization, on initiation into cannabis use. Our identification strategy exploits variation in the timing of cannabis policy reforms and our estimation framework marries a difference-in-difference approach with a discrete time duration model. Our results reveal evidence of both heterogeneity and dynamics in the response of cannabis uptake to decriminalization. Overall, we find that the impact of decriminalization is concentrated amongst minors, who have a higher rate of uptake in the first five years following its introduction. PMID:24727348

Williams, Jenny; Bretteville-Jensen, Anne Line

2014-07-01

36

Neurobiologia da Cannabis: do sistema endocanabinoide aos transtornos por uso de Cannabis / Neurobiology of Cannabis: from the endocannabinoid system to cannabis-related disorders  

Scientific Electronic Library Online (English)

Full Text Available SciELO Brazil | Language: Portuguese Abstract in portuguese OBJETIVOS: Diante das lacunas na efetividade das terapêuticas para transtornos por uso de Cannabis, a droga ilícita mais consumida no mundo, este trabalho propõe-se a rever os conhecimentos sobre o substrato neuroanatômico, biomolecular e celular do sistema endocanabinoide, descrever os mecanismos d [...] e neuroplasticidade dependente dos canabinoides e relacioná-los com a neurobiologia dos transtornos por uso de Cannabis (abuso e dependência). MÉTODOS: Recorreu-se às bases de dados Medline, Scopus e ISI Web of Knowledge; as palavras-chave pesquisadas foram "Cannabis", "neurobiology", "endocannabinoid system", "endocannabinoids", "receptors, cannabinoid", "neuronal plasticity", "long-term synaptic depression", "long-term potentiation", "marijuana abuse" e "tetrahydrocannabinol". Foram incluídos 80 trabalhos nesta revisão. DISCUSSÃO: A distribuição neuroanatômica, celular e biomolecular do sistema endocanabinoide adequa-se perfeitamente às suas funções de neuromodulação (via neuroplasticidade e metaplasticidade), nomeadamente em vias relacionadas aos transtornos por uso de substâncias. Os canabinoides exógenos perturbam essas funções. CONCLUSÃO: O sistema endocanabinoide contribui para a definição de setpoints em diversas vias neuronais, incluindo vias cruciais na instalação de transtornos por uso de substâncias; com o uso de Cannabis, esses setpoints tornar-se-ão mais permissivos, facilitando os transtornos por uso de Cannabis. Os avanços no entendimento da neurobiologia da Cannabis abrem uma janela de oportunidades para novas estratégias terapêuticas nos transtornos por uso de Cannabis. Abstract in english OBJECTIVES: Given the challenges arising from the poor effectiveness of therapies for Cannabis-related disorders, the most commonly used illicit drug in the world, this paper aims to review the present knowledge about the neuroanatomic, biomolecular and cellular substrate of the endocannabinoid syst [...] em, describing the mechanisms of cannabinoid-dependent neuronal plasticity and relating them with the neurobiology of Cannabis-related disorders (abuse and dependence). METHODS: Medline, Scopus and ISI Web of Knowledge were searched for the keywords "Cannabis", "neurobiology", "endocannabinoid system", "endocannabinoids", "receptors, cannabinoid", "neuronal plasticity", "long-term synaptic depression", "long-term potentiation", "marijuana abuse" and "tetrahydrocannabinol". Eighty studies were included in this review. DISCUSSION: The neuroanatomical, cellular and biomolecular characterization of the endocannabinoid system serves perfectly its neuromodulatory neuroplastic and metaplastic functions, particularly in pathways related to substance-related disorders. Exogenous cannabinoids disrupt these functions. CONCLUSION: The endocannabinoid system contributes to the definition of setpoints in several neuronal pathways, including pathways critical for the development of substance-related disorders; with Cannabis use these setpoints become more permissive, facilitating Cannabis-related disorders. The advances in understanding the neurobiology of Cannabis open a window of opportunities for new therapeutic strategies in Cannabis-related disorders.

José Luis G. Pinho, Costa; Lucas O., Maia; P., Orlandi-Mattos; João C., Villares; Manuel A. Fernandez, Esteves.

37

Cannabis and Breast feeding  

International Nuclear Information System (INIS)

Cannabis is a drug derived from hemp plant, Cannabis sativa, used both as a recreational drug or as medicine. It is a widespread illegal substance, generally smoked for its hallucinogenic properties. Little is known about the adverse effects of postnatal cannabis exposure throw breast feeding because of a lack of studies in lactating women. The active substance of cannabis is the delta 9 Tetrahydrocannabinol (THC). Some studies conclude that it could decrease motor development of the child at one year of age. Therefore, cannabis use and abuse of other drugs like alcohol, tobacco, or cocaine must be contraindicated during breast feeding. Mothers who use cannabis must stop breast feeding, or ask for medical assistance to stop cannabis use in order to provide her baby with all the benefits of human milk.

38

Two cases of "cannabis acute psychosis" following the administration of oral cannabis  

Directory of Open Access Journals (Sweden)

Full Text Available Abstract Background Cannabis is the most commonly used illegal drug and its therapeutic aspects have a growing interest. Short-term psychotic reactions have been described but not clearly with synthetic oral THC, especially in occasional users. Case presentations We report two cases of healthy subjects who were occasional but regular cannabis users without psychiatric history who developed transient psychotic symptoms (depersonalization, paranoid feelings and derealisation following oral administration of cannabis. In contrast to most other case reports where circumstances and blood concentrations are unknown, the two cases reported here happened under experimental conditions with all subjects negative for cannabis, opiates, amphetamines, cocaine, benzodiazepines and alcohol, and therefore the ingested dose, the time-events of effects on behavior and performance as well as the cannabinoid blood levels were documented. Conclusion While the oral route of administration achieves only limited blood concentrations, significant psychotic reactions may occur.

Pin Marie

2005-04-01

39

The recent Australian debate about the prohibition on cannabis use.  

Science.gov (United States)

This paper outlines the ethical arguments used in the Australian debate about whether or not to relax the prohibition on cannabis use by adults. Over the past two decades a rising prevalence of cannabis use in the Australian population has led to proposals for the decriminalization of the personal use of cannabis. Three states and territories have removed criminal penalties for personal use while criminal penalties are rarely imposed in the remaining states. Libertarian arguments for legalization of cannabis use have attracted a great deal of media interest but very little public and political support. Other arguments in favour of decriminalization have attracted more support. One has been the utilitarian argument that prohibition has failed to deter cannabis use and the social costs of its continuation outweigh any benefits that it produces. Another has been the argument from hypocrisy that cannabis is less harmful than alcohol and so, on the grounds of consistency, if alcohol is legally available then so should cannabis. To date public opinion has not favoured legalization, although support for the decriminalization of personal cannabis use has increased. In the long term, the outcome of the debate may depend more upon trends in cannabis use and social attitudes among young adults than upon the persuasiveness of the arguments for a relaxation of the prohibition of cannabis. PMID:9374007

Hall, W

1997-09-01

40

Limited use of medicinal cannabis but for labeled indications after legalization.  

Science.gov (United States)

Since September 2003, cannabis is available for medicinal purposes in Dutch pharmacies to. It was anticipated that the medicinal cannabis use via illegal ways would decrease. The objective of this study was to get insight in the use of medicinal cannabis in daily practise as dispensed by community pharmacies and to characterize the users as well as the symptoms and conditions cannabis is prescribed for.A prospective follow-up study among 200 patients who filled a prescription for medicinal cannabis was performed in the period between September 2003 and January 2004. The patients filled out a structured questionnaire concerning symptoms and conditions and their experience with cannabis. Of all patients, 42% suffered from multiple sclerosis, 11% suffered from rheumatic diseases, and 60% of respondents already used cannabis before the legalization. Cannabis was mainly used for chronic pain and muscle cramp/stiffness.The indication of medicinal cannabis use was in accordance with the labeled indications. However, more than 80% of the patients still obtained cannabis for medicinal purpose from the illegal circuit. Because of the higher prices in pharmacies, ongoing debate on the unproven effectiveness of the drug and the hesitation by physicians to prescribe cannabis. PMID:16149121

Erkens, J A; Janse, A F C; Herings, R M C

2005-11-01

41

Cannabis use and schizotypy: the role of social anxiety and other negative affective states.  

Science.gov (United States)

Emerging research suggests that cannabis use might be related to psychosis onset in people vulnerable to developing schizophrenia-spectrum disorders. Furthermore, individuals with high-positive and disorganized schizotypy traits report more cannabis use and cannabis-related problems than controls. Social anxiety, a frequently co-occurring schizotypal feature, is related to increased cannabis-related problems in the general population. Building on this research, we explored the impact of social anxiety, measured by the Social Interaction Anxiety Scale (SIAS), and depression and trait anxiety reported on the Brief Symptom Inventory (BSI), on the relationship of schizotypy, measured by the Schizotypy Personality Questionnaire-Brief Revised (SPQ-BR), to cannabis use (n=220 schizotypy, 436 controls) and frequent use and cannabis-related problems among users (n=88 schizotypy, 83 controls) in college undergraduates. Among cannabis users, social anxiety moderated the relationships of schizotypy to frequent cannabis use and more cannabis-related problems in the total schizotypy group, and across high-positive, negative, and disorganized schizotypy subgroups. Depression and trait anxiety also moderated the relationship of schizotypy to frequent cannabis use and more cannabis-related problems, but results varied across high-positive, negative, and disorganized schizotypy subgroups. Results suggest therapeutically targeting negative affective states may be useful in psychosocial intervention for cannabis-related problems in schizotypy. PMID:22920791

Najolia, Gina M; Buckner, Julia D; Cohen, Alex S

2012-12-30

42

Statistics on cannabis users skew perceptions of cannabis use  

OpenAIRE

Collecting information about the prevalence of cannabis use is necessary but not sufficient for understanding the size, dynamics, and outcomes associated with cannabis markets. This paper uses two data sets describing cannabis consumption in the United States and Europe to highlight (1) differences in inferences about sub-populations based on the measure used to quantify cannabis-related activity; (2) how different measures of cannabis-related activity can be used to more accurately describe ...

RachelMelissaBurns; JonathanPaulCaulkins; BeauKilmer

2013-01-01

43

Alcohol and drug dependence symptom items as brief screeners for substance use disorders: results from the Clinical Trials Network  

Science.gov (United States)

Aim To address an urgent need for screening of substance use problems in medical settings, we examined substance-specific dependence criteria as potential brief screeners for the detection of patients with a substance use disorder (SUD). Methods The sample included 920 opioid-dependent adults who were recruited from outpatient treatment settings at 11 programs in 10 U.S. cities and who completed intake assessments of SUDs for a multisite study of the National Drug Abuse Treatment Clinical Trials Network (CTN003). Data were analyzed by factor analysis, item response theory (IRT), sensitivity, and specificity procedures. Results Across all substances (alcohol, amphetamines, cannabis, cocaine, sedatives), withdrawal was among the least prevalent symptoms, while taking large amounts and inability to cut down were among the most prevalent symptoms. Items closely related to the latent trait of a SUD showed good-to-high values of area under the receiver operating characteristic curve in identifying cases of a SUD; IRT-defined severe and less discriminative items exhibited low sensitivity in identifying cases of a SUD (withdrawal for all substances; time using for alcohol and sedatives; giving up activities for sedatives). Conclusions Study results suggest that withdrawal and time using are much less reliable indicators for a SUD than taking larger amounts than intended and inability to cut down and should be studied further for consideration in developing a simplified tool for screening patients for SUDs in medical settings. These findings have implications for the use of common health indicators in electronic health records systems to improve patient care. PMID:22204775

Wu, Li-Tzy; Blazer, Dan G.; Woody, George E.; Burchett, Bruce; Yang, Chongming; Pan, Jeng-Jong; Ling, Walter

2011-01-01

44

Cannabis og graviditet.  

DEFF Research Database (Denmark)

In two Copenhagen University hospitals 12,885 pregnant women, seen during the period 1.8.1992 to 30.04.1995, answered questionnaires regarding consumption of alcohol, tobacco, cannabis and other drugs. The prevalence of cannabis use was 0.8%. Women using cannabis but no other illicit drugs were each retrospectively matched with four randomly chosen pregnant women in the same period and the same age group and with same parity. Eighty-four cannabis users were included. These women were socioeconomically disadvantaged and had a higher prevalence of present and past use of alcohol, tobacco and other drugs. No significant difference in pregnancy, delivery or puerperal outcome was found. Children of women using cannabis were 150 g lighter, 1.2 cm shorter and had 0.2 cm smaller head circumference than the control infants. Controlling for the child's sex and maternal use of alcohol did not eliminate the significant differences in birthweight and length; however, they were eliminated by controlling for maternal tobacco smoking. It is concluded, that the use of cannabis is not a major prognostic factor regarding the outcome of pregnancy, but is an indicator of low socioeconomic status and use of other substances.

Balle, J; Olofsson, May Jonna

1999-01-01

45

Policy designs for cannabis legalization: starting with the eight Ps.  

Science.gov (United States)

The cannabis policy landscape is changing rapidly. In November 2012 voters in Colorado and Washington State passed ballot initiatives to remove the prohibition on the commercial production, distribution, and possession of cannabis. This paper does not address the question of whether cannabis should be legal; it instead focuses on the design considerations confronting jurisdictions that are pondering a change in cannabis policy. Indeed, whether or not cannabis legalization is net positive or negative for public health and public safety largely depends on regulatory decisions and how they are implemented. This essay presents eight of these design choices which all conveniently begin with the letter "P": production, profit motive, promotion, prevention, potency, purity, price, and permanency. PMID:24853283

Kilmer, Beau

2014-07-01

46

Abuso e dependência de maconha: comparação entre sexos e preparação para mudanças comportamentais entre usuários que iniciam a busca por tratamento Cannabis abuse and dependency: differences between men and women and readiness to behavior change among users seeking treatment  

Directory of Open Access Journals (Sweden)

Full Text Available OBJETIVOS: Descrever o perfil sociodemográfico de usuários de maconha que iniciam tratamento e comparar os sexos dos indivíduos em relação aos estágios de prontidão para mudança e uso associado de outras drogas. MÉTODO: Estudo transversal descritivo, com amostra não probabilística de indivíduos que ligaram para um teleatendimento especializado em dependência química. RESULTADOS: A amostra se constituiu de 72% de indivíduos do sexo masculino na faixa etária de 12 a 25 anos. Um percentual de 85,5% fazia uso associado de outras drogas. O estágio motivacional predominante foi de ação (56%, sem diferenças entre sexos (p = 0,4. Os homens mais frequentemente procuraram auxílio para o tratamento do uso de maconha. CONCLUSÕES: Com base nesses dados, foi possível delinear o perfil dos usuários de maconha para auxiliar no direcionamento de informações e atendimento adequado.OBJECTIVES: To describe the social and demographic profile of cannabis users seeking treatment and to compare differences between sex in relation to readiness to behavior change and in relation to associated use of marijuana and other drugs. METHOD: A cross-sectional, descriptive study including a nonprobability sample of individuals who called a chemical dependency hotline. RESULTS: The sample comprised 72% male individuals aged between 12 and 25 years. The sample was composed by 85.5% used other drugs in association with cannabis. The action stage was the most frequent stage of readiness to behavior change observed, in 56% of the callers, with no differences between sex (p = 0.4. Men more frequently sought treatment for the use of cannabis. CONCLUSIONS: Our findings allowed delineating a profile of cannabis users, so as to better guide the provision of adequate information and treatment services.

Simone Fernandes

2010-01-01

47

Associations between Cannabinoid Receptor-1 (CNR1) Variation and Hippocampus and Amygdala Volumes in Heavy Cannabis Users  

OpenAIRE

Heavy cannabis users display smaller amygdalae and hippocampi than controls, and genetic variation accounts for a large proportion of variance in liability to cannabis dependence (CD). A single nucleotide polymorphism in the cannabis receptor-1 gene (CNR1), rs2023239, has been associated with CD diagnosis and intermediate phenotypes, including abstinence-induced withdrawal, cue-elicited craving, and parahippocampal activation to cannabis cues. This study compared hippocampal and amygdalar vol...

Schacht, Joseph P.; Hutchison, Kent E.; Filbey, Francesca M.

2012-01-01

48

Nicotine Dependence, PTSD Symptoms, and Depression Proneness Among Male and Female Smokers  

OpenAIRE

Several studies have linked posttraumatic stress disorder with heavy smoking. It is not known to what extent this association is specific, as opposed to being a function of a joint association of PTSD and heavy smoking with a third variable such as depression proneness. In a cross-sectional study of 157 current regular smokers, severity of nicotine dependence (but not cigarettes smoked per day) was positively correlated with total PTSD symptoms, hyperarousal symptoms, and avoidance symptoms. ...

Thorndike, Frances P.; Wernicke, Rachel; Pearlman, Michelle Y.; Haaga, David A. F.

2006-01-01

49

The Medical Necessity for Medicinal Cannabis: Prospective, Observational Study Evaluating the Treatment in Cancer Patients on Supportive or Palliative Care  

OpenAIRE

Background. Cancer patients using cannabis report better influence from the plant extract than from synthetic products. However, almost all the research conducted to date has been performed with synthetic products. We followed patients with a medicinal cannabis license to evaluate the advantages and side effects of using cannabis by cancer patients. Methods. The study included two interviews based on questionnaires regarding symptoms and side effects, the first held on the day the license was...

Ella Muller; Anat Omer; Saher Drawsheh; Gil Bar-Sela; Marina Vorobeichik; Victoria Goldberg

2013-01-01

50

Respiratory health effects of cannabis: position statement of the Thoracic Society of Australia and New Zealand.  

Science.gov (United States)

Both the gaseous and the particulate phases of tobacco and cannabis smoke contain a similar range of harmful chemicals. However, differing patterns of inhalation mean that smoking a 'joint' of cannabis results in exposure to significantly greater amounts of combusted material than with a tobacco cigarette. The histopathological effects of cannabis smoke exposure include changes consistent with acute and chronic bronchitis. Cellular dysplasia has also been observed, suggesting that, like tobacco smoke, cannabis exposure has the potential to cause malignancy. These features are consistent with the clinical presentation. Symptoms of cough and early morning sputum production are common (20-25%) even in young individuals who smoke cannabis alone. Almost all studies indicate that the effects of cannabis and tobacco smoking are additive and independent. Public health education should dispel the myth that cannabis smoking is relatively safe by highlighting that the adverse respiratory effects of smoking cannabis are similar to those of smoking tobacco, even although it remains to be confirmed that smoking cannabis alone leads to the development of chronic lung disease. PMID:12823677

Taylor, D R; Hall, W

2003-07-01

51

Longitudinal relationship between expressed emotion and cannabis misuse in young people with first-episode psychosis.  

Science.gov (United States)

Carers' expressed emotion (EE) and patients' cannabis misuse are two of the most robust predictors of psychotic relapse. We aimed to examine the temporal relationship between EE and cannabis misuse. Sixty-three key carers of young people with first-episode psychosis (FEP) were assessed at baseline and 7-month follow-up. EE was measured in carers using the Family Questionnaire (FQ) and cannabis misuse in patients using the Alcohol, Smoking and Substance Involvement Screening Test (ASSIST). Correlational and hierarchical logistic regression analyses were conducted to examine the temporal relationship between EE components (i.e. criticism and emotional over involvement) and cannabis misuse. Carers' criticism at baseline significantly predicted cannabis misuse according to the ASSIST at 7-month follow-up. The association remained significant after controlling for baseline symptom severity and social functioning (B=0.15, P=.02). Conversely, baseline cannabis misuse was not associated with carers' criticism at 7-month follow-up. Patients in families with high criticism showed a tendency to increase cannabis misuse over time whereas the opposite trend was observed in those with carers with low criticism. A family environment characterized by high criticism may become a key risk factor for worsening cannabis misuse over time in young people with FEP. Further studies should investigate the potential mechanisms (e.g., patient's anxiety or perceived stress) through which criticism increases cannabis misuse in FEP. PMID:25174270

González-Blanch, C; Gleeson, J F; Cotton, S M; Crisp, K; McGorry, P D; Alvarez-Jimenez, M

2015-01-01

52

Correlates to the variable effects of cannabis in young adults: a preliminary study  

Directory of Open Access Journals (Sweden)

Full Text Available Abstract Background Cannabis use can frequently have adverse affects in those that use it and these can be amplified by various characteristics of an individual, from demographic and environmental variations to familial predisposition for mental illnesses. Methods The current study of 100 individuals, who were cannabis users during their adolescence and may still be users, was a survey of the self perceived effects of cannabis and their correlates. A reliable family member was also interviewed for determination of family history of various major mental illnesses and substance use. Results As many as 40% of cannabis users had paranoid feelings (suspiciousness when using cannabis, although the most frequent effect was feeling relaxed (46%. Having a familial background for mental illnesses such as depression or schizophrenia did not determine the effects of cannabis nor its pattern of use, although the number of subjects with such a history was small. An age at which an individual began using cannabis did have an effect on how heavily it was used and the heavier the cannabis use, the more likely the individual was also to have had psychotic symptoms after use. There were no sex differences in effects of cannabis. These results are tempered by the reliance on self-report for many of the variables ascertained. Conclusion Cannabis can frequently have negative effects in its users, which can be amplified by certain demographic and/or psychosocial factors. Thus, users with a specific profile may be at a higher risk of unpleasant effects from cannabis use and caution should be noted when cannabis is administered to young people for medicinal purposes.

Camera Ariella A

2012-03-01

53

Fatty acid relationships in former cannabis users with schizophrenia.  

Science.gov (United States)

Abnormalities in the fatty acid (FA)-based endocannabinoid lipid signaller anandamide, and prevalent cannabis use, have been found to be associated with schizophrenia and may potentially alter stress mechanisms. Other FA-based signallers, however, reportedly enhance anandamide function. The aim of the present study was to investigate the relationship between peripherally-measured levels of the FA sources of anandamide and its related signallers. The authors examined erythrocyte FA levels in patients who were former cannabis users ("C-ever") (n=6) or cannabis-naïve ("C-never") (n=6), in relation to symptoms of stress measured by the Brief Symptom Inventory (BSI) and the Depression, Anxiety and Stress Scales (DASS). The results showed that, in former cannabis users only, arachidonic acid (AA, anandamide's precursor) was positively correlated with total 16- and 18-carbon monounsaturated and saturated FAs (16,18m+sFAs), precursors of lipid signallers that enhance or interact with anandamide function. In C-ever, both AA and 16,18m+sFAs correlated inversely with stress, while the 18-carbon polyunsaturated FA, linoleic acid, was positively correlated with stress. Although the findings are tentative in this small sample, potential interventions are indicated. Future research may determine whether these FAs are involved in hypothesised links between anandamide abnormalities, cannabis use and stress in schizophrenia. PMID:16236415

Monterrubio, Sharon; Solowij, Nadia; Meyer, Barbara J; Turner, Nigel

2006-03-01

54

Maladaptive dependency schemas, posttraumatic stress hyperarousal symptoms, and intimate partner aggression perpetration.  

Science.gov (United States)

This study examined the associations between maladaptive dependency-related schemas, posttraumatic stress disorder (PTSD) hyperarousal symptoms, and intimate-partner psychological and physical aggression in a sample of court-referred men (N = 174) participating in a domestic-abuser-intervention program. The men were largely African American; average age was 33.5 years. The extent to which hyperarousal symptoms moderated the association between dependency schemas and aggression was also examined. Maladaptive dependency-related schemas were positively associated with severe psychological, and mild and severe physical aggression perpetration. Hyperarousal symptoms were positively associated with mild and severe psychological aggression, and mild physical aggression perpetration. Multiple regression analyses showed a significant interaction for mild physical aggression: For those with high levels of hyperarousal symptoms, greater endorsement of maladaptive dependency schemas was associated with the perpetration of aggression (B = 0.98, p = .001). For those with low levels of hyperarousal symptoms, there was no association between dependency schemas and aggression (B = 0.04, ns). These findings suggest that focusing on problematic dependency and PTSD-hyperarousal symptoms in domestic-abuser-intervention programs may be helpful, and that examining related variables as possible moderators between dependency schemas and intimate aggression would be a fruitful area for future research. PMID:24030885

Kachadourian, Lorig K; Taft, Casey T; Holowka, Darren W; Woodward, Halley; Marx, Brian P; Burns, Anthony

2013-10-01

55

Acamprosate-induced Extrapyramidal Symptoms in an Elderly Patient with Alcohol Dependence.  

Science.gov (United States)

Acamprosate reduces the craving for alcohol by decreasing glutamate activity and increasing gamma-aminobutyric acid (GABA) action in patients with alcohol dependence. Acamprosate has tolerable side effects that include diarrhea, headache, dizziness and pruritus. In this study, we report acamprosate-induced extrapyramidal symptoms in an elderly patient with no history of neurologic disease. Severe extrapyramidal symptoms developed two days after the administration of acamprosate and improved over one week after the acamprosate was stopped. Extrapyramidal symptoms are commonly associated with dopamine receptor antagonists. However, there have been several reports of extrapyramidal symptoms occurring with drugs targeting other systems, including GABA, glutamate and serotonin. Acamprosate may decrease dopamine levels in the ventral tegmental area mediated by glutamatergic action and thus cause extrapyramidal symptoms. We suggest that acamprosate carries the risk of causing extrapyramidal symptoms. PMID:25191510

Woo, Jungmin; Rim, Hyo-Deog

2014-08-01

56

Cannabidiol Attenuates the Appetitive Effects of ?9-Tetrahydrocannabinol in Humans Smoking Their Chosen Cannabis  

OpenAIRE

Abstract Worldwide cannabis dependence is increasing, as is the concentration of the ?9-tetrahydrocannabinol (THC) in street cannabis. At the same time, the concentration of the second most abundant cannabinoid in street cannabis, cannabidiol (CBD), is decreasing. These two cannabinoids have opposing effects both pharmacologically and behaviourally when administered in the laboratory. No research has yet examined how the ratio of these constituents impacts upon the appetitive/rein...

Morgan, Celia Janet Ann; Freeman, Tom P.; Schafer, Gra?inne L.; Curran, Helen Valerie

2010-01-01

57

Alcohol Abuse and Dependence Symptoms: A Multidimensional Model of Common and Specific Etiology  

OpenAIRE

This study tested a theoretical model hypothesizing differential pathways from five predictors to alcohol abuse and dependence symptoms. The participants were college students (N= 2,270) surveyed on two occasions in a 6-month prospective design. Social norms, perceived utility of alcohol use, and family history of alcohol problems were indirectly associated with Time 2 (T2) abuse and dependence symptoms through influencing level of alcohol consumption. Poor behavioral control had a direct eff...

Simons, Jeffrey S.; Carey, Kate B.; Wills, Thomas A.

2009-01-01

58

Alcohol Abuse/Dependence Symptoms Among Hospital Employees Exposed to a SARS Outbreak  

OpenAIRE

Aims: The aim of this study was to examine alcohol abuse/dependence symptoms among hospital employees exposed to a severe acute respiratory syndrome (SARS) outbreak, and the relationship between types of exposure to the SARS outbreak and subsequent alcohol abuse/dependence symptoms. Methods: A survey was conducted among 549 randomly selected hospital employees in Beijing, China, concerning the psychological impact of the 2003 SARS outbreak. Subjects were assessed on sociodemographic factors a...

Wu, Ping; Liu, Xinhua; Fang, Yunyun; Fan, Bin; Fuller, Cordelia J.; Guan, Zhiqiang; Yao, Zhongling; Kong, Junhui; Lu, Jin; Litvak, Iva J.

2008-01-01

59

Fitness to drive and cannabis: validation of two blood THCCOOH thresholds to distinguish occasional users from heavy smokers.  

Science.gov (United States)

Many studies based on either an experimental or an epidemiological approach, have shown that the ability to drive is impaired when the driver is under the influence of cannabis. Baseline performances of heavy users remain impaired even after several weeks of abstinence. Symptoms of cannabis abuse and dependence are generally considered incompatible with safe driving. Recently, it has been shown that traffic safety can be increased by reporting the long-term unfit drivers to the driver licensing authorities and referring the cases for further medical assessment. Evaluation of the frequency of cannabis use is a prerequisite for a reliable medical assessment of the fitness to drive. In a previous paper we advocated the use of two thresholds based on 11-nor-9-carboxy-?9-tetrahydrocannabinol (THCCOOH) concentration in whole blood to help to distinguish occasional cannabis users (?3 ?g/L) from heavy regular smokers (?40 ?g/L). These criteria were established on the basis of results obtained in a controlled cannabis smoking study with placebo, carried out with two groups of young male volunteers; the first group was characterized by a heavy use (?10 joints/month) while the second group was made up of occasional users smoking at most 1 joint/week. However, to date, these cutoffs have not been adequately assessed under real conditions. Their validity can now be evaluated and confirmed with 146 traffic offenders' real cases in which the whole blood cannabinoid concentrations and the frequency of cannabis use are known. The two thresholds were not challenged by the presence of ethanol (40% of cases) and of other therapeutic and illegal drugs (24%). Thus, we propose the following procedure that can be very useful in the Swiss context but also in other countries with similar traffic policies: if the whole blood THCCOOH concentration is higher than 40 ?g/L, traffic offenders must be directed first and foremost toward medical assessment of their fitness to drive. This evaluation is not recommended if the THCCOOH concentration is lower than 3 ?g/L and if the self-rated frequency of cannabis use is less than 1 time/week. A THCCOOH level between these two thresholds cannot be reliably interpreted. In such a case, further medical assessment and follow-up of the fitness to drive are also suggested, but with lower priority. PMID:24999608

Fabritius, Marie; Augsburger, Marc; Chtioui, Haithem; Favrat, Bernard; Giroud, Christian

2014-09-01

60

Cannabis abuse and risk for psychosis in a prodromal sample  

OpenAIRE

The goal of the present study was to examine the rate of cannabis use among participants in the Cognitive Assessment and Risk Evaluation (CARE) Program, a longitudinal program for individuals who are “at risk” for developing a psychotic disorder. Cannabis abuse was assessed in 48 individuals identified as “at risk” for schizophrenia based on subsyndromal psychotic symptoms and/or family history. At 1 year follow-up, 6 of the 48 (12.5%) at risk subjects had made the transition to psych...

Kristensen, Karin; Cadenhead, Kristin S.

2007-01-01

61

[Effects of oral cannabis and dronabinol on driving capacity].  

Science.gov (United States)

Two retrospective epidemiologic studies have shown that cannabis is the main psychoactive substance detected in the blood of drivers suspected of driving under the influence of psychotropic drugs. An oral administration double-blind crossover study was carried out with eight healthy male subjects, aged 22 to 30 years, all occasional cannabis smokers. Three treatments and one placebo were administered to all participants at a two week interval: 20 mg dronabinol, 16.5 mg D9-tétrahydrocannabinol (THC) and 45.7 mg THC as a cannabis milk decoction. Participants were asked to report the subjective drug effects and their willingness to drive under various circumstances on a visual analog scale. Clinical observations, a psychomotor test and a tracking test on a driving simulator were also carried out. Compared to cannabis smoking, THC, 11-OH-THC and THC-COOH blood concentrations remained low through the whole study (cannabis or when driving and smoking a joint. No clear association could be found between these adverse reactions and a susceptibility gene to propensity to anxiety and psychotic symptoms (genetic polymorphism of the catechol-O-methyltransferase). The questionnaires have shown that the willingness to drive was lower when the drivers were assigned an insignificant task and was higher when the mission was of crucial importance. The subjects were aware of the effects of cannabis and their performances on the road sign and tracking test were greatly impaired, especially after ingestion of the strongest dose. The Cannabis Influence Factor (CIF) which relies on the molar ratio of active and inactive cannabinoids in blood provided a good estimate of the fitness to drive. PMID:16710114

Giroud, C; Augsburger, M; Favrat, B; Menetrey, A; Pin, M-A; Rothuizen, L-E; Appenzeller, M; Buclin, T; Mathieu, S; Castella, V; Hazekamp, A; Mangin, P

2006-05-01

62

Pharmacological treatment of alcohol dependence: target symptoms and target mechanisms.  

Science.gov (United States)

Alcoholism is a major public health problem and resembles, in many ways, other chronic relapsing medical conditions. At least 2 separate dimensions of its symptomatology offer targetable pathophysiological mechanisms. Systems that mediate positive reinforcement by alcohol are likely important targets in early stages of the disease, particularly in genetically susceptible individuals. In contrast, long term neuroadaptive changes caused by chronic alcohol use primarily appear to affect systems mediating negative affective states, and gain importance following a prolonged history of dependence. Feasibility of pharmacological treatment in alcoholism has been demonstrated by a first wave of drugs which consists of 3 currently approved medications, the aldehyde dehydrogenase blocker disulfiram, the opioid antagonist naltrexone (NTX) and the functional glutamate antagonist acamprosate (ACM). The treatment toolkit is likely to be expanded in the near future. This will improve overall efficacy and allow individualized treatment, ultimately taking in account the patient's genetic makeup. In a second wave, early human efficacy data are available for the 5HT3 antagonist ondansetron, the GABA-B agonist baclofen and the anticonvulsant topiramate. The third wave is comprised of compounds predicted to be effective based on a battery of animal models. Using such models, a short list of additional targets has accumulated sufficient preclinical validation to merit clinical development. These include the cannabinoid CB1 receptor, receptors modulating glutamatergic transmission (mGluR2, 3 and 5), and receptors for stress-related neuropeptides corticotropin releasing factor (CRF), neuropeptide Y (NPY) and nociceptin. Once novel treatments are developed, the field faces a major challenge to assure their delivery to patients. PMID:16545872

Heilig, Markus; Egli, Mark

2006-09-01

63

Depressive symptoms during buprenorphine vs. methadone maintenance: findings from a randomised, controlled trial in opioid dependence.  

Science.gov (United States)

Research suggests that buprenorphine may possess antidepressant activity. The Beck Depression Inventory was completed at baseline and 3 months by heroin dependent subjects receiving either buprenorphine or methadone maintenance as part of a larger, pre-existing, double blind trial conducted by NDARC (Australia). Depressive symptoms improved in all subjects, with no difference between methadone and buprenorphine groups, suggesting no differential benefit on depressive symptoms for buprenorphine compared to methadone. PMID:15589713

Dean, Angela J; Bell, James; Christie, Macdonald J; Mattick, Richard P

2004-12-01

64

Statistics on cannabis users skew perceptions of cannabis use  

Directory of Open Access Journals (Sweden)

Full Text Available Collecting information about the prevalence of cannabis use is necessary but not sufficient for understanding the size, dynamics, and outcomes associated with cannabis markets. This paper uses two data sets describing cannabis consumption in the United States and Europe to highlight 1 differences in inferences about sub-populations based on the measure used to quantify cannabis-related activity; 2 how different measures of cannabis-related activity can be used to more accurately describe trends in cannabis usage over time; and 3 the correlation between frequency of use in the past month and average grams consumed per day. Key findings: Focusing on days of use instead of prevalence shows substantially greater increases in U.S. cannabis use in recent years; however, the recent increase is mostly among adults, not youth. Relatively more rapid growth in use days also occurred among the college-educated and Hispanic. Further, data from a survey conducted in several European countries show a strong positive correlation between frequency of use and quantity consumed per day of use, suggesting consumption is even more skewed toward the minority of heavy users than is suggested by days-of-use calculations.

RachelMelissaBurns

2013-11-01

65

CANNABIS, UNA OPCIÓN TERAPÉUTICA / CANNABIS, A THERAPEUTIC OPTION  

Scientific Electronic Library Online (English)

Full Text Available SciELO Colombia | Language: Spanish Abstract in spanish Las preparaciones de Cannabis sativa L. tales como marihuana, hashish y dagga, han sido usadas en medicina por varios siglos. Ahora se sabe que el ?9tetrahidrocannabinol (?9-THC) y sus compuestos relacionados, ejercen una amplia gama de efectos sobre los sistemas inmune, digestivo, reproductivo, ocu [...] lar, cardiovascular, y nervioso central. La presente revisión analiza la literatura disponible relacionada con los efectos terapéuticos de la Cannabis. Abstract in english Cannabis sativa L. preparations, such as marijuana, hashish and dagga, have been used in medicine for many centuries. It is now known that ?9tetrahydrocannabinol (?9-THC) and its related compounds, exert a wide array of effects on the immune, digestive, reproductive, ocular, cardiovascular, and cent [...] ral nervous systems. The present review analyses the literature related to the therapeutic effects of Cannabis.

José Henry, Osorio; Hugo Fernando, Tangarife.

2009-12-01

66

Hemp (Cannabis sativa L.).  

Science.gov (United States)

Hemp (Cannabis sativa L.) suspension culture cells were transformed with Agrobacterium tumefaciens strain EHA101 carrying the binary plasmid pNOV3635. The plasmid contains a phosphomannose isomerase (PMI) selectable marker gene. Cells transformed with PMI are capable of metabolizing the selective agent mannose, whereas cells not expressing the gene are incapable of using the carbon source and will stop growing. Callus masses proliferating on selection medium were screened for PMI expression using a chlorophenol red assay. Genomic DNA was extracted from putatively transformed callus lines, and the presence of the PMI gene was confirmed using PCR and Southern hybridization. Using this method, an average transformation frequency of 31.23%?±?0.14 was obtained for all transformation experiments, with a range of 15.1-55.3%. PMID:25416268

Feeney, Mistianne; Punja, Zamir K

2015-01-01

67

Refining the Depression-Nicotine Dependence Link: Patterns of Depressive Symptoms in Psychiatric Outpatients with Current, Past, and No History of Nicotine Dependence  

OpenAIRE

The aim of this study was to elucidate the depression-nicotine dependence link by evaluating which specific depressive symptoms are uniquely associated with nicotine dependence in psychiatric outpatients. Participants were assessed using structured clinical interviews which yielded psychiatric diagnoses and clinical ratings on a wide variety of depressive symptoms. Depressive symptoms were compared across three groups: (1) patients with no history of nicotine dependence (NND; n=1015); (2) pat...

Leventhal, Adam M.; Kahler, Christopher W.; Ray, Lara A.; Zimmerman, Mark

2008-01-01

68

Impairment of inhibitory control processing related to acute psychotomimetic effects of cannabis.  

Science.gov (United States)

Cannabis use can induce acute psychotic symptoms and increase the risk of schizophrenia. Impairments in inhibitory control and processing are known to occur both under the influence of cannabis and in schizophrenia. Whether cannabis-induced impairment in inhibitory processing is related to the acute induction of psychotic symptoms under its influence is unclear. We investigated the effects of acute oral administration of 10mg of delta-9-tetrahydrocannabinol (delta-9-THC), the main psychoactive ingredient of cannabis, on inhibitory control and regional brain activation during inhibitory processing in humans and examined whether these effects are related to the induction of psychotic symptoms under its influence using a repeated-measures, placebo-controlled, double-blind, within-subject design. We studied thirty-six healthy, English-speaking, right-handed men with minimal previous exposure to cannabis and other illicit drugs twice using functional magnetic resonance imaging (fMRI) while they performed a response inhibition (Go/No-Go) task. Relative to placebo, delta-9-THC caused transient psychotic symptoms, anxiety, intoxication and sedation, inhibition errors and impaired inhibition efficiency. Severity of psychotic symptoms was directly correlated with inhibition error frequency and inversely with inhibition efficiency under the influence of delta-9-THC. Delta-9-THC attenuated left inferior frontal activation which was inversely correlated with the frequency of inhibition errors and severity of psychotic symptoms and positively with inhibition efficiency under its influence. These results provide experimental evidence that impairments in cognitive processes involved in the inhibitory control of thoughts and actions and inferior frontal function under the influence of cannabis may have a role in the emergence of transient psychotic symptoms under its influence. PMID:25532865

Bhattacharyya, Sagnik; Atakan, Z; Martin-Santos, R; Crippa, J A; Kambeitz, J; Malhi, S; Giampietro, V; Williams, S; Brammer, M; Rubia, K; Collier, D A; McGuire, P K

2015-01-01

69

Quality of life and depressive symptoms among caregivers and drug dependent people.  

Science.gov (United States)

The aim of this study was to evaluate the quality of life and the presence of depressive symptoms among the caregivers and drug dependent people of the CAPSad. This is a cross-sectional study, with 109 users of four Psychosocial Care Centers for alcohol and other drugs of Mato Grosso and their caregivers, using the instruments: Medical Outcomes Studies 36 (SF-36), Beck Depression Inventory (BDI) and a sociodemographic variables questionnaire. The QoL of the caregivers in the domains functional capacity, physical aspect, pain and vitality were more affected when compared to the users. A strong correlation between QoL and depressive symptoms was found in both groups. The comparisons performed demonstrate a compromise in the quality of life of both, with the group of caregivers most affected, confirming the situation of drug dependence as an important factor in the perception of the caregiver regarding their quality of life. PMID:22481735

Marcon, Samira Reschetti; Rubira, Elizete Aparecida; Espinosa, Mariano Martinez; Barbosa, Dulce Aparecida

2012-01-01

70

Functional capacity and dependency in transfer and dressing are associated with depressive symptoms in older people  

OpenAIRE

Gustaf Boström,1 Mia Conradsson,1 Erik Rosendahl,1,2 Peter Nordström,1 Yngve Gustafson,1 Håkan Littbrand1,21Department of Community Medicine and Rehabilitation, Geriatric Medicine, Umeå University, Umeå, Sweden; 2Department of Community Medicine and Rehabilitation, Physiotherapy, Umeå University, Umeå, SwedenBackground: This study examined associations between depressive symptoms and functional capacity, overall dependency in personal activities of dail...

Boström G; Conradsson M; Rosendahl E; Nordström P; Gustafson Y; Littbr; Van, H

2014-01-01

71

Cannabidiol, a Cannabis sativa constituent, as an antipsychotic drug  

Scientific Electronic Library Online (English)

Full Text Available SciELO Brazil | Language: English Abstract in english A high dose of delta9-tetrahydrocannabinol, the main Cannabis sativa (cannabis) component, induces anxiety and psychotic-like symptoms in healthy volunteers. These effects of delta9-tetrahydrocannabinol are significantly reduced by cannabidiol (CBD), a cannabis constituent which is devoid of the typ [...] ical effects of the plant. This observation led us to suspect that CBD could have anxiolytic and/or antipsychotic actions. Studies in animal models and in healthy volunteers clearly suggest an anxiolytic-like effect of CBD. The antipsychotic-like properties of CBD have been investigated in animal models using behavioral and neurochemical techniques which suggested that CBD has a pharmacological profile similar to that of atypical antipsychotic drugs. The results of two studies on healthy volunteers using perception of binocular depth inversion and ketamine-induced psychotic symptoms supported the proposal of the antipsychotic-like properties of CBD. In addition, open case reports of schizophrenic patients treated with CBD and a preliminary report of a controlled clinical trial comparing CBD with an atypical antipsychotic drug have confirmed that this cannabinoid can be a safe and well-tolerated alternative treatment for schizophrenia. Future studies of CBD in other psychotic conditions such as bipolar disorder and comparative studies of its antipsychotic effects with those produced by clozapine in schizophrenic patients are clearly indicated.

A.W., Zuardi; J.A.S., Crippa; J.E.C., Hallak; F.A., Moreira; F.S., Guimarães.

2006-04-01

72

The Importance of Family Relations for Cannabis Users: The Case of Serbian Adolescents  

Science.gov (United States)

Background Adolescence is transitional stage of physical and mental human development occuring between childhood and adult life. Social interactions and environmental factors together are important predictors of adolescent cannabis use. This study aimed to examine the relationship between the social determinants and adolescents behavior with cannabis consumption. Methods: A cross sectional study as part of the European School Survey Project on Alcohol and other Drugs was conducted among 6.150 adolescents aged 16 years in three regions of Serbia, and three types of schools (gymnasium, vocational – professional, and vocational – handicraft) during May – June 2008. A multivariate logistic regression analysis was carried out to obtain adjusted odds ratios with 95% confidence intervals in which the dependent variable was cannabis consumption non-user and user. Results: Among 6.7% of adolescents who had tried cannabis at least one in their lives, boys were more involved in cannabis use than girls, especially boys from gymnasium school. Well off family, lower education of mother, worse relations with parents were significantly associated with cannabis use (P < 0.05). Behaviors like skipping from schools, frequent evening outs, and playing on slot machines were also related to cannabis use (P < 0.05). Conclusions: The study confirmed the importance of family relationship development. Drug use preventive programmes should include building interpersonal trust in a family lifecycle and school culture. PMID:23641402

TERZIC SUPIC, Zorica; SANTRIC MILICEVIC, Milena; SBUTEGA, Isidora; VASIC, Vladimir

2013-01-01

73

Pharmacology of Marihuana (Cannabis sativa)  

Science.gov (United States)

A detailed discussion of marihuana (Cannabis sativa) providing the modes of use, history, chemistry, and physiologic properties of the drug. Cites research results relating to the pharmacologic effects of marihuana. These effects are categorized into five areas: behavioral, cardiovascular-respiratory, central nervous system, toxicity-toxicology,…

Maickel, Roger P.

1973-01-01

74

Inhaled medicinal cannabis and the immunocompromised patient.  

Science.gov (United States)

Medicinal cannabis is an invaluable adjunct therapy for pain relief, nausea, anorexia, and mood modification in cancer patients and is available as cookies or cakes, as sublingual drops, as a vaporized mist, or for smoking. However, as with every herb, various microorganisms are carried on its leaves and flowers which when inhaled could expose the user, in particular immunocompromised patients, to the risk of opportunistic lung infections, primarily from inhaled molds. The objective of this study was to identify the safest way of using medicinal cannabis in immunosuppressed patients by finding the optimal method of sterilization with minimal loss of activity of cannabis. We describe the results of culturing the cannabis herb, three methods of sterilization, and the measured loss of a main cannabinoid compound activity. Systematic sterilization of medicinal cannabis can eliminate the risk of fatal opportunistic infections associated with cannabis among patients at risk. PMID:25216851

Ruchlemer, Rosa; Amit-Kohn, Michal; Raveh, David; Hanuš, Lumír

2015-03-01

75

Idiopathic acute eosinophilic pneumonia demanding ECMO for a teenager smoking tobacco and cannabis  

OpenAIRE

Abstract We describe what we believe is an entirely novel case of a 15-year-old boy with idiopathic acute eosinophilic pneumonia and unusual, resistant hypoxaemia which necessitated extracorporeal membrane oxygenation. Response to corticosteroids was excellent and a full recovery was observed. Smoking cigarettes and cannabis on the day the symptoms began may have contributed to the occurrence of this rare disease.

Sauvaget, Emilie; Dellamonica, Jean; Arlaud, Kevin; Sanfiorenzo, Ce?line; Bernardin, Gilles; Padovani, Bernard; Viard, Laurent; Dubus, Jean-christophe

2010-01-01

76

Determination of Pesticide Residues in Cannabis Smoke  

OpenAIRE

The present study was conducted in order to quantify to what extent cannabis consumers may be exposed to pesticide and other chemical residues through inhaled mainstream cannabis smoke. Three different smoking devices were evaluated in order to provide a generalized data set representative of pesticide exposures possible for medical cannabis users. Three different pesticides, bifenthrin, diazinon, and permethrin, along with the plant growth regulator paclobutrazol, which are readily available...

Nicholas Sullivan; Sytze Elzinga; Raber, Jeffrey C.

2013-01-01

77

[Therapeutic use of cannabis derivatives].  

Science.gov (United States)

The therapeutic use of cannabis has generated a lot of interest in the past years, leading to a better understanding of its mechanisms of action. Countries like the United States and Canada have modified their laws in order to make cannabinoid use legal in the medical context. It's also the case in France now, where a recent decree was issued, authorizing the prescription of medication containing "therapeutic cannabis" (decree no. 2013-473, June 5, 2013). Cannabinoids such as dronabinol, Sativex and nabilone have been tested for the treatment of acute and chronic pain. These agents are most promising to relieve chronic pain associated with cancer, with human immunodeficiency virus infection and with multiple sclerosis. However, longer-term studies are required to determine potential long-term adverse effects and risks of misuse and addiction. PMID:24701869

Benyamina, Amine; Reynaud, Michel

2014-02-01

78

Unilateral Angle-Closure Glaucoma with Ciliochoroidal Effusion after the Consumption of Cannabis: A Case Report  

Science.gov (United States)

A 35-year-old male patient, diagnosed with acute angle-closure glaucoma, did not improve despite intensive treatment with antiglaucoma medications. Ultrasound biomicroscopy revealed a ciliochoroidal effusion. Due to his past history of drug abuse, a urine test was analyzed and found to be positive for cannabis. After topical cycloplegia and oral steroid therapy, his symptoms improved substantially. The present case highlights the role of ultrasound biomicroscopy in evaluating patients with acute angle-closure glaucoma and the role of cannabis abuse in the development of ciliochoroidal effusion. PMID:25606036

Hanna, Rana; Tiosano, Beatrice; Dbayat, Noora; Gaton, Dan

2014-01-01

79

A survey of cannabis (marijuana) use and self-reported benefit in men with chronic prostatitis/chronic pelvic pain syndrome  

Science.gov (United States)

Introduction: Chronic prostatitis/chronic pelvic pain syndrome (CP/CPPS) is a chronic pelvic pain condition largely refractory to treatment. Cannabis (marijuana) use has been reported for a wide variety of chronic pain conditions, but no study has examined prevalence of cannabis use, symptom benefit or side effects, or frequency in CP/CPPS. Methods: Participants were recruited from an outpatient CP/CPPS urology clinic (n = 98) and online through the Prostatitis Foundation website (n = 244). Participants completed questionnaires (demographics, CP/CPPS, depression, cannabis). Results: The clinic sample included Canadian patients and the online sample included primarily American patients. Due to differences, groups were examined separately. Almost 50% of respondents reported using cannabis (clinic n = 49; online n = 89). Of the cannabis users, 36.8% of clinic and 75% of online respondents reported that it improved their symptoms. Most of the respondents (from the clinic and online groups) reported that cannabis improved their mood, pain, muscle spasms, and sleep. However, they did not note any improvements for weakness, fatigue, numbness, ambulation, and urination. Overall, the effectiveness of cannabis for CP/CPPS was “somewhat/very effective” (57% clinic; 63% online). There were no differences between side effects or choice of consumption and most reported using cannabis rarely. Conclusions: These are the first estimates in men suffering from CP/CPPS and suggest that while cannabis use is prevalent, its medical use and benefit are unknown. This is an understudied area and the benefit or hazard for cannabis use awaits further study. PMID:25553163

Tripp, Dean A.; Nickel, J. Curtis; Katz, Laura; Krsmanovic, Adrijana; Ware, Mark A.; Santor, Darcy

2014-01-01

80

Regulating compassion: an overview of Canada's federal medical cannabis policy and practice  

Directory of Open Access Journals (Sweden)

Full Text Available Abstract Background In response to a number of court challenges brought forth by Canadian patients who demonstrated that they benefited from the use of medicinal cannabis but remained vulnerable to arrest and persecution as a result of its status as a controlled substance, in 1999 Canada became the second nation in the world to initiate a centralized medicinal cannabis program. Over its six years of existence, this controversial program has been found unconstitutional by a number of courts, and has faced criticism from the medical establishment, law enforcement, as well as the patient/participants themselves. Methods This critical policy analysis is an evidence-based review of court decisions, government records, relevant studies and Access to Information Act data related to the three main facets of Health Canada's medicinal cannabis policy – the Marihuana Medical Access Division (MMAD; the Canadians Institute of Health Research Medical Marijuana Research Program; and the federal cannabis production and distribution program. This analysis also examines Canada's network of unregulated community-based dispensaries. Results There is a growing body of evidence that Health Canada's program is not meeting the needs of the nation's medical cannabis patient community and that the policies of the Marihuana Medical Access Division may be significantly limiting the potential individual and public health benefits achievable though the therapeutic use of cannabis. Canada's community-based dispensaries supply medical cannabis to a far greater number of patients than the MMAD, but their work is currently unregulated by any level of government, leaving these organizations and their clients vulnerable to arrest and prosecution. Conclusion Any future success will depend on the government's ability to better assess and address the needs and legitimate concerns of end-users of this program, to promote and fund an expanded clinical research agenda, and to work in cooperation with community-based medical cannabis dispensaries in order to address the ongoing issue of safe and timely access to this herbal medicine.

Lucas Philippe G

2008-01-01

81

The Long and Winding Road to Cannabis Legalization  

OpenAIRE

In almost all countries supply, distribution and use of cannabis is prohibited. Nevertheless, cannabis is the most popular illicit drug. Prohibition does not seem to work. The debate on legalization of cannabis is often emotional with strong views of both proponents and opponents but ignorance prevails. There are supposedly detrimental health effects of cannabis use but researchers debate whether they are causal or mere associations. As long as nowhere in the world cannabis is legalized it is...

Ours, J. C.

2011-01-01

82

Dose-dependent increase in subjective symptoms among toluene-exposed workers  

Energy Technology Data Exchange (ETDEWEB)

A factory survey on dose-response relationship in toluene toxicity was conducted in 1985-1989 in four cities in China. The examination items consisted of personal diffusive sampling for TWA exposure measurement, questionnaires on subjective symptoms, hematology and serum biochemistry, and clinical examination including simple neurology tests. Hippuric acid was also determined in urine samples collected at the end of the shift. With selection criteria that (1) complete results were available on all study items and (2) valid toluene exposure data (i.e., toluene shared 90% or more of the exposure) were obtained for the exposed, 452 toluene-exposed workers (206 men and 246 women; toluene exposure at 24.7 ppm as GM) and 517 nonexposed controls (246 men and 271 women) were selected. The subjective symptoms increased in close association with the intensity of exposure to toluene; the threshold concentration appeared to exist at 100 ppm in the case of symptoms during work, and it might be at 50-100 ppm when symptoms off work were evaluated. During the work with exposure at higher concentrations, various symptoms possibly related to CNS or local effects (e.g., eyes, nose, and throat) were complained, and dizziness and floating sensations were identified as typical symptoms with significant dose-response relationship. Several symptoms persisted off work, most of which were apparently related but not necessarily limited to CNS effects. Hematology and serum biochemistry were essentially negative. 46 refs., 4 figs., 6 tabs.

Ukai, Hirohiko (Kyoto Industrial Health Association (Japan)); Watanabe, Takao (Miyagi Univ. of Education, Sendai (Japan)); Nakatsuka, Haruo (Tohoku Univ. School of Medicine, Sendai (Japan)); Satoh, Toshihiko (Keio Univ., Tokyo (Japan)); Liu, Shijie; Jin, Chui (Beijing Medical Univ. School of Public Health (China)); Qiao, Xin (Institute for Prevention and Treatment of Occupational Diseases, Beijing (China)); Li, Guilan (Institute of Occupational Medicine, Beijing (China)); Ikeda, Masayuki (Kyoto Univ. Faculty of Medicine (Japan))

1993-02-01

83

[(18) F]MK-9470 PET measurement of cannabinoid CB1 receptor availability in chronic cannabis users.  

Science.gov (United States)

?(9) -Tetrahydrocannabinol, the main psychoactive component of cannabis, exerts its central effects through activation of the cerebral type 1 cannabinoid (CB1 ) receptor. Pre-clinical studies have provided evidence that chronic cannabis exposure is linked to decreased CB1 receptor expression and this is thought to be a component underlying drug tolerance and dependence. In this study, we make first use of the selective high-affinity positron emission tomography (PET) ligand [(18) F]MK-9470 to obtain in vivo measurements of cerebral CB1 receptor availability in 10 chronic cannabis users (age?=?26.0?±?4.1 years). Each patient underwent [(18) F]MK-9470 PET within the first week following the last cannabis consumption. A population of 10 age-matched healthy subjects (age?=?23.0?±?2.9 years) was used as control group. Parametric modified standardized uptake value images, reflecting CB1 receptor availability, were calculated. Statistical parametric mapping and volume-of-interest (VOI) analyses of CB1 receptor availability were performed. Compared with controls, cannabis users showed a global decrease in CB1 receptor availability (-11.7 percent). VOI-based analysis demonstrated that the CB1 receptor decrease was significant in the temporal lobe (-12.7 percent), anterior (-12.6 percent) and posterior cingulate cortex (-13.5 percent) and nucleus accumbens (-11.2 percent). Voxel-based analysis confirmed this decrease and regional pattern in CB1 receptor availability in cannabis users. These findings revealed that chronic cannabis use may alter specific regional CB1 receptor expression through neuroadaptive changes in CB1 receptor availability, opening the way for the examination of specific CB1 -cannabis addiction interactions which may predict future cannabis-related treatment outcome. PMID:24373053

Ceccarini, Jenny; Kuepper, Rebecca; Kemels, Dieter; van Os, Jim; Henquet, Cécile; Van Laere, Koen

2015-03-01

84

Anthrax: Symptoms  

Science.gov (United States)

... message, please visit this page: About CDC.gov . Anthrax Share Compartir Symptoms The symptoms of anthrax depend on the type of infection and can ... than 2 months to appear. All types of anthrax have the potential, if untreated, to spread throughout ...

85

Prescribing smoked cannabis for chronic noncancer pain  

Science.gov (United States)

Objective To offer preliminary guidance on prescribing smoked cannabis for chronic pain before the release of formal guidelines. Quality of evidence We reviewed the literature on the analgesic effectiveness of smoked cannabis and the harms of medical and recreational cannabis use. We developed recommendations on indications, contraindications, precautions, and dosing of smoked cannabis, and categorized the recommendations based on levels of evidence. Evidence is mostly level II (well conducted observational studies) and III (expert opinion). Main message Smoked cannabis might be indicated for patients with severe neuropathic pain conditions who have not responded to adequate trials of pharmaceutical cannabinoids and standard analgesics (level II evidence). Smoked cannabis is contraindicated in patients who are 25 years of age or younger (level II evidence); who have a current, past, or strong family history of psychosis (level II evidence); who have a current or past cannabis use disorder (level III evidence); who have a current substance use disorder (level III evidence); who have cardiovascular or respiratory disease (level III evidence); or who are pregnant or planning to become pregnant (level II evidence). It should be used with caution in patients who smoke tobacco (level II evidence), who are at increased risk of cardiovascular disease (level III evidence), who have anxiety or mood disorders (level II evidence), or who are taking higher doses of opioids or benzodiazepines (level III evidence). Cannabis users should be advised not to drive for at least 3 to 4 hours after smoking, for at least 6 hours after oral ingestion, and for at least 8 hours if they experience a subjective “high” (level II evidence). The maximum recommended dose is 1 inhalation 4 times per day (approximately 400 mg per day) of dried cannabis containing 9% delta-9-tetrahydrocannabinol (level III evidence). Physicians should avoid referring patients to “cannabinoid” clinics (level III evidence). Conclusion Future guidelines should be based on systematic review of the literature on the safety and effectiveness of smoked cannabis. Further research is needed on the effectiveness and long-term safety of smoked cannabis compared with pharmaceutical cannabinoids, opioids, and other standard analgesics. PMID:25500598

Kahan, Meldon; Srivastava, Anita; Spithoff, Sheryl; Bromley, Lisa

2014-01-01

86

Classification and Short-Term Course of DSM-IV Cannabis, Hallucinogen, Cocaine, and Opioid Disorders in Treated Adolescents  

Science.gov (United States)

This study examined the latent class structure of Diagnostic and Statistical Manual of Mental Disorders (text rev.; DSM-IV; American Psychiatric Association, 2000) symptoms used to diagnose cannabis, hallucinogen, cocaine, and opiate disorders among 501 adolescents recruited from addictions treatment. Latent class results were compared with the…

Chung, Tammy; Martin, Christoper S.

2005-01-01

87

Reprint of "Treatment of cannabis use disorders in people with schizophrenia spectrum disorders--a systematic review"  

DEFF Research Database (Denmark)

Cannabis use disorders (CUD) are prevalent among people with schizophrenia spectrum disorders (SSD), with a range of detrimental effects, e.g. reduced compliance to medication and psychosocial interventions, and increased level of psychotic-dimension symptoms. The aim of this study was to review literature on treatments of CUD in SSD-patients.

HjorthØj, Carsten; Fohlmann, Allan

2009-01-01

88

Mortality in GOLD stages of COPD and its dependence on symptoms of chronic bronchitis  

Directory of Open Access Journals (Sweden)

Full Text Available Abstract Background The GOLD classification of COPD severity introduces a stage 0 (at risk comprising individuals with productive cough and normal lung function. The aims of this study were to investigate total mortality risks in GOLD stages 0–4 with special focus on stage 0, and furthermore to assess the influence of symptoms of chronic bronchitis on mortality risks in GOLD stages 1–4. Method Between 1974 and 1992, a total of 22 044 middle-aged individuals participated in a health screening, which included a spirometry as well as recording of respiratory symptoms and smoking habits. Individuals with comorbidity at baseline (diabetes, stroke, cancer, angina pectoris, or heart infarction were excluded from the analyses. Hazard ratios (HR 95% CI of total mortality were analyzed in GOLD stages 0–4 with individuals with normal lung function and without symptoms of chronic bronchitis as a reference group. HR:s in smoking individuals with symptoms of chronic bronchitis within the stages 1–4 were calculated with individuals with the same GOLD stage but without symptoms of chronic bronchitis as reference. Results The number of deaths was 3674 for men and 832 for women based on 352 324 and 150 050 person-years respectively. The proportion of smokers among men was 50% and among women 40%. Self reported comorbidity was present in 4.6% of the men and 6.6% of the women. Among smoking men, Stage 0 was associated with an increased mortality risk, HR; 1.65 (1.32–2.08, of similar magnitude as in stage 2, HR; 1.41 (1.31–1.70. The hazard ratio in stage 0 was significantly higher than in stage 1 HR; 1.13 (0.98–1.29. Among male smokers with stage 1; HR: 2.04 (1.34–3.11, and among female smokers with stage 2 disease; HR: 3.16 (1.38–7.23, increased HR:s were found in individuals with symptoms of chronic bronchitis as compared to those without symptoms of chronic bronchitis. Conclusion Symptoms fulfilling the definition of chronic bronchitis were associated with an increased mortality risk among male smokers with normal pulmonary function (stage 0 and also with an increased risk of death among smoking individuals with mild to moderate COPD (stage 1 and 2.

Nilsson Peter M

2005-08-01

89

Functional connectivity in inhibitory control networks and severity of cannabis use disorder  

Science.gov (United States)

Background Loss of control is a prominent feature of cannabis use disorders (CUD) and involves orchestrated activity from several brain inhibitory control networks. Objectives In this study, we determined the associations between inhibitory control network activation and connectivity and CUD severity. Methods To that end, we compared cannabis-dependent (N = 44) vs. nondependent (N = 30) users during a Stop Signal Task. First, we compared differences in neural response during response inhibition via general linear model analysis within a priori regions of interest. Second, we examined functional connectivity via psychophysiological interaction (PPI) analysis between the right frontal control network (seed region) and inhibitory control networks. Results There was no significant difference in network activation between cannabis-dependent and nondependent users in any of the inhibitory control networks. However, preliminary findings using the PPI analysis showed that during successful response inhibition, cannabis-dependent users had greater connectivity between right frontal control network and substantia nigra/subthalamic nucleus (STN) network compared to nondependent users (small volume correction, FWE-corrected p<0.05). Further, multiple regression analyses on the PPI maps showed modulatory effects of age of onset and quantity of cannabis use in the nondependent users. Conclusions Taken together, these findings suggest that functional connectivity between frontal control and substantia nigra/STN networks during response inhibition is sensitive to the effects of CUD severity unlike behavioral task performance and neural activation in inhibitory control networks. Further, modulators of this connectivity, such as onset and quantity of cannabis use, show attenuated effects with progression of CUD. PMID:24200208

Filbey, Francesca; Yezhuvath, Uma

2015-01-01

90

Insight in psychosis: relationship with neurocognition, social cognition and clinical symptoms depends on phase of illness.  

Science.gov (United States)

Reduced insight has been reported in a majority of patients with a psychotic disorder. Most studies have focused on associations with neurocognition, neglecting relations with social cognition. Two hundred seventy patients with nonaffective psychosis participated in this study, which was part of the GROUP (Genetic Risk and OUtcome of Psychosis)-project. Linear regression analyses were performed to investigate the predictive value of composite measures of neurocognition, social cognition, and clinical symptoms. The moderating effect of phase of illness was also investigated. Insight was measured with a composite measure, based on the insight item on the Positive And Negative Syndrome Scale (PANSS) and the Birchwood Insight Scale (BIS). Insight on the BIS and the PANSS correlated significantly (r = .406). All independent variables correlated with the insight composite measure. The additional effect of social cognition and clinical symptoms were both significant. Phase of illness was a moderating variable: In patients with recent-onset psychosis (ROP), none of the independent variables explained variance. In patients with multiple episode or chronic psychosis, both social cognition and clinical symptoms had additional effects and explained insight, along with neurocognition, together explaining 20% of the variance. These findings indicate that multiple factors are associated with insight in psychosis. Specifically, associations of insight with social cognitive and clinical symptom measures were observed, over and above a contribution of neurocognition. This supports theories that imply a role for deficient emotion recognition and mentalizing in reduced insight. Further studies need to investigate insight in ROP into more detail. PMID:21097989

Quee, Piotr J; van der Meer, Lisette; Bruggeman, Richard; de Haan, Lieuwe; Krabbendam, Lydia; Cahn, Wiepke; Mulder, Niels C L; Wiersma, Durk; Aleman, André

2011-01-01

91

Blood Oxygenation Level Dependent Activation in Basal Ganglia Nuclei Relates to Specific Symptoms in De Novo Parkinson's Disease  

OpenAIRE

To aid the development of symptomatic and disease modifying therapies in Parkinson's disease (PD), there is a strong need to identify non-invasive measures of basal ganglia function that are sensitive to disease severity. This study examines the relation between blood oxygenation level dependent (BOLD) activation in every nucleus of the basal ganglia and symptom-specific disease severity in early stage, de novo PD. BOLD activation measured at 3 Tesla was compared between 20 early stage de nov...

Prodoehl, Janey; Spraker, Mathew; Corcos, Daniel; Comella, Cynthia; Vaillancourt, David

2010-01-01

92

Application of medical cannabis in patients with the neurodegeneration disorders  

OpenAIRE

Medical cannabis is the dried flowers of the female Cannabis sativa L. plant. Cannabis contains a number of active elements, including dronabinol (THC) and cannabidiol (CBD). Dronabinol is usually the main ingredient. The body’s own cannabinoid system has been identified. The discovery of this system, which comprises endocannabinoids and receptors, confirmed that cannabis has a positive effect on certain illnesses and conditions. Two types of cannabinoid receptors have been identified: CB1 ...

Lidia Kotu?a; Paulina Sobstyl; Jan Sobstyl; Paulina Chwil; Karol Terlecki; Jolanta Karwat; Paulina Gil-Kulik; Alicja Niedojad?o; Janusz Kocki

2014-01-01

93

Cannabis use during adolescent development: susceptibility to psychiatric illness  

OpenAIRE

Cannabis use is increasingly pervasive among adolescents today, even more common than cigarette smoking. The evolving policy surrounding the legalization of cannabis reaffirms the need to understand the relationship between cannabis exposure early in life and psychiatric illnesses. Cannabis contains psychoactive components, notably ?9-tetrahydrocannbinol (THC), that interfere with the brain’s endogenous endocannabinoid system, which is critically involved in both pre- and post-natal neurod...

MichaelLawrenceMiller; YasminLHurd

2013-01-01

94

Reactivity to Cannabis Cues in Virtual Reality Environments†  

OpenAIRE

Virtual reality (VR) cue environments have been developed and successfully tested in nicotine, cocaine, and alcohol abusers. Aims in the current article include the development and testing of a novel VR cannabis cue reactivity assessment system. It was hypothesized that subjective craving levels and attention to cannabis cues would be higher in VR environments merits with cannabis cues compared to VR neutral environments. Twenty nontreatment-seeking current cannabis smokers participated in th...

Bordnick, Patrick S.; Copp, Hilary L.; Traylor, Amy; Graap, Ken M.; Carter, Brian L.; Walton, Alicia; Ferrer, Mirtha

2009-01-01

95

THE EFFECT OF CANNABIS COMPARED WITH ALCOHOL ON DRIVING  

OpenAIRE

The prevalence of both alcohol and cannabis use and the high morbidity associated with motor vehicle crashes has lead to a plethora of research on the link between the two. Drunk drivers are involved in 25% of motor vehicle fatalities, and many accidents involve drivers who test positive for cannabis. Cannabis and alcohol acutely impair several driving-related skills in a dose-related fashion, but the effects of cannabis vary more between individuals than they do with alcohol because of toler...

Sewell, R. Andrew; Poling, James; Sofuoglu, Mehmet

2009-01-01

96

Mortality in GOLD stages of COPD and its dependence on symptoms of chronic bronchitis  

OpenAIRE

Abstract Background The GOLD classification of COPD severity introduces a stage 0 (at risk) comprising individuals with productive cough and normal lung function. The aims of this study were to investigate total mortality risks in GOLD stages 0–4 with special focus on stage 0, and furthermore to assess the influence of symptoms of chronic bronchitis on mortality risks in GOLD stages 1–4. Method Between 1974 and 1992, a total of 22 044 middle-aged individuals...

Nilsson Peter M; Nilsson Jan-Åke; Pehrsson Kerstin; Ekberg-Aronsson Marie; Löfdahl Claes-Göran

2005-01-01

97

High-intensity cannabis use and adherence to antiretroviral therapy among people who use illicit drugs in a canadian setting.  

Science.gov (United States)

Cannabis is increasingly prescribed clinically and utilized by people living with HIV/AIDS (PLWHA) to address symptoms of HIV disease and to manage side effects of antiretroviral therapy (ART). In light of concerns about the possibly deleterious effect of psychoactive drug use on adherence to ART, we sought to determine the relationship between high-intensity cannabis use and adherence to ART among a community-recruited cohort of HIV-positive illicit drug users. We used data from the ACCESS study, an ongoing prospective cohort study of HIV-seropositive illicit drug users linked to comprehensive ART dispensation records in a setting of universal no-cost HIV care. We estimated the relationship between at least daily cannabis use in the last 6 months, measured longitudinally, and the likelihood of optimal adherence to ART during the same period, using a multivariate linear mixed-effects model accounting for relevant socio-demographic, behavioral, clinical and structural factors. From May 2005 to May 2012, 523 HIV-positive illicit drug users were recruited and contributed 2,430 interviews. At baseline, 121 (23.1 %) participants reported at least daily cannabis use. In bivariate and multivariate analyses we did not observe an association between using cannabis at least daily and optimal adherence to prescribed HAART (Adjusted Odds Ratio = 1.12, 95 % Confidence Interval [95 % CI]: 0.76-1.64, p value = 0.555.) High-intensity cannabis use was not associated with adherence to ART. These findings suggest cannabis may be utilized by PLWHA for medicinal and recreational purposes without compromising effective adherence to ART. PMID:25012624

Slawson, Gregory; Milloy, M-J; Balneaves, Lynda; Simo, Annick; Guillemi, Silvia; Hogg, Robert; Montaner, Julio; Wood, Evan; Kerr, Thomas

2015-01-01

98

Low efficacy of non-opioid drugs in opioid withdrawal symptoms.  

Science.gov (United States)

Opioid withdrawal, stress or cues associated with opioid consumption can induce opioid craving. If opioids are not available, opioid-dependent patients usually search for alternative drugs. Because several non-opioid drugs stimulate the endogenous opioidergic system, this concept may explain their frequent use by opioid-dependent patients. We hypothesized that non-opioid drugs alleviate opioid withdrawal symptoms and are therefore consumed by opioid addicts. We asked 89 opioid-dependent patients participating in an out-patient opioid maintenance program to estimate the potential of several non-opioid drugs in being able to alleviate opioid withdrawal. We applied a five-point Lickert scale (1 = very good reduction of opioid withdrawal; 5 = no reduction of opioid withdrawal). Patients could also indicate a worsening of opioid withdrawal. Values (mean +/- SD) were: for benzodiazepines, 3.2 +/- 1.1; tricyclic antidepressants, 3.6 +/- 1.1; cannabis, 3.6 +/- 1.0; alcohol, 4.1 +/- 1.1; cocaine, 4.2 +/- 1.1; amphetamine, 4.4 +/- 0.9; nicotine, 4.7 +/- 0.7; and caffeine, 4.9 +/- 0.5. A worsening of opioid withdrawal was reported by 62% of the patients for cocaine, 62% for amphetamine, 50% for caffeine, 37.5% for cannabis, 27% for nicotine, 26% for alcohol, 8% for tricyclic antidepressants and 3% for benzodiazepines. Our study shows a low efficacy of non-opioid drugs in alleviating opioid withdrawal symptoms. The data basis of this study was good and the sample was suitable to be asked for estimations of drug-drug interactions. Of the patients, 26 - 62% even reported a worsening of opioid withdrawal for cannabis, alcohol, cocaine and amphetamine. Only benzodiazepines and tricyclic antidepressants were reported to have a moderate positive effect on opioid withdrawal. PMID:16191669

Hermann, Derik; Klages, Eckard; Welzel, Helga; Mann, Karl; Croissant, Bernhard

2005-06-01

99

Methamphetamine and cannabis abuse in adolescence: a quasi-experimental study on specific and long-term neurocognitive effects  

Science.gov (United States)

Objectives Methamphetamine abuse affects brain structure and function. Although methamphetamine and cannabis are commonly abused together, few studies have investigated the differential neurocognitive consequences of methamphetamine abuse with or without cannabis. Furthermore, the effects of drug use on the developing adolescent brain remain poorly understood. We compared neurocognitive function between adolescents with ‘pure’ methamphetamine abuse, those with comorbid methamphetamine and cannabis abuse, and healthy controls at baseline and follow-up. Methods Individuals residing in the greater Cape Town region, between the ages of 13 and 18?years, were recruited into either Methamphetamine only group (Meth-only; n=10), Methamphetamine and cannabis group (Meth-cann; n=10) or healthy control (n=20) groups using a quasi-experimental design. All participants underwent a comprehensive neurocognitive assessment. Substance-use variables and psychiatric symptom counts were also recorded. A portion of the Meth-only and control participants completed 12-month follow-up assessments. Results While the Meth-cann group demonstrated widespread neurocognitive deficits at baseline, these deficits were restricted to the self-monitoring domain in the Meth-only group at baseline and at follow-up. Conclusions Methamphetamine abuse with cannabis abuse is associated with significantly more neurocognitive impairment than methamphetamine abuse alone, and such deficits may be enduring. PMID:25636791

Cuzen, Natalie L; Koopowitz, Sheri-Michelle; Ferrett, Helen L; Stein, Dan J; Yurgelun-Todd, Deborah

2015-01-01

100

History of cannabis as a medicine: a review / História da cannabis como medicamento: uma revisão  

Scientific Electronic Library Online (English)

Full Text Available SciELO Brazil | Language: English Abstract in portuguese Antes da Era Cristã, a cannabis foi utilizada na Ásia como medicamento, com grande importância na Índia. A introdução da cannabis na Medicina Ocidental ocorreu em meados do século XIX, atingindo o clímax na última década deste século, com a disponibilidade e o uso de extratos e tinturas da cannabis. [...] Nas primeiras décadas do século XX, o uso médico da cannabis no Ocidente diminuiu significativamente, em grande parte pela dificuldade na obtenção de resultados consistentes de amostras da planta com diferentes potências. A identificação da estrutura química de componentes da cannabis e a possibilidade de se obter seus constituintes puros foram relacionadas a um aumento significativo no interesse científico pela planta, desde 1965. Este interesse foi renovado nos anos 90, com a descrição dos receptores de canabinóides e a identificação de um sistema canabinóide endógeno no cérebro. Usos terapêuticos. Um novo e mais consistente ciclo de uso dos derivados de cannabis como medicamento começa, já que a sua eficácia e segurança no tratamento começam a estar cientificamente provados. Abstract in english Cannabis as a medicine was used before the Christian era in Asia, mainly in India. The introduction of cannabis in the Western medicine occurred in the midst of the 19th century, reaching the climax in the last decade of that century, with the availability and usage of cannabis extracts or tinctures [...] . In the first decades of the 20th century, the Western medical use of cannabis significantly decreased largely due to difficulties to obtain consistent results from batches of plant material of different potencies. The identification of the chemical structure of cannabis components and the possibility of obtaining its pure constituents were related to a significant increase in scientific interest in such plant, since 1965. This interest was renewed in the 1990's with the description of cannabinoid receptors and the identification of an endogenous cannabinoid system in the brain. A new and more consistent cycle of the use of cannabis derivatives as medication begins, since treatment effectiveness and safety started to be scientifically proven.

Antonio Waldo, Zuardi.

2006-06-01

101

The Occurrence of Cannabis Use Disorders and other Cannabis-Related Problems among First-Year College Students  

OpenAIRE

This study reports the prevalence of cannabis use disorders (CUD) and other cannabis-related problems in a large cohort (n=1253) of first-year college students, 17 to 20 years old, at one large public university in the mid-Atlantic region of the U.S. Interviewers assessed past-year cannabis use, other drug use, and cannabis-related problems (including DSM-IV criteria for CUD). The prevalence of CUD was 9.4%wt among all first-year students and 24.6% among past-year cannabis users (n=739). Of t...

Caldeira, Kimberly M.; Arria, Amelia M.; O’grady, Kevin E.; Vincent, Kathryn B.; Wish, Eric D.

2007-01-01

102

Marijuana (Cannabis) and Multiple Sclerosis  

Science.gov (United States)

... sativa — should be used for symptom management in multiple sclerosis (MS) is a complex one. It is generally ... pdf) Download Brochure Complementary and Alternative Medicine and Multiple Sclerosis (book) Find Book Massage and Bodywork Learn More ...

103

Sativex for the management of multiple sclerosis symptoms.  

Science.gov (United States)

Sativex (R) is a cannabis-based pharmaceutical product containing delta 9-tetrahydrocannabinol (THC) and cannabidiol (CBD) in a 1:1 ratio, delivered in an oromucosal (mouth) spray. It has been approved as adjunctive treatment for neuropathic pain in patients with multiple sclerosis (MS). It is being investigated for the management of other MS symptoms, such as spasticity. THC:CBD spray is regulated as a narcotic. Five randomized controlled trials (RCTs) compared the benefits and harms of THC:CBD spray with placebo. A total of 368 patients with various neurological conditions (including MS) were recruited. In some trials, THC:CBD spray significantly reduced neuropathic pain, spasticity, muscle spasms and sleep disturbances. The most common adverse events (AEs) reported in trials were dizziness, sleepiness, fatigue, feeling of intoxication and a bad taste. Long-term safety and the potential for dependence, abuse, misuse and diversion are unknown. PMID:16317825

Perras C

2005-09-01

104

The rapidly increasing trend of cannabis use in burn injury.  

Science.gov (United States)

The use of cannabis is currently increasing according to U.S. Department of Health and Human Services (HHS). Surprisingly, cannabis use among burn patients is poorly reported in literature. In this study, rates of cannabis use in burn patients are compared with general population. Data from the National Burn Repository (NBR) were used to investigate incidence, demographics, and outcomes in relation to use of cannabis as evidenced by urine drug screen (UDS). Thousands of patients from the NBR from 2002 to 2011 were included in this retrospective study. Inclusion criteria were patients older than 12 years of age who received a drug screen. Data points analyzed were patients' age, sex, UDS status, mechanism of burn injury, total body surface area, length of stay, ICU days, and insurance characteristics. Incidence of cannabis use in burn patients from the NBR was compared against national general population rates (gathered by Health and Human Services) using chi-square tests. Additionally, the burn patient population was analyzed using bivariate analysis and t-tests to find differences in the characteristics of these patients as well as differences in outcomes. Seventeen thousand eighty out of over 112,000 patients from NBR had information available for UDS. The incidence of cannabis use is increasing among the general population, but the rate is increasing more quickly among patients in the burn patient population (P = .0022). In 2002, 6.0% of patients in burn units had cannabis+ UDS, which was comparable with national incidence of 6.2%. By 2011, 27.0% of burn patients tested cannabis+ while national incidence of cannabis use was 7.0%. Patients who test cannabis+ are generally men (80.1%, P test cannabis+ or cannabis- are similar. Flame injury makes up >60% of injuries, followed by scalds that are >15%. In comparing cannabis+/- patients, cannabis+ patients are more likely to be uninsured (25.2% vs 17.26%, P test cannabis+ have larger burns (TBSA% of 12.94 vs 10.98, P testing positive for cannabis in burn units is growing quickly. These patients are younger and are less likely to be insured. These patients also have larger burns, spend more time in ICUs, and have a greater number of operations. The increasing use of cannabis, as expected from legalization of cannabis in multiple states, among burn patient population may lead to increased burden on already tenuous health care resources. PMID:25412052

Jehle, Charles Christopher; Nazir, Niaman; Bhavsar, Dhaval

2015-01-01

105

Brain alterations and clinical symptoms of dementia in diabetes: Abeta/tau-dependent and independent mechanisms  

Directory of Open Access Journals (Sweden)

Full Text Available Emerging evidence suggests that diabetes affects cognitive function and increases the incidence of dementia. However, the mechanisms by which diabetes modifies cognitive function still remains unclear. Morphologically, diabetes is associated with neuronal loss in the frontal and temporal lobes including the hippocampus, and aberrant functional connectivity of the posterior cingulate cortex and medial frontal/temporal gyrus. Clinically, diabetic patients show decreased executive function, information processing, planning, visuospatial construction, and visual memory. Therefore, in comparison with the characteristics of AD brain structure and cognition, diabetes seems to affect cognitive function through not only simple AD pathological feature-dependent mechanisms, but also independent mechanisms. As an Abeta/tau-independent mechanism, diabetes compromises cerebrovascular function, increases subcortical infarction and might alter the blood brain barrier (BBB. Diabetes also affects glucose metabolism, insulin signaling and mitochondrial function in the brain. Diabetes also modifies metabolism of Abeta and tau and causes Abeta/tau-dependent pathological changes. Moreover, there is evidence that suggests an interaction between Abeta/tau-dependent and independent mechanisms. Therefore, diabetes modifies cognitive function through Abeta/tau-dependent and independent mechanisms. Interaction between these two mechanisms forms a vicious cycle.

NaoyukiSato

2014-09-01

106

Genetic predisposition to schizophrenia associated with increased use of cannabis.  

Science.gov (United States)

Cannabis is the most commonly used illicit drug worldwide. With debate surrounding the legalization and control of use, investigating its health risks has become a pressing area of research. One established association is that between cannabis use and schizophrenia, a debilitating psychiatric disorder affecting ~1% of the population over their lifetime. Although considerable evidence implicates cannabis use as a component cause of schizophrenia, it remains unclear whether this is entirely due to cannabis directly raising risk of psychosis, or whether the same genes that increases psychosis risk may also increase risk of cannabis use. In a sample of 2082 healthy individuals, we show an association between an individual's burden of schizophrenia risk alleles and use of cannabis. This was significant both for comparing those who have ever versus never used cannabis (P=2.6 × 10(-4)), and for quantity of use within users (P=3.0 × 10(-3)). Although directly predicting only a small amount of the variance in cannabis use, these findings suggest that part of the association between schizophrenia and cannabis is due to a shared genetic aetiology. This form of gene-environment correlation is an important consideration when calculating the impact of environmental risk factors, including cannabis use. PMID:24957864

Power, R A; Verweij, K J H; Zuhair, M; Montgomery, G W; Henders, A K; Heath, A C; Madden, P A F; Medland, S E; Wray, N R; Martin, N G

2014-11-01

107

[Neurobiology of cannabis--recent data enlightening driving disturbances].  

Science.gov (United States)

During the last decades a new landscape of cannabis has been designed on account of: the increase in its use the greater youth of its users; the increase in the content of its main active constituent tetrahydrocannabinol (THC) and a lot of new epidemiological and neurobiological data. THC displays an exceptional lipophilicity, allowing its cerebral storage, leading to long lasting effects, by far more lasting than its presence in blood, and beyond the period throughout the intoxicated people feel a disablement. This is linked to its slow release from brain areas in which large proportion of spare receptors exists (reserve receptors). THC disturbs cognition and various skills required in driving. It may be responsible for psychiatric troubles: anxiety, depression, suicide attempt, psychotic attack, triggering of schizophrenia. It potentiates the alcohol effects and incites to alcohol drinking. It displays close relationships with dependence to heroin. This new landscape of cannabis urges to make a radical alteration in the public communication about this drug of abuse as it has yet collected so many troubles, accidents or tragedies. PMID:16710113

Costentin, J

2006-05-01

108

79 FR 18111 - In the Matter of Advanced Cannabis Solutions, Inc.; Order of Suspension of Trading  

Science.gov (United States)

...File No. 500-1] In the Matter of Advanced Cannabis Solutions, Inc.; Order of Suspension of...information concerning the securities of Advanced Cannabis Solutions, Inc. (``Advanced Cannabis''), a Colorado corporation...

2014-03-31

109

Clinical Efficacy of Sertraline Alone and Augmented With Gabapentin in Recently Abstinent Cocaine-Dependent Patients With Depressive Symptoms  

Science.gov (United States)

Background Cocaine dependence is a major public health problem with no available robustly effective pharmacotherapy. This study’s aim was to determine if treatment with sertraline (SERT) or SERT plus gabapentin (GBP) improved treatment retention, depressive symptoms, and/or cocaine use. Methods Depressed cocaine-dependent patients (N = 99) were enrolled in a 12-week, double-blind, randomized, placebo (PLA)-controlled, clinical trial and placed in research beds at a residential treatment facility (Recovery Centers of Arkansas). They were randomized by depressive symptom severity and inducted onto 1 of the following while residing at the Recovery Centers of Arkansas: SERT (200 mg/d), SERT (200 mg/d) plus GBP (1200 mg/d), or PLA. Participants transferred to outpatient treatment at the start of their third week, continued receiving study medications or PLA (weeks 3–12), and participated in weekly individual cognitive behavioral therapy. Compliance was facilitated through the use of contingency management procedures. Supervised urine samples were obtained thrice weekly and self-reported mood weekly. At the end of 12 weeks, participants were tapered off the study medication over 5 days and referred to a local treatment program. Results Sertraline, but not SERT plus GBP, showed a significantly lower overall percentage of cocaine-positive urine samples compared with that of PLA. A significantly greater percentage of participants experienced relapse in the PLA group (88.9%) compared with that of the SERT group (65.2%). Hamilton depression ratings decreased significantly over time regardless of the treatment group. Retention in treatment did not differ significantly between the treatment groups. Conclusions Sertraline plus GBP may not be superior to SERT alone in delaying relapse among abstinent cocaine-dependent individuals undergoing cognitive behavioral therapy. PMID:24525654

Mancino, Michael J.; McGaugh, Janette; Chopra, Mohit P.; Guise, Joseph B.; Cargile, Christopher; Williams, D. Keith; Thostenson, Jeff; Kosten, Thomas R.; Sanders, Nichole; Oliveto, Alison

2014-01-01

110

Oral fluid cannabinoids in chronic frequent cannabis smokers during ad libitum cannabis smoking.  

Science.gov (United States)

Oral fluid (OF) offers a simple, non-invasive, directly observable sample collection for clinical and forensic drug testing. Given that chronic cannabis smokers often engage in drug administration multiple times daily, evaluating OF cannabinoid pharmacokinetics during ad libitum smoking is important for practical development of analytical methods and informed interpretation of test results. Eleven cannabis smokers resided in a closed research unit for 51?days, and underwent four, 5-day oral delta-9-tetrahydrocannabinol (THC) treatments. Each medication period was separated by 9?days of ad libitum cannabis smoking from 12:00 to 23:00?h daily. Ten OF samples were collected from 9:00-22:00?h on each of the last ad libitum smoking days (Study Days 4, 18, 32, and 46). As the number of cannabis cigarettes smoked increased over the study days, OF THC, cannabinol (CBN), and 11-nor-9-carboxy-THC (THCCOOH) also increased with a significant effect of time since last smoking (?time; range, 0.0-17.4?h) and ?88% detection rates; concentrations on Day 4 were significantly lower than those on Days 32 and 46 but not Day 18. Within 30?min of smoking, median THC, CBN, and THCCOOH concentrations were 689?µg/L, 116?µg/L, and 147?ng/L, respectively, decreasing to 19.4?µg/L, 2.4?µg/L, and 87.6?ng/L after 10?h. Cannabidiol and 11-hydroxy-THC showed overall lower detection rates of 29 and 8.6%, respectively. Cannabinoid disposition in OF was highly influenced by ?time and composition of smoked cannabis. Furthermore, cannabinoid OF concentrations increased over ad libitum smoking days, in parallel with increased cannabis self-administration, possibly reflecting development of increased cannabis tolerance. Copyright © 2014 John Wiley & Sons, Ltd. PMID:25220020

Lee, Dayong; Vandrey, Ryan; Mendu, Damodara R; Murray, Jeannie A; Barnes, Allan J; Huestis, Marilyn A

2014-09-14

111

Hemp (Cannabis sativa L.) as an Environmentally Friendly Energyplant  

Science.gov (United States)

Hemp is suitable as a renewable energy resource. The aim of this study was to clarify local hemp's (Cannabis sativa L.) possibilities for energy use. Arsenic (As), cadmium (Cd), lead (Pb) and titanium (Ti) presence in hemp was determined using an inductively coupled plasma optical emission spectrometer Optima 2100 DV. If there were increased N fertilizer rates, there were increased hemp `P?ri?i' seeds and shive yield increases, but the oil content was reduced. Arsenic content was higher in the shives than in the stems with fibre. The ash content depends on non-organic substances which the plants absorb during the vegetation season. The lignin content depends on several factors: plant parts, and the N fertilizer rate. The unexplored factors have a great effect on the ash and lignin content. Hemp is suitable for cultivation and for bio-energy production in the agro-climatic conditions in Latvia.

Poisa, Liena; Adamovics, Aleksandrs

2010-01-01

112

Effect of alcohol and Cannabis sativa consumption on handwriting.  

Science.gov (United States)

This study reports on the separate effect of Cannabis sativa smoking and of alcohol consumption on handwriting performance in Cannabis users and in alcoholic volunteers, respectively. Handwriting samples were obtained prior to, during, and after 1 hr of Cannabis or alcohol consumption. Handwriting was evaluated for speed, letter forms, size, slant, and alignment. Cannabis sativa smoking exerted greater effect on handwriting than did alcohol drinking. This effect was noted during Cannabis smoking and lasted for 1 hr thereafter. Changes noted in handwriting performance test, which reflect involuntary muscular movement and tremor, suggest a differential CNS depressant action of the compounds used under the experimental trials listed. The results suggest possible forensic application, i.e., the use of handwriting for the purpose of signature comparison obtained under the influence of alcohol or under Cannabis intoxication. PMID:6866197

Zaki, N N; Ibraheim, M A

1983-01-01

113

Anormalidades cognitivas no uso da cannabis / Cognitive abnormalities and cannabis use  

Scientific Electronic Library Online (English)

Full Text Available SciELO Brazil | Language: Portuguese Abstract in portuguese OBJETIVO: Evidências de que o uso de cannabis prejudica funções cognitivas em humanos têm-se acumulado nas décadas recentes. O propósito desta revisão é o de atualizar o conhecimento nesta área com novos achados a partir da literatura mais recente. MÉTODO: As buscas na literatura foram realizadas ut [...] ilizando-se o banco de dados Web of Science até fevereiro de 2010. Foram buscados os termos "cannabi*" ou "marijuana" e "cogniti*" ou "memory" ou "attention" ou "executive function", e os estudos em humanos foram revisados preferencialmente em relação aos estudos em animais. DISCUSSÃO: O uso de cannabis prejudica a memória, a atenção, o controle inibitório, as funções executivas e a tomada de decisões, tanto durante como após o período de intoxicação aguda, persistindo por horas, dias, semanas ou mais após o último uso. Os estudos de desafio farmacológico em humanos estão elucidando a natureza e os substratos neurais das alterações cognitivas associadas a vários canabinoides. O uso pesado ou de longo prazo de cannabis parece resultar em anormalidades cognitivas mais duradouras e possivelmente em alterações cerebrais estruturais. Efeitos cognitivos adversos maiores estão associados ao uso de cannabis quando este começa no início da adolescência. CONCLUSÃO: O sistema canabinoide endógeno está envolvido nos mecanismos de regulação neural que modulam os processos subjacentes a uma gama de funções cognitivas que estão prejudicadas pela cannabis. Os déficits em usuários humanos muito provavelmente refletem, portanto, neuroadaptações e o funcionamento alterado do sistema canabinoide endógeno. Abstract in english OBJECTIVE: Evidence that cannabis use impairs cognitive function in humans has been accumulating in recent decades. The purpose of this overview is to update knowledge in this area with new findings from the most recent literature. METHOD: Literature searches were conducted using the Web of Science [...] database up to February 2010. The terms searched were: "cannabi*" or "marijuana", and "cogniti*" or "memory" or "attention" or "executive function", and human studies were reviewed preferentially over the animal literature. DISCUSSION: Cannabis use impairs memory, attention, inhibitory control, executive functions and decision making, both during the period of acute intoxication and beyond, persisting for hours, days, weeks or more after the last use of cannabis. Pharmacological challenge studies in humans are elucidating the nature and neural substrates of cognitive changes associated with various cannabinoids. Long-term or heavy cannabis use appears to result in longer-lasting cognitive abnormalities and possibly structural brain alterations. Greater adverse cognitive effects are associated with cannabis use commencing in early adolescence. CONCLUSION: The endogenous cannabinoid system is involved in regulatory neural mechanisms that modulate processes underlying a range of cognitive functions that are impaired by cannabis. Deficits in human users most likely therefore reflect neuroadaptations and altered functioning of the endogenous cannabinoid system.

Nadia, Solowij; Nicole, Pesa.

2010-05-01

114

Roadside sobriety tests and attitudes toward a regulated cannabis market  

OpenAIRE

Abstract Background Many argue that prohibition creates more troubles than alternative policies, but fewer than half of American voters support a taxed and regulated market for cannabis. Some oppose a regulated market because of concerns about driving after smoking cannabis. Although a roadside sobriety test for impairment exists, few voters know about it. The widespread use of a roadside sobriety test that could detect recent cannabis use might lead some voters who currently...

Earleywine Mitch; Looby Alison; Gieringer Dale

2007-01-01

115

Cannabis and tobacco smoke are not equally carcinogenic  

OpenAIRE

Abstract More people are using the cannabis plant as modern basic and clinical science reaffirms and extends its medicinal uses. Concomitantly, concern and opposition to smoked medicine has occurred, in part due to the known carcinogenic consequences of smoking tobacco. Are these reactions justified? While chemically very similar, there are fundamental differences in the pharmacological properties between cannabis and tobacco smoke. Cannabis smoke contains cannabinoids whereas tobac...

Melamede Robert

2005-01-01

116

The effect of cannabis use on memory function: an update  

OpenAIRE

Tabea Schoeler, Sagnik BhattacharyyaDepartment of Psychosis Studies, King's College London, Institute of Psychiatry, London, UKAbstract: Investigating the effects of cannabis use on memory function appears challenging. While early observational investigations aimed to elucidate the longer-term effects of cannabis use on memory function in humans, findings remained equivocal and pointed to a pattern of interacting factors impacting on the relationship between cannabis use and memory fu...

Schoeler T; Bhattacharyya S

2013-01-01

117

Gebruik en aanschaf van cannabis door 16- en 17-jarigen:  

OpenAIRE

Naar aanleiding van een toezegging van de Minister van Justitie tijdens het Nationaal Jeugddebat 2001 is door het WODC een beknopt literatuuronderzoek uitgevoerd naar het gebruik en de aanschaf van cannabis door 16- en 17-jarigen. Hieronder de belangrijkste bevindingen. Cannabis is bij 16- en 17-jarige jongeren verreweg de meest gebruikte drug. Gebruik van harddrugs komt veel minder voor. Een minderheid van de jongeren heeft naast cannabis ooit andere drugs genomen. Het cannabisgebruik onder ...

Ooyen-houben, M.; Siepermann, M.

2002-01-01

118

Cannabis Use during Adolescent Development: Susceptibility to Psychiatric Illness.  

Science.gov (United States)

Cannabis use is increasingly pervasive among adolescents today, even more common than cigarette smoking. The evolving policy surrounding the legalization of cannabis reaffirms the need to understand the relationship between cannabis exposure early in life and psychiatric illnesses. cannabis contains psychoactive components, notably ?(9)-tetrahydrocannabinol (THC), that interfere with the brain's endogenous endocannabinoid system, which is critically involved in both pre- and post-natal neurodevelopment. Consequently, THC and related compounds could potentially usurp normal adolescent neurodevelopment, shifting the brain's developmental trajectory toward a disease-vulnerable state, predisposing early cannabis users to motivational, affective, and psychotic disorders. Numerous human studies, including prospective longitudinal studies, demonstrate that early cannabis use is associated with major depressive disorder and drug addiction. A strong association between schizophrenia and cannabis use is also apparent, especially when considering genetic factors that interact with this environmental exposure. These human studies set a foundation for carefully controlled animal studies which demonstrate similar patterns following early cannabinoid exposure. Given the vulnerable nature of adolescent neurodevelopment and the persistent changes that follow early cannabis exposure, the experimental findings outlined should be carefully considered by policymakers. In order to fully address the growing issues of psychiatric illnesses and to ensure a healthy future, measures should be taken to reduce cannabis use among teens. PMID:24133461

Chadwick, Benjamin; Miller, Michael L; Hurd, Yasmin L

2013-01-01

119

The nonpsychoactive cannabis constituent cannabidiol is an oral anti-arthritic therapeutic in murine collagen-induced arthritis  

OpenAIRE

The therapeutic potential of cannabidiol (CBD), the major nonpsychoactive component of cannabis, was explored in murine collagen-induced arthritis (CIA). CIA was elicited by immunizing DBA/1 mice with type II collagen (CII) in complete Freund's adjuvant. The CII used was either bovine or murine, resulting in classical acute CIA or in chronic relapsing CIA, respectively. CBD was administered after onset of clinical symptoms, and in both models of arthritis the treatment effectively blocked pro...

Malfait, Am; Gallily, R.; Sumariwalla, Pf; Malik, As; Andreakos, E.; Mechoulam, R.; Feldmann, M.

2000-01-01

120

Síntomas depresivos como factor de riesgo de dependencia en adultos mayores Depressive symptoms as a risk factor for dependence in elderly people  

Directory of Open Access Journals (Sweden)

Full Text Available OBJETIVO: Determinar la relación entre síntomas depresivos y dependencia funcional. MATERIAL Y MÉTODOS: Estudio longitudinal con 1 880 adultos mayores evaluados en 2001 y 2003. Se determinaron los síntomas depresivos con una versión modificada de la Escala de Depresión del Centro de Estudios Epidemiológicos y la dependencia con las escalas de Lawton y Brody, y Katz. La dependencia implicó la asistencia y ayuda para realizar alguna de las actividades interrogadas. Los análisis multifactoriales probaron el nexo entre síntomas depresivos y desarrollo de dependencia. RESULTADOS: En 2001, 37.9% mostró síntomas depresivos. En 2003, 6.1 y 12.7% desarrollaron dependencia para al menos una de las actividades básicas (ABVD e instrumentales de la vida diaria (AIVD, respectivamente. En el análisis multivariado, los síntomas depresivos fueron factor de riesgo sólo para dependencia en las AIVD. CONCLUSIONES: Los síntomas depresivos favorecen el desarrollo de dependencia funcional. Es necesario su reconocimiento sistemático durante la evaluación clínica del adulto mayor.OBJECTIVE: To determine the relationship between depressive symptoms and dependence in activities of daily living. MATERIAL AND METHODS: Participants, aged 70 to 104 (n= 1 880, were evaluated twice (2001 and 2003. Depressive symptoms were established by a modified version of Center for Epidemiologic Studies Depression scale, whereas functional dependence was assessed with Lawton & Brody and Katz scales. Dependence implies the attendance and assistance of another person to accomplish the activity. Multivariate regression analyses were used to determine the effect of depressive symptoms on incident dependence. RESULTS: At baseline, 37.9% had depressive symptoms. After two years, 6.1 and 12.7% developed functional dependence for one or more ADL and IADL, respectively. Multivariate analyses showed that depressive symptoms were a risk factor to the development of functional dependence only for the instrumental activities for daily living. CONCLUSIONS: Depressive symptoms are a risk factor for functional dependence. Systematic screening it seems necessary in the evaluation of geriatric patients.

José Alberto Ávila-Funes

2007-10-01

121

Cannabis use by children and young people  

OpenAIRE

A popular internet site1 describes cannabis as “a leafy plant, the leaves and flowering tops (buds) of which may be either smoked or eaten. It also comes in a more concentrated resinous form called hashish, and as a sticky black liquid called hash oil”. It is said that users often report a pleasant “subjective enhancement of visual and auditory perception, sometimes with synaesthesia (sounds take on visual colourful qualities)” and the sense that time passes more quickly than real tim...

Mcardle, P. A.

2006-01-01

122

LONG TERM EFFECTS OF CANNABIS1  

OpenAIRE

50 chronic cannabis users were studied for their physical, mental, cognitive and socio-economic aspects of health. They were given W.M.S., Bhatia Battery of intelligence and B.G.T. It was observed that only 12% provided clue for suspecting cognitive deficiency. No social breakdown phenomenon was observed in the sample. Also, no significant physical illness was detected in the subjects.

Sethi, B. B.; Trivedi, J. K.; Singh, Harjeet

1981-01-01

123

Etat limite, adolescence, cannabis et cocaïne  

Scientific Electronic Library Online (English)

Full Text Available SciELO Brazil | Language: French Abstract in english Borderline, teenagers, cannabis and cocaine. Teenagers are fond of psychoactive products. Somme of them, according to their personality, go to the limits of their psychic structure. In the practical field, we can often observe the revealing of borderline states, very different from the usual problem [...] atic teenagers. Psychoactive substances, used for the first time as anxiolytics, become quickly a cause of anxiety, therefore revealing the subjects in borderline states.

Didier, Lauru.

2014-08-01

124

Legalising medical use of cannabis in South Africa: Is the empirical evidence sufficient to support policy shifts in this direction?  

Scientific Electronic Library Online (English)

Full Text Available SciELO South Africa | Language: English Abstract in english Inkatha Freedom Party MP Mario Oriani-Ambrosini's impassioned plea to legalise the medical use of cannabis must be understood in the context of his own condition as well as legislative changes in at least ten countries. This article argues that any decisions to shift policy must be based on a consid [...] eration of the evidence on the risks and benefits associated with the medical use of cannabis for the individual and broader society. It concludes that there are important gaps in the evidence base, particularly in human trials supporting the efficacy of cannabis use for treating and preventing medical conditions and alleviating negative symptoms associated with these conditions. South African researchers should be enabled actively to support development of the necessary evidence base by conducting preclinical and clinical research in this area. Human trials to establish the efficacy of the use of cannabis/cannabinoids in addressing AIDS wasting syndrome and other negative sequelae of HIV and AIDS are especially needed.

C D H, Parry; B J, Myers.

2014-06-01

125

Cannabinoid hyperemesis syndrome: Clinical diagnosis of an underrecognised manifestation of chronic cannabis abuse  

OpenAIRE

Cannabis is a common drug of abuse that is associated with various long-term and short-term adverse effects. The nature of its association with vomiting after chronic abuse is obscure and is underrecognised by clinicians. In some patients this vomiting can take on a pattern similar to cyclic vomiting syndrome with a peculiar compulsive hot bathing pattern, which relieves intense feelings of nausea and accompanying symptoms. In this case report, we describe a twenty-two year-old-male with a hi...

Siva P Sontineni, Sanjay Chaudhary

2009-01-01

126

Neuronal substrates and functional consequences of prenatal cannabis exposure.  

Science.gov (United States)

Cannabis remains one of the world's most widely used substance of abuse amongst pregnant women. Trends of the last 50 years show an increase in popularity in child-bearing women together with a constant increase in cannabis potency. In addition, potent herbal "legal" highs containing synthetic cannabinoids that mimic the effects of cannabis with unknown pharmacological and toxicological effects have gained rapid popularity amongst young adults. Despite the surge in cannabis use during pregnancy, little is known about the neurobiological and psychological consequences in the exposed offspring. In this review, we emphasize the importance of maternal programming, defined as the intrauterine presentation of maternal stimuli to the foetus, in neurodevelopment. In particular, we focus on cannabis-mediated maternal adverse effects, resulting in direct central nervous system alteration or sensitization to late-onset chronic and neuropsychiatric disorders. We compare clinical and preclinical experimental studies on the effects of foetal cannabis exposure until early adulthood, to stress the importance of animal models that permit the fine control of environmental variables and allow the dissection of cannabis-mediated molecular cascades in the developing central nervous system. In sum, we conclude that preclinical experimental models confirm clinical studies and that cannabis exposure evokes significant molecular modifications to neurodevelopmental programs leading to neurophysiological and behavioural abnormalities. PMID:24793873

Calvigioni, Daniela; Hurd, Yasmin L; Harkany, Tibor; Keimpema, Erik

2014-10-01

127

Cannabis use and destructive periodontal diseases among adolescents  

DEFF Research Database (Denmark)

AIM: The aim of this experiment was to investigate the association between cannabis use and destructive periodontal disease among adolescents. MATERIAL AND METHODS: Data from a population screening examination carried out among Chilean high school students from the Province of Santiago were used to determine whether there was an association between the use of cannabis and signs of periodontal diseases as defined by (1) the presence of necrotizing ulcerative gingival (NUG) lesions or (2) the presence of clinical attachment loss (CAL) > or =3 mm. The cannabis exposures variables considered were "Ever use of cannabis" (yes/no) and "Regular use of cannabis" (yes/no). The associations were investigated using multiple logistic regression analyses adjusted for age, gender, paternal income, paternal education, frequency of tooth-brushing and time since last dental visit. RESULTS: Multiple logistic regression analyses showed that "Ever use of cannabis" was significantly negatively associated with the presence of NUG lesions (OR=0.47 [0.2;0.9]) among non-smokers only. No significant associations were observed between the presence of CAL > or =3 mm and cannabis use in either of the smoking groups. CONCLUSIONS: There was no evidence to suggest that the use of cannabis is positively associated with periodontal diseases in this adolescent population.

López, Rodrigo; Baelum, Vibeke

2009-01-01

128

Believability of Messages about Cannabis, Cocaine and Heroin among Never-Triers, Trier-Rejecters and Current Users of Cannabis  

Science.gov (United States)

This paper examines the believability of strong warnings about the negative consequences of drug use among young adults in Australia who have never tried, currently use, or have tried and rejected cannabis. It finds that the strong warnings about cannabis are generally believed by never-triers. The same warnings are perceived by current users as…

Jones, Sandra C.; Rossiter, John R.

2004-01-01

129

Cannabis users differ from non-users on measures of personality and schizotypy  

OpenAIRE

Accumulating evidence indicates that cannabis use may be a risk factor for schizophrenia (SZ), and chronic cannabis users score higher than non-users on measures of schizotypal personality traits. The purpose of the present study was to investigate the relations between normal personality, schizotypy, and cannabis use. Sixty-two chronic cannabis users and 45 cannabis-naïve controls completed a measure of normal personality, the NEO-Five Factor Inventory (NEO-FFI), and two measures of schizot...

Fridberg, Daniel J.; Vollmer, Jennifer M.; O Donnell, Brian F.; Skosnik, Patrick D.

2011-01-01

130

Difference between the prevalence of symptoms of depression and anxiety in non-diabetic smokers and in patients with type 2 diabetes with and without nicotine dependence  

Directory of Open Access Journals (Sweden)

Full Text Available Abstract Background Individuals with diabetes who are smokers have higher risks of cardiovascular disease, premature death, and microvascular complications. The present study aims to determine the prevalence of symptoms of depression and anxiety in smokers with type 2 diabetes mellitus (T2D and to evaluate if the prevalence of symptoms of depression and anxiety differ between the three groups studied (patients with T2D who smoke; patients with T2D who do not smoke; smokers without T2D, and finally determine if the degree of nicotine dependence is related to symptoms of anxiety and depression in smokers (with or without T2D. Methods Three study groups were formed: 46 T2D smokers (DS, 46 T2D non-smokers (D, and 46 smokers without diabetes (S, totaling 138 participants. Hospital Anxiety and Depression (HAD scale and Fagerström Test were applied. Results The prevalence of symptoms of depression and anxiety in smokers with T2D was 30.4% and 50%, respectively. There was no significant difference in the proportion of individuals with symptoms of anxiety (p?=?0.072 or depression (p?=?0.657 in the DS group compared to group D or S. Among male patients with T2D, the smokers had a higher prevalence of anxiety symptoms (19.6% than non-smokers (4,3% (p?=?0,025. The prevalence of high nicotine dependence among smokers with and without T2D was 39.1% and 37.1%, respectively (p?=?0.999. Fagerström scores showed no significant correlation with the scores obtained on the subscale of anxiety (p?=?0,735 or depression (p?=?0,364. Conclusions The prevalence of depression and anxiety among smokers with and without diabetes and non-smokers T2D is similar. Among male individuals with T2D, the smokers have more symptoms of anxiety than the non-smokers. There is no difference in the prevalence of nicotine dependence among smokers with and without diabetes. The presence of symptoms of anxiety or depression is similar between patients who are dependent and not dependent on nicotine.

Osme Simone

2012-08-01

131

Compulsive showering and marijuana use – the cannabis hyperemisis syndrome  

Science.gov (United States)

Patient: Male, 26 Final Diagnosis: Marihuana addiction Symptoms: Compulsive showering • nausea • vomiting Medication: — Clinical Procedure: — Specialty: Toxicology Objective: Unexpected drug reaction Background: The use or misuse of Cannabis is well recognized in the Caribbean region. Recently, the cannabinoid hyperemesis syndrome has been described. The triad is characterized by chronic marijuana use, cyclical vomiting, and compulsive bathing. With the extensive use to marijuana as a recreational drug and also the increased use as prescription medication, a patient presenting with this symptomatology needs to be assessed appropriately and this syndrome needs to be one of the differential diagnoses. Case Report: To our knowledge, we report the first such case in the Caribbean region. Here, we report on the case of a 26-year-old Caucasian male with a 3-week history of nausea and week of epigastric pain and vomiting. The patient was known to use marijuana daily for 2 years and had similar complaints for the last 6 months. Conclusions: Because this popular recreational drug is now being used with increased frequency as a prescribed medication, it is crucial that clinicians be aware of this condition, which can present as a diagnostic dilemma. PMID:23997851

Mohammed, Fawwaz; Panchoo, Kirby; Bartholemew, Maria; Maharaj, Dale

2013-01-01

132

Achieving cannabis cessation -- evaluating N-acetylcysteine treatment (ACCENT): design and implementation of a multi-site, randomized controlled study in the National Institute on Drug Abuse Clinical Trials Network.  

Science.gov (United States)

Despite recent advances in behavioral interventions for cannabis use disorders, effect sizes remain modest, and few individuals achieve long-term abstinence. One strategy to enhance outcomes is the addition of pharmacotherapy to complement behavioral treatment, but to date no efficacious medications targeting cannabis use disorders in adults through large, randomized controlled trials have been identified. The National Institute on Drug Abuse Clinical Trials Network (NIDA CTN) is currently conducting a study to test the efficacy of N-acetylcysteine (NAC) versus placebo (PBO), added to contingency management, for cannabis cessation in adults (ages 18-50). This study was designed to replicate positive findings from a study in cannabis-dependent adolescents that found greater odds of abstinence with NAC compared to PBO. This paper describes the design and implementation of an ongoing 12-week, intent-to-treat, double-blind, randomized, placebo-controlled study with one follow-up visit four weeks post-treatment. Approximately 300 treatment-seeking cannabis-dependent adults will be randomized to NAC or PBO across six study sites in the United States. The primary objective of this 12-week study is to evaluate the efficacy of twice-daily orally-administered NAC (1200 mg) versus matched PBO, added to contingency management, on cannabis abstinence. NAC is among the first medications to demonstrate increased odds of abstinence in a randomized controlled study among cannabis users in any age group. The current study will assess the cannabis cessation efficacy of NAC combined with a behavioral intervention in adults, providing a novel and timely contribution to the evidence base for the treatment of cannabis use disorders. PMID:25179587

McClure, Erin A; Sonne, Susan C; Winhusen, Theresa; Carroll, Kathleen M; Ghitza, Udi E; McRae-Clark, Aimee L; Matthews, Abigail G; Sharma, Gaurav; Van Veldhuisen, Paul; Vandrey, Ryan G; Levin, Frances R; Weiss, Roger D; Lindblad, Robert; Allen, Colleen; Mooney, Larissa J; Haynes, Louise; Brigham, Gregory S; Sparenborg, Steve; Hasson, Albert L; Gray, Kevin M

2014-11-01

133

A Preliminary Examination of the Relationships between Posttraumatic Stress Symptoms and Crack/Cocaine, Heroin, and Alcohol Dependence  

OpenAIRE

High rates of co-occurrence between posttraumatic stress (PTS) and substance use disorders (SUDs) have led to the suggestion that substance use among individuals experiencing PTS symptoms might serve a self-medication function. However, research is still needed to provide a more comprehensive evaluation of the unique associations between PTS symptom clusters and substances (licit and illicit) with both anxiolytic/depressant and stimulant properties. Consequently, this study examined the relat...

Tull, Matthew T.; Gratz, Kim L.; Aklin, Will M.; Lejuez, C. W.

2010-01-01

134

Cannabis use correlates with schizotypal personality traits in healthy students.  

Science.gov (United States)

The literature suggests that cannabis use and schizotypal traits both constitute risk factors for the later development of schizophrenia. However, their interrelationships remain to be evaluated. The present study examined the association between cannabis use and schizotypal traits in 232 healthy students who ranged in age from 18 to 25 years. All the students had completed the Schizotypal Personality Questionnaire and four of the Chapman Psychosis Proneness Scales: the Magical Ideation Scale; the Perceptual Aberration Scale; the Revised Physical Anhedonia Scale; and the Revised Social Anhedonia Scale. Subjects were divided into three groups according to cannabis use typology: those who had never used cannabis, those who were past or occasional users, and those who were regular users. Higher scores on the Schizotypal Personality Questionnaire and the Magical Ideation Scale characterized the regular and past or occasional users compared with those who had never used cannabis. The co-occurrence of cannabis use and schizotypal traits appeared to be independent of anxiety and depression dimensions. These data suggest that cannabis use and schizotypal traits have to be jointly considered in further longitudinal studies of schizophrenia risk factors. PMID:11850048

Dumas, Patrick; Saoud, Mohamed; Bouafia, Sébastien; Gutknecht, Christel; Ecochard, René; Daléry, Jean; Rochet, Thierry; d'Amato, Thierry

2002-01-31

135

Cultivation of Cannabis sativa L. in northern Morocco.  

Science.gov (United States)

Field studies on cannabis cultivation have provided socio-economic data relating to, inter alia, production, yield and income. But only laboratory analyses of cannabis plants can provide information on their chemical composition and their levels of psychoactive constituents, thus enabling them to be classed as a drug type or a fibre type. The present study, which covers cannabis in its fresh, dried and powdered forms, drew on fresh samples, obtained on the day they were harvested or immediately after preparation; that was done in order to prevent any alteration in the A-9-tetrahydrocannabinol (THC) caused by the oxidation that takes place as the product ages. The purpose of this study is to determine the THC level in 245 specimens obtained from 30 cannabis plots in three provinces of northern Morocco: Al Hoceima and Chefchaouen, where cannabis cultivation has a long tradition, and Larache, where cannabis cultivation has started only recently. Qualitative analysis using high performance liquid chromatography with diode array detection revealed the presence of both the acid and the decarboxylated form of the main cannabinoids, cannabidiol, THC and cannabinol, and gas chromatography/mass spectrometry was used for the characterization of minor cannibinoids. Quantitative analysis using gas chromatography coupled with mass spectrometry made it possible to determine the average delta-9-THC content of cannabis in its fresh form (0.5 per cent), its dry form (2.21 per cent) and its powdered form (8.3 per cent). The results show that the traditional areas of cannabis cultivation--Al Hoceima and Chefchaouen--produce cannabis with a higher delta-9-THC content than the Larache region. In addition, the present study establishes that male plants, often considered deficient in delta-9-THC, contain levels of the same order as those recorded for female plants, both in the leaves and in the tops. PMID:21338017

Stambouli, H; El Bouri, A; Bellimam, M A; Bouayoun, T; El Karni, N

2005-01-01

136

Síntomas depresivos como factor de riesgo de dependencia en adultos mayores / Depressive symptoms as a risk factor for dependence in elderly people  

Scientific Electronic Library Online (English)

Full Text Available SciELO Public Health | Language: Spanish Abstract in spanish OBJETIVO: Determinar la relación entre síntomas depresivos y dependencia funcional. MATERIAL Y MÉTODOS: Estudio longitudinal con 1 880 adultos mayores evaluados en 2001 y 2003. Se determinaron los síntomas depresivos con una versión modificada de la Escala de Depresión del Centro de Estudios Epidemi [...] ológicos y la dependencia con las escalas de Lawton y Brody, y Katz. La dependencia implicó la asistencia y ayuda para realizar alguna de las actividades interrogadas. Los análisis multifactoriales probaron el nexo entre síntomas depresivos y desarrollo de dependencia. RESULTADOS: En 2001, 37.9% mostró síntomas depresivos. En 2003, 6.1 y 12.7% desarrollaron dependencia para al menos una de las actividades básicas (ABVD) e instrumentales de la vida diaria (AIVD), respectivamente. En el análisis multivariado, los síntomas depresivos fueron factor de riesgo sólo para dependencia en las AIVD. CONCLUSIONES: Los síntomas depresivos favorecen el desarrollo de dependencia funcional. Es necesario su reconocimiento sistemático durante la evaluación clínica del adulto mayor. Abstract in english OBJECTIVE: To determine the relationship between depressive symptoms and dependence in activities of daily living. MATERIAL AND METHODS: Participants, aged 70 to 104 (n= 1 880), were evaluated twice (2001 and 2003). Depressive symptoms were established by a modified version of Center for Epidemiolog [...] ic Studies Depression scale, whereas functional dependence was assessed with Lawton & Brody and Katz scales. Dependence implies the attendance and assistance of another person to accomplish the activity. Multivariate regression analyses were used to determine the effect of depressive symptoms on incident dependence. RESULTS: At baseline, 37.9% had depressive symptoms. After two years, 6.1 and 12.7% developed functional dependence for one or more ADL and IADL, respectively. Multivariate analyses showed that depressive symptoms were a risk factor to the development of functional dependence only for the instrumental activities for daily living. CONCLUSIONS: Depressive symptoms are a risk factor for functional dependence. Systematic screening it seems necessary in the evaluation of geriatric patients.

José Alberto, Ávila-Funes; Efrén, Melano-Carranza; Hélène, Payette; Hélène, Amieva.

2007-10-01

137

Síntomas depresivos como factor de riesgo de dependencia en adultos mayores / Depressive symptoms as a risk factor for dependence in elderly people  

Scientific Electronic Library Online (English)

Full Text Available SciELO Mexico | Language: Spanish Abstract in spanish OBJETIVO: Determinar la relación entre síntomas depresivos y dependencia funcional. MATERIAL Y MÉTODOS: Estudio longitudinal con 1 880 adultos mayores evaluados en 2001 y 2003. Se determinaron los síntomas depresivos con una versión modificada de la Escala de Depresión del Centro de Estudios Epidemi [...] ológicos y la dependencia con las escalas de Lawton y Brody, y Katz. La dependencia implicó la asistencia y ayuda para realizar alguna de las actividades interrogadas. Los análisis multifactoriales probaron el nexo entre síntomas depresivos y desarrollo de dependencia. RESULTADOS: En 2001, 37.9% mostró síntomas depresivos. En 2003, 6.1 y 12.7% desarrollaron dependencia para al menos una de las actividades básicas (ABVD) e instrumentales de la vida diaria (AIVD), respectivamente. En el análisis multivariado, los síntomas depresivos fueron factor de riesgo sólo para dependencia en las AIVD. CONCLUSIONES: Los síntomas depresivos favorecen el desarrollo de dependencia funcional. Es necesario su reconocimiento sistemático durante la evaluación clínica del adulto mayor. Abstract in english OBJECTIVE: To determine the relationship between depressive symptoms and dependence in activities of daily living. MATERIAL AND METHODS: Participants, aged 70 to 104 (n= 1 880), were evaluated twice (2001 and 2003). Depressive symptoms were established by a modified version of Center for Epidemiolog [...] ic Studies Depression scale, whereas functional dependence was assessed with Lawton & Brody and Katz scales. Dependence implies the attendance and assistance of another person to accomplish the activity. Multivariate regression analyses were used to determine the effect of depressive symptoms on incident dependence. RESULTS: At baseline, 37.9% had depressive symptoms. After two years, 6.1 and 12.7% developed functional dependence for one or more ADL and IADL, respectively. Multivariate analyses showed that depressive symptoms were a risk factor to the development of functional dependence only for the instrumental activities for daily living. CONCLUSIONS: Depressive symptoms are a risk factor for functional dependence. Systematic screening it seems necessary in the evaluation of geriatric patients.

José Alberto, Ávila-Funes; Efrén, Melano-Carranza; Hélène, Payette; Hélène, Amieva.

2007-10-01

138

[Maternal cannabis use and intra-uterine growth restriction].  

Science.gov (United States)

Marijuana is the most commonly used illegal drug, especially among young women in Western societies. The effects of cannabis use during pregnancy have been studied for many years. The vast majority of studies have shown a link between maternal consumption of cannabis and foetal development. Foetal growth restriction seems to be the major complication of cannabis exposure. Nevertheless, all these studies have suffered from several methodological biases. The maternal marijuana use should be first and foremost detected in pregnant women for a specific addiction management and pregnancy follow-up. PMID:16890472

Davitian, C; Uzan, M; Tigaizin, A; Ducarme, G; Dauphin, H; Poncelet, C

2006-01-01

139

[Caffeine, cannabis and cocaine: from automedication to 'automutilation' in adults with ADHD].  

Science.gov (United States)

Four patients whose automedication had attracted medical attention had signs compatible with adult attention deficit hyperactivity disorder (ADHD). Two of them, men aged 42 and 28, were seen with their hyperactive children in the outpatient department; they appeared to drink huge amounts of coffee, smoked heavily or used cannabis to facilitate sleep. The other two patients, a man aged 25 and a woman aged 35, were initially not diagnosed with ADHD; they had noticed that dopaminergic drugs like cocaine and an amphetamine-containing medication taken to lose weight made their behaviour much more 'normal', although the man was addicted. All experienced relief of their chaotic mental activity when they were treated with methylphenidate. Smoking and addiction due to undiagnosed ADHD may lead to 'automutilation'. Early recognition and awareness of the symptoms of ADHD is important; the clinical interview should also cover items like automedication and other ADHD symptoms in the family. PMID:15646857

Pereira, R Rodrigues; van de Wetering, B J M

2004-12-25

140

Eysenck Personality Dimensions in a Sample of Cannabis Users  

Directory of Open Access Journals (Sweden)

Full Text Available     Objective: The objective of this study is to examine Eysenck personality dimensions in cannabis users  Method:100 regular cannabis users were selected and completed Eysenck Personality Questionnaire (EPQ which easures Neuroticism (N,Extraversion-Introversion (E-I and Psychoticism (P dimensions of Eysenck personality structures  Results:The scores of 51% of cannabis users were higher than mean in all dimensions of EPQ. Also the mean score of N and P were higher than the score which Eysenck has reported for Iranian population Conclusions:This research reinforces our call for a public health information campaign about a drug which may young people still see as being risk-free.Psychiatric morbidity and cases of psychotic disorder could be prevented by discouraging cannabis use among vulnerable youths.

Arash Vahdat

2007-06-01

141

Cannabis misinterpretation and misadventure in a coroner's court.  

LENUS (Irish Health Repository)

A 37-year-old, one-pack-per-day tobacco smoker collapsed and died at home. At autopsy, he had an occluded left anterior descending coronary artery. ?(9)-Tetrahydrocannabinol-carboxylic acid was found in his urine but no cannabinoids were detected in his blood. Misadventure was the inquest verdict on the basis of the urinary cannabis, with acute myocardial infarction as the primary cause and cannabis as the secondary cause of death. Such a conclusion is a misinterpretation of the evidence when the time duration for cannabis as a trigger for myocardial infarction is at most two hours. The absence of cannabis in the blood likely places the time since inhalation at more than two hours. The role of tobacco smoking as a trigger was ignored. Cotinine, the biochemical marker of tobacco smoke, should be added to the standard toxicological screen in the guidelines on autopsy practice of the Royal College of Pathologists.

Tormey, William Patrick

2012-10-01

142

Cannabis, motivation, and life satisfaction in an internet sample  

OpenAIRE

Abstract Although little evidence supports cannabis-induced amotivational syndrome, sources continue to assert that the drug saps motivation 1, which may guide current prohibitions. Few studies report low motivation in chronic users; another reveals that they have higher subjective wellbeing. To assess differences in motivation and subjective wellbeing, we used a large sample (N = 487) and strict definitions of cannabis use (7 days/week) and ...

Wilcox Rand; Earleywine Mitch; Barnwell Sara

2006-01-01

143

[Pathological gambling and addiction to cannabis: common psychosocial profile?].  

Science.gov (United States)

Addiction can involve substances (heroin, cannabis, cocaine) or be characterised by behaviour (pathological gambling, addiction to sport, etc.). The question is to establish whether or not there is a specific personality profile (character, temperament) and emotional functioning (anxiety, depression, alexithymia) in subjects presenting addictive behaviour with and without substance use. To find some answers, a team from Sainte-Marguerite General Hospital in Marseille carried out a study comparing a group of cannabis addicts and a group of pathological gamblers. PMID:24741830

Parolaa, Nathalie; Boyer, Laurent; Simon, Nicolas; Aghababian, Valérie; Lançon, Christophe

2014-01-01

144

SYNTHESIS AND CHARACTERIZATION OF CANNABIS INDICA FIBER REINFORCED COMPOSITES  

OpenAIRE

This paper reports on the synthesis of Cannabis indica fiber-reinforced composites using Urea-Resorcinol-Formaldehyde (URF) as a novel matrix through compression molding technique. The polycondensation between urea, resorcinol, and formaldehyde in different molar ratios was applied to the synthesis of the URF polymer matrix. A thermosetting matrix based composite, reinforced with lignocellulose from Cannabis indica with different fiber loadings 10, 20, 30, 40, and 50% by weight, was obtained....

Amar Singh Singha,; Kaith, Balbir S.; Aishwarya Jyoti Khanna

2011-01-01

145

Persecutory ideation and a history of cannabis use.  

OpenAIRE

Background: Cannabis use is associated with the occurrence of psychotic experiences. However there are multiple distinct psychotic experiences, each likely to occur as quantitative traits in the general population. In this study we tested for an association of cannabis use with a dimensional assessment of persecutory ideation. Method: A total of 1714 individuals from the general population completed a dimensional measure of current persecutory ideation and reported on whether they had ever ta...

Freeman, D.; Morrison, Pd; Murray, Rm; Evans, N.; Lister, R.; Dunn, G.

2013-01-01

146

The effect of cannabis compared with alcohol on driving.  

Science.gov (United States)

The prevalence of both alcohol and cannabis use and the high morbidity associated with motor vehicle crashes has lead to a plethora of research on the link between the two. Drunk drivers are involved in 25% of motor vehicle fatalities, and many accidents involve drivers who test positive for cannabis. Cannabis and alcohol acutely impair several driving-related skills in a dose-related fashion, but the effects of cannabis vary more between individuals than they do with alcohol because of tolerance, differences in smoking technique, and different absorptions of Delta(9)-tetrahydrocannabinol (THC), the active ingredient in marijuana. Detrimental effects of cannabis use vary in a dose-related fashion, and are more pronounced with highly automatic driving functions than with more complex tasks that require conscious control, whereas alcohol produces an opposite pattern of impairment. Because of both this and an increased awareness that they are impaired, marijuana smokers tend to compensate effectively while driving by utilizing a variety of behavioral strategies. Combining marijuana with alcohol eliminates the ability to use such strategies effectively, however, and results in impairment even at doses which would be insignificant were they of either drug alone. Epidemiological studies have been inconclusive regarding whether cannabis use causes an increased risk of accidents; in contrast, unanimity exists that alcohol use increases crash risk. Furthermore, the risk from driving under the influence of both alcohol and cannabis is greater than the risk of driving under the influence of either alone. Future research should focus on resolving contradictions posed by previous studies, and patients who smoke cannabis should be counseled to wait several hours before driving, and avoid combining the two drugs. PMID:19340636

Sewell, R Andrew; Poling, James; Sofuoglu, Mehmet

2009-01-01

147

Binge Drinking, Cannabis and Tobacco Use Among Ethnic Norwegian and Ethnic Minority Adolescents in Oslo, Norway.  

Science.gov (United States)

The aim of the study was to assess prevalence and factors associated with binge drinking, cannabis use and tobacco use among ethnic Norwegians and ethnic minority adolescents in Oslo. We used data from a school-based cross-sectional survey of adolescents in junior- and senior high schools in Oslo, Norway. The participants were 10,934 adolescents aged 14-17 years, and just over half were females. The sample was comprised of 73.2 % ethnic Norwegian adolescents, 9.8 % 1st generation immigrants, and 17 % 2nd generation adolescents from Europe, the US, the Middle East, Asia and Africa. Logistic regression models were applied for the data analyses. Age, gender, religion, parental education, parent-adolescent relationships, depressive symptoms and loneliness were covariates in the regression models. Ethnic Norwegian adolescents reported the highest prevalence of binge drinking (16.1 %), whereas the lowest prevalence was found among 2nd generation adolescents from Asia (2.9 %). Likewise, the past-year prevalence for cannabis use ranged from 10.6 % among 2nd generation Europeans and those from the US to 3.7 % among 2nd generation Asians. For daily tobacco use, the prevalence ranged from 12.9 % among 2nd generation Europeans and the US to 5.1 % among 2nd generation Asians. Ethnicity, age, gender, religion, parental education, and parent-adolescent relationships and mental health status were significantly associated with binge drinking, cannabis and tobacco use. These factors partly explained the observed differences between ethnic Norwegians and ethnic minority adolescents in the current study. There are significant differences in substance use behaviors between ethnic Norwegian and immigrant youth. Factors like age, gender, religion, parental education and relationships and mental health status might influence the relationship between ethnicity and substance abuse. The findings have implications for planning selective- as well as universal prevention interventions. PMID:25037580

Abebe, Dawit S; Hafstad, Gertrud S; Brunborg, Geir Scott; Kumar, Bernadette Nirmal; Lien, Lars

2014-07-19

148

Herbicidal treatments for control of Cannabis sativa L.  

Science.gov (United States)

In order to test herbicides for the destruction of illicit stands of cannabis (Cannabis sativa L.) a series of commercially available herbicides were sprayed on glasshouse-grown plants having 2 to 6 leaves. The following herbicides caused complete kill or severe injury to cannabis plants: (a) herbicides with root and foliage activity--ametryn, atrazine, metribuzin, prometryn, terbutryne, diuron, fluometuron, linuron, methabenzthiazuron, phenobenzuron, ethofumesate, karbutilate, methazole and oxadiazon; and (b) foliar-acting herbicides with brief or no soil persistence--amitrole, bentazon, 2,4-D, diquat + paraquat, glyphosate and phenmedipham. In field experiments herbicides of the latter group, and ioxynil, metribuzin, and a MSMA-cacodylate mixture, caused death or severe damage to young cannabis plants. Glyphosate, ioxynil and bentazon destroyed developed cannabis plants. In glasshouse and field experiments the following herbicides applied to young cannabis plants caused marked deformations of stems, leaves and/or inflorescences: barban, butralin, dalapon, difenzoquat, dinitramine, diphenamid, IPC, napropamide, penoxalin, triffuralin, and U-27267. PMID:585583

Horowitz, M

1977-01-01

149

The carbon footprint of indoor Cannabis production  

International Nuclear Information System (INIS)

The emergent industry of indoor Cannabis production – legal in some jurisdictions and illicit in others – utilizes highly energy intensive processes to control environmental conditions during cultivation. This article estimates the energy consumption for this practice in the United States at 1% of national electricity use, or $6 billion each year. One average kilogram of final product is associated with 4600 kg of carbon dioxide emissions to the atmosphere, or that of 3 million average U.S. cars when aggregated across all national production. The practice of indoor cultivation is driven by criminalization, pursuit of security, pest and disease management, and the desire for greater process control and yields. Energy analysts and policymakers have not previously addressed this use of energy. The unchecked growth of electricity demand in this sector confounds energy forecasts and obscures savings from energy efficiency programs and policies. While criminalization has contributed to the substantial energy intensity, legalization would not change the situation materially without ancillary efforts to manage energy use, provide consumer information via labeling, and other measures. Were product prices to fall as a result of legalization, indoor production using current practices could rapidly become non-viable. - Highlights: ? The emergent industry of indoor Cannabis production utilizes highly energy intensive processes and is highly inefficient. ? In the United Stay inefficient. ? In the United States, this represents an annual energy expenditure of $6 billion. ? One kg of final product is associated with emissions of 4600 kg of CO2 emissions to the atmosphere. ? Aggregate U.S. emissions are equivalent those of 3 million cars. ? Energy analysts and policymakers have not previously addressed this use of energy.

150

Menopausal symptoms  

OpenAIRE

In the UK, the median age for onset of menopausal symptoms is 45.5 to 47.5 years. Symptoms associated with the menopause include vasomotor symptoms, sleeplessness, mood changes, reduced energy levels, loss of libido, vaginal dryness, and urinary symptoms.Many symptoms, such as hot flushes, are temporary, but those resulting from reduced hormone levels, such as genital atrophy, may be permanent.

Rymer, Janice; Morris, Edward P.

2000-01-01

151

Psychomotor performance in relation to acute oral administration of Delta9-tetrahydrocannabinol and standardized cannabis extract in healthy human subjects.  

Science.gov (United States)

Abnormalities in psychomotor performance are a consistent finding in schizophrenic patients as well as in chronic cannabis users. The high levels of central cannabinoid (CB(1)) receptors in the basal ganglia, the cerebral cortex and the cerebellum indicate their implication in the regulation of motor activity. Based on the close relationship between cannabis use, the endogenous cannabinoid system and motor disturbances found in schizophrenia, we expected that administration of cannabinoids may change pattern of psychomotor activity like in schizophrenic patients. This prospective, double-blind, placebo-controlled cross-over study investigated the acute effects of cannabinoids on psychomotor performance in 24 healthy right-handed volunteers (age 27.9 +/- 2.9 years, 12 male) by comparing Delta(9)-tetrahydrocannabinol (Delta(9)-THC) and standardized cannabis extract containing Delta(9)-THC and cannabidiol. Psychomotor performance was assessed by using a finger tapping test series. Cannabis extract, but not Delta(9)-THC, revealed a significant reduction of right-hand tapping frequencies that was also found in schizophrenia. As to the pure Delta(9)-THC condition, left-hand tapping frequencies were correlated with the plasma concentrations of the Delta(9)-THC metabolite 11-OH-THC. These effects are thought to be related to cannabinoid actions on CB(1) receptors in the basal ganglia, the cerebral cortex and the cerebellum. Our data further demonstrate that acute CB(1) receptor activation under the cannabis extract condition may also affect intermanual coordination (IMC) as an index of interhemispheric transfer. AIR-Scale scores as a measure of subjective perception of intoxication were dose-dependently related to IMC which was shown by an inverted U-curve. This result may be due to functional changes involving GABAergic and glutamatergic neurotransmission within the corpus callosum. PMID:19224107

Roser, Patrik; Gallinat, Jürgen; Weinberg, Gordon; Juckel, Georg; Gorynia, Inge; Stadelmann, Andreas M

2009-08-01

152

Revisão: funcionamento executivo e uso de maconha Review: executive functioning and cannabis use  

Directory of Open Access Journals (Sweden)

Full Text Available OBJETIVO: A maconha é a droga ilícita mais consumida no mundo, porém ainda existem poucos estudos examinando eventuais prejuízos cognitivos relacionados ao seu uso. As manifestações clínicas associadas a esses déficits incluem síndrome amotivacional, prejuízo na flexibilidade cognitiva, desatenção, dificuldade de raciocínio abstrato e formação de conceitos, aspectos intimamente ligados às funções executivas, as quais potencialmente exercem um papel central na dependência de substâncias. O objetivo do estudo foi fazer uma revisão a respeito das implicações do uso da maconha no funcionamento executivo. MÉTODO: Esta revisão foi conduzida utilizando-se bases de dados eletrônicas (MedLine, Pubmed, SciELO and Lilacs. DISCUSSÃO: Em estudos de efeito agudo, doses maiores de tetrahidrocanabinol encontram-se associadas a maior prejuízo no desempenho de usuários leves em tarefas de controle inibitório e planejamento; porém, este efeito dose-resposta não ocorre em usuários crônicos. Embora haja controvérsias no que se refere a efeitos residuais da maconha, déficits persistentes parecem estar presentes após 28 dias de abstinência, ao menos em um subgrupo de usuários crônicos. CONCLUSÕES: Os estudos encontrados não tiveram como objetivo principal a avaliação das funções executivas. A seleção de testes padronizados, desenhos de estudos mais apropriados e o uso concomitante com técnicas de neuroimagem estrutural e funcional podem auxiliar na melhor compreensão das conseqüências deletérias do uso crônico da maconha no funcionamento executivo.OBJECTIVE: Cannabis is the most used illicit drug worldwide, however only a few studies have examined cognitive deficits related to its use. Clinical manifestations associated with those deficits include amotivational syndrome, impairment in cognitive flexibility, inattention, deficits in abstract reasoning and concept formation, aspects intimately related to the executive functions, which potentially exert a central role in substance dependence. The objective was to make a review about consequences of cannabis use in executive functioning. METHOD: This review was carried out on reports drawn from MedLine, SciELO, and Lilacs. DISCUSSION: In studies investigating acute use effects, higher doses of tetrahydrocannabinol are associated to impairments in performance of nonsevere users in planning and control impulse tasks. However, chronic cannabis users do not show those impairments. Although demonstration of residual effects of cannabis in the executive functioning is controversial, persistent deficits seem to be present at least in a subgroup of chronic users after 28 days of abstinence. CONCLUSIONS: The neuropsychological studies found did not have as a main aim the evaluation of executive functioning. A criterial selection of standardized neuropsychological tests, more appropriate study designs as well as concomitant investigations with structural and functional neuroimaging techniques may improve the understanding of eventual neurotoxicity associated with cannabis use.

Priscila Previato Almeida

2008-03-01

153

Exposure to the tsunami disaster, PTSD symptoms and increased substance use – an Internet based survey of male and female residents of Switzerland  

Directory of Open Access Journals (Sweden)

Full Text Available Abstract Background After the tsunami disaster in the Indian Ocean basin an Internet based self-screening test was made available in order to facilitate contact with mental health services. Although primarily designed for surviving Swiss tourists as well as relatives and acquaintances of the victims, the screening instrument was open to anyone who felt psychologically affected by this disaster. The aim of this study was to evaluate the influences between self-declared increased substance use in the aftermath of the tsunami disaster, trauma exposure and current PTSD symptoms. Methods One section of the screening covered addiction related behavior. We analyzed the relationship between increased substance use, the level of PTSD symptoms and trauma exposure using multivariable logistic regression with substance use as the dependent variable. Included in the study were only subjects who reported being residents of Switzerland and the analyses were stratified by gender in order to control for possible socio-cultural or gender differences in the use of psychotropic substances. Results In women PTSD symptoms and degree of exposure enlarged the odds of increased alcohol, pharmaceuticals and cannabis use significantly. In men the relationship was more specific: PTSD symptoms and degree of exposure only enlarged the odds of increased pharmaceutical consumption significantly. Increases in alcohol, cannabis and tobacco use were only significantly associated with the degree of PTSD symptoms. Conclusion The tsunami was associated with increased substance use. This study not only replicates earlier findings but also suggests for a gender specificity of post-traumatic substance use increase.

Bisson Jonathan I

2008-03-01

154

Effectiveness of Different Web-Based Interventions to Prepare Co-Smokers of Cigarettes and Cannabis for Double Cessation: A Three-Arm Randomized Controlled Trial  

Science.gov (United States)

Background The relationship between tobacco and cannabis use is strong. When co-smokers try to quit only one substance, this relationship often leads to a substitution effect, that is, the increased use of the remaining substance. Stopping the use of both substances simultaneously is therefore a reasonable strategy, but co-smokers rarely report feeling ready for simultaneous cessation. Thus, the question of how co-smokers can be motivated to attempt a simultaneous cessation has arisen. To reach as many co-smokers as possible, we developed brief Web-based interventions aimed at enhancing the readiness to simultaneously quit tobacco and cannabis use. Objective Our aim was to analyze the efficacy of three different Web-based interventions designed to enhance co-smokers’ readiness to stop tobacco and cannabis use simultaneously. Methods Within a randomized trial, three brief Web-based and fully automated interventions were compared. The first intervention combined the assessment of cigarette dependence and problematic cannabis use with personalized, normative feedback. The second intervention was based on principles of motivational interviewing. As an active psychoeducational control group, the third intervention merely provided information on tobacco, cannabis, and the co-use of the two substances. The readiness to quit tobacco and cannabis simultaneously was measured before and after the intervention (both online) and 8 weeks later (online or over the phone). Secondary outcomes included the frequency of cigarette and cannabis use, as measured at baseline and after 8 weeks. Results A total of 2467 website users were assessed for eligibility based on their self-reported tobacco and cannabis co-use, and 325 participants were ultimately randomized and analyzed. For the post-intervention assessment, generalized estimating equations revealed a significant increase in the readiness to quit tobacco and cannabis in the total sample (B=.33, 95% CI 0.10-0.56, P=.006). However, this effect was not significant for the comparison between baseline and the 8-week follow-up assessment (P=.69). Furthermore, no differential effects between the interventions were found, nor were any significant intervention or time effects found on the frequency of tobacco or cannabis use. Conclusions In the new field of dual interventions for co-smokers of tobacco and cannabis, Web-based interventions can increase the short-term readiness to quit tobacco and cannabis simultaneously. The studied personalized techniques were no more effective than was psychoeducation. The analyzed brief interventions did not change the secondary outcomes, that is the frequency of tobacco and cannabis use. Trial Registration International Standard Randomized Controlled Trial Number (ISRCTN): 56326375; http://www.isrctn.com/ISRCTN56326375 (Archived by WebCite at http://www.webcitation.org/6UUWBh8u0). PMID:25486674

Haug, Severin; Sullivan, Robin; Schaub, Michael Patrick

2014-01-01

155

Effects of cannabis on cognition in patients with MS  

Science.gov (United States)

Objective: To determine functional and structural neuroimaging correlates of cognitive dysfunction associated with cannabis use in multiple sclerosis (MS). Methods: In a cross-sectional study, 20 subjects with MS who smoked cannabis and 19 noncannabis users with MS, matched on demographic and neurologic variables, underwent fMRI while completing a test of working memory, the N-Back. Resting-state fMRI and structural MRI data (lesion and normal-appearing brain tissue volumes, diffusion tensor imaging metrics) were also collected. Neuropsychological data pertaining to verbal (Selective Reminding Test Revised) and visual (10/36 Spatial Recall Test) memory, information processing speed (Paced Auditory Serial Addition Test [2- and 3-second versions] and Symbol Digit Modalities Test), and attention (Word List Generation) were obtained. Results: The cannabis group performed more poorly on the more demanding of the Paced Auditory Serial Addition Test tasks (i.e., 2-second version) (p Test (p < 0.03). Cannabis users had more diffuse cerebral activation across all N-Back trials and made more errors on the 2-Back task (p < 0.006), during which they displayed increased activation relative to nonusers in parietal (p < 0.007) and anterior cingulate (p < 0.001) regions implicated in working memory. No group differences in resting-state networks or structural MRI variables were found. Conclusions: Patients with MS who smoke cannabis are more cognitively impaired than nonusers. Cannabis further compromises cerebral compensatory mechanisms, already faulty in MS. These imaging data boost the construct validity of the neuropsychological findings and act as a cautionary note to cannabis users and prescribers. PMID:24789863

Pavisian, Bennis; MacIntosh, Bradley J.; Szilagyi, Greg; Staines, Richard W.; O'Connor, Paul

2014-01-01

156

[Psychopathology and differential diagnosis of so-called Cannabis psychoses].  

Science.gov (United States)

From 237 patients examined for drug-induced psychoses, 50 cannabis psychoses were examined according to the criterion "main cause of addiction" and 107 were examined according to the criterion "consumption during the last three months before hospitalization". The cannabis psychoses were compared to the other drug-induced psychoses as well as to a control group consisting of 219 schizophrenic patients. General agreement was found with the other drug-induced psychoses as well as with the group of schizophrenic patients. The variation from the symptomatology of the schizophrenics is generally common to both the cannabis psychoses and the other drug-induced psychoses. Judging by the results of our investigations, it must be concluded that there is no disease "cannabis psychosis" in its own right, just as the disease "drug-induced psychosis" also does not exist in its own right. While there is a certain slight drug-specific psychopathological undertone, it does not entitle us to speak of a syndromatic or indeed a nosological entity. The psychopathological cross section does not permit a differentiation in the individual psychoses groups mentioned, although this has often been attempted in the literature. That there are no relevant psychopathological differences between cannabis psychoses and endogenous schizophrenia could, for one, be based on the fact that we are observing the final stage of one and the same underlying pathological process. In this case both syndromes would in practice be endogenous psychoses, with the cause not being known in one case. The psychopathologic similarity of these two psychoses forms could, however, also be based on the assumption that cannabis psychoses are triggered schizophrenias, so that we could in both cases be dealing with one and the same disease. We see the solution to the problem of diagnosing symptomatic psychoses, and in particular cannabis psychoses, in making a diagnosis that takes the etiology into consideration in addition to the syndrome diagnosis. PMID:6618409

Täschner, K L

1983-07-01

157

Cannabis, possible cardiac deaths and the coroner in Ireland.  

LENUS (Irish Health Repository)

BACKGROUND: The elevated risk of triggering a myocardial infarction by smoking cannabis is limited to the first 2 h after smoking. AIM: To examine the possible role of cannabis in cardiac deaths. CASES AND RESULTS: From 3,193 coroners\\' cases over 2 years, there were 13 cases where the clinical information was compatible with a primary cardiac cause of death. An inquest was held in three cases. Myocardial infarction was the primary cause of death in 54%. Other causes were sudden adult death syndrome, sudden death in epilepsy, and poisoning by alcohol and diazepam. Cannabis was mentioned once only on a death certificate, but not as a cause of death. Blood delta9-tetrahydrocannabinol-carboxylic acid was recorded in one case and in no case was plasma tetrahydrocannabinol (THC) measured. CONCLUSIONS: To attribute sudden cardiac death to cannabis, plasma THC should be measured in the toxicology screen in coroners\\' cases where urine cannabinoids are positive. A positive urine cannabinoids immunoassay alone is insufficient evidence in the linkage of acute cardiac death and cannabis.

Tormey, W P

2012-01-10

158

[Pharmacotherapy of substance dependence and withdrawal syndromes].  

Science.gov (United States)

Substance use disorders (SUD) include substance abuse and dependence as well as acute intoxication, withdrawal, and various psychiatric disorders. In the course of the SUD, severe comorbid disorders and somatic consequences can occur. The treatment of withdrawal symptoms focuses on the relief of immediate symptoms and the prevention of complications. The treatment of SUDs should achieve long-term abstinence with relapse prevention or harm reduction using maintenance treatment strategies. Beside psychosocial interventions, the pharmacotherapy has become an important factor for the treatment of SUDs and withdrawal syndromes. This review reports evidence-based pharmacologic treatment strategies of the most frequent SUDs according to current guidelines for SUDs. In the pharmacological treatment of alcohol dependence long-lasting benzodiazepines or clomethiazole for alcohol withdrawal, and acamprosate or naltrexone for relapse prevention are preferable. There exists no effective relapse prevention for cannabis dependence. During cocaine withdrawal tricyclic antidepressants demonstrated the highest efficacy. For cocaine dependence no medication can be recommended, so far. However, mood stabilizers such as topiramate and tiagabine or disulfirame were found to be efficacious in preliminary studies. There is consistent evidence for methylphenidate in treating cocaine dependence co-occurring with attention-deficit/hyperactivity disorder. For opioid dependence, methadone or buphrenorphine treatment is the pharmacotherapy of first choice. Nicotine replacement therapy, Bupropion and Vareniclin are efficacious in smoking cessation. PMID:19496041

Walter, Marc; Wiesbeck, Gerhard A

2009-06-01

159

Some determinants of psychological deficits associated with chronic cannabis consumption.  

Science.gov (United States)

The present study was done in order to investigate the following general hypothesis: "Other conditions being equal, the lower the non-drug level of proficiency on tests of cognitive and psychomotor performance the smaller the size of function deficit associated with drug taking". Twelve objective tests generating 16 test variables were administered to 850 chronic cannabis takers and 839 comparable non-takers, all males ranging in age between 15 and 50 years and representing various positions on "literacy-illiteracy" and "urbanism-ruralism". Six specific predictions were formulated; (1) Performance on the test is expected to be correlated with the level of leteracy of the subject. (2) the lower the level of literacy the smaller the size of function deficit associated with cannabis taking. (3) Performance on the tests is expected to be correlated with the level of urbanism of the subject. (4) The lower the level of urbanism (i.e. more ruralism) the smaller the size of function deficit associated with drug taking. (5) Performance on the tests is expected to correlate inversely with age. (6) The older the subject the smaller the amount of function deficit associated with cannabis consumption. All our predictions were confirmed. The consistency of these results raises the possibility that a basic regularity governing the relationship between cannabis consumption and psychological-function deficit is being uncovered. The suggestion was made that our major hypothesis might prove valid with regard to the area of acute effects of cannabis taking as well. Our hypothesis was shown to provide a broad framework capable of integrating a number of conflicting reports both in the area of long term and that of short term cannabis use. PMID:1046371

Soueif, M I

1976-01-01

160

Long term marijuana users seeking medical cannabis in California (2001–2007): demographics, social characteristics, patterns of cannabis and other drug use of 4117 applicants  

OpenAIRE

Abstract Background Cannabis (marijuana) had been used for medicinal purposes for millennia. Cannabinoid agonists are now attracting growing interest and there is also evidence that botanical cannabis is being used as self-medication for stress and anxiety as well as adjunctive therapy by the seriously ill and by patients with terminal illnesses. California became the first state to authorize medicinal use of cannabis in 1996, and it was recently estimated that between 250,00...

Bou-Matar Ché B; O'Connell Thomas J

2007-01-01

161

Increased extrapyramidal symptoms in patients with schizophrenia and a comorbid substance use disorder  

OpenAIRE

Few data have been gathered about the impact of psychoactive substances on extrapyramidal symptoms (EPS) in schizophrenia, and so far, inconsistent results have been reported. We studied 41 outpatients with schizophrenia (based on DSM?IV criteria), who were divided into two groups: with (n?=?17) and without (n?=?24) a substance use disorder (alcohol, cannabis, and/or cocaine). Both groups were matched for sociodemographic data and psychiatric symptoms (Positive and Negative Syndrome...

Potvin, S.; Pampoulova, T.; Mancini?marie?, A.; Lipp, O.; Bouchard, R?h; Stip, E.

2006-01-01

162

Cannabis sativa var. indica : une plante complexe aux effets pervers Cannabis sativa var. indica : a complex plant with perverse effects  

Directory of Open Access Journals (Sweden)

Full Text Available Cannabis sativa var. indica appartient à la famille des Cannabinaceae et à l'ordre des Urticales. Parmi les 60 cannabinoïdes contenus dans la plante, essentiellement dans les feuilles et les sommités fleuries, le delta-9-tétrahydrocannabinol (THC constitue le principal responsable des effets observables chez l'homme. La teneur en THC est très variable selon les conditions de culture, pouvant dépasser 20 % dans le cas de cultures sous serre aux conditions parfaitement contrôlées. Après inhalation, le THC pénètre dans la circulation sanguine puis, très lipophile, va se fixer sur les tissus riches en lipides et en particulier au niveau du cerveau. Ses effets chez l'homme reposent sur l'existence des récepteurs CB1 (essentiellement au niveau central et CB2 (surtout présents au niveau périphérique. Tandis que la présence du THC dans le sang n'est observable que pendant 2 à 3 heures après inhalation, des travaux très récents chez l'homme et chez l'animal nous ont permis de montrer qu'il restait fixé dans la plupart des structures cérébrales pendant de très nombreuses heures, cela expliquant la persistance importante de ses effets sur le système nerveux central. Les effets aigus sur le psychisme consistent principalement en des perturbations sensorielles, des troubles thymiques et dissociatifs, une diminution des performances intellectuelles, motrices et cognitives, des perturbations de la mémoire à court terme. Lors d'un usage important, régulier et prolongé, on note fréquemment l'apparition de crises d'angoisse aiguë et d'un syndrome amotivationnel. Si les risques pour soi-même liés à son usage sont loin d'être négligeables, les conséquences pour autrui peuvent être considérables lorsque les consommateurs sont des conducteurs d'automobiles, des femmes enceintes ou des travailleurs occupant des postes à risque et/ou de sécurité en entreprise. L'importance du risque est majorée par un nombre de consommateurs de plus en plus grand. C'est pour cette raison que la France a récemment mis en place une législation destinée à sanctionner les conducteurs ayant fait usage de cannabis, sur la base des résultats de l'analyse sanguine. C'est aussi pourquoi il serait désormais opportun d'instaurer par voie législative des dépistages chez les personnes occupant des postes à risque et/ou de sécurité dans les entreprises. Cannabis sativa var. indica is a Cannabaceae, belonging to Urticales order. Among the 60 cannabinoids present in the plant and essentially in leaves and flowering tops, delta-9-tetrahydrocannabinol (THC is the main responsible of the effects observed in human using it. THC content is very variable depending on cultivation conditions, being able to contain more than 20 % of THC in the case of under glass cultivations with well controlled conditions. After inhalation, THC moves to the blood and, because of its lipophily, distribution very fastly into the brain and other lipidic tissues. Its effects on human are supported by the presence of CB1 receptors (mainly in central nervous system and CB2 (mainly present in other tissues. As THC is found in blood during only 2 to 3 hours after inhalation, recent studies allowed us to indicate that it remained present in brain structures during many hours, which explains the long persistence of its effects on central nervous system. Acute side effects on behavior and central nervous system consist essentially in sensitive perturbations, thymic and dissociative troubles, a decrease of intellectual, motor and cognitive performances, short term memory disorders. For an important, regular and long term use, the occurrence of acute angor attacks or an amotivational syndrome are frequently observed. While risks for oneself related to cannabis use are not negligible, consequences for others may be extensive when consumers are car drivers, pregnant women or workers occupying a risk position. This risk is becoming very important today considering account of the number of consumers. Consequently, the French government and th

Mura Patrick

2009-03-01

163

HIV Symptoms  

Science.gov (United States)

... Submit Home > HIV/AIDS > What is HIV/AIDS? HIV/AIDS This information in Spanish ( en español ) HIV symptoms Photo courtesy of AIDS.gov Facing AIDS ... and brain Return to top More information on HIV symptoms Explore other publications and websites Basic Information ...

164

Cannabis, cannabidiol, and epilepsy--from receptors to clinical response.  

Science.gov (United States)

Recreational cannabis use in adults with epilepsy is widespread. The use of cannabis for medicinal purposes is also becoming more prevalent. For this purpose, various preparations of cannabis of varying strengths and content are being used. The recent changes in the legal environment have improved the availability of products with high cannabidiol (CBD) and low tetrahydrocannabinol (THC) concentrations. There is some anecdotal evidence of their potential efficacy, but the mechanisms of such action are not entirely clear. Some suspect an existence of synergy or "entourage effect" between CBD and THC. There is strong evidence that THC acts via the cannabinoid receptor CB1. The mechanism of action of CBD is less clear but is likely polypharmacological. The scientific data support the role of the endocannabinoid system in seizure generation, maintenance, and control in animal models of epilepsy. There are clear data for the negative effects of cannabis on the developing and mature brain though these effects appear to be relatively mild in most cases. Further data from well-designed studies are needed regarding short- and long-term efficacy and side effects of CBD or high-CBD/low-THC products for the treatment of seizures and epilepsy in children and adults. PMID:25282526

Szaflarski, Jerzy P; Bebin, E Martina

2014-12-01

165

Trajectory of adolescent cannabis use on addiction vulnerability.  

Science.gov (United States)

The adolescent brain is a period of dynamic development making it vulnerable to environmental factors such as drug exposure. Of the illicit drugs, cannabis is most used by teenagers since it is perceived by many to be of little harm. This perception has led to a growing number of states approving its legalization and increased accessibility. Most of the debates and ensuing policies regarding cannabis were done without consideration of its impact on one of the most vulnerable population, namely teens, or without consideration of scientific data. We provide an overview of the endocannabinoid system in relation to adolescent cannabis exposure and provide insights regarding factors such as genetics and behavioral traits that confer risk for subsequent addiction. While it is clear that more systematic scientific studies are needed to understand the long-term impact of adolescent cannabis exposure on brain and behavior, the current evidence suggests that it has a far-reaching influence on adult addictive behaviors particularly for certain subsets of vulnerable individuals. This article is part of a Special Issue entitled 'NIDA 40th Anniversary Issue'. PMID:23954491

Hurd, Yasmin L; Michaelides, Michael; Miller, Michael L; Jutras-Aswad, Didier

2014-01-01

166

Reasons for cannabis use in men with and without psychosis.  

Science.gov (United States)

Psychoses are relatively low prevalence disorders that have a disproportionately negative impact on individuals and society. Cannabis use is one factor that can exacerbate the negative consequences associated with psychotic disorders. Relatively few studies have examined the effects or reasons for using cannabis self-reported by individuals with psychosis. The present study is the first known to compare directly such factors in individuals with and without psychosis, within a single study. At baseline and follow-up participants with psychosis most commonly reported using cannabis for positive mood alteration (36% and 42%), coping with negative affect (27% and 29%) and for social activity reasons (38% and 29%). The control group most commonly reported using cannabis for relaxation (34% and 43%) and social activity reasons (49% and 51%). Participants with psychosis were less likely to report relaxation as the most important effect after use (27%) or expect it at follow-up (49%) compared to the control group (53% and 70%). In both groups, addiction and positive affect enhancement were the composite variable scores correlated most consistently with concurrent amount and frequency of use. PMID:15763749

Green, Bob; Kavanagh, David J; Young, Ross M C D

2004-12-01

167

Chronic cannabis users: Further analysis of objective test results.  

Science.gov (United States)

Twelve objective tests, generating 16 psychological test variables were administered to 850 chronic cannabis takers and 839 non-takers, all Egyptian males, ranging in age between 15 and 50 years, and representing various positions on continua of literacy-illiteracy and urbanism-ruralism. The tests were intended to assess different modalities of 5 broad psychological functions: speed of psychomotor performance, estimation of moderate distances, estimation of a few minutes time interval, immediate memory for digits and designs and visual-motor co-ordination. Analysis of variance based on 3 x 3 x 2 factorial design was carried out and revealed statistically significant differences between the two groups of subjects on most of the test variables. Detailed analyses showed that controls displayed better performance than drug users on the majority of the variables. Significant second order interaction effects emerged in a big number of cases denoting that, under certain conditions relating to literacy-illiteracy and urbanism-ruralism, the superiority of controls over cannabis users became much more impressive. Our findings were discussed in the light of investigations which were conducted on the psychological correlates and/or effects of long term and short term cannabis consumption. The clinical psychological literature was cited where slowness of psychomotor performance, defective visual-motor co-ordination and impaired memory for designs were reported to be associated with psychiatric disorder. It is suggested that our results point to meaningful associations between chronic cannabis consumption and manifestations of psychopathology. PMID:1044285

Soueif, M I

1975-01-01

168

Long-Term Heavy Cannabis Use: Implications for Health Education  

Science.gov (United States)

There is growing evidence that cannabis can have negative effects on health. While the ongoing debate about the nature and duration of these effects recognizes mild cognitive impairment, the evidence for irreversibility of cognitive impairment and causal links with psychiatric illness is not conclusive. There is undoubtedly potential for…

Coggans, Niall; Dalgarno, Phil; Johnson, Lindsay; Shewan, David

2004-01-01

169

Reversal of metabolic and neurological symptoms of phenylketonuric mice treated with a PAH containing helper-dependent adenoviral vector.  

Science.gov (United States)

Phenylketonuria (PKU) is one of the most common inborn errors of metabolism and is due to a deficit of phenylalanine hydroxylase, the enzyme that converts phenylalanine (Phe) into tyrosine (Tyr). The resultant hyperphenylalaninemia (HPA) leads to severe neurological impairment, whose pathogenesis has not been entirely elucidated. Treatment of PKU consists essentially in lifelong protein restriction and, in mild cases, in tetrahydrobiopterin supplementation. However, compliance to both strategies, particularly to the long-term diet, is low and therefore other therapies are desirable. We explored a gene therapy approach aimed at long-term correction of the pathologic phenotype of BTBR-PahEnu2 mice, a mouse model of PKU. To this aim, we developed a helper-dependent adenoviral (HD-Ad) vector expressing phenylalanine hydroxylase and administered it to 3-week-old PKU mice. This resulted in complete normalization of Phe and Tyr levels and reversal of coat hypopigmentation that lasted throughout the observation period of six months. The spatial learning deficits observed in PKU mice were also reversed and hippocampus levels of the N-methyl-D-Aspartate and 2-amino-3-(5-methyl-3-oxo-1,2- oxazol-4-yl) propanoic acid receptor subunits returned to normal. Long-term potentiation, which is impaired in PKU mice, was also restored by treatment. Therefore, HD-Ad vector-mediated gene therapy is a promising approach to PKU treatment. PMID:22348550

Cerreto, Monica; Mehdawy, Bisan; Ombrone, Daniela; Nisticò, Robert; Ruoppolo, Margherita; Usiello, Alessandro; Daniele, Aurora; Pastore, Lucio; Salvatore, Francesco

2012-02-01

170

Syphilis Symptoms  

Science.gov (United States)

... JavaScript on. Read more information on enabling JavaScript. Syphilis Skip Content Marketing Share this: Main Content Area ... occurs in four stages that sometimes overlap. Primary Syphilis The first symptom of primary syphilis is often ...

171

Los productos de Cannabis sativa: situación actual y perspectivas en medicina / Cannabis sativa products: current status and perspectives in medicine  

Scientific Electronic Library Online (English)

Full Text Available SciELO Mexico | Language: Spanish Abstract in spanish Los productos psicoactivos de la Cannabis sativa, como marihuana y hachís, se han usado desde hace varios siglos con fines medicinales, religiosos y recreativos. Ahora, la marihuana es la droga ilegal de mayor consumo en el mundo, particularmente por adolescentes y adultos jóvenes. La adolescencia e [...] s una etapa crítica en el desarrollo y maduración del Sistema Nervioso Central. La marihuana está constituida por un gran número y variedad de substancias químicas que pueden interactuar entre sí. Sus efectos agudos se caracterizan por euforia, relajación e intensificación de las experiencias sensoriales ordinarias. Su consumo crónico induce tolerancia, dependencia, síndrome de carencia, déficit cognitivo y aumenta el riesgo de enfermedades psiquiátricas. El descubrimiento de un sistema cannabinoide endógeno renovó el interés médico por la marihuana y los datos de los últimos 20 años indican que el sistema endocannabinoide regula la función de diversos tipos de sinapsis y juega un papel importante en el desarrollo cerebral extrauterino. Recientemente el interés sobre la marihuana se centró en sus propiedades medicinales y existe un buen número de ensayos clínicos controlados que apoyan su uso en ciertas condiciones médicas; sin embargo, su eficacia y seguridad siguen siendo motivo de controversia. En este artículo se analizan los conocimientos farmacológicos sobre la marihuana, se establecen los riesgos de su consumo, la información sobre sus propiedades medicinales y, con base en la evidencia disponible, se opina contra su legalización. Finalmente, aquí se postula que la marihuana en su forma herbaria, por vía enteral, puede ser de gran valor para mitigar el sufrimiento de pacientes con enfermedad terminal. Abstract in english Psychoactive preparations of Cannabis sativa, such as marijuana and hashish, have been used for centuries for medicinal, religious and recreational purposes. Today marijuana is the most widely used illegal drug worldwide, particularly among teenagers and young adults. Adolescence is a critical phase [...] in Central Nervous System development, characterized by neuronal maturation and rearrangement processes. Marijuana is very complex in its chemistry due to the large number of active constituents capable of interacting with each other. With inhaled marihuana, subjects experience euphoria, a feeling of relaxation, and intensification of ordinary sensory experiences. Chronic consumption results in tolerance, dependence, withdrawal syndrome, cognitive deterioration, and increased risk of psychiatric illnesses. The discovery of an endogenous cannabinoid system renewed the medical interest in marijuana and data from the last 20 years have shown that, in the postnatal brain, endocannabinoids regulate the function of many synapses and play an important role in brain development; also, that chronic consumption of marijuana early in life negatively affects Central Nervous System development. Recently, interest on marijuana has centered on its medicinal properties, and a good number of controlled clinical studies support its use in certain medical conditions; however, safety and efficacy of marijuana remains controversial. In this article we analyze the pharmacological knowledge on marijuana, the risks of its consumption, data on its medicinal properties and, based on the available evidence, we conclude that its legalization should be discouraged. Finally, we postulate that marijuana in its herbal form, by the enteral route, could be of a great value in mitigating suffering in patients with terminal illness.

Rodolfo, Rodríguez Carranza.

2012-06-01

172

Extraction of High Quality DNA from Seized Moroccan Cannabis Resin (Hashish)  

OpenAIRE

The extraction and purification of nucleic acids is the first step in most molecular biology analysis techniques. The objective of this work is to obtain highly purified nucleic acids derived from Cannabis sativa resin seizure in order to conduct a DNA typing method for the individualization of cannabis resin samples. To obtain highly purified nucleic acids from cannabis resin (Hashish) free from contaminants that cause inhibition of PCR reaction, we have tested two protocols: the CTAB protoc...

El Alaoui, Moulay Abdelaziz; Melloul, Marouane; Alaoui Amine, Sanaa?; Stambouli, Hamid; El Bouri, Aziz; Soulaymani, Abdelmajid; El Fahime, Elmostafa

2013-01-01

173

Lower Risk Cannabis Use Guidelines for Canada (LRCUG) : A?Narrative Review of Evidence and Recommendations  

OpenAIRE

Objectives: More than one in ten adults – and about one in three young adults – report past year cannabis use in Canada. While cannabis use is associated with a variety of health risks, current policy prohibits all use, rather than adopting a public health approach focusing on interventions to address specific risks and harms as do policies for alcohol. The objective of this paper was to develop ‘Lower Risk Cannabis Use Guidelines’ (LRCUG) based on research evidence on the adverse hea...

Fischer, B.; Jeffries, V.; Hall, W.; Room, Robin; Goldner, E.; Rehm, J.

2011-01-01

174

Disposition of smoked cannabis with high [Delta]9-tetrahydrocannabinol content: a kinetic model  

OpenAIRE

Introduction No model exists to describe the disposition and kinetics of inhaled cannabis containing a high THC dose. We aimed to develop a kinetic model providing estimates of the THC serum concentrations after smoking cannabis cigarettes containing high THC doses (up to 69 mg THC).Methods Twenty-four male non-daily cannabis users smoked cannabis cigarettes containing 29.3 mg, 49.1 mg, and 69.4 mg THC. Blood samples were collected over a period of 0-8 h and serum THC concentrations wer...

Hunault, C. C.; Eijkeren, J. C. H.; Mensinga, T. T.; Vries, Irma; Leenders, M. E. C.; Meulenbelt, J.

2010-01-01

175

Early onset cannabis use and progression to other drug use in a sample of Dutch twins.  

Science.gov (United States)

One possible explanation of the commonly reported associations between early onset cannabis use and elevated risks of other illicit drug use is that early onset cannabis use increases access and availability to other drugs. It was this argument that in part motivated policy changes in the Netherlands that led to the de facto legalization of cannabis there. This study examines, using a co-twin control design, whether previously observed associations between early onset cannabis use and elevated lifetime rates of other illicit drug use would also be observed in a sample of 219 same sex Dutch twin pairs discordant for cannabis use before age 18. After adjustment for covariates, rates of lifetime party drug use (OR=7.4, 95% CI=2.3-23.4), hard drug use (OR=16.5, 95% CI=2.4-111.3), but not regular cannabis use (OR=1.3, 95% CI=0.3-5.1) were significantly elevated in individuals who reported early onset cannabis use, relative to their co-twin who had not used cannabis by age 18. The elevated odds of subsequent illicit drug use in early cannabis users relative to their non early using co-twins suggests that this association could not be explained by common familial risk factors, either genetic or environmental, for which our co-twin methodology provided rigorous control. PMID:16402286

Lynskey, Michael T; Vink, Jacqueline M; Boomsma, Dorret I

2006-03-01

176

A nonsynonymous polymorphism in the human fatty acid amide hydrolase gene did not associate with either methamphetamine dependence or schizophrenia.  

Science.gov (United States)

Genetic contributions to the etiology of substance abuse and dependence are topics of major interest. Acute and chronic cannabis use can produce drug-induced psychosis resembling schizophrenia and worsen positive symptoms of schizophrenia. The endocannabinoid system is one of the most important neural signaling pathways implicated in substance abuse and dependence. The fatty acid amide hydrolase (FAAH) is a primary catabolic enzyme of endocannabinoids. To clarify a possible involvement of FAAH in the etiology of methamphetamine dependence/psychosis or schizophrenia, we examined the genetic association of a nonsynonymous polymorphism of the FAAH gene (Pro129Thr) by a case-control study. We found no significant association in allele and genotype frequencies of the polymorphism with either disorder. Because the Pro129Thr polymorphism reduces enzyme instability, it is unlikely that dysfunction of FAAH and enhanced endocannabinoid system induce susceptibility to either methamphetamine dependence/psychosis or schizophrenia. PMID:15721218

Morita, Yukitaka; Ujike, Hiroshi; Tanaka, Yuji; Uchida, Naohiko; Nomura, Akira; Ohtani, Kyohei; Kishimoto, Makiko; Morio, Akiko; Imamura, Takaki; Sakai, Ayumu; Inada, Toshiya; Harano, Mutsuo; Komiyama, Tokutaro; Yamada, Mitsuhiko; Sekine, Yoshimoto; Iwata, Nakao; Iyo, Masaomi; Sora, Ichiro; Ozaki, Norio; Kuroda, Shigetoshi

2005-03-16

177

Antigiardial Activity and Toxicological Exploration of Cannabis Sativa Extracts  

Directory of Open Access Journals (Sweden)

Full Text Available The present study has been attempt to elucidate antigiardial activity and explore the cytoxicity, investigation on liver Diagnostic Enzymes and Changes in serum constituents of Cannabis Sativa aerial parts and seeds, which were extracted by Petroleum ether and methanol. Aerial parts methanolic extract gave 63.6% mortality after 72 hours at concentration 1000 ppm (IC50 0.13 ppm comparing with metrondizole (IC50 0.0125 ppm. While the other extracts found inactive as antigiardiasis after 72 hours. The slight increase in Aspartate amino transferase (AST, Alanine amino transferase (ALT and Alkaline phosphatase (ALP liver enzyme and total protein, urea, albumin and calcium which indicate some degree hepatic nefropathy effect of such plant petroleum ether extract. Moreover, phytochemical examination was carried out firstly and revealed that, the petroleum ether extract of Cannabis sativa seed do not contain tetrahydrocannbinol (THC, cannabinol (CBN and cannabidaiol (CBD. However, all extracts showed no significant cytotoxic activity against vero cell line.

Mahmoud M.DAHAB

2013-05-01

178

Crop physiology of fibre hemp (Cannabis sativa L.).  

OpenAIRE

Fibre hemp ( Cannabis sativa L.) may be an alternative to wood as a raw material for the production of paper pulp. The effects of enviromnental factors and cultural measures on the functioning, yield and quality of fibre hemp crops in the Netherlands were investigated.Until flowering (generally in August), the radiation use efficiency (RUE, above-ground dry matter accumulated per unit of photosynthetically active radiation intercepted) of hemp was 2.2 g MJ -1, after flowering it d...

Werf, H.

1994-01-01

179

Effect of hydrolysis on identifying prenatal cannabis exposure  

OpenAIRE

Identification of prenatal cannabis exposure is important due to potential cognitive and behavioral consequences. A two-dimensional gas chromatography–mass spectrometry method for cannabinol, ?9-tetrahydrocannabinol (THC), 11-hydroxy-THC (11-OH-THC), 8?,11-dihydroxy-THC, and 11-nor-9-carboxy-THC (THCCOOH) quantification in human meconium was developed and validated. Alkaline, enzymatic, and enzyme–alkaline tandem hydrolysis conditions were optimized with THC- and THCCOOH-glucuronide ref...

Gray, Teresa R.; Barnes, Allan J.; Huestis, Marilyn A.

2010-01-01

180

Cloud point extraction of ?9-tetrahydrocannabinol from cannabis resin  

OpenAIRE

A cloud point extraction coupled with high performance liquid chromatography (HPLC/UV) method was developed for the determination of ?9-tetrahydrocannabinol (THC) in micellar phase. The nonionic surfactant "Dowfax 20B102" was used to extract and pre-concentrate THC from cannabis resin, prior to its determination with a HPLC-UV system (diode array detector) with isocratic elution. The parameters and variables affecting the extraction were investigated. Under optimum conditions (1 wt.% Dowfax ...

Ameur, S.; Haddou, Boumediene; Derriche, Zoubir; Canselier, Jean-paul; Gourdon, Christophe

2013-01-01

181

Differential association between chronic cannabis use and brain function deficits.  

Science.gov (United States)

To summarize, 12 objective tests that generated 16 test variables were administered to 850 male regular cannabis users and 839 nonusers. The tests were designed to assess various modalities, including speed of psychomotor performance, distance estimation, time estimation, immediate memory, and visuomotor coordination. Most of the test variables differentiated significantly between consumers and controls. At the same time, a significant second-order interaction emerged in most cases. This interaction meant that, under certain conditions that relate to the two dimensions "literacy-illiteracy" and/or "urbanism-ruralism," the superiority of controls over cannabis users became impressive, whereas under other conditions it almost disappeared. To account for this complex pattern of results, a working hypothesis was presented to the effect that "other conditions being equal, the lower the nondrug level of proficiency on tests of cognitive and psychomotor performance the smaller the size of function deficit associated with drug usage." For an empirical examination of the hypothesis, six predictions were formulated. Three predictions defined specific relationships between level of performance, on one hand, and each of three organismic variables, on the other: literacy, urbanism, and age. The remaining predictions delineated relationships to be expected between size of function deficit and the three organismic variables. All our predictions were confirmed, showing less function impairment to be contingent with cannabis usage among the illiterates, rurals, and older subjects. Level of cortical arousal was suggested as the central process associated with the three organismic variables. Because the version of our working hypothesis was formulated with reference to chronic material, the possibility of a transposition of the paradign to research on the acute effects of the drug was discussed. The suggestion was made that our working hypothesis, in either version, is capable of establishing genuine integration between reports that present conflicting results on possible function deficits contingent with cannabis consumption. PMID:1071386

Soueif, M I

1976-01-01

182

Antibacterial Cannabinoids from Cannabis sativa: A Structure?Activity Study  

OpenAIRE

Marijuana (Cannabis sativa) has long been known to contain antibacterial cannabinoids, whose potential to address antibiotic resistance has not yet been investigated. All five major cannabinoids (cannabidiol (lb), cannabichromene (2), cannabigerol (3b), ?9-tetrahydrocannabinol (4b), and cannabinol (5)) showed potent activity against a variety of methicillin- resistant Staphylococcus aureus (MRSA) strains of current clinical relevance. Activity was remarkably tolerant to the nature of the pre...

Appendino, G.; Gibbons, S.; Giana, A.; Pagani, A.; Grassi, G.; Stavri, M.; Smith, E. C. J.; Rahman, M. M.

2008-01-01

183

Design paper: The CapOpus trial: a randomized, parallel-group, observer-blinded clinical trial of specialized addiction treatment versus treatment as usual for young patients with cannabis abuse and psychosis  

DEFF Research Database (Denmark)

BACKGROUND: A number of studies indicate a link between cannabis-use and psychosis as well as more severe psychosis in those with existing psychotic disorders. There is currently insufficient evidence to decide the optimal way to treat cannabis abuse among patients with psychosis. OBJECTIVES: The major objective for the CapOpus trial is to evaluate the additional effect on cannabis abuse of a specialized addiction treatment program adding group treatment and motivational interviewing to treatment as usual. DESIGN: The trial is designed as a randomized, parallel-group, observer-blinded clinical trial. Patients are primarily recruited through early-psychosis detection teams, community mental health centers, and assertive community treatment teams. Patients are randomized to one of two treatment arms, both lasting six months: 1) specialized addiction treatment plus treatment as usual or 2) treatment as usual. The specialized addiction treatment is manualized and consists of both individual and group-based motivational interviewing and cognitive behavioral therapy, and incorporates both the family and the case manager of the patient.The primary outcome measure will be changes in amount of cannabis consumption over time. Other outcome measures will be psychosis symptoms, cognitive functioning, quality of life, social functioning, and cost-benefit analyses. TRIAL REGISTRATION: ClinicalTrials.gov NCT00484302.

HjorthØj, Carsten; Fohlmann, Allan

2008-01-01

184

Design paper: The CapOpus trial: A randomized, parallel-group, observer-blinded clinical trial of specialized addiction treatment versus treatment as usual for young patients with cannabis abuse and psychosis  

Directory of Open Access Journals (Sweden)

Full Text Available Abstract Background A number of studies indicate a link between cannabis-use and psychosis as well as more severe psychosis in those with existing psychotic disorders. There is currently insufficient evidence to decide the optimal way to treat cannabis abuse among patients with psychosis. Objectives The major objective for the CapOpus trial is to evaluate the additional effect on cannabis abuse of a specialized addiction treatment program adding group treatment and motivational interviewing to treatment as usual. Design The trial is designed as a randomized, parallel-group, observer-blinded clinical trial. Patients are primarily recruited through early-psychosis detection teams, community mental health centers, and assertive community treatment teams. Patients are randomized to one of two treatment arms, both lasting six months: 1 specialized addiction treatment plus treatment as usual or 2 treatment as usual. The specialized addiction treatment is manualized and consists of both individual and group-based motivational interviewing and cognitive behavioral therapy, and incorporates both the family and the case manager of the patient. The primary outcome measure will be changes in amount of cannabis consumption over time. Other outcome measures will be psychosis symptoms, cognitive functioning, quality of life, social functioning, and cost-benefit analyses. Trial registration ClinicalTrials.gov NCT00484302.

Gluud Christian

2008-07-01

185

Aspectos terapêuticos de compostos da planta Cannabis sativa / Therapeutical aspects of compounds of the plant Cannabis sativa  

Scientific Electronic Library Online (English)

Full Text Available SciELO Brazil | Language: Portuguese Abstract in portuguese [...] Abstract in english Several cannabinoid compounds present therapeutic properties, but also have psychotropic effects, limiting their use as medicine. Nowadays, many important discoveries on the compounds extracted from the plant Cannabis sativa (cannabinoids) have contributed to understand the therapeutic properties of [...] these compounds. The main discoveries in the last years on the cannabinoid compounds were: the cannabinoid receptors CB1 and CB2, the endogenous cannabinoids and the possible mechanisms of action involved in the interaction between cannabinoid compounds and the biological receptors. So, from the therapeutical aspects presented in this work, we intended to show the evolution of the Cannabis sativa research and the possible medicinal use of cannabinoid compounds.

Káthia Maria, Honório; Agnaldo, Arroio; Albérico Borges Ferreira da, Silva.

2006-04-01

186

Cannabis sativa var. indica : une menace croissante pour les entreprises Cannabis sativa var. indica: an increasing hazard for firms  

OpenAIRE

Parmi les drogues illicites, le cannabis est de très loin le produit le plus consommé. Les effets sur l'organisme sont principalement dus au delta-9-tétrahydrocannabinol (THC). Lors d'un usage peu important et occasionnel, ils consistent en une euphorie, une désinhibition, un état de somnolence, avec détérioration de la perception temporelle et spatiale. Les perturbations de la vision consistent en une mydriase, pouvant être accompagnée d'un nystagmus et d'une diplopie. Des troubles ...

Mura Patrick

2009-01-01

187

Temperature response of photosynthesis in different drug and fiber varieties of Cannabis sativa L.  

Science.gov (United States)

The temperature response on gas and water vapour exchange characteristics of three medicinal drug type (HP Mexican, MX and W1) and four industrial fiber type (Felinq 34, Kompolty, Zolo 11 and Zolo 15) varieties of Cannabis sativa, originally from different agro-climatic zones worldwide, were studied. Among the drug type varieties, optimum temperature for photosynthesis (Topt) was observed in the range of 30-35 °C in high potency Mexican HPM whereas, it was in the range of 25-30 °C in W1. A comparatively lower value (25 °C) for Topt was observed in MX. Among fiber type varieties, Topt was around 30 °C in Zolo 11 and Zolo 15 whereas, it was near 25 °C in Felinq 34 and Kompolty. Varieties having higher maximum photosynthesis (PN max) had higher chlorophyll content as compared to those having lower PN max. Differences in water use efficiency (WUE) were also observed within and among the drug and fiber type plants. However, differences became less pronounced at higher temperatures. Both stomatal and mesophyll components seem to be responsible for the temperature dependence of photosynthesis (PN) in this species, however, their magnitude varied with the variety. In general, a two fold increase in dark respiration with increase in temperature (from 20 °C to 40 °C) was observed in all the varieties. However, a greater increase was associated with the variety having higher rate of photosynthesis, indicating a strong association between photosynthetic and respiratory rates. The results provide a valuable indication regarding variations in temperature dependence of PN in different varieties of Cannabis sativa L. PMID:23573022

Chandra, Suman; Lata, Hemant; Khan, Ikhlas A; Elsohly, Mahmoud A

2011-07-01

188

Behavioral therapies for treatment-seeking cannabis users: a meta-analysis of randomized controlled trials.  

Science.gov (United States)

Narrative reviews conclude that behavioral therapies (BTs) produce better outcomes than control conditions for cannabis use disorders (CUDs). However, the strength and consistency of this effect has not been directly empirically examined. The present meta-analysis combined multiple well-controlled studies to help clarify the overall impact of behavioral interventions in the treatment of CUDs. A comprehensive literature search produced 10 randomized controlled trials (RCTs; n = 2,027) that were included in the final analyses. Analyses indicated an effect of BTs (including contingency management, relapse prevention, and motivational interviewing, and combinations of these strategies with cognitive behavioral therapy) over control conditions (including waitlist [WL], psychological placebo, and treatment as usual) across pooled outcomes and time points (Hedges' g = 0.44). These results suggest that the average patient receiving a behavioral intervention fared better than 66% of those in the control conditions. BT also outperformed control conditions when examining primary outcomes alone (frequency and severity of use) and secondary outcomes alone (psychosocial functioning). Effect sizes were not moderated by inclusion of a diagnosis (RCTs including treatment-seeking cannabis users who were not assessed for abuse or dependence vs. RCTs including individuals diagnosed as dependent), dose (number of treatment sessions), treatment format (either group vs. individual treatment or in-person vs. non-in-person treatment), sample size, or publication year. Effect sizes were significantly larger for studies that included a WL control comparison versus those including active control comparisons, such that BT significantly outperformed WL controls but not active control comparisons. PMID:24695072

Davis, Michelle L; Powers, Mark B; Handelsman, Pamela; Medina, Johnna L; Zvolensky, Michael; Smits, Jasper A J

2015-03-01

189

Cannabis Use and Related Harms in the Transition to Young Adulthood: A Longitudinal Study of Australian Secondary School Students  

Science.gov (United States)

The current study documents the changing rates of cannabis use, misuse and cannabis-related social harms among Australian adolescents as they grow into young adulthood. It utilised data from a longitudinal study of young people at ages 15, 16, 17, and 19. The rates of cannabis use were found to increase as participants aged; past year use…

Scholes-Balog, Kirsty E.; Hemphill, Sheryl A.; Patton, George C.; Toumbourou, John W.

2013-01-01

190

Characteristics and Predictors of Health Problems from Use among High-Frequency Cannabis Users in a Canadian University Student Population  

Science.gov (United States)

Aims: Assess key cannabis use, risk and outcome characteristics among high-frequency cannabis users within a university student sample in Toronto, Canada. Methods: N = 134 active universities students (ages of 18-28) using cannabis at least three times per week were recruited by mass advertisement, telephone-screened and anonymously assessed by an…

Fischer, Benedikt; Dawe, Meghan; Mcguire, Fraser; Shuper, Paul A; Jones, Wayne; Rudzinski, Katherine; Rehm, Jurgen

2012-01-01

191

[Addiction and schizophrenia. Nosological, clinical and therapeutic questions. 2. Substance dependence and schizophrenia].  

Science.gov (United States)

While schizophrenia-like psychosis is known to occur with chronic alcoholism the nosological differentiation of schizophrenia-like psychosis in patients with drug abuse remains difficult. An increased risk for the development of such psychoses has been discussed for various substances, e.g. cannabis. On the one hand this is supported by clinical and epidemiological studies but a final agreement has not been reached. On the other hand high prevalence estimates for substance abuse in schizophrenics have been reported in the angloamerican literature. Prevalence estimates for drug abuse and dependence range between 7-65% and a comparatively distinct abuse pattern in schizophrenics has been discerned: Apart from alcohol schizophrenics tend to abuse cannabis and psychostimulants including cocaine and hallucinogenes, whereas narcotics are abused only infrequently. Whether these recent figures for substance abuse and dependence are due to a real increase (32) or to improved diagnostic instruments and differences in the classification of psychiatric disorders or to selected samples (3, 122) is still a matter of controversy. In comparison with other schizophrenics dual diagnosis schizophrenics show more positive (psychotic) and less negative symptoms. In this review some clinical and neuro-biological problems concerning the concept of drug-induced psychosis and basic principles of pharmacotherapy and psychotherapy in schizophrenic patients with substance abuse are discussed. PMID:8050773

Soyka, M

1994-06-01

192

Cannabis-based medicines--GW pharmaceuticals: high CBD, high THC, medicinal cannabis--GW pharmaceuticals, THC:CBD.  

Science.gov (United States)

GW Pharmaceuticals is undertaking a major research programme in the UK to develop and market distinct cannabis-based prescription medicines [THC:CBD, High THC, High CBD] in a range of medical conditions. The cannabis for this programme is grown in a secret location in the UK. It is expected that the product will be marketed in the US in late 2003. GW's cannabis-based products include selected phytocannabinoids from cannabis plants, including D9 tetrahydrocannabinol (THC) and cannabidiol (CBD). The company is investigating their use in three delivery systems, including sublingual spray, sublingual tablet and inhaled (but not smoked) dosage forms. The technology is protected by patent applications. Four different formulations are currently being investigated, including High THC, THC:CBD (narrow ratio), THC:CBD (broad ratio) and High CBD. GW is also developing a specialist security technology that will be incorporated in all its drug delivery systems. This technology allows for the recording and remote monitoring of patient usage to prevent any potential abuse of its cannabis-based medicines. GW plans to enter into agreements with other companies following phase III development, to secure the best commercialisation terms for its cannabis-based medicines. In June 2003, GW announced that exclusive commercialisation rights for the drug in the UK had been licensed to Bayer AG. The drug will be marketed under the Sativex brand name. This agreement also provides Bayer with an option to expand their license to include the European Union and certain world markets. GW was granted a clinical trial exemption certificate by the Medicines Control Agency to conduct clinical studies with cannabis-based medicines in the UK. The exemption includes investigations in the relief of pain of neurological origin and defects of neurological function in the following indications: multiple sclerosis (MS), spinal cord injury, peripheral nerve injury, central nervous system damage, neuroinvasive cancer, dystonias, cerebral vascular accident and spina bifida, as well as for the relief of pain and inflammation in rheumatoid arthritis and also pain relief in brachial plexus injury. The UK Government stated that it would be willing to amend the Misuse of Drugs Act 1971 to permit the introduction of a cannabis-based medicine. GW stated in its 2002 Annual Report that it was currently conducting five phase III trials of its cannabis derivatives, including a double-blind, placebo-controlled trial with a sublingual spray containing High THC in more than 100 patients with cancer pain in the UK. Also included is a phase III trial of THC:CBD (narrow ratio) being conducted in patients with severe pain due to brachial plexus injury, as are two more phase III trials of THC:CBD (narrow ratio) targeting spasticity and bladder dysfunction in multiple sclerosis patients. Another phase III trial of THC:CBD (narrow ratio) in patients with spinal cord injury is also being conducted. Results from the trials are expected during 2003. Three additional trials are also in the early stages of planning. These trials include a phase I trial of THC:CBD (broad ratio) in patients with inflammatory bowel disease, a phase I trial of High CBD in patients with psychotic disorders such as schizophrenia, and a preclinical trial of High CBD in various CNS disorders (including epilepsy, stroke and head injury). GW Pharmaceuticals submitted an application for approval of cannabis-based medicines to UK regulatory authorities in March 2003. Originally GW hoped to market cannabis-based prescription medicines by 2004, but is now planning for a launch in the UK towards the end of 2003. Several trials for GW's cannabis derivatives have also been completed, including four randomised, double-blind, placebo-controlled phase III clinical trials conducted in the UK. The trials were initiated by GW in April 2002, to investigate the use of a sublingual spray containing THC:CBD (narrow ratio) in the following medical conditions: pain in spinal cord injury, pain and sleep in MS and spinal cord injury, neuro

2003-01-01

193

Temperament and character traits associated with the use of alcohol, cannabis, cocaine, benzodiazepines, and hallucinogens: evidence from a large Brazilian web survey  

Scientific Electronic Library Online (English)

Full Text Available SciELO Brazil | Language: English Abstract in english Objectives: To evaluate how personality traits are associated with occasional use, abuse, and dependence of alcohol, cannabis, cocaine, benzodiazepines, and hallucinogens in a large availability sample of adults [...] via online questionnaires. Methods: The sample consisted of 8,646 individuals (24.7% men and 75.3% women) who completed an anonymous web survey. Involvement with drugs and temperament/character traits were assessed through the Alcohol, Smoking and Substance Involvement Screening Test (ASSIST) and the Temperament and Character Inventory - Revised (TCI-R), respectively. Interactions among variables were analyzed using MANOVA with Bonferroni adjustment. Results: Novelty seeking was the trait most associated with increased involvement with alcohol, cannabis, and cocaine. There was a significant association between harm avoidance and benzodiazepine use. Persistence was lower in cannabis-, benzodiazepine-, and cocaine-dependent subjects, as well as in hallucinogen abusers. Self-directedness was reduced in dependents of all drug classes. No strong relationships were found between other temperament or character dimensions and the severity of drug use. Conclusions: Novelty seeking was associated with increased involvement with all drugs studied in this sample, although to a lesser extent with benzodiazepines and hallucinogens. The temperament and character profile for benzodiazepine use was different from that of other drugs due to the relationship with higher harm avoidance and self-transcendence and lower self-directedness.

Ricardo, Schneider Jr.; Gustavo L., Ottoni; Hudson W. de, Carvalho; Elaine, Elisabetsky; Diogo R., Lara.

194

A rare case of cannabis hyperemesis syndrome relieved by hot water bathing.  

Science.gov (United States)

We present here a case of cannabinoid hyperemesis syndrome (CHS), which is an under-recognised disorder presenting in chronic abusers of cannabis typically as cyclical vomiting relieved by frequent hot baths. Increased awareness of CHS allows for earlier recognition by emergency departments, leading to prompter treatment and the prevention of future recurrence through cannabis cessation. PMID:24532755

Warner, Ben; Cairns, Stuart; Stone, Andy

2014-02-01

195

High-pressure liquid chromatography of cannabis. Quantitative analysis of acidic and neutral cannabinoids.  

Science.gov (United States)

A reversed-phase high-pressure liquid chromatographic method has been developed for the simultaneous analysis of the acidic and neutral cannabinoids in cannabis. Cannabigerol and cannabigerolic acid have been located in the liquid chromatogram of cannabis and factors affecting the chromatographic process are discussed. A method for quantitating one component in the presence of a second unresolved component is described. PMID:12189

Smith, R N; Vaughan, C G

1976-12-22

196

Association of gene-enviroment and age of pre-onset cannabis use with age at onset of psychosis in frist-episode patients  

OpenAIRE

Es conocida la influencia negativa del uso de cannabis sobre el curso y pronóstico de la esquizofrenia. El cannabis es, además, la sustancia de abuso más utilizada en pacientes con esquizofrenia (15%-65%). Sin embargo sólo una pequeña proporción de consumidores de cannabis desarrollan psicosis. Varios estudios han demostrado que el uso de cannabis precede al debut de la psicosis en varios años (entre 4 y 5 ). El inicio precoz del consumo de cannabis en la adolescencia, puede por tanto,...

Valdiza?n, Elsa M.; Pe?rez-iglesias, Roci?o; Mata, Ignacio; Moreno, Teresa; Pelayo-tera?n, J. M.; Vargas, Vero?nica Ine?s; Sa?nchez, M. Blanca; Pazos, A?ngel; Crespo-facorro, Benedicto

2009-01-01

197

Antimicrobial Activity of Cannabis sativa L.  

Directory of Open Access Journals (Sweden)

Full Text Available The oil of the seeds, petroleum ether and methanol extracts of the whole plant of Cannabis sativa belonging to the family Cannabinaceae were screened for their antimicrobial activity against two Gram positive organisms (Bacillus subtilis, Staphylococcus aureus, two Gram negative organisms (Escherichia coli, Pseudomonas aeruginosa and two fungi namely Aspergillus niger and Candida albicans using the cup plate agar diffusion method. The oil of the seeds of Cannabis sativa exerted pronounced antibacterial activity (21 - 28 mm against Bacillus subtilis and Staphylococcus aureus, moderate activity (15 mm against Escherichia coli and high activity (16 mm against Pseudomonas aeruginosa and inactive against the two fungi tested. The petroleum ether extract of the whole plant exhibited pronounced antibacterial activity (23 - 28 mm against both Bacillus subtilis and Staphylococcus aureus organisms, high activity (16 mm against Escherichia coli and inactive against Pseudomonas aeruginosa and both fungi. The methanol extract of the whole plant showed also pronounced antibacterial activity (29 mm against Bacillus subtilis, low activity (12 mm against Staphylococcus aureus and high activity (16 - 18 mm against both Gram negative organisms, inactive against Aspergillus niger and low activity (13 mm against Candida albicans. The minimum inhibitory concentrations of Cannabis sativa methanol extracts of the seeds and the whole plant against the standard organisms were determined using the agar plate dilution method. The standard organisms were tested against reference antibacterial and antifungal drugs and the results were compared with the activity of the extracts.

Esra M. M. Ali

2012-03-01

198

Complete sequence of a cryptic virus from hemp (Cannabis sativa).  

Science.gov (United States)

Hemp (Cannabis sativa) was found to be a useful propagation host for hop latent virus, a carlavirus. However, when virus preparations were analysed by electron microscopy, along with the expected filamentous particles, spherical particles with a diameter of around 34 nm were found. RNA from virus preparations was purified, and cDNA was prepared and cloned. Sequence information was used to search databases, and the greatest similarity was found with Primula malacoides virus 1, a putative new member of the genus Partitivirus. The full sequences of RNA 1 and RNA 2 of this new hemp cryptic virus were obtained. PMID:22075921

Ziegler, Angelika; Matoušek, Jaroslav; Steger, Gerhard; Schubert, Jörg

2012-02-01

199

Evolution of substance use, neurological and psychiatric symptoms in schizophrenia and substance use disorder patients: a 12-week, pilot, case-control trial with quetiapine  

Directory of Open Access Journals (Sweden)

Full Text Available Neurological and psychiatric symptoms are consequences of substance abuse in schizophrenia and non-schizophrenia patients. The present case-control study examined changes in substance abuse/dependence and neurological and psychiatric symptoms in substance abusers with (DD group, n=26 and without schizophrenia (SUD group, n=24 and in non-abusing schizophrenia patients (SCZ group, n=23 undergoing 12-week treatment with the atypical antipsychotic, quetiapine. Neurological and psychiatric symptoms were evaluated with the Positive and Negative Syndrome Scale, the Calgary Depression Scale for Schizophrenia, the Extrapyramidal Symptoms Rating Scale and the Barnes Akathisia Rating Scale. At endpoint, DD and SCZ patients were receiving significantly higher doses of quetiapine (mean = 554mg/d and 478mg/d, respectively, relative to SUD patients (mean = 150mg/d. We found that SUD patients showed greater improvement in weekly dollars spent on alcohol and drugs and SUD severity, compared to DD patients. At endpoint, there was no significant difference in dollars spent, but DD patients still had a higher mean SUD severity. Interestingly, DD patients had significantly higher Parkinsonism and depression than SCZ patients at baseline and endpoint. On the other hand, we found that SUD patients had significantly more akathisia at baseline, improved more than SCZ patients and this was related to cannabis abuse/dependence. Finally, SUD patients improved more in PANSS positive scores than DD and SCZ patients. Taken together, our results provide evidence for increased vulnerability to the adverse effects of alcohol and drugs in schizophrenia patients. They also suggest that substance abuse/withdrawal may mimic some symptoms of schizophrenia. Future studies will need to determine the role quetiapine played in these improvements.

StephanePotvin

2011-05-01

200

Cannabis, pesticides and conflicting laws: the dilemma for legalized States and implications for public health.  

Science.gov (United States)

State laws on the legalization of medical and recreational cannabis are rapidly evolving. Similar to other crops, cannabis is susceptible to multiple pests during cultivation. Growers have an economic incentive to produce large yields and high quality plants, and may resort to pesticides to achieve these outcomes. Currently, there are no pesticides registered for cannabis in the United States, given its illegal status by the federal government. This discrepancy creates a regulatory vacuum and dilemma for States with legal medical and recreational cannabis that seek to balance lawful compliance with pesticides and worker or public health. Pesticide use presents occupational safety issues that can be mitigated through established worker protection measures. The absence of approved products for cannabis may result in consumer exposures to otherwise more hazardous pesticides or higher residue levels. While many legal and scientific hurdles exist to register conventional pesticides for use on cannabis, legalized States have explored other opportunities to leverage the present regulatory infrastructure. Stakeholder engagement and outreach to the cannabis industry from credible sources could mitigate pesticide misuse and harm. PMID:24859075

Stone, Dave

2014-08-01

201

Multiple Myeloma Symptoms  

Science.gov (United States)

... CALL NOW Home » About Multiple Myeloma » Symptoms Multiple Myeloma Symptoms Multiple myeloma symptoms may vary by patient, ... be managed or prevented. The most common multiple myeloma symptoms may include: • Bone pain or bone fractures • ...

202

Symptoms of Parkinson's  

Science.gov (United States)

... Parkinson’s Disease? Coping with a Diagnosis What is Parkinson’s Disease? Diagnosis Symptoms Primary Motor Symptoms Secondary Motor Symptoms Nonmotor Symptoms Causes Progression Medications & Treatments Clinical Trials Statistics on Parkinson's Chasing the Cure ...

203

[Psychosis and cannabis consumption: study of the psychopathologic differences and risk factors].  

Science.gov (United States)

The consumption of Cannabis has been related with different psychiatric disorders. However the role of this drug in the etiology of disorders has not yet precisely been established. It has been discussed that the existence of an Induced Psychosis is brought about by the consumption of Cannabis. The objective of our study is to determine if there exists specific characteristics in the psychotic disorders manifested after the Cannabis consumption in comparison with a group of Psychotics non consumers. We also defined the risk factors that influence the appearance of the psychopathologic troubles. PMID:2368637

Crespo, M D; Morales, M P; Viñas, R; Ríos, B; Ruiz, L; Franco, B

1990-01-01

204

Legalization, decriminalization & medicinal use of cannabis: a scientific and public health perspective.  

Science.gov (United States)

Empirical and clinical studies clearly demonstrate significant adverse effects of cannabis smoking on physical and mental health as well as its interference with social and occupational functioning. These negative data far outweigh a few documented benefits for a limited set of medical indications, for which safe and effective alternative treatments are readily available. If there is any medical role for cannabinoid drugs, it lies with chemically defined compounds, not with unprocessed cannabis plant. Legalization or medical use of smoked cannabis is likely to impose significant public health risks, including an increased risk of schizophrenia, psychosis, and other forms of substance use disorders. PMID:22675784

Svrakic, Dragan M; Lustman, Patrick J; Mallya, Ashok; Lynn, Taylor Andrea; Finney, Rhonda; Svrakic, Neda M

2012-01-01

205

Quality and Yield of Cannabis Products : Danish seizures from 2008-2011  

DEFF Research Database (Denmark)

Abstract. 180 seizures containing 667 different samples of cannabis products from 5 police districts in Jutland were examined from 2008 to the present. The samples were divided into the groups: hashish, marihuana (leaves and buds) and whole plants (indoors and outdoors). Cannabis seized from indoor cultivation was examined in order to determine THC content and yield. The results are used by the Danish Police Attorney to estimate expected yields in cases with unripe cannabis plants. The results indicate that the THC content found in locally grown marihuana is slightly higher than in hashish. However, the way the plants are snipped during growth has a major impact on the overall yield.

Kastorp, Grith; Lindholst, Christian

206

Cannabis use and related harms in the transition to young adulthood: a longitudinal study of Australian secondary school students.  

Science.gov (United States)

The current study documents the changing rates of cannabis use, misuse and cannabis-related social harms among Australian adolescents as they grow into young adulthood. It utilised data from a longitudinal study of young people at ages 15, 16, 17, and 19. The rates of cannabis use were found to increase as participants aged; past year use increased from 7.5% at age 15 to 29.8% at age 19. Further, at ages 17 and 19, cannabis use was more prevalent among males than females. Among those who reported cannabis use, the rates of cannabis-related harms were low to moderate, and did not increase with age in the same manner as rates of cannabis use. The most prevalent self-reported cannabis-related harm was anxiety/depression; affecting between 20-30% of the cannabis users at each age. These findings may assist in understanding the extent of cannabis-related problems among youth, and in planning relevant services. PMID:23522345

Scholes-Balog, Kirsty E; Hemphill, Sheryl A; Patton, George C; Toumbourou, John W

2013-06-01

207

Quality of life and depressive symptoms among caregivers and drug dependent people Calidad de vida y los síntomas depresivos en cuidadores y los adictos a las drogas Qualidade de vida e sintomas depressivos entre cuidadores e dependentes de drogas  

OpenAIRE

The aim of this study was to evaluate the quality of life and the presence of depressive symptoms among the caregivers and drug dependent people of the CAPSad. This is a cross-sectional study, with 109 users of four Psychosocial Care Centers for alcohol and other drugs of Mato Grosso and their caregivers, using the instruments: Medical Outcomes Studies 36 (SF-36), Beck Depression Inventory (BDI) and a sociodemographic variables questionnaire. The QoL of the caregivers in the domains functiona...

Samira Reschetti Marcon; Elizete Aparecida Rubira; Mariano Martinez Espinosa; Dulce Aparecida Barbosa

2012-01-01

208

Effectiveness of combined high–dosed trospium and solifenacin depending on severity of OAB symptoms in elderly men and women under cyclic therapy  

Science.gov (United States)

Material and methods 313 patients, 196 women and 117 men over 65 (average age 68.6) were included in this study. All patients underwent urodynamic examination before enrollment and after the study was completed. For clinical evaluation of LUT state ICIQ-SF questionnaires and bladder diaries were used. Patients with moderate (?, n = 155) and severe (?, n = 158) symptoms of OAB. Each group was divided into subgroups in which patients received Trospium 60 mg/day and Solifenacin 20 mg/day during two cycles – 1.5 and 1 month with one month interval (?1 and ?1); subgroups in which second cycle was substituted with placebo (?2, ?2), and control groups (?3, ?3). Results In groups with moderate symptoms of OAB ratio of patients demonstrated decrease of frequency of EI ?1.5 a day remained at the level of 45-60% during all observation period. In subgroups with severe symptoms of OAB percentage of such patients was 55.3% for the subgroup which received two cycle therapy, and decreased to 26% in the subgroup which underwent 1 cycle therapy. Urodynamic indices for state of LUT correlated with clinical indicators (r =0.57-0.71 at p? 0.05). Conclusions Short single cycle of high-dosed Solifenacin and Trospium in elderly patients with moderate symptoms of OAB enables to maintain long therapeutic effect with acceptable level of side effects. This treatment algorithm applied in two cycle course is an effective and safe method for management of severe symptoms of OAB in elderly patients without increased risk of side effects. PMID:24982780

Loparev, Sergey; Iwanowskaya, Marina; Kosilova, Liliya

2014-01-01

209

Cannabis sativa var. indica : une menace croissante pour les entreprises Cannabis sativa var. indica: an increasing hazard for firms  

Directory of Open Access Journals (Sweden)

Full Text Available Parmi les drogues illicites, le cannabis est de très loin le produit le plus consommé. Les effets sur l'organisme sont principalement dus au delta-9-tétrahydrocannabinol (THC. Lors d'un usage peu important et occasionnel, ils consistent en une euphorie, une désinhibition, un état de somnolence, avec détérioration de la perception temporelle et spatiale. Les perturbations de la vision consistent en une mydriase, pouvant être accompagnée d'un nystagmus et d'une diplopie. Des troubles de la mémoire à court terme sont fréquemment observés. Ces effets, qui persistent pendant 2 à 10 heures, sont difficilement compatibles avec la réalisation d'actes complexes. Un usage fréquent et important peut conduire à des attaques de panique, des crises d'angoisse, voire l'apparition d'une psychose cannabique avec notamment la survenue d'hallucinations visuelles. C'est en raison de ces effets que son usage est considéré comme étant incompatible avec une conduite automobile en toute sécurité. Une étude française récente, réalisée chez 900 conducteurs impliqués dans un accident corporel de la voie publique et 900 sujets témoins, a montré que le nombre des accidents était multiplié par 2,5 chez les conducteurs ayant consommé du cannabis dans les heures précédentes. Aussi la législation française permet désormais de dépister son usage chez les conducteurs impliqués dans un accident corporel de la circulation, avec une obligation dans le cas des accidents mortels. L'absence de récepteurs au niveau bulbaire, et ce faisant l'absence de décès par overdose, a conduit certaines personnes à classer ce produit parmi les substances addictives les moins dangereuses pour l'homme. Une telle classification fait abstraction de la neurotoxicité fonctionnelle importante du THC qui fait que l'usage de ce produit peut constituer un facteur de risque pour autrui. Cela est vrai pour la conduite automobile. Cela peut être tout aussi vrai lorsque les consommateurs occupent des postes de travail dans lesquels les fautes professionnelles peuvent mettre en péril l'entreprise et/ou la collectivité. Ce risque était négligeable à une époque où la consommation de cannabis était marginale. Il devient majeur aujourd'hui compte tenu du nombre de consommateurs et des mesures de prévention s'imposent désormais, au delà du seul principe de précaution. Among the various drugs of abuse, cannabis is by far the most consumed. The effects on human organism are mainly due to delta-9 tetrahydrocannabinol (THC. With low doses and infrequent use, the effects are euphoria, desinhibition, drowsiness, and an alteration of temporal and spatial perception. Visual disorders consist in a mydriasis sometimes accompanied with a nystagmus and a diplopia. Short-memory troubles are frequently observed. These effects, which can persist during 2 to 10 hours, are not compatible with the realization of complex activities. A frequent use may lead to panic and anxiety attacks, and psychiatric disorders such as psychosis with visual hallucinations. Because of these effects, its use is considered to affect traffic safety. A recent French study, performed on 900 drivers involved in a corporal accident and 900 control subjects, indicated the number of accidents was multiplied by 2.5 when drivers had smoked cannabis a few hours before. So, a French law allows to identify drug users in drivers involved in a corporal car accident, with an obligation in the case of fatal accidents. The lack of receptors in the bulb, and then the non-occurrence of deaths by overdose, led some people to the conclusion that cannabis is the least dangerous of addict products. Such an assertion disregards the important functional neurotoxicity of THC which is the reason why cannabis use may represent a risk factor for others. That is true for car driving. That may be also true in factories when consumers occupy operation stations in which professional errors may imperil the enterprise and/or the collectivity. This risk was negligible when cannabis consumpti

Mura Patrick

2009-04-01

210

Sedative activity of cannabis in relation to its delta'-trans-tetrahydrocannabinol and cannabidiol content.  

OpenAIRE

1. The oral sedative potencies of cannabis herb, crude ethanolic and petroleum-ether fractions, were assayed against delta'-trans-tetrahydrocannabinol (THC) administered orally to mice, by measuring spontaneous motor activity over 30 min periods, at selected times, up to 6 h. 2. The THC contents of the extracts were determined chemically by gas-liquid chromatography analysis and the B/C ratio (biological activity divided by chemical activity) calculated for each. The B/C values for cannabis h...

Pickens, J. T.

1981-01-01

211

A novel component of cannabis extract potentiates excitatory synaptic transmission in rat olfactory cortex in vitro.  

OpenAIRE

Cannabis is a potential treatment for epilepsy, although the few human studies supporting this use have proved inconclusive. Previously, we showed that a standardized cannabis extract (SCE), isolated Delta9-tetrahydrocannabinol (Delta9-THC), and even Delta9-THC-free SCE inhibited muscarinic agonist-induced epileptiform bursting in rat olfactory cortical brain slices, acting via CB1 receptors. The present work demonstrates that although Delta9-THC (1 microM) significantly depressed evoked depo...

Whalley, B. J.; Wilkinson, J. D.; Williamson, E. M.; Constanti, A.

2004-01-01

212

Medical Marijuana programs: Implications for cannabis control policy - Observations from Canada.  

Science.gov (United States)

While prohibition has been the dominant regime of cannabis control in most countries for decades, an increasing number of countries have been implementing cannabis control reforms recently, including decriminalization or even legalization frameworks. Canada has held out from this trend, although it has among the highest cannabis use rates in the world. Cannabis use is universally criminalized, and the current (conservative) federal government has vowed not to implement any softening reforms to cannabis control. As a result of several higher court decisions, the then federal government was forced to implement a 'medical marijuana access regulations' program in 2001 to allow severely ill patients therapeutic use and access to therapeutic cannabis while shielding them from prosecution. The program's regulations and approval processes were complex and subject to extensive criticism; initial uptake was low and most medical marijuana users continued their use and supply outside the program's auspices. This year, the government introduced new 'marijuana for medical purposes regulations', which allow physicians to 'authorize' medical marijuana use for virtually any health condition for which this is considered beneficial; supply is facilitated by licensed commercial producers. It is expected that some 500,000 users, and dozens of commercial producers will soon be approved under the program, arguably constituting - as with medical marijuana schemes elsewhere, e.g. in California - de facto 'legalization'. We discuss the question whether the evolving scope and realities of 'medical cannabis' provisions in Canada offer a 'sneaky side door' or a 'better third way' to cannabis control reform, and what the potential wider implications are of these developments. PMID:25287942

Fischer, Benedikt; Kuganesan, Sharan; Room, Robin

2015-01-01

213

Beneficial effects of a Cannabis sativa extract treatment on diabetes-induced neuropathy and oxidative stress  

OpenAIRE

Abstract Neuropathy is the most common complication of diabetes and it is still considered to be relatively refractory to most of the analgesics. The aim of the present study was to explore the antinociceptive effect of a controlled cannabis extract (eCBD) in attenuating diabetic neuropathic pain. Repeated treatment with cannabis extract significantly relieved mechanical allodynia and restored the physiological thermal pain perception in streptozotocin (STZ)-induced diabetic rats w...

Comelli, Francesca; Bettoni, Isabella; Colleoni, Mariapia; Giagnoni, Gabriella; Costa, Barbara

2009-01-01

214

Detecting Cannabis Use on the Human Skin Surface via an Electronic Nose System  

OpenAIRE

The most commonly used drug testing methods are based on the analysis of hair and urine using gas chromatography-mass spectrometry, liquid chromatography-mass spectrometry or immunoassay screening. These methods are time-consuming and partly expensive. One alternative method could be the application of an “electronic nose” (eNose). We have developed an eNose to detect directly on the human skin surface metabolic changes in the human body odor caused by cannabis consumption. Twenty cannabi...

Andreas Voss; Katharina Witt; Tobias Kaschowitz; Wolf Poitz; Andreas Ebert; Patrik Roser; Karl-Jürgen Bär

2014-01-01

215

Considerações sobre a toxicocinética da Cannabis sativa L. ou maconha, com enfase no homem Some aspects of pharmacokinetics of Cannabis sativa L. (Marihuana with emphasis on man  

Directory of Open Access Journals (Sweden)

Full Text Available O presente artigo consiste em uma análise sobre a origem da Cannabis no Brasil, suas principais substâncias químicas, realçando o ?9 tetrahidrocanabinol como responsável pelos efeitos farmacológicos. é citado também o fato de existirem duas formas de numeração dos carbonos do ?THC. Para melhor entender a toxicocinética foram feitas considerações sobre as doses de maconha, que vão variar de acordo com o usuário, e origem do vegetal. Finalmente é feito urn estudo detalhado sobre, absorção, distribuição, armazenamento, biotransformação e eliminação dos diversos componentes químicos da maconha.This paper contains an analysis of the origin of the introduction of Cannabis in Brazil, the identify of its chemical components, mainly tetrahydrocannabinol responsible for the pharmacological effects of Cannabis. Toxicokinetic studies were developed in relation the amounts of marihuana consumed, characteristics of the user and origin of the drug. Absorption, distribution, storage, biotransformation and elimination of marihuana derived metabolites were studies.

Luiz Marques de Sá

1989-01-01

216

Cannabis Use Is Quantitatively Associated with Nucleus Accumbens and Amygdala Abnormalities in Young Adult Recreational Users  

Science.gov (United States)

Marijuana is the most commonly used illicit drug in the United States, but little is known about its effects on the human brain, particularly on reward/aversion regions implicated in addiction, such as the nucleus accumbens and amygdala. Animal studies show structural changes in brain regions such as the nucleus accumbens after exposure to ?9-tetrahydrocannabinol, but less is known about cannabis use and brain morphometry in these regions in humans. We collected high-resolution MRI scans on young adult recreational marijuana users and nonusing controls and conducted three independent analyses of morphometry in these structures: (1) gray matter density using voxel-based morphometry, (2) volume (total brain and regional volumes), and (3) shape (surface morphometry). Gray matter density analyses revealed greater gray matter density in marijuana users than in control participants in the left nucleus accumbens extending to subcallosal cortex, hypothalamus, sublenticular extended amygdala, and left amygdala, even after controlling for age, sex, alcohol use, and cigarette smoking. Trend-level effects were observed for a volume increase in the left nucleus accumbens only. Significant shape differences were detected in the left nucleus accumbens and right amygdala. The left nucleus accumbens showed salient exposure-dependent alterations across all three measures and an altered multimodal relationship across measures in the marijuana group. These data suggest that marijuana exposure, even in young recreational users, is associated with exposure-dependent alterations of the neural matrix of core reward structures and is consistent with animal studies of changes in dendritic arborization. PMID:24741043

Gilman, Jodi M.; Kuster, John K.; Lee, Sang; Lee, Myung Joo; Kim, Byoung Woo; Makris, Nikos; van der Kouwe, Andre; Blood, Anne J.

2014-01-01

217

Influence of mevinolin on chloroplast terpenoids in Cannabis sativa.  

Science.gov (United States)

Plants synthesize a myriad of isoprenoid products that are required both for essential constitutive processes and for adaptive responses to the environment. Two independent pathways for the biosynthesis of isoprenoid precursors coexist within the plant cell: the cytosolic mevalonic acid (MVA) pathway and the plastidial methylerythritol phosphate (MEP) pathway. In this study, we investigated the inhibitory effect of the MVA pathway on isoprenoid biosynthesized by the MEP pathway in Cannabis sativa by treatment with mevinolin. The amount of chlorophyll a, b, and total showed to be significantly enhanced in treated plants in comparison with control plants. Also, mevinolin induced the accumulation of carotenoids and ?-tocopherol in treated plants. Mevinolin caused a significant decrease in tetrahydrocannabinol (THC) content. This result show that the inhibition of the MVA pathway stimulates MEP pathway but none for all metabolites. PMID:24757332

Mansouri, Hakimeh; Salari, Fatemeh

2014-04-01

218

Cloud point extraction of ?9-tetrahydrocannabinol from cannabis resin.  

Science.gov (United States)

A cloud point extraction coupled with high performance liquid chromatography (HPLC/UV) method was developed for the determination of ?(9)-tetrahydrocannabinol (THC) in micellar phase. The nonionic surfactant "Dowfax 20B102" was used to extract and pre-concentrate THC from cannabis resin, prior to its determination with a HPLC-UV system (diode array detector) with isocratic elution. The parameters and variables affecting the extraction were investigated. Under optimum conditions (1 wt.% Dowfax 20B102, 1 wt.% Na2SO4, T = 318 K, t = 30 min), this method yielded a quite satisfactory recovery rate (~81 %). The limit of detection was 0.04 ?g mL(-1), and the relative standard deviation was less than 2 %. Compared with conventional solid-liquid extraction, this new method avoids the use of volatile organic solvents, therefore is environmentally safer. PMID:23354583

Ameur, S; Haddou, B; Derriche, Z; Canselier, J P; Gourdon, C

2013-04-01

219

The Influence of Inhibitory Control and Episodic Memory on the Risky Sexual Behavior of Young Adult Cannabis Users  

OpenAIRE

Cannabis use is associated with risky sexual behavior (RSB) and sex-related negative health consequences. This investigation examined the role of inhibitory control and episodic memory in predicting RSB and sex-related negative consequences among current cannabis users. Findings indicated that the relationships between cannabis, neurocognition and sexual-risk varied according to the dimension of neurocognition and the parameter of RSB in question. Specifically, more risk-taking was associated...

Schuster, Randi Melissa; Crane, Natania A.; Mermelstein, Robin; Gonzalez, Raul

2012-01-01

220

Caractérisation de l'huile de graines de Cannabis sativa L. cultivé au nord du Maroc Seed oil characterization of Cannabis sativa L. cultivated in Northern Morocco  

OpenAIRE

La présente étude porte sur la caractérisation de la compo-sition lipidique de l'huile des graines de Cannabis sativa L. type drogue cultivé au Nord du Maroc. Les résultats obtenus montrent que la composition en acides gras de cette huile est assez proche de celle des huiles de graines de cannabis type fibre cultivé dans d'autres parties du monde. Un taux d'aci-de linolénique (oméga-3) de 16 %, un ratio pondéral acides poly-insaturés/acides saturés (P/S) de 6:1 et un rapport oméga...

Stambouli Hamid; El Bouri Aziz; Bouayoun Taoufik; Bellimam Ahmed

2007-01-01

221

12-month follow-up of an exploratory ‘brief intervention’ for high-frequency cannabis users among Canadian university students  

Directory of Open Access Journals (Sweden)

Full Text Available Abstract Background One in three young people use cannabis in Canada. Cannabis use can be associated with a variety of health problems which occur primarily among intensive/frequent users. Availability and effectiveness of conventional treatment for cannabis use is limited. While Brief Interventions (BIs have been shown to result in short-term reductions of cannabis use risks or problems, few studies have assessed their longer-term effects. The present study examined 12-month follow-up outcomes for BIs in a cohort of young Canadian high-frequency cannabis users where select short-term effects (3?months had previously been assessed and demonstrated. Findings N?=?134 frequent cannabis users were recruited from among university students in Toronto, randomized to either an oral or a written cannabis BI, or corresponding health controls, and assessed in-person at baseline, 3-months, and 12-months. N?=?72 (54?% of the original sample were retained for follow-up analyses at 12-months where reductions in ‘deep inhalation/breathholding’ (Q?=?13.1; p? Conclusions The results confirm findings from select other studies indicating the potential for longer-term and sustained risk reduction effects of BIs for cannabis use. While further research is needed on the long-term effects of BIs, these may be a valuable – and efficient – intervention tool in a public health approach to high-risk cannabis use.

Fischer Benedikt

2012-04-01

222

CANABIC: CANnabis and Adolescents: effect of a Brief Intervention on their Consumption – study protocol for a randomized controlled trial  

OpenAIRE

BACKGROUND: Cannabis is the most consumed illegal substance in France. General practitioners (GPs) are the health professionals who are most consulted by adolescents. Brief intervention (BI) is a promising care initiative for the consumption of cannabis, and could be a tool for GPs in caring for adolescents who consume cannabis. The aim of the CANABIC study is to measure the impact of a BI carried out by a GP on the consumption of cannabis by adolescents of 15 to 25 years of age. METHODS: A r...

Laporte, Catherine; Vaillant-roussel, He?le?ne; Pereira, Bruno; Blanc, Olivier; Tanguy, Gilles; Frappe?, Paul; Costa, David; Gaboreau, Yoann; Badin, Me?lanie; Marty, Laurent; Cle?ment, Gilles; Dubray, Claude; Falissard, Bruno; Llorca, Pierre-michel; Vorilhon, Philippe

2014-01-01

223

Plant ozone injury symptoms  

Energy Technology Data Exchange (ETDEWEB)

A study of the phytotoxicity of ozone to plants was conducted in controlled-atmosphere greenhouses to determine if the symptoms of such exposure would be similar to symptoms exhibited by plants exposed to photochemical smog (which contains ozone) in the Tokyo area. Test plants used were herbaceous plants and woody plants, which were fumigated to 20 pphm ozone. Plants used as controls for the oxone exposure experiments were placed in a carbon filtered greenhouse. Herbaceous plants were generally sensitive to injury, especially Brassica rapa, Brassica pekinensis and others were extremely responsive species. In comparison with herbaceous plants, woody plants were rather resistant except for poplar. Depending on plant species and severity of injury, ozone-injury symptoms of herbaceous plants were bleaching, chlorosis, necrosis, and red-dish-brown flecks. Leaves of woody plants developed discrete, punctate spots, reddish-brown pigment on the upper surfaces and lastly defoliation. Ozone injury was typically confined to the upper leaf surfaces and notably greater mature leaves. Microscopic examination showed that pallisade cells were much more prone to ozone injury than other tissues.

Nouchi, I.; Odaira, T.; Sawada, T.; Oguchi, K.; Komeiji, T.

1973-01-01

224

Behavioral and biochemical effects of Cannabis Sativa and their modulation by antidepressant drugs  

Scientific Electronic Library Online (English)

Full Text Available SciELO Mexico | Language: English Abstract in spanish Nos propusimos estudiar el efecto de Cannabis sativa sobre el estrés oxidativo en cerebro y determinar si las respuestas causadas por canabis sobre el comportamiento podrían revertirse por fármacos antidepresivos estándar. Cannabis sativa (5, 10 o 15 mg/kg) (expresada como ?9-tetrahidrocanabinol) se [...] administró subcutáneamente (s.c.) sola o con fluoxetina, sertralina o imipramina una vez al día por 24 días. En la prueba de nado forzado, el tiempo de in movilidad, se incrementó significativamente en los ratones tratados con canabis (5-15 mg/kg, s.c.) a partir del 9° día post-administración. Fluoxetina (20mg/kg, s.c.), coadministrada con canabis (5 mg/kg, s.c.), dio como resultado una disminución significativa en el tiempo de inmovilidad alrededor del día 21 del estudio comparado con el grupo tratado sólo con canabis. Los ratones co-administrados con sertralina o imipramina y canabis no fueron estadísticamente diferentes del grupo control de vehículo respecto al tiempo de inmovilidad. Canabis provocó una disminución significativa en la actividad de levantamientos que fue aumentada tanto por fluoxetina como por sertralina. Cannabis sativa incrementó la glutationa reducida en cerebro y disminuyó los niveles de óxido nítrico. Flouxetina, sertralina o imipramina administrados con canabis disminuyó la malondialdehido e incrementó la glutationa reducida. En conclusión: La administración de canabis disminuye el estrés oxidativo cerebral pero ejerce un efecto parecido a la depresión y disminuye la actividad de levantamientos que puede revertirse por fármacos antidepresivos. Abstract in english We aimed to study the effect of Cannabis sativa on brain oxidative stress and determine whether behavioral responses caused by cannabis could be reversed by standard antidepressant drugs. Cannabis sativa (5, 10 or 15 mg/kg) (expressed as ?9-tetrahydrocannabinol) was given alone or with fluoxetine, s [...] ertraline or imipramine, once daily subcutaneously (s.c.) for 24 days. In the forced-swimming test, the immobility time, was significantly increased in mice treated with cannabis (5-15 mg/kg, s.c.) starting from the 9th day post-injection. Fluoxetine (20 mg/kg, s.c.) coadministered with cannabis (5 mg/kg, s.c.) resulted in significant decrease in the immobility time by the day 21 of the study compared with the cannabis only group. Mice co-administered sertraline or imipramine with cannabis were not statistically different from the vehicle control group as regards their immobility time. Cannabis resulted in a significant decrease in the rearing activity which was ameliorated by either fluoxetine or sertraline. Cannabis sativa increased brain reduced glutathione, but decreased the level of nitric oxide. Fluoxetine, sertraline or imipramine given with cannabis decreased malondialdehyde and increased reduced glutathione. In conclusion: The administration of cannabis decreases brain oxidative stress but exerts depressive-like effect and decreases rearing activity which can be reversed by antidepressant drugs.

Omar M.E., Abdel-Salam; Rehab Fawzy, Abdel-Rahman; Alaa El-Din M., Gaafar.

225

Conceptualization and validation of questionnaires that could be used as surrogate endpoints in clinical trials in cocaine dependence : craving and psychotic symptoms  

OpenAIRE

Cocaine dependence is a growing public health concern in France. There is no pharmacological treatment validated for cocaine dependence treatment. Clinical trials require that validated methods are used to ascertain the efficacy of new drugs that are tested. There was no validated tool available to conduct pharmacological trials for cocaine dependence in French. We conceptualized and validated questionnaires that could be used as surrogate endpoints in pharmacological trials for cocaine depen...

Vorspan, Florence

2012-01-01

226

Symptoms of Ankylosing Spondylitis  

Science.gov (United States)

Ankylosing Spondylitis (AS): Quick Links Overview >>> Symptoms >>> Diagnosis >>> Treatment >>> Medication >>> Doctor Q&A From Spondylitis Plus >>> ANKYLOSING SPONDYLITIS Most Common Symptoms It is important to note ...

227

Long term marijuana users seeking medical cannabis in California (2001–2007: demographics, social characteristics, patterns of cannabis and other drug use of 4117 applicants  

Directory of Open Access Journals (Sweden)

Full Text Available Abstract Background Cannabis (marijuana had been used for medicinal purposes for millennia. Cannabinoid agonists are now attracting growing interest and there is also evidence that botanical cannabis is being used as self-medication for stress and anxiety as well as adjunctive therapy by the seriously ill and by patients with terminal illnesses. California became the first state to authorize medicinal use of cannabis in 1996, and it was recently estimated that between 250,000 and 350,000 Californians may now possess the physician's recommendation required to use it medically. More limited medical use has also been approved in 12 additional states and new initiatives are being considered in others. Despite that evidence of increasing public acceptance of "medical" use, a definitional problem remains and all use for any purpose is still prohibited by federal law. Results California's 1996 initiative allowed cannabis to be recommended, not only for serious illnesses, but also "for any other illness for which marijuana provides relief," thus maximally broadening the range of allowable indications. In effect, the range of conditions now being treated with federally illegal cannabis, the modes in which it is being used, and the demographics of the population using it became potentially discoverable through the required screening of applicants. This report examines the demographic profiles and other selected characteristics of 4117 California marijuana users (62% from the Greater Bay Area who applied for medical recommendations between late 2001 and mid 2007. Conclusion This study yielded a somewhat unexpected profile of a hitherto hidden population of users of America's most popular illegal drug. It also raises questions about some of the basic assumptions held by both proponents and opponents of current policy.

Bou-Matar Ché B

2007-11-01

228

Non-smoker exposure to secondhand cannabis smoke. I. Urine screening and confirmation results.  

Science.gov (United States)

Increased cannabis potency has renewed concerns that secondhand exposure to cannabis smoke can produce positive drug tests. A systematic study was conducted of smoke exposure on drug-free participants. Six experienced cannabis users smoked cannabis cigarettes (5.3% THC in Session 1 and 11.3% THC in Sessions 2 and 3) in a sealed chamber. Six non-smokers were seated with smokers in an alternating manner. Sessions 1 and 2 were conducted with no ventilation and ventilation was employed in Session 3. Non-smoking participant specimens (collected 0-34 h) were analyzed with four immunoassays at different cutoff concentrations (20, 50, 75 and 100 ng/mL) and by GC-MS (LOQ = 0.75 ng/mL). No presumptive positives occurred for non-smokers at 100 and 75 ng/mL; a single positive occurred at 50 ng/mL; and multiple positives occurred at 20 ng/mL. Maximum THCCOOH concentrations by GC-MS for non-smokers ranged from 1.3 to 57.5 ng/mL. THCCOOH concentrations generally increased with THC potency, but room ventilation substantially reduced exposure levels. These results demonstrate that extreme cannabis smoke exposure can produce positive urine tests at commonly utilized cutoff concentrations. However, positive tests are likely to be rare, limited to the hours immediately post-exposure, and occur only under environmental circumstances where exposure is obvious. PMID:25326203

Cone, Edward J; Bigelow, George E; Herrmann, Evan S; Mitchell, John M; LoDico, Charles; Flegel, Ronald; Vandrey, Ryan

2015-01-01

229

Extraction of high quality DNA from seized Moroccan cannabis resin (Hashish).  

Science.gov (United States)

The extraction and purification of nucleic acids is the first step in most molecular biology analysis techniques. The objective of this work is to obtain highly purified nucleic acids derived from Cannabis sativa resin seizure in order to conduct a DNA typing method for the individualization of cannabis resin samples. To obtain highly purified nucleic acids from cannabis resin (Hashish) free from contaminants that cause inhibition of PCR reaction, we have tested two protocols: the CTAB protocol of Wagner and a CTAB protocol described by Somma (2004) adapted for difficult matrix. We obtained high quality genomic DNA from 8 cannabis resin seizures using the adapted protocol. DNA extracted by the Wagner CTAB protocol failed to give polymerase chain reaction (PCR) amplification of tetrahydrocannabinolic acid (THCA) synthase coding gene. However, the extracted DNA by the second protocol permits amplification of THCA synthase coding gene using different sets of primers as assessed by PCR. We describe here for the first time the possibility of DNA extraction from (Hashish) resin derived from Cannabis sativa. This allows the use of DNA molecular tests under special forensic circumstances. PMID:24124454

El Alaoui, Moulay Abdelaziz; Melloul, Marouane; Alaoui Amine, Sanaâ; Stambouli, Hamid; El Bouri, Aziz; Soulaymani, Abdelmajid; El Fahime, Elmostafa

2013-01-01

230

On the legality of cannabis; the responsibility of the expert witness.  

Science.gov (United States)

The controversy concerning the taxonomic status of the genus Cannabis has now advanced to a stage where the forensic scientist has limitations to his testimony in identification of "marihuana" plant material in jurisdictions where the law defines "marihuana" as Cannabis sativa L. Whether the genus Cannabis is monotypic or polytypic is as yet uncertain, but recent taxonomic reviews weigh heavily toward the existence of three or more species within the genus. The taxonomists or forensic scientists cannot, therefore, positively state for fact that C. sativa is the only species existing within the genus Cannabis. The popular concept of "marihuana" is actually based on the chemical characteristics of the plant Cannabis, rather than on the taxonomic classification. This is evident in its inclusion as a drug or hallucinogenic substance under Federal and local statutes. It is therefore proposed that "marihuana" be redefined legally to include all members belonging to the genus, in jurisdictions where legal definition warrants such an act, or that these jurisdictions follow the format set forth by Federal rulings. PMID:1176918

Lowry, W T; Garriott, J C

1975-10-01

231

A prospective study of natural recovery from cannabis use in early psychosis  

Scientific Electronic Library Online (English)

Full Text Available SciELO Spain | Language: English Abstract in english Background and Objectives: Cannabis use is common in early psychosis and has been linked to adverse outcomes. However, factors that influence and maintain change in cannabis use in this population are poorly understood. An existing prospective dataset was used to predict abstinence from cannabis use [...] over the 6 months following inpatient admission for early psychosis. Methods: Participants were 67 inpatients with early psychosis who had used cannabis in the 6 weeks prior to admission. Current diagnoses of psychotic and substance use disorders were confirmed using a clinical checklist and structured diagnostic interview. Measures of clinical, substance use and social and occupational functioning were administered at baseline and at least fortnightly over the 6-month follow up. Results: No substance use or clinical variables were associated with 6-months’ of cannabis abstinence. Only Caucasian ethnicity, living in private accommodation and receiving an income before the admission were predictive. Only private accommodation and receiving an income were significant predictors of abstinence when these variables were entered into a multivariate analysis. Conclusions: While the observed relationships do not necessarily imply causation, they suggest that more optimal substance use outcomes could be achieved by addressing the accommodation and employment needs of patients.

Shane, Rebgetz; Leanne, Hides; David J., Kavanagh; Sharon, Dawe; Ross M., Young.

2014-12-01

232

Intoxicación accidental por cannabis: presentación de cuatro casos pediátricos en un hospital terciario del sur de España / Accidental cannabis poisoning in children: report of four cases in a tertiary care center from southern Spain  

Scientific Electronic Library Online (English)

Full Text Available SciELO Argentina | Language: Spanish Abstract in spanish Introducción. El cannabis es la droga ilegal más consumida en España. La intoxicación accidental por cannabis es una forma infrecuente de intoxicación en niños; pero potencialmente grave. Objetivo. Describir la presentación clínica, diagnóstico y tratamiento de niños con intoxicación accidental por [...] cannabis en un hospital pediátrico de tercer nivel. Presentamos 4 pacientes con intoxicación accidental por cannabis. La clínica de presentación fue deterioro brusco del nivel de conciencia, tendencia al sueño, ataxia, temblor, apnea, hipotonía y convulsión. La pesquisa de tóxicos en orina detectó tetrahidrocannabinol (THC) en todos los casos. En los cuatro pacientes se establecieron medidas de soporte. Todos los casos se recuperaron satisfactoriamente y fueron dados de alta a las 24 horas del ingreso. Conclusión. Se ha de mantener un alto índice de sospecha para la intoxicación por cannabis en niños previamente sanos con aparición brusca de síntomas neurológicos de etiología desconocida. Abstract in english Introduction. Cannabis is the most frequently consumed illicit substance in Spain. Pediatric accidental cannabis poisoning is an uncommon but life-threatening intoxication. Objective. To describe clinical findings, diagnosis and management of children with accidental cannabis poisoning in a tertiary [...] care pediatric hospital. We report four patients with accidental cannabis poisoning. Clinical presentation included reduced level of consciousness, drowsiness, ataxia, tremble, apnea, hypotonia, and seizures. Tetrahydrocannabinol (THC) was detected by urine screening for cannabinoids and other toxic substances in all cases. The four patients were treated with supportive care. All cases recovered uneventfully and were discharged within 24 hours of admission. Conclusion. The possibility of cannabis poisoning should be considered in cases of unexplained acute onset of neurological findings in previously healthy children.

Borja, Croche Santander; María Teresa, Alonso Salas; Mercedes, Loscertales Abril.

2011-02-01

233

Induction of mutants in Cannabis Sativa L. by ? radiation  

International Nuclear Information System (INIS)

A description is given of the mutations induced in a well known cultivar of fibre hemp belonging to the species Cannabis sativa in order to obtain new phenotypic characters that could unequivocally differentiate it from drug hemp. Two new dioecious hemp cultivars, characterized by clear morphological markers and low (?0.2%)?-9-tetrahydrocannabinol (THC) content, have been obtained by mutagenesis of seeds irradiated with 60Co ? rays(optimum dose 300-350 Gy) and selection of the segregant progenies. These new cultivars, named red petiole (exhibiting anthocyanin leaf petioles) and yellow apex (exhibiting yellow distal leaflets), have been compared with varieties C.S., carmagnola and fibranova by growing them in three different areas (centre-north and south) of Italy. These agronomical trials highlighted the good performance of both new cultivars as for yield in dry matter and in fibre, not significantly different from the results of carmagnola. Besides, the new cultivars showed THC contents (0.09 and 0.17%) lower than the threshold set by the E.U. (0.2%). (Author)

234

Cognitive Mechanisms Underlying Risky Decision-Making in Chronic Cannabis Users.  

Science.gov (United States)

Chronic cannabis users are known to be impaired on a test of decision-making, the Iowa Gambling Task (IGT). Computational models of the psychological processes underlying this impairment have the potential to provide a rich description of the psychological characteristics of poor performers within particular clinical groups. We used two computational models of IGT performance, the Expectancy-Valence Learning model (EVL) and the Prospect-Valence Learning model (PVL), to assess motivational, memory, and response processes in 17 chronic cannabis abusers and 15 control participants. Model comparison and simulation methods revealed that the PVL model explained the observed data better than the EVL model. Results indicated that cannabis abusers tended to be under-influenced by loss magnitude, treating each loss as a constant and minor negative outcome regardless of the size of the loss. In addition, they were more influenced by gains, and made decisions that were less consistent with their expectancies relative to non-using controls. PMID:20419064

Fridberg, Daniel J; Queller, Sarah; Ahn, Woo-Young; Kim, Woojae; Bishara, Anthony J; Busemeyer, Jerome R; Porrino, Linda; Stout, Julie C

2010-02-01

235

The personality traits and social characteristics of Croatian heroin addicts and cannabis users.  

Science.gov (United States)

The purpose of this study was to investigate differences in social characteristics (level of education, working and family status, and criminal record) between heroin addicts, cannabis users and a control group. Additional goal was to explore the possibility of discerning subjects of different addiction status (of both gender) based on their scores on Eysenck Personality Questionnaire (EPQ). In comparison to the control group, heroin addicts and cannabis users had lower level of education, were more frequently unemployed and with criminal record, and more often came from dysfunctional families. In cannabis users the frequency of these characteristics was generally lower than in heroin addicts. Proportion of correct classification of subjects in groups of different addiction status based on the EPQ scores was 23.3% for males (higher than by chance alone), and 30% for females. PMID:22053544

Anticevi?, Vesna; Britvi?, Dolores; Sodi?, Lidija

2011-09-01

236

Do ?9-Tetrahydrocannabinol Concentrations Indicate Recent Use in Chronic Cannabis Users?  

Science.gov (United States)

AIMS To quantify blood ?9-tetrahydrocannabinol (THC) concentrations in chronic cannabis users over seven days of continuous monitored abstinence. PARTICIPANTS Twenty-five frequent, long-term cannabis users resided on a secure clinical research unit at the U.S. National Institute on Drug Abuse under continuous medical surveillance to prevent cannabis self-administration. MEASUREMENTS Whole blood cannabinoid concentrations were determined by two-dimensional gas chromatography-mass spectrometry. FINDINGS Nine chronic users (36%) had no measurable THC during seven days of cannabis abstinence; 16 had at least one positive THC ?0.25 ng/mL, but not necessarily on the first day. On day 7, six full days after entering the unit, six participants still displayed detectable THC concentrations (mean ± SD, 0.3 ± 0.7 ng/mL) and all 25 had measurable carboxy-metabolite (6.2 ± 8.8 ng/mL). The highest observed THC concentrations on admission (day 1) and day 7 were 7.0 and 3.0 ng/mL, respectively. Interestingly, five participants, all female, had THC positive whole blood specimens all seven days. Body mass index did not correlate with time until last THC positive specimen (N = 16; R = ?0.2; p = 0.445). CONCLUSIONS Substantial whole blood THC concentrations persist multiple days after drug discontinuation in heavy chronic cannabis users. It is currently unknown whether neurocognitive impairment occurs with low blood THC concentrations, and whether return to normal performance, as previously documented following extended cannabis abstinence, is accompanied by removal of residual THC in brain. These findings also may impact the implementation of per se limits in driving under the influence of drugs legislation. PMID:19804462

Karschner, Erin L.; Schwilke, Eugene W.; Lowe, Ross H.; Darwin, W. David; Pope, Harrison G.; Herning, Ronald; Cadet, Jean Lud; Huestis, Marilyn A.

2009-01-01

237

Cannabis smoking and lung cancer risk: Pooled analysis in the International Lung Cancer Consortium.  

Science.gov (United States)

To investigate the association between cannabis smoking and lung cancer risk, data on 2,159 lung cancer cases and 2,985 controls were pooled from 6 case-control studies in the US, Canada, UK, and New Zealand within the International Lung Cancer Consortium. Study-specific associations between cannabis smoking and lung cancer were estimated using unconditional logistic regression adjusting for sociodemographic factors, tobacco smoking status and pack-years; odds-ratio estimates were pooled using random effects models. Subgroup analyses were done for sex, histology and tobacco smoking status. The shapes of dose-response associations were examined using restricted cubic spline regression. The overall pooled OR for habitual versus nonhabitual or never users was 0.96 (95% CI: 0.66-1.38). Compared to nonhabitual or never users, the summary OR was 0.88 (95%CI: 0.63-1.24) for individuals who smoked 1 or more joint-equivalents of cannabis per day and 0.94 (95%CI: 0.67-1.32) for those consumed at least 10 joint-years. For adenocarcinoma cases the ORs were 1.73 (95%CI: 0.75-4.00) and 1.74 (95%CI: 0.85-3.55), respectively. However, no association was found for the squamous cell carcinoma based on small numbers. Weak associations between cannabis smoking and lung cancer were observed in never tobacco smokers. Spline modeling indicated a weak positive monotonic association between cumulative cannabis use and lung cancer, but precision was low at high exposure levels. Results from our pooled analyses provide little evidence for an increased risk of lung cancer among habitual or long-term cannabis smokers, although the possibility of potential adverse effect for heavy consumption cannot be excluded. PMID:24947688

Zhang, Li Rita; Morgenstern, Hal; Greenland, Sander; Chang, Shen-Chih; Lazarus, Philip; Teare, M Dawn; Woll, Penella J; Orlow, Irene; Cox, Brian; Brhane, Yonathan; Liu, Geoffrey; Hung, Rayjean J

2015-02-15

238

Predictors of age at onset of tobacco and cannabis use in Danish adolescents  

DEFF Research Database (Denmark)

INTRODUCTION: Early onset of tobacco and cannabis use predicts later substance abuse and risk behaviour and has large health consequences. OBJECTIVES: The aim of this study was to examine risk factors for the age at onset of smoking and cannabis use among a group of Danish children between 7 years and 18 years of age. METHODS: Four hundred and eighty randomly selected children and their parents participated in a study about the prevalence of asthma. The study included questions about alcohol, tobacco and cannabis use. The children were interviewed face-to-face while the parents answered a questionnaire. RESULTS: The age at onset of daily smoking was significantly associated with the adolescents' tendency to binge drink [hazard ratio 4.78, 95% confidence interval (CI) (1.85-12.34), P = 0.001) and to use hard drugs [hazard ratio 2.81, 95% CI (1.03-7.78), P = 0.047], whereas the age at onset of cannabis use was significantly associated with binge drinking [hazard ratio 3.29, 95% CI (1.51-7.20), P = 0.003] and cigarette smoking [hazard ratio 2.51, 95% CI (1.26-5.00), P = 0.009]. There were no significant effect of the parents' smoking and alcohol habits, their socioeconomic or marital status on the adolescent' age at onset of smoking or cannabis. CONCLUSION: This study shows a close connection between adolescent tobacco and cannabis use and alcohol habits. Knowledge of this is important when planning future prevention strategies.

Wium-Andersen, Ida Kim; Wium-Andersen, Marie Kim

2010-01-01

239

Prediction of cannabis and cocaine use in adolescence using decision trees and logistic regression  

OpenAIRE

Spain is one of the European countries with the highest prevalence of cannabis and cocaine use among young people. The aim of this study was to investigate the factors related to the consumption of cocaine and cannabis among adolescents. A questionnaire was administered to 9,284 students between 14 and 18 years of age in Palma de Mallorca (47.1% boys and 52.9% girls) whose mean age was 15.59 years. Logistic regression and decision trees were carried out in order to model the consumption of ca...

Palmer, Alfonso L.; Elena Gervilla

2010-01-01

240

Disposition of smoked cannabis with high ?9-tetrahydrocannabinol content: A kinetic model  

International Nuclear Information System (INIS)

Introduction: No model exists to describe the disposition and kinetics of inhaled cannabis containing a high THC dose. We aimed to develop a kinetic model providing estimates of the THC serum concentrations after smoking cannabis cigarettes containing high THC doses (up to 69 mg THC). Methods: Twenty-four male non-daily cannabis users smoked cannabis cigarettes containing 29.3 mg, 49.1 mg, and 69.4 mg THC. Blood samples were collected over a period of 0-8 h and serum THC concentrations were measured. A two-compartment open model was fitted on the individual observed data. Results: Large inter-individual variability was observed in the pharmacokinetic parameters. The median pharmacokinetic parameters generated by the model were Cmax = 175 ng/mL, Tmax = 14 min, and AUC0-8h = 8150 ng x min/mL for the 69.4 mg THC dose. Median model results show an almost linear dose response relation for Cmax/Dose = 2.8 x 10-6/mL and AUC0-8h/Dose = 136 x 10-6 min/mL. However, for increasing dose level, there was a clear decreasing trend: Cmax/Dose = 3.4, 2.6 and 2.5 x 10-6/mL and AUC0-8h/Dose = 157, 133 and 117 x 10-6 min/mL for the 29.3, 49.1 and 69.4 mg dose, respectively. Within the restriction of 8 h of observation, the apparent terminal half life of THC was 150 min. Conclusion: The model offers insight into the pharmacokinetics of THC in recreational cannabis userstics of THC in recreational cannabis users smoking cannabis containing high doses of THC mixed with tobacco. The model is an objective method for providing serum THC concentrations up to 8 h after smoking cannabis with a high THC content (up to 23%).

241

Advice of the Italian CCTN on the toxicity of Cannabis sativa  

Energy Technology Data Exchange (ETDEWEB)

This recommendation of the Italian National Toxicological Committee (CCTN) regards the possible toxic effects of some products derived from Cannabis sativa, indica variety. The CCTN has especially evaluated genotoxic, immunological and toxic to reproduction effects of these substances, on the basis of the results from both experimental studies and observations on humans. [Italiano] Il documento contiene il parere della CCTN sui potenziali effetti tossici di alcuni derivati della Cannabis sativa, varieta` indica. Il parere e` stato elaborato sulla base dei risultati sia di studi sperimentali sia dei limitati studi sull`uomo, prendendo in particolare considerazione gli effetti genotossici, tossico-riproduttivi ed immunologici.

Camoni, I. [ed.] [Istituto Superiore di Sanita`, Rome (Italy). Lab. di Tossicologia Applicata; Mucci, N. [ed.] [ISPESL, Monteporzio Catone, Roma (Italy). Dip. di Medicina del Lavoro; Paroli, E. [ed.] [Rome, Univ. `La Sapienza` (Italy). Fac. di Medicina, Ist. di Farmacologia

1998-06-01

242

Survey of medicinal cannabis use among childbearing women: patterns of its use in pregnancy and retroactive self-assessment of its efficacy against 'morning sickness'.  

Science.gov (United States)

A majority of women experience some nausea and/or vomiting during pregnancy. This condition can range from mild nausea to extreme nausea and vomiting, with 1-2% of women suffering from the life-threatening condition hyperemesis gravidarum. Cannabis (Cannabis sativa) may be used therapeutically to mitigate pregnancy-induced nausea and vomiting. This paper presents the results of a survey of 84 female users of medicinal cannabis, recruited through two compassion societies in British Columbia, Canada. Of the seventy-nine respondents who had experienced pregnancy, 51 (65%) reported using cannabis during their pregnancies. While 59 (77%) of the respondents who had been pregnant had experienced nausea and/or vomiting of pregnancy, 40 (68%) had used cannabis to treat the condition, and of these respondents, 37 (over 92%) rated cannabis as 'extremely effective' or 'effective.' Our findings support the need for further investigations into cannabis therapy for severe nausea and vomiting during pregnancy. PMID:16401527

Westfall, Rachel E; Janssen, Patricia A; Lucas, Philippe; Capler, Rielle

2006-02-01

243

Signs and Symptoms  

Science.gov (United States)

... MDA Search form Search Charcot-Marie-Tooth Disease (CMT) Signs and Symptoms Partly because there are different types of Charcot-Marie-Tooth disease (CMT) , the exact symptoms vary greatly from person to ...

244

Melanoma: Signs and Symptoms  

Science.gov (United States)

... Diseases and treatments M - P Melanoma Signs, symptoms Melanoma: Signs and symptoms Anyone can get melanoma. It’s ... look for the ABCDEs of melanoma. ABCDEs of melanoma A = Asymmetry One half is unlike the other ...

245

E. coli Symptoms  

Science.gov (United States)

... JavaScript on. Read more information on enabling JavaScript. E. coli Skip Content Marketing Share this: Main Content Area Symptoms Shiga toxin-producing E. coli (STEC) can cause the following symptoms: Nausea Severe ...

246

Symptoms of Ovarian Cancer  

Science.gov (United States)

... Informed Cancer Home What Are the Symptoms of Ovarian Cancer? Language: English Español (Spanish) Share Compartir Gynecologic cancer symptoms diaries Ovarian cancer may cause one or more of these ...

247

Hyperhidrosis: Signs and Symptoms  

Science.gov (United States)

... treatments E - H Hyperhidrosis Hyperhidrosis: Signs and symptoms Hyperhidrosis: Signs and symptoms If you have this medical ... itch are common skin infections. Two types of hyperhidrosis Both types cause excessive sweating, but there are ...

248

Symptoms: a new approach  

OpenAIRE

Symptoms are a major reason for patients to see doctors. Modern medicine and modern psychiatry both conceptualize symptoms in terms of pathology. For medicine it is organic bodily pathology and for psychiatry it is psychopathology. However, these simple pathology-based approaches to symptoms are increasingly found to be both scientifically and clinically inadequate. An alternative is to regard symptoms not simply as a manfestation of pathology but rather as the expression of a combination of ...

Sharpe, M.; Walker, J.

2009-01-01

249

Functional genetic variation of the cannabinoid receptor 1 and cannabis use interact on prefrontal connectivity and related working memory behavior.  

Science.gov (United States)

Cannabinoid signaling is involved in different brain functions and it is mediated by the cannabinoid receptor 1 (CNR1), which is encoded by the CNR1 gene. Previous evidence suggests an association between cognition and cannabis use. The logical interaction between genetically determined cannabinoid signaling and cannabis use has not been determined. Therefore, we investigated whether CNR1 variation predicts CNR1 prefrontal mRNA expression in postmortem prefrontal human tissue. Then, we studied whether functional variation in CNR1 and cannabis exposure interact in modulating prefrontal function and related behavior during working memory processing. Thus, 208 healthy subjects (113 males) were genotyped for the relevant functional SNP and were evaluated for cannabis use by the Cannabis Experience Questionnaire. All individuals performed the 2-back working memory task during functional magnetic resonance imaging. CNR1 rs1406977 was associated with prefrontal mRNA and individuals carrying a G allele had reduced CNR1 prefrontal mRNA levels compared with AA subjects. Moreover, functional connectivity MRI demonstrated that G carriers who were also cannabis users had greater functional connectivity in the left ventrolateral prefrontal cortex and reduced working memory behavioral accuracy during the 2-back task compared with the other groups. Overall, our results indicate that the deleterious effects of cannabis use are more evident on a specific genetic background related to its receptor expression. PMID:25139064

Colizzi, Marco; Fazio, Leonardo; Ferranti, Laura; Porcelli, Annamaria; Masellis, Rita; Marvulli, Daniela; Bonvino, Aurora; Ursini, Gianluca; Blasi, Giuseppe; Bertolino, Alessandro

2015-02-01

250

Comparison of cannabinoid concentrations in oral fluid and whole blood between occasional and regular cannabis smokers prior to and after smoking a cannabis joint  

OpenAIRE

A cross-over controlled administration study of smoked cannabis was carried out on occasional and heavy smokers. The participants smoked a joint (11 % ?9-tetrahydrocannabinol (THC)) or a matching placebo on two different occasions. Whole blood (WB) and oral fluid (OF) samples were collected before and up to 3.5 h after smoking the joints. Pharmacokinetic analyses were obtained from these data. Questionnaires assessing the subjective effects were administered to the subjects during each sessi...

Fabritius, Marie; Chtioui, Haithem; Battistella, Giovanni; Annoni, Jean Marie; Dao, Kim; Favrat, Bernard; Fornari, Eleonora; Lauer, Estelle; Maeder, Philippe; Giroud, Christian

2014-01-01

251

Concentrations du ?9 - THC dans les cultures de Cannabis sativa L. du nord du Maroc ?9-THC concentrations in Cannabis sativa L. cultivated in Northern Morocco  

Directory of Open Access Journals (Sweden)

Full Text Available La présente étude concerne la détermination du taux de tetrahydrocannabinol des cultures de cannabis dans trois régions du nord du Maroc : Al Hoceima, Chefcliaouen et Larache, à partir de plantes vertes en croissance, sèches arrivées à maturité et réduites en poudre. L'analyse quantitative conduite en chromatographie gazeuse couplée à la spectrométrie de masse, sur les extraits organiques de 245 échantillons issus de 30 parcelles, a permis la détermination des teneurs moyennes en $Delta^9$-THC dans la plante verte (0,5 %, sèche (2,1 % et dans la poudre (8,3 %. En outre, ces résultats démontrent que les régions de culture traditionnelle Al Hoceima et Chefcliaouen produisent du cannabis à plusforte teneur en. $Delta^9$-THC comparativement à la région de Larache, appelée zone d'extension où le cannabis a été mis en culture plus récemment. Par ailleurs, cette étude a établi que les plants mâles, souvent considérés déficients en $Delta^9$-THC, renferment des teneurs de même ordre que celles enregistrées pour les plants femelles aussi bien dans les feuilles que dans les sommités. This study proposes GC/MS determination of $Delta^9$-THC level in plant material grown in Northern Morocco : Al Hoceima, Chefcliaouen and Larache. 245 samples of growing plant, raw and powder sampled from 30 parcels were analysed. The average $Delta^9$-THC concentrations are evaluated for growing plant (0.5 %, raw (2.1 % and powder samples (8.3 %. Furthermore, these results demonstrate that cannabis production coming from traditional cultivation area Al Hoceima and Chefcliaouen, is more concentrated in $Delta^9$-THC than Larache which is a recent cultivation area. Otherwise, this study showed that the male plants, often considered deficient in $Delta^9$-THC, contain approximately the same concentrations present in the female plants.

Stambouli Hamid

2008-02-01

252

Considerações sobre a toxicocinética da Cannabis sativa L. ou maconha, com enfase no homem Some aspects of pharmacokinetics of Cannabis sativa L. (Marihuana) with emphasis on man  

OpenAIRE

O presente artigo consiste em uma análise sobre a origem da Cannabis no Brasil, suas principais substâncias químicas, realçando o ?9 tetrahidrocanabinol como responsável pelos efeitos farmacológicos. é citado também o fato de existirem duas formas de numeração dos carbonos do ?THC. Para melhor entender a toxicocinética foram feitas considerações sobre as doses de maconha, que vão variar de acordo com o usuário, e origem do vegetal. Finalmente é feito urn estudo deta...

Luiz Marques de Sá

1989-01-01

253

Concentrations du ?9 - THC dans les cultures de Cannabis sativa L. du nord du Maroc ?9-THC concentrations in Cannabis sativa L. cultivated in Northern Morocco  

OpenAIRE

La présente étude concerne la détermination du taux de tetrahydrocannabinol des cultures de cannabis dans trois régions du nord du Maroc : Al Hoceima, Chefcliaouen et Larache, à partir de plantes vertes en croissance, sèches arrivées à maturité et réduites en poudre. L'analyse quantitative conduite en chromatographie gazeuse couplée à la spectrométrie de masse, sur les extraits organiques de 245 échantillons issus de 30 parcelles, a permis la détermination des teneurs moyennes ...

Stambouli Hamid; El Bouri Aziz; Bellemam My Ahmed; Bouayoun Taoufik; El Karni Naima

2008-01-01

254

Perfil de consumo de cocaína, cannabis y opiáceos en el laboratorio toxicológico CENATOXA Profile of consumption of cocaine, cannabis and opiates in the toxicology laboratory CENATOXA  

OpenAIRE

Con el propósito de conocer, en la población que concurre al laboratorio del CENATOXA, qué droga de abuso se consume más, cuál es la modalidad de consumo y el perfil de la consulta, se realizó un estudio retrospectivo de 2.635 casos a los que durante el período 1995-2006 se les solicitó investigación en orina de cannabis, cocaína y opiáceos. Los análisis se realizaron utilizando pruebas inmunológicas, cromatografía en capa delgada normalizada y cromatografía gaseosa-espectromet...

Patricia Noemí Quiroga; Isabel Yohena; Cecilia Mariel Contartese; Herme González; Clara Magdalena López

2008-01-01

255

Considerações sobre a toxicocinética da Cannabis sativa L. ou maconha, com enfase no homem / Some aspects of pharmacokinetics of Cannabis sativa L. (Marihuana) with emphasis on man  

Scientific Electronic Library Online (English)

Full Text Available SciELO Brazil | Language: Portuguese Abstract in portuguese O presente artigo consiste em uma análise sobre a origem da Cannabis no Brasil, suas principais substâncias químicas, realçando o ?9 tetrahidrocanabinol como responsável pelos efeitos farmacológicos. é citado também o fato de existirem duas formas de numeração dos carbonos do ?THC. Para melhor enten [...] der a toxicocinética foram feitas considerações sobre as doses de maconha, que vão variar de acordo com o usuário, e origem do vegetal. Finalmente é feito urn estudo detalhado sobre, absorção, distribuição, armazenamento, biotransformação e eliminação dos diversos componentes químicos da maconha. Abstract in english This paper contains an analysis of the origin of the introduction of Cannabis in Brazil, the identify of its chemical components, mainly tetrahydrocannabinol responsible for the pharmacological effects of Cannabis. Toxicokinetic studies were developed in relation the amounts of marihuana consumed, c [...] haracteristics of the user and origin of the drug. Absorption, distribution, storage, biotransformation and elimination of marihuana derived metabolites were studies.

Luiz Marques de, Sá.

256

Early-Onset, Regular Cannabis Use Is Linked to IQ Decline  

Science.gov (United States)

... R) and the Wechsler Adult Intelligence Scale-IV (WAIS-IV) to assess IQ in childhood and adulthood, respectively. The team averaged ... cannabis use before age 18, there was little difference in average IQ loss between those who had reduced or stopped ...

257

The Medicinal Cannabis Treatment Agreement: Providing Information to Chronic Pain Patients via a Written Document.  

Science.gov (United States)

Over 20 states now approve medical marijuana for a long list of "indications," and more states may well offer access in the near future. Surveys have demonstrated that pain is the most common indication for medical use of cannabis. As more individuals gain access to this botanical product through state ballot initiatives and legislative mandate, the pain specialist is likely to be confronted by patients either seeking such treatment where permitted, or otherwise inquiring about its potential benefits and harms, and alternative pharmaceuticals containing cannabinoids. Whether or not they are in the position to prescribe medical cannabis, pain physicians would seem to have an obligation to understand and inform their patients on key issues of the evidence base on cannabinoid therapeutics. One way to fulfill this obligation might be to borrow from concepts developed in the prescription of opioids: the use of a written agreement to describe and minimize risks. Regrettably, the widespread adoption of opioids was undertaken while harmful effects were minimized; obviously, no one wants to repeat this misstep. This article describes a method of educating patients in a manner analogous to other treatment agreements. Undoubtedly, the knowledge base concerning risks will be an iterative process as we learn more about the long-term use of medicinal cannabis. But we should start the process now so that patients may be instructed about our current conception of what the use of medicinal cannabis entails. PMID:25370134

Wilsey, Barth; Atkinson, J Hampton; Marcotte, Thomas D; Grant, Igor

2014-11-01

258

Legalized or Not? Poor Public Communication Causes Confusion over the New Cannabis Policy in Belgium  

Science.gov (United States)

During the last three years, the newly announced drug policy, specifically cannabis, has been the subject of debate between the Government and the opposition parties within the Belgian Federal Government. Public communication by the Federal Government and the competent ministers was incomplete, untimely, inconsistent, tendentious and polemical.…

Gelders, Dave; Van Mierlo, Jan

2004-01-01

259

Effects of Parthenium hysterophorus L. on Soil Characteristics Initially Inhabited to Cannabis sativa L.  

Directory of Open Access Journals (Sweden)

Full Text Available Parthenium hysterophorus is a new entry and successfully growing on all types of soils in fields and waste lands. Parthenium is drought resistant highly resistant weed which sustain its survival in highly unfavorable conditions where other delicate flora can not grow. Due to its allelopathic nature, no other plant can grow near it successfully and the chemical nature of the soil also changes which further accelerate the unfavourness for the other species. Because of the weedy characteristics and production of large number of seeds, it grew on an alarming rate and presently it has occupied the large areas in NWFP and Punjab with increasing tendency. It has been found that this weed can grow in association of many other plants of which Cannabis sativa is more important but further studies indicated that even Cannabis is replaced by this weed which means it is highly tolerant and hardy in its nature and due to absence of some natural enemy (Predate it tends to grow on unprecented rate. During the present study it has been observed that Parthenium can grow in variety of soil types with different pH values. Mostly sandy loam and sandy clay loam are found highly conductive for its growth. It is nature of its wide adaptability of various soil types due to which it is found replacing the Cannabis and other natural flora. However, well grown Cannabis plants compete for survival with this weed.

Rizwana Aleem Qureshi

2006-01-01

260

Is the Party Over? Cannabis and Juvenile Psychiatric Disorder: The Past 10 Years  

Science.gov (United States)

Objective: To critically review cannabis research during the past 10 years in relation to rates of use, behavioral problems, and mental disorders in young people. Method: Studies published in English between 1994 and 2004 were identified through systematic searches of literature databases. The material was selectively reviewed focusing on child…

Rey, Joseph M.; Martin, Andres; Krabman, Peter

2004-01-01

261

Caractérisation de l'huile de graines de Cannabis sativa L. cultivé au nord du Maroc Seed oil characterization of Cannabis sativa L. cultivated in Northern Morocco  

Directory of Open Access Journals (Sweden)

Full Text Available La présente étude porte sur la caractérisation de la compo-sition lipidique de l'huile des graines de Cannabis sativa L. type drogue cultivé au Nord du Maroc. Les résultats obtenus montrent que la composition en acides gras de cette huile est assez proche de celle des huiles de graines de cannabis type fibre cultivé dans d'autres parties du monde. Un taux d'aci-de linolénique (oméga-3 de 16 %, un ratio pondéral acides poly-insaturés/acides saturés (P/S de 6:1 et un rapport oméga-6/oméga-3 de 3:1, ont été déterminés. Les teneurs de cette huile en stérols et en tocophérols $(alpha , eta , gamma $ ont été évaluées respectivement à 3765 mg/kg, 13 mg/kg, 2 mg/kg et 426 mg/kg. Cette composition en acides gras, sté-rols et tocophérols, présente de fortes similitudes avec celle de l'huile de soja. Enfin, un lavage à l'hexane des graines avant extraction de l'huile, permet d'obtenir un produit pratiquement exempt de traces de $Delta $-9-THC The object of this study was to characterize the lipid compo-sition of hemp seed oil obtained from Cannabis sativa L plants of the drug-type cultivated in the north of Morocco. Linolenic acid (oméga-3 constituted 16% of the total fatty acids. The weight ratios of polyunsaturated to saturated acids (P/S and omega-6 to omega-3 fatty acids were 6:1 and 3:1, respectively. The total sterol concentration was 3765 mg/kg and the $alpha $-, $eta $- and $gamma $- tocopherol concentrations were 13, 2 and 426 mg/kg, respectively. We conclude that this oil has the same fatty acid composition as the oils obtained from fiber-type cannabis cultivated in other parts of the world. Furthermore, the fatty acid, sterol and tocopherol composi-tions of the cannabis oil determined in this study are very similar to the soybean oil. Finally, we showed that washing the seeds with hexane before extraction results in an oil without any detectable amount of $Delta $-9-THC.

Stambouli Hamid

2007-12-01

262

Medicinal cannabis: is delta9-tetrahydrocannabinol necessary for all its effects?  

Science.gov (United States)

Cannabis is under clinical investigation to assess its potential for medicinal use, but the question arises as to whether there is any advantage in using cannabis extracts compared with isolated Delta9-trans-tetrahydrocannabinol (Delta9THC), the major psychoactive component. We have compared the effect of a standardized cannabis extract (SCE) with pure Delta9THC, at matched concentrations of Delta9THC, and also with a Delta9THC-free extract (Delta9THC-free SCE), using two cannabinoid-sensitive models, a mouse model of multiple sclerosis (MS), and an in-vitro rat brain slice model of epilepsy. Whilst SCE inhibited spasticity in the mouse model of MS to a comparable level, it caused a more rapid onset of muscle relaxation, and a reduction in the time to maximum effect compared with Delta9THC alone. The Delta9THC-free extract or cannabidiol (CBD) caused no inhibition of spasticity. However, in the in-vitro epilepsy model, in which sustained epileptiform seizures were induced by the muscarinic receptor agonist oxotremorine-M in immature rat piriform cortical brain slices, SCE was a more potent and again more rapidly-acting anticonvulsant than isolated Delta9THC, but in this model, the Delta9THC-free extract also exhibited anticonvulsant activity. Cannabidiol did not inhibit seizures, nor did it modulate the activity of Delta9THC in this model. Therefore, as far as some actions of cannabis were concerned (e.g. antispasticity), Delta9THC was the active constituent, which might be modified by the presence of other components. However, for other effects (e.g. anticonvulsant properties) Delta9THC, although active, might not be necessary for the observed effect. Above all, these results demonstrated that not all of the therapeutic actions of cannabis herb might be due to the Delta9THC content. PMID:14738597

Wilkinson, J D; Whalley, B J; Baker, D; Pryce, G; Constanti, A; Gibbons, S; Williamson, E M

2003-12-01

263

Reduced memory and attention performance in a population-based sample of young adults with a moderate lifetime use of cannabis, ecstasy and alcohol.  

Science.gov (United States)

Regular use of illegal drugs is suspected to cause cognitive impairments. Two substances have received heightened attention: 3,4-methylenedioxymethamphetamine (MDMA or 'ecstasy') and delta-9-tetrahydrocannabinol (THC or 'cannabis'). Preclinical evidence, as well as human studies examining regular ecstasy consumers, indicated that ecstasy use may have negative effects on learning, verbal memory and complex attentional functions. Cannabis has also been linked to symptoms of inattention and deficits in learning and memory. Most of the published studies in this field of research recruited participants by means of newspaper advertisements or by using word-of-mouth strategies. Because participants were usually aware that their drug use was critical to the research design, this awareness may have caused selection bias or created expectation effects. Focussing on attention and memory, this study aimed to assess cognitive functioning in a community-based representative sample that was derived from a large-scale epidemiological study. Available data concerning drug use history allowed sampling of subjects with varying degrees of lifetime drug experiences. Cognitive functioning was examined in 284 young participants, between 22 and 34 years. In general, their lifetime drug experience was moderate. Participants completed a neuropsychological test battery, including measures for verbal learning, memory and various attentional functions. Linear regression analysis was performed to investigate the relationship between cognitive functioning and lifetime experience of drug use. Ecstasy and cannabis use were significantly related to poorer episodic memory function in a dose-related manner. For attentional measures, decrements of small effect sizes were found. Error measures in tonic and phasic alertness tasks, selective attention task and vigilance showed small but significant effects, suggesting a stronger tendency to experience lapses of attention. No indication for differences in reaction time was found. The results are consistent with decrements of memory and attentional performance described in previous studies. These effects are relatively small; however, it must be kept in mind that this study focussed on assessing young adults with moderate drug use from a population-based study. PMID:18635709

Indlekofer, F; Piechatzek, M; Daamen, M; Glasmacher, C; Lieb, R; Pfister, H; Tucha, O; Lange, K W; Wittchen, H U; Schütz, C G

2009-07-01

264

Cannabis consumption by female psychology students: the influence of perceived stress, coping and consumption of drugs in their social environment [Consumo de cannabis en alumnas de Psicología: influencia del estrés percibido, afrontamiento y consumo de drogas en su entorno  

OpenAIRE

The consumption of cannabis has increased in the female population. The risk and protection factors associated with an increase or decrease in its consumption may differ as a function of gender, age and substance consumed. The objectives of the present study were to examine the relevance to cannabis consumption by female students of legal drugs consumed by the university students and family members, the consumption of legal and illicit drugs by friends, sociodemographic factors and, psycholog...

Cristina Vargas; Humberto Manuel Trujillo

2012-01-01

265

21 CFR 1308.35 - Exemption of certain cannabis plant material, and products made therefrom, that contain...  

Science.gov (United States)

...made therefrom, that contain tetrahydrocannabinols. 1308.35 Section 1308.35 Food and Drugs DRUG ENFORCEMENT ADMINISTRATION...Made Therefrom, That Contain Tetrahydrocannabinols § 1308.35 Exemption of certain cannabis plant...

2010-04-01

266

67 FR 7073 - Exemption From Control of Certain Industrial Products and Materials Derived From the Cannabis Plant  

Science.gov (United States)

...Part 1308 [DEA-206] RIN 1117-AA55 Exemption From Control of Certain Industrial Products and Materials Derived From the Cannabis Plant AGENCY: Drug Enforcement Administration (DEA), Department of Justice. ACTION: Interim Rule; extension of...

2002-02-15

267

Early psychosis symptoms  

International Nuclear Information System (INIS)

Objective: To determine the prodromal symptoms of schizophrenia in the pathways to help-seeking. Study Design: A cross-sectional study. Place and Duration of Study: The Department of Psychiatry, the Aga Khan University, Karachi, from 2008 to 2009. Methodology: A total of 93 patients were interviewed in the pathways to care of schizophrenia. The diagnosis was based on ICD-10 criteria. The pathways to care were assessed through a semi-structured questionnaire. The onset, course and symptoms of psychosis were assessed through Interview for Retrospective Assessment at Age at Onset of Psychosis (IROAS). Results: Fifty five (59%) participants were male while 41% (n=38%) were female. Using IROAS, 108 symptoms were identified as concerning behaviour. Alternatively, 60 (55%) concerning behaviours were reported in the open-ended inquiry of the reasons for help seeking as assessed by the pathways to care questionnaire with a statistically significant difference between most symptoms category. The difference was most pronounced (p < 0.001) for depressed mood (66%), worries (65%), tension (63%), withdrawal/mistrust (54%) and loss of self-confidence (53%). Thought withdrawal (22%) and passivity (15%) were elicited only through structured interview (IROAS). When symptoms were categorized together, about 83% of the subjects presented with affective and non-specific prodromal symptoms. Roughly, 10% of the subjects presented with positive symptoms and 3% presented with the negative symptoms of psychosis. The non-specific, affective symptoms appear to predominate the prodromal phase of the illness. Conclusion: Prodromal symptoms of schizophrenia include non-specific, affective symptoms. Attention needs to be paid on identifying the prodromal symptoms and change in social functioning in order to identify those who are at risk of long term psychosis. (author)

268

Report of a parent survey of cannabidiol-enriched cannabis use in pediatric treatment-resistant epilepsy  

OpenAIRE

Severe childhood epilepsies are characterized by frequent seizures, neurodevelopmental delays and impaired quality of life. In these treatment-resistant epilepsies, families often seek alternative treatments. This survey explored the use of cannabidiol-enriched cannabis in children with treatment-resistant epilepsy. The survey was presented to parents belonging to a Facebook group dedicated to sharing information about the use of cannabidiol-enriched cannabis to treat their child’s seizures...

Porter, Brenda E.; Jacobson, Catherine

2013-01-01

269

Cannabidiol, a nonpsychotropic component of cannabis, inhibits cue-induced heroin-seeking and normalizes discrete mesolimbic neuronal disturbances  

OpenAIRE

There remains debate regarding the impact of cannabis on neuropsychiatric disorders. Here, we examined the effects of cannabidiol (CBD), a nonpsychoactive constituent of cannabis on heroin self-administration and drug-seeking behavior using an experimental rat model. CBD (5-20 mg/kg) did not alter stable intake of heroin self-administration, extinction behavior, or drug seeking induced by a heroin prime injection. Instead, it specifically attenuated heroin-seeking behavior reinstated by expos...

Ren, Yanhua; Whittard, John; Higuera-matas, Alejandro; Morris, Claudia V.; Hurd, Yasmin L.

2009-01-01

270

Identifying New Cannabis Use with Urine Creatinine-Normalized THCCOOH Concentrations and Time Intervals Between Specimen Collections*  

OpenAIRE

A previously recommended a method for detecting new cannabis use with creatinine-normalized 11-nor-9-carboxy-?9-tetrahydrocannabinol (THCCOOH) urine concentrations in periodically collected specimens for treatment, workplace and judicial drug testing applications is refined by considering the time interval between urine collections. All urine specimens were collected from six less-than-daily cannabis users who smoked placebo, 1.75%, and 3.55% THC cigarettes in randomized order, each separate...

Smith, Michael L.; Barnes, Allan J.; Huestis, Marilyn A.

2009-01-01

271

Report of a parent survey of cannabidiol-enriched cannabis use in pediatric treatment-resistant epilepsy  

Science.gov (United States)

Severe childhood epilepsies are characterized by frequent seizures, neurodevelopmental delays and impaired quality of life. In these treatment-resistant epilepsies, families often seek alternative treatments. This survey explored the use of cannabidiol-enriched cannabis in children with treatment-resistant epilepsy. The survey was presented to parents belonging to a Facebook group dedicated to sharing information about the use of cannabidiol-enriched cannabis to treat their child’s seizures. Nineteen responses met the inclusion criteria for the study: a diagnosis of epilepsy and current use of cannabidiol-enriched cannabis. Thirteen children had Dravet syndrome, four had Doose syndrome, and one each had Lennox-Gastaut syndrome and idiopathic epilepsy. The average number of anti-epileptic drugs (AEDs) tried before using cannabidiol-enriched cannabis was 12. Sixteen (84%) of the 19 parents reported a reduction in their child’s seizure frequency while taking cannabidiol-enriched cannabis. Of these, two (11%) reported complete seizure freedom, eight (42%) reported a greater than 80% reduction in seizure frequency, and six (32%) reported a 25-60% seizure reduction. Other beneficial effects included increased alertness, better mood and improved sleep. Side effects included drowsiness and fatigue. Our survey shows that parents are using cannabidiol-enriched cannabis as a treatment for children with treatment-resistant epilepsy. Because of the increasing number of states that allow access to medical cannabis, its use will likely be a growing concern for the epilepsy community. Safety and tolerability data for cannabidiol-enriched cannabis use among children is not available. Objective measurements of a standardized preparation of pure cannabidiol are needed to determine whether it is safe, well tolerated and efficacious at controlling seizures in this difficult-to-treat pediatric population. PMID:24237632

Porter, Brenda E.; Jacobson, Catherine

2013-01-01

272

Efeitos cerebrais da maconha: resultados dos estudos de neuroimagem / Brain effects of cannabis: neuroimaging findings  

Scientific Electronic Library Online (English)

Full Text Available SciELO Brazil | Language: Portuguese Abstract in portuguese A maconha é a droga ilícita mais utilizada. Apesar disto, apenas um pequeno número de estudos investigaram as conseqüências neurotóxicas de longo prazo do uso de cannabis. As técnicas de neuroimagem se constituem em poderosos instrumentos para investigar alterações neuroanatômicas e neurofuncionais [...] e suas correlações clínicas e neuropsicológicas. Uma revisão computadorizada da literatura foi conduzida nos indexadores MEDLINE e PsycLIT entre 1966 e novembro de 2004 com os termos 'cannabis', 'marijuana', 'neuroimaging', 'magnetic resonance', 'computed tomography', 'positron emission tomography', 'single photon emission computed tomography", 'SPET', 'MRI' e 'CT'. Estudos de neuroimagem estrutural apresentam resultados conflitantes, com a maioria dos estudos não relatando atrofia cerebral ou alterações volumétricas regionais. Contudo, há uma pequena evidência de que usuários de longo prazo que iniciaram um uso regular no início da adolescência apresentam atrofia cerebral assim como redução na substância cinzenta. Estudos de neuroimagem funcional relatam aumento na atividade neural em regiões que podem estar relacionadas com intoxicação por cannabis e alteração do humor (lobos frontais mesial e orbital) e redução na atividade de regiões relacionadas com funções cognitivas prejudicadas durante a intoxicação aguda. A questão crucial se efeitos neurotóxicos residuais ocorrem após o uso prolongado e regular de maconha permanece obscura, não existindo até então estudo endereçando esta questão diretamente. Estudos de neuroimagem com melhores desenhos, combinados com avaliação cognitiva, podem ser elucidativos neste aspecto. Abstract in english Cannabis is the most widely used illicit drug. Despite this, only a small number of studies have investigated the long-term neurotoxic consequences of cannabis use. Structural and functional neuroimaging techniques are powerful research tools to investigate possible cannabis-induced pathophysiologic [...] al changes. A computer literature review was conducted in the MEDLINE and PsycLIT databases between 1966 and November of 2004 with the search terms 'cannabis', 'marijuana', 'neuroimaging', 'magnetic resonance', 'computed tomography', 'positron emission tomography', 'single photon emission computed tomography", 'SPET', 'MRI' and 'CT'. Structural neuroimaging studies have yielded conflicting results. Most studies report no evidence of cerebral atrophy or regional changes in tissue volumes, and one study suggested that long-term users who started regular use on early adolescence have cerebral atrophy as well as reduction in gray matter. However, several methodological shortcomings limit the interpretation of these results.Functional neuroimaging studies have reported increases in neural activity in regions that may be related with cannabis intoxication or mood-change effects (orbital and mesial frontal lobes, insula, and anterior cingulate) and decreases in activity of regions related with cognitive functions impaired during acute intoxication.The important question whether residual neurotoxic effects occur after prolonged and regular use of cannabis remains unclear, with no study addressing this question directly. Better designed neuroimaging studies, combined with cognitive evaluation, may be elucidative on this issue.

José Alexandre, Crippa; Acioly L T, Lacerda; Edson, Amaro; Geraldo, Busatto Filho; Antonio Waldo, Zuardi; Rodrigo A, Bressan.

2005-03-01

273

Efeitos cerebrais da maconha: resultados dos estudos de neuroimagem Brain effects of cannabis: neuroimaging findings  

Directory of Open Access Journals (Sweden)

Full Text Available A maconha é a droga ilícita mais utilizada. Apesar disto, apenas um pequeno número de estudos investigaram as conseqüências neurotóxicas de longo prazo do uso de cannabis. As técnicas de neuroimagem se constituem em poderosos instrumentos para investigar alterações neuroanatômicas e neurofuncionais e suas correlações clínicas e neuropsicológicas. Uma revisão computadorizada da literatura foi conduzida nos indexadores MEDLINE e PsycLIT entre 1966 e novembro de 2004 com os termos 'cannabis', 'marijuana', 'neuroimaging', 'magnetic resonance', 'computed tomography', 'positron emission tomography', 'single photon emission computed tomography", 'SPET', 'MRI' e 'CT'. Estudos de neuroimagem estrutural apresentam resultados conflitantes, com a maioria dos estudos não relatando atrofia cerebral ou alterações volumétricas regionais. Contudo, há uma pequena evidência de que usuários de longo prazo que iniciaram um uso regular no início da adolescência apresentam atrofia cerebral assim como redução na substância cinzenta. Estudos de neuroimagem funcional relatam aumento na atividade neural em regiões que podem estar relacionadas com intoxicação por cannabis e alteração do humor (lobos frontais mesial e orbital e redução na atividade de regiões relacionadas com funções cognitivas prejudicadas durante a intoxicação aguda. A questão crucial se efeitos neurotóxicos residuais ocorrem após o uso prolongado e regular de maconha permanece obscura, não existindo até então estudo endereçando esta questão diretamente. Estudos de neuroimagem com melhores desenhos, combinados com avaliação cognitiva, podem ser elucidativos neste aspecto.Cannabis is the most widely used illicit drug. Despite this, only a small number of studies have investigated the long-term neurotoxic consequences of cannabis use. Structural and functional neuroimaging techniques are powerful research tools to investigate possible cannabis-induced pathophysiological changes. A computer literature review was conducted in the MEDLINE and PsycLIT databases between 1966 and November of 2004 with the search terms 'cannabis', 'marijuana', 'neuroimaging', 'magnetic resonance', 'computed tomography', 'positron emission tomography', 'single photon emission computed tomography", 'SPET', 'MRI' and 'CT'. Structural neuroimaging studies have yielded conflicting results. Most studies report no evidence of cerebral atrophy or regional changes in tissue volumes, and one study suggested that long-term users who started regular use on early adolescence have cerebral atrophy as well as reduction in gray matter. However, several methodological shortcomings limit the interpretation of these results.Functional neuroimaging studies have reported increases in neural activity in regions that may be related with cannabis intoxication or mood-change effects (orbital and mesial frontal lobes, insula, and anterior cingulate and decreases in activity of regions related with cognitive functions impaired during acute intoxication.The important question whether residual neurotoxic effects occur after prolonged and regular use of cannabis remains unclear, with no study addressing this question directly. Better designed neuroimaging studies, combined with cognitive evaluation, may be elucidative on this issue.

José Alexandre Crippa

2005-03-01

274

Unheated Cannabis sativa extracts and its major compound THC-acid have potential immuno-modulating properties not mediated bu CB1 en CB2 receptor coupled pathways  

OpenAIRE

There is a great interest in the pharmacological properties of cannabinoid like compounds that are not linked to the adverse effects of ?9-tetrahydrocannabinol (THC), e.g. psychoactive properties. The present paper describes the potential immuno-modulating activity of unheated Cannabis sativa extracts and its main non-psychoactive constituent ?9-tetrahydrocanabinoid acid (THCa). By heating Cannabis extracts, THCa was shown to be converted into THC. Unheated Cannabis extract and THCa were ab...

Verhoeckx, K. C. M.; Korthout, H. A. A. J.; Meeteren-kreikamp, A. P.; Ehlert, K. A.; Wang, M.; Greef, J.; Rodenburg, R. J. T.; Witkamp, R. F.

2006-01-01

275

Cognitive and psychomotor effects in males after smoking a combination of tobacco and cannabis containing up to 69 mg delta-9-tetrahydrocannabinol (THC)  

OpenAIRE

RATIONALE: Delta(9)-Tetrahydrocannabinol (THC) is the main active constituent of cannabis. In recent years, the average THC content of some cannabis cigarettes has increased up to approximately 60 mg per cigarette (20% THC cigarettes). Acute cognitive and psychomotor effects of THC among recreational users after smoking cannabis cigarettes containing such high doses are unknown. OBJECTIVES: The objective of this study was to study the dose-effect relationship between the THC dose contained in...

Hunault, C. C.; Mensinga, T. T.; Bo?cker, K. B. E.; Schipper, C. M. A.; Kruidenier, Maaike; Leenders, Marianne E. C.; Vries, Irma; Meulenbelt, J.

2009-01-01

276

Reliability of respiratory symptoms to diagnose atopy.  

Science.gov (United States)

As reliance of responses to epidemiological questionnaires on atopic symptoms is doubtful, we studied the predictive value of these questions relative to atopy, defined by the presence of serum specific IgE, taking into account some extraneous variables such as age and sex. The study population included 2067 adults, 20-60 years old. The protocol consisted of a standardized questionnaire and an evaluation of serum specific IgE using the Phadiatop (Pharmacia Diagnostics, Uppsala, Sweden) test. The predictive value of each symptom suggestive of atopy was quite low, but was much dependent on age and sex. Women more often than men reported atopic symptoms in the absence of atopy. Similarly, the predictive value of each symptom decreased with age. Thus atopic symptoms do not have the same value as predictors of atopy. These findings have both clinical and epidemiological important implications. PMID:1777833

Vervloet, D; Haddi, E; Tafforeau, M; Lanteaume, A; Kulling, G; Charpin, D

1991-11-01

277

Can the weather influence arthritis symptoms?  

Directory of Open Access Journals (Sweden)

Full Text Available By reviewing twelve previous studies on the relationship between the weather and arthritis symptoms, this article summarized the major findings on this controversial topic. It has been supported by most of the studies that arthritis symptoms are associated with weather conditions. Factors such as barometric pressure and temperature were generally believed to be related to arthritis symptoms. However, controversies arose at minor levels. Whether the weather-symptom relationship depends on the specific type of arthritis, weather variables, demographic and pathological heterogeneity of the patients is still a matter of debate. This article calls for standardization in future research design, and hope the mechanism underlying the weather-symptom association will be found.

Wai Chin Li

2014-06-01

278

Cocaine and Psychiatric Symptoms  

OpenAIRE

Background: Cocaine is an addictive drug that produces numerous psychiatric symptoms, syndromes, and disorders. The symptoms include agitation, paranoia, hallucinations, delusions, violence, as well as suicidal and homicidal thinking. They can be primary to the drug's effect or secondary to exacerbation of comorbid psychiatric disorders.

Morton, W. Alexander

1999-01-01

279

Physical symptoms of depression.  

Science.gov (United States)

The incidence of physical symptoms in depression was studied in 51 drug-free patients and in an age and sex-matched control group. Mean symptom intensity and number of symptoms were significantly higher in the patient than in the control group. The subjects' personality structure and relationships between their symptoms and degrees of depression and anxiety were examined using the Eysenck Personality Inventory (EPI), the Beck Depression Inventory, and the Spielberger State-Trait Anxiety Inventory, respectively. Of the variables studied, only the N score of the EPI was shown to influence the symptoms significantly. The effect of such non-specific factors as age, gender, use of alcohol, coffee, tea, and cigarettes was also evaluated and found to be minimal. PMID:7326538

Mathew, R J; Weinman, M L; Mirabi, M

1981-10-01

280

Legalizing a market for cannabis for pleasure: Colorado, Washington, Uruguay and beyond.  

Science.gov (United States)

Colorado, Washington state and Uruguay are currently designing legal non-medical markets for cannabis. These clearly contravene the 1961 and 1988 drug conventions; options for what may happen next are discussed. The current provisions in the three regulatory schemes are summarized. From a public health perspective, the emphasis should be on holding down consumption with regulatory measures, but the public health agenda does not seem to be a strong consideration in the implementation of the US schemes, and they are paying little attention to what can be learned from the history of alcohol and tobacco regulation. While alternative paths to a cannabis market under the conventions are noted, the legalization initiatives underline the need to revise the drug conventions, making prohibition of domestic markets an optional matter. Such changes would also ease the path for including alcohol under the conventions, which would be an important step forward in global health. PMID:24180513

Room, Robin

2014-03-01

281

Fatty acid composition of Achene oils from five Moroccan climatic cultivars of Cannabis.  

Directory of Open Access Journals (Sweden)

Full Text Available The fatty acid composition of achene oil from five Cannabis climatic cultivars cultivated in the nort of Morrocco is determined. Linoleic acid predominated (40 to 45%, followed by linolenic (12 to 17% and oleic (7 to 10% acids. Differences in the fatty acid composition of oils are attributed to environmental factors.

Se estudia la composición en ácidos grasos del aceite de los aquenios de cinco variedades climáticas del cáñamo (Cannabis sativa L cultivadas en el norte de Marruecos. Predomina el ácido linoleico (40 a 45% seguido por el linolénico (12 a 17% y el oleico (7 a 10%. Las diferencias en la composición de los ácidos grasos del aceite se atribuyen a factores ambientales.

Merzouki, A.

1997-06-01

282

El uso terapéutico del Cannabis Sativa L. en la medicina Árabe  

Directory of Open Access Journals (Sweden)

Full Text Available Arab scientists were various centuries ahead of our current knowledge of the curative power of hemp (Cannabis sativa L., Cannabaceae. Modem scientific literature ignores their contribution on the subject. We review in this paper the therapeutic uses of the plant in Arabic medicine from the 8th to the 18th century. Arab physicians knew and used its diuretic, anti-emetic, anti-epileptic, anti-inflammatory, pain-killing and antypiretic properties, among others.

Los científicos árabes se adelantaron en varios siglos a nuestros actuales conocimientos sobre el poder terapéutico del cáñamo (Cannabis sativa L.. Sin embargo, la moderna literatura científica ignora su importante contribución en este terreno. En el presente artículo se estudian los usos terapéuticos de la planta en la medicina árabe entre los siglos VIII y XVIII. Los médicos árabes conocieron y utilizaron sus propiedades diuréticas, antieméticas, antiepilépticas, antiinflamatorias, analgésicas y antipiréticas, entre otras.

Lozano, Indalecio

1997-12-01

283

A test of state dependency effects in marihuana intoxication for the learning of psychomotor tasks.  

Science.gov (United States)

Cannabis cigarettes calibrated to deliver 7 mg delta9-THC were administered to experienced cannabis users and to novices in a 2 x 2 state-dependency learning design using psychomotor tasks. Subjects given four training sessions under marihuana performed no better on the fifth (test) session with the drug than those subjects who had trained in the non-drug condition and were tested in the drug condition. Cannabis-induced impairment in the performance of these tasks is such that prior training in the non-drug condition appears to confer no advantage to the subject. There was no evidence of state-dependency effects in psychomotor performance between drug and non-drug conditions. PMID:1257366

Beautrais, A L; Marks, D F

1976-01-01

284

High school students' posttraumatic symptoms, substance abuse and involvement in violence in the aftermath of war.  

Science.gov (United States)

This study examined one-year after effects of exposure to war events on adolescents' Posttraumatic Stress Symptoms (PTS) and risk behaviors (substance use and involvement in school violence). In addition, it addressed two potential vulnerability factors: at the micro level, it examined whether childhood trauma raised the vulnerability of Israeli adolescents to PTS and risk behaviors when exposed to war events. At the macro level, we explored whether ethnicity, i.e., being an Israeli Arab, is a vulnerability factor to PTS and risk behaviors. We used a representative sample of 7th to 11th grade students from the north of Israel that included 4151 students: 1800 Jewish (54.4% boys) and 2351 Arab (41.5% boys). We assessed exposure to war events and childhood traumatic events, PTS and PTSD, substance use (alcohol, cannabis, Ecstasy) and involvement in school violence. The findings revealed extensive exposure to war events among both Jewish and Arab students. A year after the war, its effects on adolescents were still manifested in PTS, and involvement in school violence and substance use. Exposure to child physical abuse was associated with higher levels of PTS symptoms, substance use and involvement in violence. Exposure to other traumatic events was also associated with greater PTS symptoms and involvement in violence but not with greater substance use. Arab students were a more vulnerable population. They reported higher PTS symptoms, more cannabis use and greater involvement in school violence than Jewish students. However, exposure to war events had similar effects on both Arab and Jewish students. We conclude that war effects include a broad range of psychological distress and risk behaviors that last long after the war ends, especially among youth who have experienced childhood trauma and high exposure to war-related stressors. PMID:22727650

Schiff, Miriam; Pat-Horenczyk, Ruth; Benbenishty, Rami; Brom, Danny; Baum, Naomi; Astor, Ron Avi

2012-10-01

285

Cognitive Mechanisms Underlying Risky Decision-Making in Chronic Cannabis Users  

OpenAIRE

Chronic cannabis users are known to be impaired on a test of decision-making, the Iowa Gambling Task (IGT). Computational models of the psychological processes underlying this impairment have the potential to provide a rich description of the psychological characteristics of poor performers within particular clinical groups. We used two computational models of IGT performance, the Expectancy-Valence Learning model (EVL) and the Prospect-Valence Learning model (PVL), to assess motivational, me...

Fridberg, Daniel J.; Queller, Sarah; Ahn, Woo-young; Kim, Woojae; Bishara, Anthony J.; Busemeyer, Jerome R.; Porrino, Linda; Stout, Julie C.

2010-01-01

286

Antidepressant-like effect of ?9-tetrahydrocannabinol and other cannabinoids isolated from Cannabis sativa L  

OpenAIRE

The antidepressant action of cannabis as well as the interaction between antidepressants and the endocannabinoid system has been reported. This study was conducted to assess the antidepressant-like activity of ?9-THC and other cannabinoids. Cannabinoids were initially evaluated in the mouse tetrad assay to determine doses that do not induce hypothermia or catalepsy. The automated mouse forced swim (FST) and tail suspension (TST) tests were used to determine antidepressant action. At doses la...

El-alfy, Abir T.; Ivey, Kelly; Robinson, Keisha; Ahmed, Safwat; Radwan, Mohamed; Slade, Desmond; Khan, Ikhlas; Elsohly, Mahmoud; Ross, Samir

2010-01-01

287

Photosynthetic response of Cannabis sativa L., an important medicinal plant, to elevated levels of CO2  

OpenAIRE

The effect of elevated CO2 concentrations (545 and 700 ?mol mol?1) on gas exchange and stomatal response of four high ?9-THC yielding varieties of Cannabis sativa (HPM, K2, MX and W1) was studied to assess their response to the rising atmospheric CO2 concentration. In general, elevated CO2 concentration (700 ?mol mol?1) significantly (p?

Chandra, Suman; Lata, Hemant; Khan, Ikhlas A.; Elsohly, Mahmoud A.

2011-01-01

288

Los productos de Cannabis sativa: situación actual y perspectivas en medicina  

OpenAIRE

Los productos psicoactivos de la Cannabis sativa, como marihuana y hachís, se han usado desde hace varios siglos con fines medicinales, religiosos y recreativos. Ahora, la marihuana es la droga ilegal de mayor consumo en el mundo, particularmente por adolescentes y adultos jóvenes. La adolescencia es una etapa crítica en el desarrollo y maduración del Sistema Nervioso Central. La marihuana está constituida por un gran número y variedad de substancias químicas que pueden interactuar ent...

Edguez Carranza, Rodolfo Rodr U.

2012-01-01

289

Alcohol and cannabis use in Norway during the period 1995-2009  

Directory of Open Access Journals (Sweden)

Full Text Available The description of alcohol and cannabis use in the period 1995-2009 is based on data from five sets of surveys. Sales figures for alcohol consumption are also included. Alcohol sales in Norway increased by 40 per cent during the period 1995-2009, from 4.8 to 6.7 litres of pure alcohol per inhabitant aged 15 years and over. This increase largely reflects a sharp increase in the sale of wine. Also when taking into account unregistered alcohol consumption, the consumption of alcohol increased considerably in Norway during the period in question. The increased alcohol consumption seems to be due to an increase in moderate alcohol consumers and/or an increase in situations involving moderate alcohol consumption. Population surveys indicate that there has been an increase in the proportion who drink alcohol and in the proportion of people who drink relatively often, but the increased drinking frequency is not accompanied by a corresponding increase in the proportion who often drink until they are intoxicated. On average, men drink more often and greater quantities than women, with the exception of wine. The proportion who drink alcohol at least twice a month or more has increased in all age groups, and the increase has been particularly marked among those above the age of 50. Despite a reduction in consumption among young people in recent years, consumption and drinking until intoxicated are still widespread. Young girls drink alcohol as often as boys and are equally often intoxicated. As for cannabis, there was an increase in the age group 15-20 years in the second half of the 1990s, followed by a decrease and stagnation since the turn of the millennium. There was little or no difference between boys and girls in the 15-20 age group in the use of cannabis, while among young adults, far more men than women reported that they had used cannabis

Elin K. Bye

2011-12-01

290

Alcohol, tobacco and cannabis use among Nova Scotia adolescents: implications for prevention and harm reduction  

OpenAIRE

OBJECTIVE: To characterize adolescent drug use in terms of a risk continuum and to explore the rationale for harm reduction as a potential approach for school-based drug prevention. DESIGN: Self-reported surveys, in 1991 and 1996, of adolescent students concerning their use of drugs, especially alcohol, tobacco and cannabis, and the harmful consequences of such use. SETTING: Nova Scotia. PARTICIPANTS: A total of 3452 (in 1991) and 3790 (in 1996) junior and high school students in randomly sel...

Poulin, C.; Elliott, D.

1997-01-01

291

Sex Hormones Levels as Influenced by Cannabis sativa in Rats and Men  

OpenAIRE

This study targeted the possible effects of chronic marijuana use on reproductive hormones. To pursue this effect, the levels of the testosterone, the Luteinizing Hormone (LH) and the Follicle Stimulating Hormone (FSH) were assayed in men users in Sudan and in Cannabis sativa extract treated rats. Results were compared to non using groups as controls. Luteinizing Hormone (LH), Stimulating Hormone (FSH) and testosterone levels showed significant changes after 10 days in rat groups. In a...

Gubara, Abdulrahim A.; Elbagir, Nabiela M.; Mukhtar, Amna H.

2012-01-01

292

Pleuritic chest pain and fluid levels on imaging in a heavy cannabis smoker.  

Science.gov (United States)

We present the case of a 48-year-old man with an extensive cannabis smoking history who presented with pleuritic chest pain. A chest X-ray revealed multiple large, apical lung bullae with fluid levels, an appearance consistent with infection. Lung function tests showed moderate airflow obstruction and decreased gas transfer. The infection was treated with a prolonged course of antimicrobials, and the patient followed up by respiratory physicians. PMID:25650062

Cary, Rachel Margaret; Bragg, Craig; Mukherjee, Jayanta

2015-01-01

293

Primary Prevention of Cannabis Use: A Systematic Review of Randomized Controlled Trials  

OpenAIRE

A systematic review of primary prevention was conducted for cannabis use outcomes in youth and young adults. The aim of the review was to develop a comprehensive understanding of prevention programming by assessing universal, targeted, uni-modal, and multi-modal approaches as well as individual program characteristics. Twenty-eight articles, representing 25 unique studies, identified from eight electronic databases (EMBASE, MEDLINE, CINAHL, ERIC, PsycINFO, DRUG, EBM Reviews, and Project CORK)...

Norberg, Melissa M.; Kezelman, Sarah; Lim-howe, Nicholas

2013-01-01

294

Beneficial effects of a Cannabis sativa extract treatment on diabetes-induced neuropathy and oxidative stress.  

Science.gov (United States)

Neuropathy is the most common complication of diabetes and it is still considered to be relatively refractory to most of the analgesics. The aim of the present study was to explore the antinociceptive effect of a controlled cannabis extract (eCBD) in attenuating diabetic neuropathic pain. Repeated treatment with cannabis extract significantly relieved mechanical allodynia and restored the physiological thermal pain perception in streptozotocin (STZ)-induced diabetic rats without affecting hyperglycemia. In addition, the results showed that eCBD increased the reduced glutathione (GSH) content in the liver leading to a restoration of the defence mechanism and significantly decreased the liver lipid peroxidation suggesting that eCBD provides protection against oxidative damage in STZ-induced diabetes that also strongly contributes to the development of neuropathy. Finally, the nerve growth factor content in the sciatic nerve of diabetic rats was restored to normal following the repeated treatment with eCBD, suggesting that the extract was able to prevent the nerve damage caused by the reduced support of this neurotrophin. These findings highlighted the beneficial effects of cannabis extract treatment in attenuating diabetic neuropathic pain, possibly through a strong antioxidant activity and a specific action upon nerve growth factor. PMID:19441010

Comelli, Francesca; Bettoni, Isabella; Colleoni, Mariapia; Giagnoni, Gabriella; Costa, Barbara

2009-12-01

295

Bilateral testicular self-castration due to cannabis abuse: a case report  

Directory of Open Access Journals (Sweden)

Full Text Available Abstract Introduction The self-mutilating patient is an unusual psychiatric presentation in the emergency room. Nonetheless, serious underlying psychiatric pathology and drug abuse are important background risk factors. A careful stepwise approach in the emergency room is essential, although the prognosis, follow-up, and eventual rehabilitation can be problematic. We present a unique and original case of bilateral self-castration caused by cannabis abuse. Case Presentation We report a case of a 40-year-old Berber man, who was presented to our emergency room with externalization of both testes using his long fingernails, associated with hemodynamic shock. After stabilization of his state, our patient was admitted to the operating room where hemostasis was achieved. Conclusion The clinical characteristics of self-mutilation are manifold and there is a lack of agreement about its etiology. The complex behavior associated with drug abuse may be one cause of self-mutilation. Dysfunction of the inhibitory brain circuitry caused by substance abuse could explain why this cannabis-addicted patient lost control and self-mutilated. To the best of our knowledge, this is the first case report which presents an association between self-castration and cannabis abuse.

Stuurman-Wieringa Roos E

2011-08-01

296

Influence of Feed Supplementation with Cannabis Sativa on Quality of Broilers Carcass  

Directory of Open Access Journals (Sweden)

Full Text Available A project was planned to study the effect of feeding powdered seeds of Cannabis sativa on the carcass quality of broiler chicks. A total of 160 day-old broiler chicks of equal weight were randomly divided into four equal groups A, B, C and D. Each group was further divided into four replicates with 10 chicks in each replicate. Dried crushed Cannabis sativa seeds were added to the feed of groups B, C and D at the rate of 5, 10 and 20% of offered feed respectively, while group A served as a control. The studied parameters were body weight, feed intake, feed conversion ratio (FCR, dressing percentage, mortality and economics. After an experimental period of 42 days, the data were analyzed statistically. It was revealed from the results that body weight gain was significantly higher (P<0.05, while feed intake was significantly lower (P<0.05, in group D compared to the control. FCR was significantly better in birds of group D compared to controls. Differences in dressing percentage and mortality were non significant between the treated and control groups. Return per chick (in rupees was significantly higher in group D compared to groups A and B (P<0.05. It was concluded from these results that seeds of Cannabis sativa have remarkable impact on growth of broiler chicks and can help in alleviating feed expenditure incurred on raising broiler chicks.

Rifat Ullah Khan1*, F. R. Durrani1, Naila Chand1 and Haseeb Anwar

2010-01-01

297

Detecting Cannabis Use on the Human Skin Surface via an Electronic Nose System  

Directory of Open Access Journals (Sweden)

Full Text Available The most commonly used drug testing methods are based on the analysis of hair and urine using gas chromatography-mass spectrometry, liquid chromatography-mass spectrometry or immunoassay screening. These methods are time-consuming and partly expensive. One alternative method could be the application of an “electronic nose” (eNose. We have developed an eNose to detect directly on the human skin surface metabolic changes in the human body odor caused by cannabis consumption. Twenty cannabis-smoking and 20 tobacco-smoking volunteers were enrolled in this study. For the sensor signal data processing, two different methods were applied: Principle component analysis (PCA with discriminant analysis, and the method of pattern recognition with subsequent support vector machines (SVM processing. The PCA analysis achieved a correct classification of 70%, whereas the SVM obtained an accuracy of 92.5% (sensitivity 95%, specificity 90% between cannabis-consuming volunteers and tobacco-smoking subjects. This study shows evidence that a low-cost, portable and fast-working eNose system could be useful for health protection, security agencies and for forensic investigations. The ability to analyze human body odor with an eNose opens up a wide field for diagnosing other drugs and also various diseases.

Andreas Voss

2014-07-01

298

Detecting cannabis use on the human skin surface via an electronic nose system.  

Science.gov (United States)

The most commonly used drug testing methods are based on the analysis of hair and urine using gas chromatography-mass spectrometry, liquid chromatography-mass spectrometry or immunoassay screening. These methods are time-consuming and partly expensive. One alternative method could be the application of an "electronic nose" (eNose). We have developed an eNose to detect directly on the human skin surface metabolic changes in the human body odor caused by cannabis consumption. Twenty cannabis-smoking and 20 tobacco-smoking volunteers were enrolled in this study. For the sensor signal data processing, two different methods were applied: Principle component analysis (PCA) with discriminant analysis, and the method of pattern recognition with subsequent support vector machines (SVM) processing. The PCA analysis achieved a correct classification of 70%, whereas the SVM obtained an accuracy of 92.5% (sensitivity 95%, specificity 90%) between cannabis-consuming volunteers and tobacco-smoking subjects. This study shows evidence that a low-cost, portable and fast-working eNose system could be useful for health protection, security agencies and for forensic investigations. The ability to analyze human body odor with an eNose opens up a wide field for diagnosing other drugs and also various diseases. PMID:25057136

Voss, Andreas; Witt, Katharina; Kaschowitz, Tobias; Poitz, Wolf; Ebert, Andreas; Roser, Patrik; Bär, Karl-Jürgen

2014-01-01

299

A preliminary DTI study showing no brain structural change associated with adolescent cannabis use  

Directory of Open Access Journals (Sweden)

Full Text Available Abstract Analyses were performed on brain MRI scans from individuals who were frequent cannabis users (N = 10; 9 males, 1 female, mean age 21.1 ± 2.9, range: 18–27 in adolescence and similar age and sex matched young adults who never used cannabis (N = 10; 9 males, 1 female, mean age of 23.0 ± 4.4, range: 17–30. Cerebral atrophy and white matter integrity were determined using diffusion tensor imaging (DTI to quantify the apparent diffusion coefficient (ADC and the fractional anisotropy (FA. Whole brain volumes, lateral ventricular volumes, and gray matter volumes of the amygdala-hippocampal complex, superior temporal gyrus, and entire temporal lobes (excluding the amygdala-hippocampal complex were also measured. While differences existed between groups, no pattern consistent with evidence of cerebral atrophy or loss of white matter integrity was detected. It is concluded that frequent cannabis use is unlikely to be neurotoxic to the normal developing adolescent brain.

Brown Kyle

2006-05-01

300

O relaxamento respiratório no manejo do craving e dos sintomas de ansiedade em dependentes de crack / Deep breathing in the management of craving and anxiety symptoms of crack-cocaine-dependent patients  

Scientific Electronic Library Online (English)

Full Text Available SciELO Brazil | Language: Portuguese Abstract in portuguese INTRODUÇÃO: O objetivo deste estudo foi verificar a efetividade do relaxamento respiratório no manejo do craving e dos sintomas de ansiedade em dependentes de crack internados para tratamento em uma unidade de desintoxicação. MÉTODO: Ensaio clínico do tipo quase-experimental de análise quantitativa. [...] A amostra foi por conveniência, sendo composta por 32 homens dependentes de cocaína (crack). Eles tinham a cocaína como a droga de escolha e haviam utilizado esta substância por última vez entre 2 e 3 semanas antes do início do tratamento, conseguindo realizar a técnica do relaxamento respiratório adequadamente do ponto de vista biomecânico. Os instrumentos aplicados foram: Cocaine Craving Questionnaire-Brief (CCQB), escala analógica visual (EAV), Inventário Beck de ansiedade (BAI) e ficha com dados sociodemográficos e referentes ao padrão de consumo de substâncias psicoativas (FDS). Foi realizada uma intervenção em grupo na qual, inicialmente, foram aplicados o CCQB, a EAV e o BAI. Depois, foram apresentadas imagens relacionadas ao uso do crack e foram reaplicados os mesmos instrumentos. A seguir, foi realizado o relaxamento respiratório durante 10 minutos e foram aplicados, pela terceira vez, os instrumentos. Após esta intervenção, foi realizada uma entrevista individual com aplicação da FDS. RESULTADOS: Os resultados desta pesquisa demonstraram uma redução dos escores do CCQB, da EAV e do BAI pelo relaxamento respiratório em uma amostra cujo perfil corresponde ao padrão geral dos usuários de crack. CONCLUSÃO: Este estudo, apesar de ter algumas limitações metodológicas, sugere que o relaxamento respiratório pode ser uma estratégia efetiva no manejo do craving e dos sintomas de ansiedade em dependentes de crack. Abstract in english INTRODUCTION: The objective of this study was to verify the effectiveness of deep breathing in the management of craving and anxiety symptoms in crack-cocaine-dependent patients hospitalized for treatment in a detoxification unit. METHODS: This is a quasi-experimental clinical trial using a quantita [...] tive analysis. The convenience sample comprised 32 crack-cocaine-dependent males. These subjects had cocaine as their drug of choice, having used this substance between 2 and 3 weeks prior to the beginning of the treatment, and were able to adequately perform the deep breathing technique. The instruments used were: the Cocaine Craving Questionnaire-Brief (CCQB), the visual analogue scale (VAS), the Beck Anxiety Inventory (BAI), and a form containing sociodemographic information and data related to the pattern of consumption of psychoactive substances (SDF). A group intervention was conducted with the administration of the CCQB, the VAS, and the BAI. After that, images related to the use of crack-cocaine were shown to the subjects and the same instruments were administered again. Next, the participants performed the deep breathing technique for 10 minutes, and the instruments were administered one more time. Finally, an individual interview was done and the SDF was completed. RESULTS: Our findings demonstrated a decrease in the scores on the CCQB, the VAS and the BAI after the deep breathing technique was performed in a sample whose profile represents the general pattern of crack-cocaine users. CONCLUSION: In spite of some methodological limitations, the present study suggests that the deep breathing technique is effective in the management of craving and anxiety symptoms in crack-cocaine-dependent patients.

Taís Cardoso de, Zeni; Renata Brasil, Araujo.

301

O relaxamento respiratório no manejo do craving e dos sintomas de ansiedade em dependentes de crack Deep breathing in the management of craving and anxiety symptoms of crack-cocaine-dependent patients  

Directory of Open Access Journals (Sweden)

Full Text Available INTRODUÇÃO: O objetivo deste estudo foi verificar a efetividade do relaxamento respiratório no manejo do craving e dos sintomas de ansiedade em dependentes de crack internados para tratamento em uma unidade de desintoxicação. MÉTODO: Ensaio clínico do tipo quase-experimental de análise quantitativa. A amostra foi por conveniência, sendo composta por 32 homens dependentes de cocaína (crack. Eles tinham a cocaína como a droga de escolha e haviam utilizado esta substância por última vez entre 2 e 3 semanas antes do início do tratamento, conseguindo realizar a técnica do relaxamento respiratório adequadamente do ponto de vista biomecânico. Os instrumentos aplicados foram: Cocaine Craving Questionnaire-Brief (CCQB, escala analógica visual (EAV, Inventário Beck de ansiedade (BAI e ficha com dados sociodemográficos e referentes ao padrão de consumo de substâncias psicoativas (FDS. Foi realizada uma intervenção em grupo na qual, inicialmente, foram aplicados o CCQB, a EAV e o BAI. Depois, foram apresentadas imagens relacionadas ao uso do crack e foram reaplicados os mesmos instrumentos. A seguir, foi realizado o relaxamento respiratório durante 10 minutos e foram aplicados, pela terceira vez, os instrumentos. Após esta intervenção, foi realizada uma entrevista individual com aplicação da FDS. RESULTADOS: Os resultados desta pesquisa demonstraram uma redução dos escores do CCQB, da EAV e do BAI pelo relaxamento respiratório em uma amostra cujo perfil corresponde ao padrão geral dos usuários de crack. CONCLUSÃO: Este estudo, apesar de ter algumas limitações metodológicas, sugere que o relaxamento respiratório pode ser uma estratégia efetiva no manejo do craving e dos sintomas de ansiedade em dependentes de crack.INTRODUCTION: The objective of this study was to verify the effectiveness of deep breathing in the management of craving and anxiety symptoms in crack-cocaine-dependent patients hospitalized for treatment in a detoxification unit. METHODS: This is a quasi-experimental clinical trial using a quantitative analysis. The convenience sample comprised 32 crack-cocaine-dependent males. These subjects had cocaine as their drug of choice, having used this substance between 2 and 3 weeks prior to the beginning of the treatment, and were able to adequately perform the deep breathing technique. The instruments used were: the Cocaine Craving Questionnaire-Brief (CCQB, the visual analogue scale (VAS, the Beck Anxiety Inventory (BAI, and a form containing sociodemographic information and data related to the pattern of consumption of psychoactive substances (SDF. A group intervention was conducted with the administration of the CCQB, the VAS, and the BAI. After that, images related to the use of crack-cocaine were shown to the subjects and the same instruments were administered again. Next, the participants performed the deep breathing technique for 10 minutes, and the instruments were administered one more time. Finally, an individual interview was done and the SDF was completed. RESULTS: Our findings demonstrated a decrease in the scores on the CCQB, the VAS and the BAI after the deep breathing technique was performed in a sample whose profile represents the general pattern of crack-cocaine users. CONCLUSION: In spite of some methodological limitations, the present study suggests that the deep breathing technique is effective in the management of craving and anxiety symptoms in crack-cocaine-dependent patients.

Taís Cardoso de Zeni

2009-01-01

302

About Kennedy's Disease: Symptoms  

Science.gov (United States)

... general public, whenever one encounters the diagnosis of Kennedy's Disease and has no idea what that might be." ... 93614 (559) 658-5950 Main Menu Home About Kennedy's Disease What is Kennedy's Disease Symptoms Common Misdiagnosis Treatments ...

303

Chiari Malformation: Symptoms  

Science.gov (United States)

... the back of the head, is the defining Chiari symptom Chiari headaches are usually described as starting ... and upper back is another common problem with Chiari due to several causes: nerves are compressed by ...

304

Signs and Symptoms  

Science.gov (United States)

... Cardiomyopathy Patients with left ventricular non-compaction cardiomyopathy (LVNC) may have symptoms of heart failure, shortness of ... stroke) or to other organs (thromboembolism). Properly diagnosing LVNC is difficult because of its obscure visual characteristics. ...

305

Listeriosis: Definition and Symptoms  

Science.gov (United States)

... page: About CDC.gov . Listeria (Listeriosis) Share Compartir Definition Listeria : Food Poisoning's Rare but Deadly Germ February ... 888) 232-6348 Contact CDC–INFO Listeria (Listeriosis) Definition & Symptoms Outbreaks Oasis Brands Inc., Cheese Recall & Advice ...

306

Amblyopia: Lazy Eye Symptoms  

Science.gov (United States)

... What Is an Ophthalmologist? Your Eyes & the Sun Eye Health News Consumer Alerts Amblyopia: Lazy Eye Symptoms Tweet ... Get eye MD-reviewed tips and information about eye health and preserving your vision. Privacy Policy Email address © ...

307

Symptom Management Concept Design Webinar  

Science.gov (United States)

Objectives Describe the review process for a symptom management concept Identify the required elements included in a symptom management concept Identify key statistical considerations for a symptom management concept Describe issues to consider

308

Quality of life and depressive symptoms among caregivers and drug dependent people Calidad de vida y los síntomas depresivos en cuidadores y los adictos a las drogas Qualidade de vida e sintomas depressivos entre cuidadores e dependentes de drogas  

Directory of Open Access Journals (Sweden)

Full Text Available The aim of this study was to evaluate the quality of life and the presence of depressive symptoms among the caregivers and drug dependent people of the CAPSad. This is a cross-sectional study, with 109 users of four Psychosocial Care Centers for alcohol and other drugs of Mato Grosso and their caregivers, using the instruments: Medical Outcomes Studies 36 (SF-36, Beck Depression Inventory (BDI and a sociodemographic variables questionnaire. The QoL of the caregivers in the domains functional capacity, physical aspect, pain and vitality were more affected when compared to the users. A strong correlation between QoL and depressive symptoms was found in both groups. The comparisons performed demonstrate a compromise in the quality of life of both, with the group of caregivers most affected, confirming the situation of drug dependence as an important factor in the perception of the caregiver regarding their quality of life.Este estudio tuvo por objetivo evaluar la calidad de vida y los síntomas depresivos en cuidadores y adictos a drogas. Se trata de un estudio transversal en 109 usuarios y sus cuidadores en cuatro Centros de Atención Psicosocial de alcohol y otras drogas en el estado de Mato Grosso. Se aplicaron los instrumentos: Medical Outcomes Studies 36 (SF-36, Inventario de Depresión de Beck (BDI y sociodemográficos. Se encontró que la calidad de vida de los cuidadores en los dominios de funcionamiento físico, dolor y vitalidad fueron más afectados en comparación a los usuarios. Se obtuvo una fuerte correlación entre la calidad de vida y los síntomas depresivos en ambos grupos. Las comparaciones demuestran que la calidad de vida del cuidador y del usuario están comprometidas, siendo que la más afectada corresponde al grupo de cuidadores, lo que confirma la situación de la dependencia de drogas como un actor importante en la percepción del cuidador sobre su calidad de vida.O objetivo deste estudo foi avaliar a qualidade de vida e a presença de sintomas depressivos entre cuidadores e dependentes de drogas, dos CAPSad. Foi utilizado, como método, o estudo transversal, com 109 usuários de quatro Centros de Atenção Psicossocial - Álcool e Drogas, de Mato Grosso, e seus cuidadores, aplicando-se os instrumentos: Medical Outcomes Studies 36 (SF-36, inventário de depressão de Beck (BDI e variáveis sociodemográficas. Constatou-se, pelos resultados, que a qualidade de vida (QV dos cuidadores, nos domínios capacidade funcional, aspecto físico, dor e vitalidade, estava mais afetada, quando comparada aos usuários. Encontrou-se forte correlação entre QV e sintomas depressivos nos dois grupos. Conclui-se que as comparações realizadas demonstram comprometimento da qualidade de vida de ambos, sendo essa mais afetada no grupo de cuidadores, confirmando a situação de dependência de drogas como importante interveniente na percepção do cuidador, quanto à sua qualidade de vida.

Samira Reschetti Marcon

2012-02-01

309

Quality of life and depressive symptoms among caregivers and drug dependent people / Calidad de vida y los síntomas depresivos en cuidadores y los adictos a las drogas / Qualidade de vida e sintomas depressivos entre cuidadores e dependentes de drogas  

Scientific Electronic Library Online (English)

Full Text Available SciELO Brazil | Language: English Abstract in portuguese O objetivo deste estudo foi avaliar a qualidade de vida e a presença de sintomas depressivos entre cuidadores e dependentes de drogas, dos CAPSad. Foi utilizado, como método, o estudo transversal, com 109 usuários de quatro Centros de Atenção Psicossocial - Álcool e Drogas, de Mato Grosso, e seus cu [...] idadores, aplicando-se os instrumentos: Medical Outcomes Studies 36 (SF-36), inventário de depressão de Beck (BDI) e variáveis sociodemográficas. Constatou-se, pelos resultados, que a qualidade de vida (QV) dos cuidadores, nos domínios capacidade funcional, aspecto físico, dor e vitalidade, estava mais afetada, quando comparada aos usuários. Encontrou-se forte correlação entre QV e sintomas depressivos nos dois grupos. Conclui-se que as comparações realizadas demonstram comprometimento da qualidade de vida de ambos, sendo essa mais afetada no grupo de cuidadores, confirmando a situação de dependência de drogas como importante interveniente na percepção do cuidador, quanto à sua qualidade de vida. Abstract in spanish Este estudio tuvo por objetivo evaluar la calidad de vida y los síntomas depresivos en cuidadores y adictos a drogas. Se trata de un estudio transversal en 109 usuarios y sus cuidadores en cuatro Centros de Atención Psicosocial de alcohol y otras drogas en el estado de Mato Grosso. Se aplicaron los [...] instrumentos: Medical Outcomes Studies 36 (SF-36), Inventario de Depresión de Beck (BDI) y sociodemográficos. Se encontró que la calidad de vida de los cuidadores en los dominios de funcionamiento físico, dolor y vitalidad fueron más afectados en comparación a los usuarios. Se obtuvo una fuerte correlación entre la calidad de vida y los síntomas depresivos en ambos grupos. Las comparaciones demuestran que la calidad de vida del cuidador y del usuario están comprometidas, siendo que la más afectada corresponde al grupo de cuidadores, lo que confirma la situación de la dependencia de drogas como un actor importante en la percepción del cuidador sobre su calidad de vida. Abstract in english The aim of this study was to evaluate the quality of life and the presence of depressive symptoms among the caregivers and drug dependent people of the CAPSad. This is a cross-sectional study, with 109 users of four Psychosocial Care Centers for alcohol and other drugs of Mato Grosso and their careg [...] ivers, using the instruments: Medical Outcomes Studies 36 (SF-36), Beck Depression Inventory (BDI) and a sociodemographic variables questionnaire. The QoL of the caregivers in the domains functional capacity, physical aspect, pain and vitality were more affected when compared to the users. A strong correlation between QoL and depressive symptoms was found in both groups. The comparisons performed demonstrate a compromise in the quality of life of both, with the group of caregivers most affected, confirming the situation of drug dependence as an important factor in the perception of the caregiver regarding their quality of life.

Samira Reschetti, Marcon; Elizete Aparecida, Rubira; Mariano Martinez, Espinosa; Dulce Aparecida, Barbosa.

2012-02-01

310

Investigating Sedative, Preanaesthetic & Anti-anxiety Effects of Herbal Extract of Cannabis Sativa in Comparison with Diazepam in Rats  

Directory of Open Access Journals (Sweden)

Full Text Available Introduction: Cannabis sativa is a plant that is Called Cannabis in Persian and has diversity all over the world. This plant grows in North region, Arak and Kashan in Iran. Chemical compounds of this plant are cannabidiol, cannabidiolic acid and tetra hydro cannabinol that cause the increase in duration of anesthesia via injection of anesthesia drugs. This effect shows the effectiveness of this plant extraction for sedation and smoothing. It is claimed that the usage of this drug for preanesthesia causes the reduction of anesthesia duration induction and increases anesthesia persistency. It seems that Cannabis and its compounds have effects on sleep through hypothalamus and posterior nucleus hemisphere. Methods: herbal extract of Cannabis Sativa (with doses of 150, 300, 450mg/kg, IP, Diazepam (with dose of 1.2mg/kg, IP, and Di-methyl sulphoxide with the equal volume was injected intraperitoneally into two different groups of male wistar rats 30 minutes before assessing the relief sedative and preanaesthetic effects (induced sleep duration by ketamine 40mg/kg, ip & anti-anxiety effects (using elevated plus maze. Results: The results showed a meaningful increase in the period of the sleep time that had been induced with Ketamine and also a meaningful increase was observed in the time spent at open arms in the treatment groups with high and low dose of extract. Conclusion: The results showed that the Cannabis Sativa extract with dose of 350mg/kg has sedative, preanaesthetic & anti-anxiety effects.

A rezaei

2014-04-01

311

The influence of inhibitory control and episodic memory on the risky sexual behavior of young adult cannabis users.  

Science.gov (United States)

Cannabis use is associated with risky sexual behavior (RSB) and sex-related negative health consequences. This investigation examined the role of inhibitory control and episodic memory in predicting RSB and sex-related negative consequences among current cannabis users. Findings indicated that the relationships among cannabis, neurocognition, and sexual-risk varied according to the dimension of neurocognition and the parameter of RSB in question. Specifically, more risk-taking was associated with more RSB. Furthermore, amount of recent cannabis use was associated with more RSB and sex-related negative consequences, but only among those with worse performances on a measure of decision-making and of risk-taking. Contrary to hypotheses, worse episodic memory also significantly predicted higher overall sexual-risk and decreased safe-sex practices. Results indicate that worse neurocognitive performance in the areas of risk-taking, decision-making, and episodic memory may influence the degree to which cannabis users engage in RSB and experience negative health consequences as a result. (JINS, 2012, 18, 1-7). PMID:22676889

Schuster, Randi Melissa; Crane, Natania A; Mermelstein, Robin; Gonzalez, Raul

2012-09-01

312

Cannabis Use and Drug Related Problems Among Adolescents in 27 European Countries: The Utility of the Prevention Paradox  

Directory of Open Access Journals (Sweden)

Full Text Available AIMS – To study the prevalence of cannabis use and drug-related problems among European adolescents and the utility of the prevention paradox. METHODS – Survey data from the European School Survey Project on Alcohol and Other Drugs (ESPAD in 2007 in the 27 countries with information about drug use and drug-related problems was used. We analysed the proportion of all drug-related problems that occurred in a high risk group and among others who had used cannabis in the previous 12 months. The cut-off for the high risk group was chosen to include 10-15 % of the most frequent cannabis users. RESULTS – The high risk groups accounted for a substantial, but a minority, of drug-related problems among boys as well as girls. A minority of those who had used cannabis reported any drug-related problem. The proportion of adolescents with drug-related problems and the average number of problems increased with frequency of cannabis use. CONCLUSIONS – We find support for policy measures of more general character, supported by the prevention paradox. However, this does not exclude a policy supporting frequent drug users if they can be identified

Romelsjö Anders

2014-10-01

313

Genetics and gastrointestinal symptoms.  

Science.gov (United States)

Gastrointestinal (GI) symptoms including nausea, vomiting, diarrhea, constipation, abdominal discomfort/pain, and heartburn are ubiquitous and as such are often the focus of nursing interventions. The etiologies of these symptoms include GI pathology (e.g., cancer, inflammation), dietary factors (e.g., lactose intolerance), infection, stress, autonomic nervous system dysregulation, medications, as well as a host of diseases outside the GI tract. This review focuses on a common condition (irritable bowel syndrome [IBS]) that is linked with both bowel pattern and abdominal discomfort/pain symptoms. Family and twin studies give evidence for a role of genetic factors in IBS. Whether genes are directly associated with IBS or influence disease risk indirectly by modulating the response to environmental factors remains unknown at this time. Given the multifactorial nature of IBS, it is unlikely that a single genetic factor is responsible for IBS. In addition, gene-gene (epistatic) interactions are also likely to play a role. Four genes coding for proteins involved in neurotransmission (i.e., the serotonin reuptake transporter [SERT], tryptophan hydroxylase [TPH], alpha2-adrenergic receptor [alpha2-ADR], catechol-o-methyl transferase [COMT]) and their potential relevance to GI symptoms and IBS will be reviewed. Further research using genome-wide association approaches with samples well characterized by ethnicity and standardized symptom subgrouping is needed. PMID:22891508

Heitkemper, Margaret M; Kohen, Ruth; Jun, Sang-Eun; Jarrett, Monica E

2011-01-01

314

Asthma Outcomes: Asthma Symptoms  

Science.gov (United States)

Background Respiratory symptoms are commonly used to assess the impact of patient-centered interventions. Objective At the request of National Institutes of Health (NIH) institutes and other federal agencies, an expert group was convened to propose which measurements of asthma symptoms should be used as a standardized measure in future clinical research studies. Methods Asthma symptom instruments were classified as daily diaries (prospectively recording symptoms between research visits) or retrospective questionnaires (completed at research visits). We conducted a systematic search in PubMed and a search for articles that cited key studies describing development of instruments. We classified outcome instruments as either core (required in future studies), supplemental (used according to study aims and standardized), or emerging (requiring validation and standardization). This work was discussed at an NIH-organized workshop in March 2010 and finalized in September 2011. Results Four instruments (3 daily diaries, 1 for adults and 2 for children; and 1 retrospective questionnaire for adults) were identified. Minimal clinically important differences have not been established for these instruments, and validation studies were only conducted in a limited number of patient populations. Validity of existing instruments may not be generalizable across racial-ethnic or other subgroups. Conclusions An evaluation of symptoms should be a core asthma outcome measure in clinical research. However, available instruments have limitations that preclude selection of a core instrument. The working group participants propose validation studies in diverse populations, comparisons of diaries versus retrospective questionnaires, and evaluations of symptom assessment alone versus composite scores of asthma control. PMID:22386505

Krishnan, Jerry A.; Lemanske, Robert F.; Canino, Glorisa J.; Elward, Kurtis S.; Kattan, Meyer; Matsui, Elizabeth C.; Mitchell, Herman; Sutherland, E. Rand; Minnicozzi, Michael

2014-01-01

315

Origin of samples of Cannabis sativa through insect fragments associated with compacted hemp drug in South America  

Directory of Open Access Journals (Sweden)

Full Text Available Origin of samples of Cannabis sativa through insect fragments associated with compacted hemp drug in South America. Insects associated with a seizure of Cannabis sativa L. may indicate the origin of the illicit drug. Nevertheless, no work regarding this subject has been previously published for South America. In the present investigation, seven kilograms of vegetal material (C. sativa were inspected for insect fragments. Three species were identified and used to test the origin of the seizure of cannabis plant material: Euschistus heros (Fabricius, 1794, Thyanta perditor (Fabricius, 1794 (Heteroptera, Pentatomidae, and Cephalotes pusillus (Klug, 1824 (Hymenoptera, Formicidae. These insect species restricted the geographic origin of the drug to the Neotropical region, and their distribution patterns showed an overlap of the State of Mato Grosso (Brazil, Argentina, and Paraguay. Based on this information, two of the three major C. sativa growing areas in South America were excluded: (1 the Colombian territory and (2 northeastern Brazil.

Marcos Patrício Macedo

2013-06-01

316

Marijuana intoxication  

Science.gov (United States)

Cannabis intoxication; Intoxication - marijuana (cannabis); Pot; Mary Jane; Weed; Grass; Cannabis ... The intoxicating effects of marijuana include relaxation, ... to fast and predictable signs and symptoms. Eating marijuana ...

317

Cannabis-based medicine reduces multiple pathological processes in A?PP/PS1 mice.  

Science.gov (United States)

Several recent findings suggest that targeting the endogenous cannabinoid system can be considered as a potential therapeutic approach to treat Alzheimer's disease (AD). The present study supports this hypothesis demonstrating that delta-9-tetrahydrocannabinol (THC) or cannabidiol (CBD) botanical extracts, as well as the combination of both natural cannabinoids, which are the components of an already approved cannabis-based medicine, preserved memory in A?PP/PS1 transgenic mice when chronically administered during the early symptomatic stage. Moreover, THC + CBD reduced learning impairment in A?PP/PS1 mice. A significant decrease in soluble A?42 peptide levels and a change in plaques composition were also observed in THC + CBD-treated A?PP/PS1 mice, suggesting a cannabinoid-induced reduction in the harmful effect of the most toxic form of the A? peptide. Among the mechanisms related with these positive cognitive effects, the anti-inflammatory properties of cannabinoids may also play a relevant role. Here we observed reduced astrogliosis, microgliosis, and inflammatory-related molecules in treated A?PP/PS1 mice, which were more marked after treatment with THC + CBD than with either THC or CBD. Moreover, other cannabinoid-induced effects were uncovered by a genome-wide gene expression study. Thus, we have identified the redox protein thioredoxin 2 and the signaling protein Wnt16 as significant substrates for the THC + CBD-induced effects in our AD model. In summary, the present findings show that the combination of THC and CBD exhibits a better therapeutic profile than each cannabis component alone and support the consideration of a cannabis-based medicine as potential therapy against AD. PMID:25125475

Aso, Ester; Sánchez-Pla, Alexandre; Vegas-Lozano, Esteban; Maldonado, Rafael; Ferrer, Isidro

2015-01-01

318

Plasma Cannabinoid Pharmacokinetics following Controlled Oral ?9-Tetrahydrocannabinol and Oromucosal Cannabis Extract Administration  

Science.gov (United States)

BACKGROUND Sativex®, a cannabis extract oromucosal spray containing ?9-tetrahydrocannabinol (THC) and cannabidiol (CBD), is currently in phase III trials as an adjunct to opioids for cancer pain treatment, and recently received United Kingdom approval for treatment of spasticity. There are indications that CBD modulates THC’s effects, but it is unclear if this is due to a pharmacokinetic and/or pharmacodynamic interaction. METHODS Cannabis smokers provided written informed consent to participate in this randomized, controlled, double-blind, double-dummy institutional review board–approved study. Participants received 5 and 15 mg synthetic oral THC, low-dose (5.4 mg THC and 5.0 mg CBD) and high-dose (16.2 mg THC and 15.0 mg CBD) Sativex, and placebo over 5 sessions. CBD, THC, 11-hydroxy-THC, and 11-nor-9-carboxy-THC were quantified in plasma by 2-dimensional GC-MS. Lower limits of quantification were ?0.25 ?g/L. RESULTS Nine cannabis smokers completed all 5 dosing sessions. Significant differences (P < 0.05) in maximum plasma concentrations (Cmax) and areas under the curve from 0–10.5 h postdose (AUC0?10.5) for all analytes were found between low and high doses of synthetic THC and Sativex. There were no statistically significant differences in Cmax, time to maximum concentration or in the AUC0?10.5 between similar oral THC and Sativex doses. Relative bioavailability was calculated to determine the relative rate and extent of THC absorption; 5 and 15 mg oral THC bioavailability was 92.6% (13.1%) and 98.8% (11.0%) of low- and high-dose Sativex, respectively. CONCLUSION These data suggest that CBD modulation of THC’s effects is not due to a pharmacokinetic interaction at these therapeutic doses. PMID:21078841

Karschner, Erin L.; Darwin, W. David; Goodwin, Robert S.; Wright, Stephen; Huestis, Marilyn A.

2013-01-01

319

European youth care sites serve different populations of adolescents with cannabis use disorder. Baseline and referral data from the INCANT trial  

Directory of Open Access Journals (Sweden)

Full Text Available Abstract Background MDFT (Multidimensional Family Therapy is a family based outpatient treatment programme for adolescent problem behaviour. MDFT has been found effective in the USA in adolescent samples differing in severity and treatment delivery settings. On request of five governments (Belgium, France, Germany, the Netherlands, and Switzerland, MDFT has now been tested in the joint INCANT trial (International Cannabis Need of Treatment for applicability in Western Europe. In each of the five countries, study participants were recruited from the local population of youth seeking or guided to treatment for, among other things, cannabis use disorder. There is little information in the literature if these populations are comparable between sites/countries or not. Therefore, we examined if the study samples enrolled in the five countries differed in baseline characteristics regarding demographics, clinical profile, and treatment delivery setting. Methods INCANT was a multicentre phase III(b randomized controlled trial with an open-label, parallel group design. It compared MDFT with treatment as usual (TAU at and across sites in Berlin, Brussels, Geneva, The Hague and Paris. Participants of INCANT were adolescents of either sex, from 13 through 18 years of age, with a cannabis use disorder (dependence or abuse, and at least one parent willing to take part in the treatment. In total, 450 cases/families were randomized (concealed into INCANT. Results We collected data about adolescent and family demographics (age, gender, family composition, school, work, friends, and leisure time. In addition, we gathered data about problem behaviour (substance use, alcohol and cannabis use disorders, delinquency, psychiatric co-morbidity. There were no major differences on any of these measures between the treatment conditions (MDFT and TAU for any of the sites. However, there were cross-site differences on many variables. Most of these could be explained by variations in treatment culture, as reflected by referral policy, i.e., participants' referral source. We distinguished 'self-determined' referral (common in Brussels and Paris and referral with some authority-related 'external' coercion (common in Geneva and The Hague. The two referral types were more equally divided in Berlin. Many cross-site baseline differences disappeared when we took referral source into account, but not all. Conclusions A multisite trial has the advantage of being efficient, but it also carries risks, the most important one being lack of equivalence between local study populations. Our site populations differed in many respects. This is not a problem for analyses and interpretations if the differences somehow can be accounted for. To a major extent, this appeared possible in INCANT. The most important factor underlying the cross-site variations in baseline characteristics was referral source. Correcting for referral source made most differences disappear. Therefore, we will use referral source as a covariate accounting for site differences in future INCANT outcome analyses. Trial registration number ISRCTN: ISRCTN51014277

Rigter Renske

2011-07-01

320

Molecular Cytogenetic Characterization of the Dioecious Cannabis sativa with an XY Chromosome Sex Determination System  

OpenAIRE

Hemp (Cannabis sativa L.) was karyotyped using by DAPI/C-banding staining to provide chromosome measurements, and by fluorescence in situ hybridization with probes for 45 rDNA (pTa71), 5S rDNA (pCT4.2), a subtelomeric repeat (CS-1) and the Arabidopsis telomere probes. The karyotype has 18 autosomes plus a sex chromosome pair (XX in female and XY in male plants). The autosomes are difficult to distinguish morphologically, but three pairs could be distinguished using the probes. The Y chromosom...

Divashuk, Mikhail G.; Alexandrov, Oleg S.; Razumova, Olga V.; Kirov, Ilya V.; Karlov, Gennady I.

2014-01-01

321

Anti-inflammatory Activity of the Plant Cannabis sativa (L) Petrolium Ether Extract in Albino Rats  

OpenAIRE

In this study the plant Cannabis sativa seeds petroleum oil extract was investigatedfor anti- inflammatory activity on albino rats. The inflammation was firstly obtained byusing carrageenan suspension 0.1 ml of 10% saline injected at the sub – plantar region ofthe left limb for inducing a local acute oedema. A decreased in oedema size was reportedafter 24 hours for the rats pretreated with carrageenan30 minutes before injection withsuspension( 4.56, 0.59 and 0.93 for control, 1ml/kg per day...

Musa E.M; El, Badwi S. M.; Jah Elnabi M.A; Osman E. A; Dahab M. M

2011-01-01

322

Temperature response of photosynthesis in different drug and fiber varieties of Cannabis sativa L.  

OpenAIRE

The temperature response on gas and water vapour exchange characteristics of three medicinal drug type (HP Mexican, MX and W1) and four industrial fiber type (Felinq 34, Kompolty, Zolo 11 and Zolo 15) varieties of Cannabis sativa, originally from different agro-climatic zones worldwide, were studied. Among the drug type varieties, optimum temperature for photosynthesis (Topt) was observed in the range of 30–35 °C in high potency Mexican HPM whereas, it was in the range of 25–30 °C in ...

Chandra, Suman; Lata, Hemant; Khan, Ikhlas A.; Elsohly, Mahmoud A.

2011-01-01

323

Sex Hormones Levels as Influenced by Cannabis sativa in Rats and Men  

Directory of Open Access Journals (Sweden)

Full Text Available This study targeted the possible effects of chronic marijuana use on reproductive hormones. To pursue this effect, the levels of the testosterone, the Luteinizing Hormone (LH and the Follicle Stimulating Hormone (FSH were assayed in men users in Sudan and in Cannabis sativa extract treated rats. Results were compared to non using groups as controls. Luteinizing Hormone (LH, Stimulating Hormone (FSH and testosterone levels showed significant changes after 10 days in rat groups. In all addicted men groups, only slight non significant changes were observed compared to non users. These findings supported previous studies and concluded that C. sativa can significantly influence the levels of sex hormones in rats.

Abdulrahim A. Gubara

2012-01-01

324

Hypertonie - Symptom oder Krankheit?  

Directory of Open Access Journals (Sweden)

Full Text Available Die kardiovaskuläre Forschung bediente sich in den letzten Jahren verschiedener molekularer und genetischer Forschungsmethoden, wobei die Erforschung der Ursachen systemischer Hypertonie eines der Hauptanliegen in diesem Zusammenhang bildete. Die vorliegende Publikation behandelt die bisher bekannten Formen genetischer Varianten der Hypertonie wie den ACE-Genpolymorphismus und ähnliche Beobachtungen im Zusammenhang mit ANP oder der NO-Synthetase und über seltene, genetisch festgelegte Symptome wie den Glukokortikoid-sensitiven Hyperaldosteronismus oder das Liddle Syndrom. Zudem werden Daten über molekulare Veränderungen bei Hypertonie wie die verringerte myokardiale GLUT 4 mRNA-Expression und die erhöhte EGR 1 mRNA-Expression im Myokard von hypertensiven Patienten vorgestellt und die Frage diskutiert, ob Hypertonie als Krankheit oder als Symptom bezeichnet werden soll.

Barth S

1999-01-01

325

[Depressive symptoms and sexuality].  

Science.gov (United States)

The mutually reinforcing dyad of depressive symptoms and erectile dysfunction is scientifically established. The cure of depression improves sexual dysfunction (SD) and the treatment of SD induces improvement of depression. Most of anti-depressants induce negative sexual side effects that lead to non-compliance of these treatments. The knowledge of interrelation between depression, anti-depressants and sexuality is of great importance in clinical practice. PMID:25148948

Porto, Robert

2014-10-01

326

Determination of cannabinoids in cannabis products using liquid chromatography-ion trap mass spectrometry.  

Science.gov (United States)

A method was developed and validated for the simultaneous determination of five cannabinoids, viz. cannabidiol (CBD), cannabidiol acid (CBD-COOH), cannabinol (CBN), delta9-tetrahydrocannabinol (THC), and 3'-carboxy-delta9-all-trans-tetrahydrocannabinol (THC-COOH) in cannabis products. The cannabinoids were extracted from the grinded cannabis samples with a mixture of methanol-chloroform and analysed using liquid chromatography with ion-trap-mass-spectrometry (LC-IT-MSn). For quantification the two most abundant diagnostic MS-MS ions of the analyte in the sample and external standard were monitored. For confirmation purposes the EU criteria as described in Commission Decision 2002/657/EC were followed. Fully satisfactory results were obtained, that is, unequivocal confirmation according to the most stringent EU criteria was possible. The limits of quantification were 0.1 g/kg for CBD, 0.04 g/kg for CBD-COOH, 0.03 g/kg for CBN, 0.28 g/kg for THC and 9.9 g/kg for THC-COOH. The repeatabilities, defined by R.S.D., were 2% for CBN, THC and THC-COOH at the concentration levels of respectively 0.023, 3.3 and 113 g/kg and 5% for CBD-COOH at the level of 0.34 g/kg (n = 6). PMID:15595662

Stolker, A A M; van Schoonhoven, J; de Vries, A J; Bobeldijk-Pastorova, I; Vaes, W H J; van den Berg, R

2004-11-26

327

Physiologische Grundlagen der Akkumulation von
Schwermetallionen beim Faserhanf (Cannabis sativa L.) und das Nutzungspotential bei der Phytoremediation
 

OpenAIRE

Im Rahmen der Arbeit sollte die Akkumulation von Schwermetallen sowie deren Einfluss auf die Synthese von Phytochelatinen in Faserhanfpflanzen - bzw. Zellkulturen (Cannabis sativa L.) untersucht und mit anderen Pflanzen oder Zellkulturen verglichen werden. Zudem sollte die Einsatzfähigkeit von Faserhanf zur Remediation schwermetallbelasteter Böden bewertet und Nutzungsmöglichkeiten für das geerntete Pflanzenmaterial aufgezeigt werden. P...

Ostwald, Anke

2010-01-01

328

Cannabis Use and Memory Brain Function in Adolescent Boys: A Cross-Sectional Multicenter Functional Magnetic Resonance Imaging Study  

Science.gov (United States)

Objective: Early-onset cannabis use has been associated with later use/abuse, mental health problems (psychosis, depression), and abnormal development of cognition and brain function. During adolescence, ongoing neurodevelopmental maturation and experience shape the neural circuitry underlying complex cognitive functions such as memory and…

Jager, Gerry; Block, Robert I.; Luijten, Maartje; Ramsey, Nick F.

2010-01-01

329

Women and Heart Attack Symptoms  

Science.gov (United States)

... the lower right-hand corner of the player. Women and Heart Attack Symptoms HealthDay October 31, 2014 ... MedlinePlus Pages Angina Heart Attack Heart Disease in Women Transcript When symptoms of heart disease strike, women ...

330

Skin Cancer: Signs and Symptoms  

Science.gov (United States)

... and treatments Q - T Skin cancer Signs, symptoms Skin cancer: Signs and symptoms The most common warning ... melanoma appears in many ways. Learn more about skin cancer: Skin cancer Skin cancer: Who gets and ...

331

Symptom Clusters of Heart Failure  

OpenAIRE

Patients with heart failure (HF) report multiple symptoms. Change in symptoms is an indicator of HF decompensation. Patients have difficulty differentiating HF symptoms from comorbid illness or aging. The study purpose was to identify the number, type, and combination of symptoms in hospitalized HF patients and test relationships with comorbid illness and age. A secondary analysis from a HF registry (N=687) was conducted. The sample was 51.7% female, mean age 71±12.5 years. The theory of unp...

Jurgens, Corrine Y.; Moser, Debra K.; Armola, Rochelle; Carlson, Beverly; Sethares, Kristen; Riegel, Barbara

2009-01-01

332

Cannabis findings in drivers suspected of driving under the influence of drugs in Finland from 2006 to 2008.  

Science.gov (United States)

The authors examined driving under the influence of drugs (DUID) cases which were found to be positive in whole blood for cannabis in Finland from 2006 to 2008. Factors studied were the number of cases positive for any combination of ?(9)-tetrahydrocannabinol (THC) and the metabolites 11-hydroxy-?(9)-tetrahydrocannabinol (THC-OH) and 11-nor-9-carboxy-?(9)-tetrahydrocannabinol (THC-COOH). Concurrent use of amphetamines, benzodiazepines and/or alcohol was also recorded, as well as the drivers' age and gender. Altogether 2957 cannabis positive cases were retrieved from the database of the Alcohol and Drug Analytics Unit, National Institute for Health and Welfare. Drug findings were examined in relation to the zero-tolerance policy operated towards DUID in Finland. The number of cannabis positive cases in each year was approximately 1000 and the main demographic of cases was males aged 20-30 years. In the majority of cases (51.6%) the inactive metabolite THC-COOH was the only indication of cannabis use, however, associated use of amphetamines (58.8% of all cases) and/or benzodiazepines (63.9%) in cannabis positive drivers was very common. Detections for amphetamines and/or benzodiazepines were especially common in drivers with THC-COOH only (92.8% of these cases). Combined use of alcohol (25.7%) was also prevalent. Suspect DUID cases generally arise from suspicion on behalf of the police and the zero-tolerance policy offers an expedient means to deal with the challenges presented in DUID, particularly in view of the high incidence of multiple drug use - the legislation is not unduly punitive when enforced in this manner. PMID:22024655

Blencowe, Tom; Pehrsson, Anna; Mykkänen, Sirpa; Gunnar, Teemu; Lillsunde, Pirjo

2012-04-10

333

Langvarige symptomer efter commotio cerebri  

DEFF Research Database (Denmark)

Patients with mild traumatic brain injury (MTBI) do not undergo consistent follow-up in Denmark and the risk factors for long-term symptoms are not fully known. The purpose of this study was to look into symptom frequency, sick-leave frequency and to try to identify risk factors for long-term symptoms following MTBI.

Rasmussen, Mikkel Mylius; Clemmensen, Dorte

2010-01-01

334

Publication trends in the drug dependence literature.  

Science.gov (United States)

Publications dealing with psychotropic drug use and dependence were analyzed for the years 1960-1980 using the numbers of articles cited in each yearly edition of Cumulated Index Medicus. The following headings were reviewed: drug abuse, drug dependence, alcoholism, smoking, heroin addiction, cannabis, cannabinoids, cocaine, phencyclidine, lysergic acid diethylamide, diazepam, and meprobamate. The number of citations for a given year was used to calculate the percentage of the literature for that year which fell under each of those headings. In general, it appears that the growth of the scientific literature included under many of these headings has been more rapid than the overall growth of the literature. PMID:6763473

Boxenbaum, H; Jaffe, J H

1982-01-01

335

Symptoms of Celiac Disease  

Science.gov (United States)

... a periodic basis. These conditions include insulin-dependent diabetes mellitus (requiring insulin therapy), Hashimoto’s thyroiditis, Turner’s syndrome, Williams syndrome, Graves disease. 4. Any ...

336

Influence of circadian typology on drug consumption, hazardous alcohol use, and hangover symptoms.  

Science.gov (United States)

Few studies have focused on the influence of circadian typology on drug use, and none has considered the use of illegal drugs and hazardous alcohol consumption. This study analyzes the influence of circadian typology on several types of drug consumption (habitual or sporadic), hangover symptoms (past 12 mos), and, more specifically, hazardous alcohol consumption of young adults. Five hundred seventeen university students (173 males), between 17 and 30 yrs of age, answered the Composite Scale of Morningness (CSM), the Alcohol Use Disorders Identification Test (AUDIT), and a self-referred questionnaire on drug consumption during the previous month and on the prevalence of different hangover symptoms during the previous year. Our results confirm a higher prevalence of consumption of addictive substances, both legal (nicotine and cola drinks) and illegal (cannabis and ecstasy), in evening- compared to morning- and neither-type subjects (p?typology is a risk factor for the development of drug consumption and that it should be taken into account both in preventive and treatment approaches. Moreover, the data regarding hazardous alcohol use and hangover symptoms emphasize the need to include circadian typology in future studies on the pattern of heavy episodic drinking. PMID:21452920

Prat, Gemma; Adan, Ana

2011-04-01

337

QUALITY OF HEMP SEED OIL DEPENDING ON ITS OBTAINING  

OpenAIRE

Hemp (Cannabis sativa L.) is probably one of the oldest field crops used in nutrition, but also for the production of fibres for clothes, ropes or canvas. Cannabis sativa is one of the most spread species of cannabis which belongs to family Cannabinaceae. The seeds are important part of cannabis sativa<...

Ladislav Staruch; Gabriela Siegrová; Lenka Kou?imská; Luboš Babi?ka; Ivana Poustkova

2010-01-01

338

Rate and predictors of psychotic symptoms after Kashmir earthquake.  

Science.gov (United States)

Psychotic symptoms are more common in general population than validated diagnosis of psychosis. There is evidence to suggest that these symptoms, hallucinations, paranoia, elated mood, thought insertion, are part of a spectrum of psychosis and may have association with the same risk factors that determine development of psychosis. These symptoms have an association with exposure to psychological trauma, post-traumatic stress disorder, anxiety and depression. The aim of this study was to explore the prevalence of psychotic symptoms in the population affected by a natural disaster, earthquake in this case and possible correlates of these symptoms. We conducted a cross-sectional survey of a population sample affected by the disaster, comprising of 1,291 individuals, 18 months after 2005 earthquake in Northern Pakistan and Kashmir to look at the prevalence of these symptoms and their correlates. Screening Instrument for Traumatic Stress in Earthquake Survivors and Self-Reporting Questionnaire and Psychosis Screening Questionnaire were used as tools. We examined association between the symptoms of anxiety, depression, PTSD and psychotic symptoms. We performed logistic regression analysis where hallucinations and delusions were dependent variables and demographic and trauma exposure variables were independent variables. The prevalence of psychotic symptoms ranged between 16.8 and 30.4 %. They were directly correlated with symptoms of post-traumatic stress disorder as well as concurrent symptoms of anxiety and depression. Lower level of education had a strong association in all the regression models. For hallucinations, living in a joint family had a negative association and participation in rescue, history of exposure to previous trauma and past psychiatric history had positive association. Paranoia was associated with female gender. Any psychiatric symptom was associated death of a family member, history of past psychiatric illness and living in a tent at the time of interview. Pattern of association of psychotic symptoms is consistent with prior literature and can be understood in the light of stress vulnerability model. PMID:25421792

Ayub, Muhammad; Saeed, Khalid; Kingdon, David; Naeem, Farooq

2014-11-25

339

Exercise Dependence  

Directory of Open Access Journals (Sweden)

Full Text Available Exercise dependence define a condition in which a person performs excessive exercise resulting in deterioration of his or her physical and mental health wellness. Despite many clinical research studies on exercise dependence, exact diagnostic criteria has not been developed yet. Clinical evidences concerning etiology, epidemiology, underlying mechanisms and treatment of exercise dependence are still not sufficient. Moreover, evaluation of this clinical disorder within dependency perspective is a fairly new concept. Recent studies have shown that exercise dependence has similar features like chemical substance dependence with regards to withdrawal and tolerance symptoms. The aim of this review was to briefly evaluate diagnostic and clinical features of exercise dependence. [Archives Medical Review Journal 2012; 21(3.000: 163-173

Erdal Vardar

2012-06-01

340

Anti-inflammatory Activity of the Plant Cannabis sativa (L Petrolium Ether Extract in Albino Rats  

Directory of Open Access Journals (Sweden)

Full Text Available In this study the plant Cannabis sativa seeds petroleum oil extract was investigatedfor anti- inflammatory activity on albino rats. The inflammation was firstly obtained byusing carrageenan suspension 0.1 ml of 10% saline injected at the sub – plantar region ofthe left limb for inducing a local acute oedema. A decreased in oedema size was reportedafter 24 hours for the rats pretreated with carrageenan30 minutes before injection withsuspension( 4.56, 0.59 and 0.93 for control, 1ml/kg per day and 0.5ml/kg per day groupsgiven C. sativa seed extracts respectively., compared to Indomethacin standard antiinflammatorydrug which reported a decrease in oedema size diameter to 0.55mm, which

Musa E.M

2011-10-01

341

Cannabidiolic acid as a selective cyclooxygenase-2 inhibitory component in cannabis.  

Science.gov (United States)

In the present study it was revealed that cannabidiolic acid (CBDA) selectively inhibited cyclooxygenase (COX)-2 activity with an IC(50) value (50% inhibition concentration) around 2 microM, having 9-fold higher selectivity than COX-1 inhibition. In contrast, Delta(9)-tetrahydrocannabinolic acid (Delta(9)-THCA) was a much less potent inhibitor of COX-2 (IC(50) > 100 microM). Nonsteroidal anti-inflammatory drugs containing a carboxyl group in their chemical structures such as salicylic acid are known to inhibit nonselectively both COX-1 and COX-2. CBDA and Delta(9)-THCA have a salicylic acid moiety in their structures. Thus, the structural requirements for the CBDA-mediated COX-2 inhibition were next studied. There is a structural difference between CBDA and Delta(9)-THCA; phenolic hydroxyl groups of CBDA are freed from the ring formation with the terpene moiety, although Delta(9)-THCA has dibenzopyran ring structure. It was assumed that the whole structure of CBDA is important for COX-2 selective inhibition because beta-resorcylic acid itself did not inhibit COX-2 activity. Methylation of the carboxylic acid moiety of CBDA led to disappearance of COX-2 selectivity. Thus, it was suggested that the carboxylic acid moiety in CBDA is a key determinant for the inhibition. Furthermore, the crude extract of cannabis containing mainly CBDA was shown to have a selective inhibitory effect on COX-2. Taken together, these lines of evidence in this study suggest that naturally occurring CBDA in cannabis is a selective inhibitor for COX-2. PMID:18556441

Takeda, Shuso; Misawa, Koichiro; Yamamoto, Ikuo; Watanabe, Kazuhito

2008-09-01

342

Hypercholesterolemic Effect of Drug-Type Cannabis sativa L. Seed (Marijuana Seed in Guinea Pig  

Directory of Open Access Journals (Sweden)

Full Text Available Cannabis sativa L. has two drug and nondrug varieties. Nondrug varieties of Cannabis are hemp but drug varieties commonly referred to as marijuana. Marijuana is considered nutritional and narcotic plant. Marijuana has not been studied extensively for its nutritional potential in recent years but whole hempseed typically contains over 30% oil (3%saturated, 28% unsaturated fatty acids and about 25% protein. The objectives of the present study were to evaluate the effects of whole marijuana seed on lipid profile of guinea pig. This study was experienced on fourteen guinea pigs as case and control groups. In control group, guinea pigs were fed with normal diet while case group had free access to normal diet and marijuana seed for 60 days. At the end of experiment the feeding of animal stopped and after 12hr fasting, the animal anesthetized by ketamine/xylazine combination and 5 ml of blood of heart was taken. The blood parameters were measured by automated biochemical analyzer. Marijuana seed significantly increased total cholesterol and LDL-c levels (p=0.00 while HDL-c and triglyceride levels didn`t significantly change. In spite of omega-3, omega-6 and omega-9 fatty acids that highly incorporated in hempseed, short term feeding of marijuana seed has not improved blood lipid profile. It may be due to hidden orexigenic phytocannabinoids that found in drug-type seed. In the light of this research, it is recommended that individuals who are affected to cardiovascular diseases and atherosclerosis, they should not use unclean marijuana seed that cultivated in Isfahan province of Iran in their food preparation on regular basis.

Hossein Hayatghaibi

2007-01-01

343

Genetic studies of depressive symptoms  

OpenAIRE

This thesis is focused on depressive symptoms particularly in late fife. Depressive symptoms are associated with serious negative outcomes a greater level of disability and with excess morbidity and mortality. This thesis includes a series of studies that explore the importance of genetic components on current and past depressive symptoms in a large sub-sample of the Swedish Twin Registry. More specifically gender differences, genetic risk factors, and the role of some genet...

Jansson, Ma?rten

2004-01-01

344

Gastrointestinal symptoms in atopic eczema  

OpenAIRE

AIMS—To determine the prevalence of gastrointestinal symptoms in children with eczema and the association of such symptoms with the extent of eczema or skin prick test results.?METHODS—Sixty five children with atopic eczema and a control group matched for age and sex were recruited. Their parents completed a questionnaire about the children's gastrointestinal symptoms. The children's skin was examined; their weight, height, and abdominal circumference were measured; an...

Caffarelli, C.; Cavagni, G.; Deriu, F.; Zanotti, P.; Atherton, D.

1998-01-01

345

ESTUDIO DEL CONTENIDO DE CANABINOIDES EN MUESTRAS DE MARIHUANA (Cannabis sativa L.) CULTIVADAS EN VARIAS REGIONES DE COLOMBIA STUDY OF CANNABINOIDS CONTENT IN MARIHUANA SAMPLES (Cannabis sativa L.) CULTIVATED IN SEVERAL REGIONS OF COLOMBIA  

OpenAIRE

El presente estudio analiza el contenido de cannabinoides en muestras de Cannabis sativa L. cultivadas ilícitamente en Colombia. En primer término se optimizan las condiciones para la extracción y cuantificación de Cannabidiol (CBD), ?9-tetrahidrocannabinol (THC) y Cannabinol (CBN) a partir de una muestra vegetal mediante cromatografía de gases con detector de ionización de llama (CG-FID), validando el respectivo método analítico. Se analizan muestras procedentes de cuatro region...

Florian, Ne?stor M. R.; Parada, Fabia?n A.; Garzo?n, William F. M.

2009-01-01

346

The Effect of Cannabis sativa Hydroalcoholic Extract on Sperm Parameters and Testis Histology in Rats Efecto del Extracto Hidroalcohólico de Cannabis sativa sobre los Parámetros Espermáticos e Histología Testicular en Ratas  

OpenAIRE

Cannabis Sativa is a multiuse herb in traditional medicine, its hydroalcoholic extract (10, 50, and 100 mg/kg) administered interaperitoneally for 14 consequent days to Wistar male rats resulted in significant decrease in progressive motility of sperm. Sperm count and seminiferous tubules diameter decreased significantly in comparison with control group. Also decrease in animal body weight in doses of 50 and 100 mg/kg was observed. Changes in testes weight and serum testosterone were not sign...

Nahid Lotfi; Mozafar Khazaei; Sayyed Mohammad Ali Shariatzadeh; Malek Soleimani Mehranjani; Ali Ghanbari

2013-01-01

347

Comparative risk assessment of alcohol, tobacco, cannabis and other illicit drugs using the margin of exposure approach.  

Science.gov (United States)

A comparative risk assessment of drugs including alcohol and tobacco using the margin of exposure (MOE) approach was conducted. The MOE is defined as ratio between toxicological threshold (benchmark dose) and estimated human intake. Median lethal dose values from animal experiments were used to derive the benchmark dose. The human intake was calculated for individual scenarios and population-based scenarios. The MOE was calculated using probabilistic Monte Carlo simulations. The benchmark dose values ranged from 2?mg/kg bodyweight for heroin to 531?mg/kg bodyweight for alcohol (ethanol). For individual exposure the four substances alcohol, nicotine, cocaine and heroin fall into the "high risk" category with MOE 100, and cannabis had a MOE > 10,000. The toxicological MOE approach validates epidemiological and social science-based drug ranking approaches especially in regard to the positions of alcohol and tobacco (high risk) and cannabis (low risk). PMID:25634572

Lachenmeier, Dirk W; Rehm, Jürgen

2015-01-01

348

In planta imaging of ?9-tetrahydrocannabinolic acid in Cannabis sativa L. with hyperspectral coherent anti-Stokes Raman scattering microscopy  

Science.gov (United States)

Nature has developed many pathways to produce medicinal products of extraordinary potency and specificity with significantly higher efficiencies than current synthetic methods can achieve. Identification of these mechanisms and their precise locations within plants could substantially increase the yield of a number of natural pharmaceutics. We report label-free imaging of ?9-tetrahydrocannabinolic acid (THCa) in Cannabis sativa L. using coherent anti-Stokes Raman scattering microscopy. In line with previous observations we find high concentrations of THCa in pistillate flowering bodies and relatively low amounts within flowering bracts. Surprisingly, we find differences in the local morphologies of the THCa-containing bodies: organelles within bracts are large, diffuse, and spheroidal, whereas in pistillate flowers they are generally compact, dense, and have heterogeneous structures. We have also identified two distinct vibrational signatures associated with THCa, both in pure crystalline form and within Cannabis plants; at present the exact natures of these spectra remain an open question.

Garbacik, Erik T.; Korai, Roza P.; Frater, Eric H.; Korterik, Jeroen P.; Otto, Cees; Offerhaus, Herman L.

2013-04-01

349

Comparative risk assessment of alcohol, tobacco, cannabis and other illicit drugs using the margin of exposure approach  

Science.gov (United States)

A comparative risk assessment of drugs including alcohol and tobacco using the margin of exposure (MOE) approach was conducted. The MOE is defined as ratio between toxicological threshold (benchmark dose) and estimated human intake. Median lethal dose values from animal experiments were used to derive the benchmark dose. The human intake was calculated for individual scenarios and population-based scenarios. The MOE was calculated using probabilistic Monte Carlo simulations. The benchmark dose values ranged from 2?mg/kg bodyweight for heroin to 531?mg/kg bodyweight for alcohol (ethanol). For individual exposure the four substances alcohol, nicotine, cocaine and heroin fall into the “high risk” category with MOE 100, and cannabis had a MOE > 10,000. The toxicological MOE approach validates epidemiological and social science-based drug ranking approaches especially in regard to the positions of alcohol and tobacco (high risk) and cannabis (low risk). PMID:25634572

Lachenmeier, Dirk W.; Rehm, Jürgen

2015-01-01

350

Intermittent Marijuana Use Is Associated with Improved Retention in Naltrexone Treatment for Opiate-Dependence  

OpenAIRE

Naltrexone is a theoretically promising alternative to agonist substitution treatment for opioid dependence, but its effectiveness has been severely limited by poor adherence. This study examined, in an independent sample, a previously observed association between moderate cannabis use and improved retention in naltrexone treatment. Opioid dependent patients (N = 63), admitted for inpatient detoxification and induction onto oral naltrexone, and randomized into a six-month trial of intensive b...

Raby, Wilfrid Noel; Carpenter, Kenneth M.; Rothenberg, Jami; Brooks, Adam C.; Jiang, Huiping; Sullivan, Maria; Bisaga, Adam; Comer, Sandra; Nunes, Edward V.

2009-01-01

351

Standardized natural product cannabis in pain management and observations at a Canadian compassion society: a case report  

OpenAIRE

An adult Caucasian male with excruciating pains following multiple traumas was monitored, daily, over one year while managing chronic pain by self-administering quantifiable amounts of natural cannabis. Tetrahydrocannabinol, Cannabidiol, and Cannabinol were all measured in tinctures, capsules, smoke-able product plus some baked goods, prior to their administration. By allowing standardization, the subject was able to develop a daily regimen of pain management that was resistant to a battery o...

Hornby, A. Paul; Sharma, Manju; Stegman, Bree

2009-01-01

352

Rapid isolation procedure for ?9-tetrahydrocannabinolic acid A (THCA) from Cannabis sativa using two flash chromatography systems.  

Science.gov (United States)

Two isolation procedures for ?9-tetrahydrocannabinolic acid A (THCA), the biogenetic precursor in the biosynthesis of the psychoactive ?9-tetrahydrocannabinol (THC) in the cannabis plant, are presented. Two flash chromatography systems that can be used independently from each other were developed to separate THCA from other compounds of a crude cannabis extract. In both systems UV absorption at 209 and 270 nm was monitored. Purity was finally determined by HPLC-DAD, NMR and GC-MS analysis with a focus on the impurity THC. System 1 consisted of a normal phase silica column (120 g) as well as cyclohexane and acetone--both spiked with the modifier pyridine--as mobile phases. Gradient elution was performed over 15 min. After the chromatographic run the fractions containing THCA fractions were pooled, extracted with hydrochloric acid to eliminate pyridine and evaporated to dryness. Loading 1800 mg cannabis extract yielded 623 mg THCA with a purity of 99.8% and a THC concentration of 0.09%. System 2 was based on a reversed-phase C18 column (150 g) combined with 0.55% formic acid and methanol as mobile phases. A very flat gradient was set over 20 minutes. After pooling the THCA-containing fractions methanol was removed in a rotary evaporator. THCA was re-extracted from the remaining aqueous phase with methyl tert-butyl ether. The organic phase was finally evaporated under high vacuum conditions. Loading 300 mg cannabis extract yielded 51 mg THCA with a purity of 98.8% and a THC concentration of 0.67%. PMID:21944900

Wohlfarth, Ariane; Mahler, Hellmut; Auwärter, Volker

2011-10-15

353

Impact of Prolonged Cannabinoid Excretion in Chronic Daily Cannabis Smokers’ Blood on Per Se Drugged Driving Laws  

Science.gov (United States)

BACKGROUND Cannabis is the illicit drug most frequently reported with impaired driving and motor vehicle accidents. Some “per se” laws make it illegal to drive with any amount of drug in the body, while others establish blood, saliva, or urine concentrations above which it is illegal to drive. The persistence of ?9-tetrahydrocannabinol (THC) in chronic daily cannabis smokers’ blood is unknown. METHODS Thirty male chronic daily cannabis smokers resided on a secure research unit for up to 33 days, with daily blood collection. Samples were processed in an ice bath during sample preparation to minimize cannabinoid adsorption onto precipitant material. We quantified THC by 2-dimensional GC-MS. RESULTS Of the 30 participants, 27 were THC-positive on admission, with a median (range) concentration of 1.4 ?g/L (0.3–6.3). THC decreased gradually; only 1 of 11 participants was negative at 26 days, 2 of 5 remained THC-positive (0.3 ?g/L) for 30 days, and 5.0% of participants had THC ?1.0 ?g/L for 12 days. Median 11-hydroxy-THC concentrations were 1.1 ?g/L on admission, with no results ?1.0 ?g/L 24 h later. 11-Nor-9-carboxy-THC (THCCOOH) detection rates were 96.7% on admission, decreasing slowly to 95.7% and 85.7% on days 8 and 22, respectively; 4 of 5 participants remained THCCOOH positive (0.6–2.7 ?g/L) after 30 days, and 1 remained positive on discharge at 33 days. CONCLUSIONS Cannabinoids can be detected in blood of chronic daily cannabis smokers during a month of sustained abstinence. This is consistent with the time course of persisting neurocognitive impairment reported in recent studies. PMID:23449702

Bergamaschi, Mateus M.; Karschner, Erin L.; Goodwin, Robert S.; Scheidweiler, Karl B.; Hirvonen, Jussi; Queiroz, Regina H.C.; Huestis, Marilyn A.

2013-01-01

354

Effect of various concentrations of Crocus sativus and Cannabis sativa extracts on luminescent biosensor Escherichia coli SM10 S1  

OpenAIRE

Introduction and objective: The potential risk of application of high dosage of traditional medicinal plants has not been fully understood. Appropriate microbial biosensors have been constructed for monitoring the toxicity of many harmful chemical compounds. The aim of this research was to see how effective are the different concentration of two medicinal plants extracts (Crocus sativus (saffron) and Cannabis sativa) on a bioluminescent marker system indicating their side effects. Materials a...

Shima Shayestehpour; Mansour Mashreghi

2011-01-01

355

Chemataxonomic researches in higher plants. XV Carotenoid and chlorophyll pigments in the leaves of Cannabis sativa L.  

OpenAIRE

In the leaves of Cannabis sativa L. were found the following carotenoid pigments: ?-carotene, lutein, zeaxanthin, violaxanthin, neoxanthin and ?-cryptoxanthin. The ratio between the content of ?-carotene and lutein - which are the principal foliar carotenoids - was supraunitary, a feature that might be used as a chemotaxonomic criterion. It is worth to be mentioned the relatively high content of zeaxanthin and ?-cryptoxanthin in comparison with the level of these pigments in the leaves of mos...

Pop, Ecaterina; Illyes, Gh; Neamtu, Gavrila

1981-01-01

356

Segmental hair analysis for 11-nor-??-tetrahydrocannabinol-9-carboxylic acid and the patterns of cannabis use.  

Science.gov (United States)

Cannabis is the most widely abused drug in the world. The purpose of this study is to detect 11-nor-9-carboxy-??-tetrahydrocannabinol (THCCOOH) in segmental hair and to evaluate the patterns of cannabis use. We investigated the relationship between the concentrations of THCCOOH in hair and the self-reported use data and the route of administration. For this purpose, the hair samples were washed, digested with 1 mL of 1 M NaOH at 85°C for 30 min along with the internal standard, THCCOOH-d? (2.5 pg/mg) and extracted in 2 mL of n-hexane-ethyl acetate (9:1) twice after adding 1 mL of 0.1N sodium acetate buffer (pH = 4.5) and 200 µL of acetic acid. The organic extract was transferred and evaporated and the mixture was derivatized with 50 µL of pentafluoropropionic anhydride and 25 µL of pentafluoropropanol for 30 min at 70°C. Reconstituted final extract was injected into the gas chromatography-tandem mass spectrometer operating in the negative chemical ionization mode. In segmental hair analysis, the concentrations of THCCOOH decreased from the proximal to distal segments. The concentrations of THCCOOH in hair and the self-reported dose and frequency of administration from cannabis users were not well correlated because of the low accuracy and reliability of the self-reported data. However, this study provides preliminary information on the dose and frequency of administration among cannabis users in our country. PMID:22417835

Han, Eunyoung; Chung, Heesun; Song, Joon Myong

2012-04-01

357

Origin of samples of Cannabis sativa through insect fragments associated with compacted hemp drug in South America  

Scientific Electronic Library Online (English)

Full Text Available SciELO Brazil | Language: English Abstract in english Origin of samples of Cannabis sativa through insect fragments associated with compacted hemp drug in South America. Insects associated with a seizure of Cannabis sativa L. may indicate the origin of the illicit drug. Nevertheless, no work regarding this subject has been previously published for Sout [...] h America. In the present investigation, seven kilograms of vegetal material (C. sativa) were inspected for insect fragments. Three species were identified and used to test the origin of the seizure of cannabis plant material: Euschistus heros (Fabricius, 1794), Thyanta perditor (Fabricius, 1794) (Heteroptera, Pentatomidae), and Cephalotes pusillus (Klug, 1824) (Hymenoptera, Formicidae). These insect species restricted the geographic origin of the drug to the Neotropical region, and their distribution patterns showed an overlap of the State of Mato Grosso (Brazil), Argentina, and Paraguay. Based on this information, two of the three major C. sativa growing areas in South America were excluded: (1) the Colombian territory and (2) northeastern Brazil.

Marcos Patrício, Macedo; Cecília, Kosmann; José Roberto, Pujol-Luz.

2013-06-01

358

Neuroacanthocytosis Presenting with Psychiatric Symptoms  

OpenAIRE

An adult male presented with dyskinetic movements of the face and choreiform movements associated with dysphagia and vocaltics.Obsessive compulsive symptoms and depressive symptoms occurred 3 months after the onset of the illness.Peripheral blood smear revealed an excess of acanthocytes. A diagnosis of neuroacanthocytosis was made and he was started on treatment.

Srivatsa,; Jacob, Rajesh; Tharyan, Prathap; Vijayan, Joy; Alexander, Mathew

2004-01-01

359

Respiratory symptoms associated with sulfur dioxide exposure  

Energy Technology Data Exchange (ETDEWEB)

Exposures to sulfur dioxide (SO/sub 2/) have been associated with progressive, dose-dependent bronchoconstriction in sensitive individuals. The clinical significance of such changes remains poorly characterized. The authors studied subjective responses following exposure to low level concentrations of SO/sub 2/ (less than 1 ppm) in a group of 10 healthy and 10 asthmatic subjects. The number and severity of complaints associated with SO/sub 2/ increased with concentrations in both healthy and asthmatic subjects. Asthmatics indicated progressive lower respiratory complaints, such as wheezing, chest tightness, dyspnea and cough with increasing levels of SO/sub 2/ while healthy subjects complained more frequently of upper airway complaints such as taste and odor with increasing levels of SO/sub 2/. Exercise increased the frequency of lower airway symptoms in asthmatics but led to no increases in symptoms in healthy subjects.

Witek, T.J. Jr.; Schachter, E.N.; Beck, G.J.; Cain, W.S.; Colice, G.; Leaderer, B.P.

1985-01-01

360

Durability of improvement in post-traumatic stress disorder symptoms and absence of harmful effects or drug dependency after 3,4-methylenedioxymethamphetamine-assisted psychotherapy: a prospective long-term follow-up study.  

Science.gov (United States)

We report follow-up data evaluating the long-term outcomes for the first completed trial of 3,4-methylenedioxymethamphetamine (MDMA)-assisted psychotherapy for chronic, treatment-resistant post-traumatic stress disorder (PTSD) (Mithoefer et al., 2011). All of the 19 subjects who received MDMA-assisted treatment in the original trial participated in the long-term follow-up (LTFU), with 16 out of 19 completing all of the long-term outcome measures, which were administered from 17 to 74 months after the original study's final MDMA session (mean = 45.4; SD = 17.3). Our primary outcome measure used was the Clinician-Administered PTSD Scale (CAPS). Secondary outcome measures were the Impact of Events Scale-Revised (IES-R) and the Neuroticism Extroversion Oppenness Personality Inventory-Revised (NEO PI-R) Personality Inventory. We also collected a long-term follow-up questionnaire. Results for the 16 CAPS completers showed there were no statistical differences between mean CAPS score at LTFU (mean = 23.7; SD = 22.8) (t (matched) = 0.1; df = 15, p = 0.91) and the mean CAPS score previously obtained at Study Exit (mean = 24.6, SD = 18.6). On average, subjects maintained statistically and clinically-significant gains in symptom relief, although two of these subjects did relapse. It was promising that we found the majority of these subjects with previously severe PTSD who were unresponsive to existing treatments had symptomatic relief provided by MDMA-assisted psychotherapy that persisted over time, with no subjects reporting harm from participation in the study. PMID:23172889

Mithoefer, Michael C; Wagner, Mark T; Mithoefer, Ann T; Jerome, Lisa; Martin, Scott F; Yazar-Klosinski, Berra; Michel, Yvonne; Brewerton, Timothy D; Doblin, Rick

2013-01-01

361

Menopause: Symptom Relief and Treatments  

Science.gov (United States)

... symptom, your mood swings may get better too. Memory problems Some women complain of memory problems or ... brochure alerts consumers and health care professionals to false and misleading claims of bio-identical hormone replacement ...

362

Toxoplasmosis (Toxoplasma infection) Disease Symptoms  

Science.gov (United States)

... visit this page: About CDC.gov . Parasites - Toxoplasmosis ( Toxoplasma infection) Parasites Home Share Compartir Disease On this ... people (nonpregnant) Healthy people who become infected with Toxoplasma gondii often do not have symptoms because their ...

363

Women and Heart Attack Symptoms  

Medline Plus

Full Text Available ... 31, 2014 Related MedlinePlus Pages Angina Heart Attack Heart Disease in Women Transcript When symptoms of heart disease strike, women often play a “dangerous waiting game.” ...

364

Symptoms and Treatment of Depression  

Medline Plus

Full Text Available ... give up. Read more about depression on this Web page. If the symptoms fit, get help now. Share More Video and Audio about: Depression Contact the Press Office 301-443-4536 NIMHpress@mail. ...

365

Symptoms and Treatment of Depression  

Medline Plus

Full Text Available ... give up. Read more about depression on this Web page. If the symptoms fit, get help now. Share ... Mental Health Information Summaries of Scientific Meetings Information about NIMH RePORTER : ...

366

Symptoms and Treatment of Depression  

Medline Plus

Full Text Available ... give up. Read more about depression on this Web page. If the symptoms fit, get help now. Share ... Portfolio Online Reporting Tool Expenditures and Results Recommendations for Reporting on Suicide ...

367

Symptoms of Valley Fever (Coccidioidomycosis)  

Science.gov (United States)

... al. The use of coccidioidin. American review of tuberculosis 1948;57:330-60. Chang A, Tung RC, ... Sources Statistics Diagnosis & Testing Treatment & Outcomes Additional Information Genital / vulvovaginal Candidiasis Definition Symptoms People at Risk & Prevention ...

368

Women and Heart Attack Symptoms  

Medline Plus

Full Text Available ... the opinion of a friend or family member. Recognition of severity of symptoms. Seeking medical attention. And ... and to act immediately by calling 911. A person's chance of surviving a heart attack increases if ...

369

Symptoms and Treatment of Depression  

Medline Plus

Full Text Available ... a minute really to do anything that took deep concentration. I tried a journal and I tried ... give up. Read more about depression on this Web page. If the symptoms fit, get help now. ...

370

Symptoms and Treatment of Depression  

Medline Plus

Full Text Available ... up. Read more about depression on this Web page. If the symptoms fit, get help now. Share More Video and Audio about: Depression Contact the Press Office 301-443-4536 NIMHpress@mail. ...

371

Heart Attack Symptoms in Women  

Science.gov (United States)

Heart Attack Symptoms in Women Updated:Dec 5,2014 Heart Attack Signs in Women Uncomfortable pressure, squeezing, fullness or ... content was last reviewed on 10/20/2012. Heart Attack • Home • About Heart Attacks • Warning Signs of a ...

372

Neuropsychiatric symptoms and celiac disease  

Science.gov (United States)

Background Neuropsychiatric symptoms may represent an atypical manifestation of celiac disease that occur before a gastroenterological diagnosis is made. Some studies suggest that a gluten-free diet is effective in treating the depression, anxiety, and neurological complications associated with celiac disease. Method The article describes the case of a patient suffering from chronic, treatment-resistant symptoms of depression and anxiety. The diagnosis of celiac disease and introduction of an elimination diet caused a significant improvement in mental state and everyday functioning in the presenting patient. Conclusion The presence of persistent anxiety and depressive symptoms, with a poor reaction to pharmacological treatment, indicates a need to identify somatic reasons for the underlying condition. It is important to remember that celiac disease can occur at any age, not only in childhood. The presence of this somatic cause of persistent depressive and anxiety symptoms should be considered in the diagnostic process in adults. PMID:25342904

Urban-Kowalczyk, Ma?gorzata; Œmigielski, Janusz; Gmitrowicz, Agnieszka

2014-01-01

373

Spasmodic Torticollis: Signs and Symptoms  

Science.gov (United States)

... from the pain and disability caused by Spasmodic Torticollis About NSTA About National Spasmodic Torticollis Association NSTA ... Contact Contact NSTA Today Request for Information Spasmodic Torticollis – Signs and Symptoms Spasmodic Torticollis (ST) can occur ...

374

Hoarding: Obsessive Symptom or Syndrome?  

OpenAIRE

Through media depictions, the public is becoming increasingly aware of the phenomenon of hoarding. Hoarding refers to the excessive acquisition of relatively worthless items, which eventually results in the compromise of living space and/or the daily activities of affected individuals. As a symptom, hoarding is relatively common in a significant minority of individuals with obsessive-compulsive disorder. In the context of obsessive-compulsive disorder, symptoms typically emerge in the teens t...

Sansone, Randy A.; Sansone, Lori A.

2010-01-01

375

Psychiatric symptoms in vertiginous patients.  

Science.gov (United States)

Backgrounds: Psychiatric comorbidity is common in vertiginous patients. The risk of psychiatric disorder is increased in patients with previous mental problems, but earlier mentally healthy may develop symptoms as well. Especially in chronic phase of vertigo, psychological factors have a significant role in the morbidity. Aims: The aim of this study was to evaluate the prevalence of psychiatric problems in vertiginous patients in a community sample. Methods: A prospective evaluation of psychiatric symptoms based on self-rating scales [Beck Depression Inventory (BDI), Zung Anxiety Scale (SAS), DSM-IV and ICD-10 Personality Questionnaire (DIP-Q)] in a community sample of 100 vertiginous subjects in the Academic Tertiary Otolaryngology Department at the Helsinki University Hospital, Finland. Results: The prevalence of any psychiatric problem was 68% (68 patients); 19% had depressiveness and 12% symptoms of anxiety. Altogether 63 (63%) patients met the criteria of personality disorder. The most prevalent personality disorder was obsessive-compulsive (46 patients). Personality disorder alone seems not to affect functional capacity and is of importance only when comorbid with symptoms of anxiety and depression. The prevalence of psychiatric symptoms did not correlate with severity of vertigo symptoms or other co-occurring diseases. Conclusions: The prevalence of any psychiatric symptoms was high among vertiginous patients. In the chronic phase of vertigo, it seems that vertigo symptoms themselves do not influence on subjective feelings of debilitation. Psychiatric disorders worsen the clinical picture of vertigo along a more debilitating and disabling course. Psychiatric differential diagnoses should accompany the neuro-otology diagnostic procedure in patients with a chronic state of vertigo and greater disability. PMID:25394373

Ketola, Sirpa; Havia, Mari; Appelberg, Björn; Kentala, Erna

2014-11-14

376

Molecular cytogenetic characterization of the dioecious Cannabis sativa with an XY chromosome sex determination system.  

Science.gov (United States)

Hemp (Cannabis sativa L.) was karyotyped using by DAPI/C-banding staining to provide chromosome measurements, and by fluorescence in situ hybridization with probes for 45 rDNA (pTa71), 5S rDNA (pCT4.2), a subtelomeric repeat (CS-1) and the Arabidopsis telomere probes. The karyotype has 18 autosomes plus a sex chromosome pair (XX in female and XY in male plants). The autosomes are difficult to distinguish morphologically, but three pairs could be distinguished using the probes. The Y chromosome is larger than the autosomes, and carries a fully heterochromatic DAPI positive arm and CS-1 repeats only on the less intensely DAPI-stained, euchromatic arm. The X is the largest chromosome of all, and carries CS-1 subtelomeric repeats on both arms. The meiotic configuration of the sex bivalent locates a pseudoautosomal region of the Y chromosome at the end of the euchromatic CS-1-carrying arm. Our molecular cytogenetic study of the C. sativa sex chromosomes is a starting point for helping to make C. sativa a promising model to study sex chromosome evolution. PMID:24465491

Divashuk, Mikhail G; Alexandrov, Oleg S; Razumova, Olga V; Kirov, Ilya V; Karlov, Gennady I

2014-01-01

377

Assessment of the genetic stability of micropropagated plants of Cannabis sativa by ISSR markers.  

Science.gov (United States)

Inter-simple sequence repeat (ISSR) markers were used to evaluate the genetic stability of the micropropagated plants of Cannabis sativa over 30 passages in culture and hardening in soil for 8 months. A total of 15 ISSR primers resulted in 115 distinct and reproducible bands. All the ISSR profiles from micropropagated plants were monomorphic and comparable to mother plants, confirming the genetic stability among clones and mother plants. Chemical analysis of cannabinoids, using gas chromatography/flame ionization detection (GC/FID), was done to further confirm whether the qualitative and quantitative differences in the major secondary metabolites exist between the mother plant and micropropagated plants. Six major cannabinoids - Delta(9)-THC, THCV, CBD, CBC, CBG, and CBN - were identified and compared with the mother plant. Our results clearly showed a similar cannabinoid profile and insignificant differences in THC content between the two types of plants. These results suggest that the micropropagation protocol developed by us for rapid IN VITRO multiplication is appropriate and applicable for clonal mass propagation of C. SATIVA. PMID:19637112

Lata, Hemant; Chandra, Suman; Techen, Natascha; Khan, Ikhlas A; ElSohly, Mahmoud A

2010-01-01

378

Effect of Induced Polyploidy on Some Biochemical Parameters in Cannabis sativa L.  

Science.gov (United States)

This study is aimed at testing the efficiency of colchicine on inducing polyploidy in Cannabis sativa L. and investigation of effects of polyploidy induction on some primary and secondary metabolites. Shoot tips were treated with three different concentrations of colchicine (0, 0.1, 0.2 %?w/v) for 24 or 48 h. The biggest proportion of the almost coplanar tetraploids (43.33 %) and mixoploids (13.33 %) was obtained from the 24-h treatment in 0.2 and 0.1 %?w/v, respectively. Colchicine with 0.2 % concentration and 48 h duration was more destructive than 24 h. The ploidy levels were screened with flow cytometry. The biochemical analyses showed that reducing sugars, soluble sugars, total protein, and total flavonoids increased significantly in mixoploid plants compared with tetraploid and diploid plants. Tetraploid plants had a higher amount of total proteins, total flavonoids, and starch in comparison with control plants. The results showed that polyploidization could increase the contents of tetrahydrocannabinol in mixoploid plants only, but tetraploid plants had lower amounts of this substance in comparison with diploids. Also, we found such changes in protein concentration in electrophoresis analysis. In overall, our study suggests that tetraploidization could not be useful to produce tetrahydrocannabinol for commercial use, and in this case, mixoploids are more suitable. PMID:25492688

Bagheri, Mahsa; Mansouri, Hakimeh

2014-12-10

379

Effect of Cannabis sativa L. Seed (Hempseed on Serum Lipid and Protein Profiles of Rat  

Directory of Open Access Journals (Sweden)

Full Text Available Cannabis sativa L. is considered as nutritional plant. Whole hempseed typically contains over 30% oil (3%saturated and 28%unsaturated fatty acids and about 25% protein. This study was conducted to evaluate the effect of hempseed on lipid and protein profiles of rats. After the acclimatization, at the beginning of experiment (day 1 the feeding of animal stopped and after 12hr fasting the animal anesthetized by ketamine/xylazine combination and 2ml blood of heart was taken. The rats had free access to normal diet and hempseed for 20 days and at the end of experiment (day 20 blood was taken again. The blood parameters were measured by automated biochemical analyzer. Hempseed significantly (p=0.004 decreased the mean fasting serum LDL level and also significantly increased the mean fasting serum HDL and total protein levels (p=0.01. The mean fasting triglyceride, total cholesterol and albumin levels didn`t significantly change. The significant level was 0.05 or less. Short term hempseed feeding has improved blood lipid and protein profile. In the light of this research, it is recommended that individuals who have high cholesterol and LDL levels or affected to coronary artery diseases (CAD and liver diseases, they can use hempseed variety that cultivated in Khorasan province of Iran in their food preparation.

Isaac Karimi

2006-01-01

380

Gastrointestinal Symptoms in Morbid Obesity  

Science.gov (United States)

Background: Several reports have shown an increased prevalence of gastrointestinal (GI) symptoms in obese subjects in community-based studies. To better understand the role of the GI tract in obesity, and because there are limited clinic-based studies, we documented the prevalence of upper and lower GI symptoms in morbidly obese individuals in a clinic setting. Objective: The aim of our study was to compare the prevalence of GI symptoms in morbidly obese individuals in a weight management clinic with non-obese individuals with similar comorbidities as morbidly obese individuals in an Internal Medicine clinic. Methods: Class II and III obese patients BMI >35?kg/m2 (N?=?114) and 182 non-obese patients (BMI dysphagia, gastroesophageal reflux, abdominal pain, and bowel habits. Responses to each symptom cluster were compared between obese group and normal weight groups using logistic regression. Results: Of the 24 items, 18 had a higher frequency in the obese group (p?dysphagia (OR 2.9, p?=?0.0006), and any gastroesophageal reflux (OR 3.8, p?symptoms: any abdominal pain (OR?=?1.7, p?=?0.042) and altered bowel habits (OR?=?2.8, p?symptoms in morbidly obese patients when compared to non-obese subjects. PMID:25593922

Huseini, Mustafa; Wood, G. Craig; Seiler, Jamie; Argyropoulos, George; Irving, Brian A.; Gerhard, Glenn S.; Benotti, Peter; Still, Christopher; Rolston, David D. K.

2014-01-01

381

Headache as presenting symptom of neurosarcoidosis.  

Science.gov (United States)

Headache may occur in neurosarcoidosis and diagnostic criteria are given in the International Classification of Headache Disorders (ICHD-II). We present a case series of patients suffering from neurosarcoidosis in whom headache was the presenting symptom. The aim of the present study was to analyze the possible clinical presentations and the corresponding cerebral lesions in a retrospective chart review of patients suffering from neurosarcoidosis in whom headache was the presenting symptom. Medical records and data of six patients were analyzed. The possible diagnoses of headache forms included in ICDH-II, and in particular the correspondence with the criteria for "headache attributed to neurosarcoidosis", as well as neuroimaging findings were evaluated in each patient. The ICHD-II criteria were fulfilled in all the six patients. As for as clinical presentation, in three patients (50 %), headache had the clinical characteristics of Tolosa-Hunt syndrome, with evidence of a lesion into the cavernous sinus. In the remaining three cases headache was the only neurological symptom found in association with systemic features of sarcoidosis, and had the clinical features of tension-type headache. Our findings confirm that the clinical features of headache in patients with this disorder may have different presentations, which depend on neuropathologic involvement. Thus, a detailed neuroimaging study and CSF evaluation are needed to confirm diagnosis, particularly in patients with no sign of systemic sarcoidosis or in those in whom head pain may mimic a primary headache syndrome. PMID:23695076

Curone, M; Tullo, V; Peccarisi, C; Bussone, G; D'Amico, D

2013-05-01

382

Tendencias en el consumo de tabaco, alcohol y cannabis de los escolares de Barcelona (1987-1999) / Trends in tobacco, alcohol and cannabis consumption among secondary school pupils in Barcelona, Spain [1987-1999  

Scientific Electronic Library Online (English)

Full Text Available SciELO Public Health | Language: Spanish Abstract in spanish Objetivo: Describir las tendencias en el consumo de tabaco, alcohol y cannabis entre los adolescentes escolarizados entre 1987 y 1999 de la ciudad de Barcelona. Métodos: Encuestas transversales realizadas a muestras representativas de escolares de segundo curso de Educación Secundaria Obligatoria (E [...] SO) entre 1987 y 1999. Los cuestionarios eran anónimos y autocontestados. Se dispone de datos de 5.013 escolares de la ciudad de Barcelona que participan en alguna de las 5 encuestas. Resultados: Tras disminuir de forma uniforme entre 1987 y 1996, en 1999 se observa un aumento del 13,4% en el consumo regular (diario o semanal) de tabaco y del 38,7% en el consumo experimental de tabaco, respecto a las prevalencias observadas en 1996. Con respecto al consumo de alcohol, se observa una disminución global del 14% de los escolares que ha bebido al menos medio vaso de alcohol entre 1987 y 1999. El consumo problemático de alcohol se iguala en ambos sexos, y la proporción que declara haberse emborrachado alguna vez es en 1999 superior en las chicas (14,0%) que en los chicos (10,5%). Mientras en 1996 un 6,9% declaraba haber probado cannabis, la proporción en 1999, sin diferencias entre sexos, era del 7,3% de la población estudiada. Conclusiones: En el período estudiado se observa un aumento del consumo regular de tabaco, una disminución del consumo de alcohol y una estabilización del consumo de cannabis. Las diferencias entre ambos sexos tienden a desaparecer. Abstract in english Objective: To describe trends in tobacco, alcohol, and cannabis consumption among secondary school pupils in Barcelona between 1987 and 1999. Methods: Cross-sectional surveys administered to representative samples of pupils in the second year of secondary school between 1987 and 1999. The questionna [...] ires were anonymous and self-completed. We present data from 5013 secondary school pupils from Barcelona who participated in one of the five surveys. Results: Regular smoking (daily and weekly) showed a uniform decrease between 1987 and 1996. The results of the last survey (1999) showed an increase over those the 1996 survey, ranging from 13.4% for regular smoking to 38.7% for experimental smoking. Between 1987 and 1999, the percentage of schoolchildren who reported drinking at least half a glass of alcohol at some time showed an overall decrease of 14.0%. No differences in sex were found in problematic alcohol consumption, while a higher proportion of girls (14.0%) than boys (10.5%) reported getting drunk at some time. Whereas in 1996, 6.9% of the population studied had smoked cannabis at some time, in 1999 this proportion was 7.3%, with no differences between sexes. Conclusions: During the study period regular smoking increased, alcohol consumption decreased and cannabis consumption tended to level-off. Differences between boys and girls tended to disappear.

C., Ariza; M., Nebot; J.R., Villalbí; E., Díez; Z., Tomás; S., Valmayor.

2003-06-01

383

Tendencias en el consumo de tabaco, alcohol y cannabis de los escolares de Barcelona (1987-1999) / Trends in tobacco, alcohol and cannabis consumption among secondary school pupils in Barcelona, Spain [1987-1999  

Scientific Electronic Library Online (English)

Full Text Available SciELO Spain | Language: Spanish Abstract in spanish Objetivo: Describir las tendencias en el consumo de tabaco, alcohol y cannabis entre los adolescentes escolarizados entre 1987 y 1999 de la ciudad de Barcelona. Métodos: Encuestas transversales realizadas a muestras representativas de escolares de segundo curso de Educación Secundaria Obligatoria (E [...] SO) entre 1987 y 1999. Los cuestionarios eran anónimos y autocontestados. Se dispone de datos de 5.013 escolares de la ciudad de Barcelona que participan en alguna de las 5 encuestas. Resultados: Tras disminuir de forma uniforme entre 1987 y 1996, en 1999 se observa un aumento del 13,4% en el consumo regular (diario o semanal) de tabaco y del 38,7% en el consumo experimental de tabaco, respecto a las prevalencias observadas en 1996. Con respecto al consumo de alcohol, se observa una disminución global del 14% de los escolares que ha bebido al menos medio vaso de alcohol entre 1987 y 1999. El consumo problemático de alcohol se iguala en ambos sexos, y la proporción que declara haberse emborrachado alguna vez es en 1999 superior en las chicas (14,0%) que en los chicos (10,5%). Mientras en 1996 un 6,9% declaraba haber probado cannabis, la proporción en 1999, sin diferencias entre sexos, era del 7,3% de la población estudiada. Conclusiones: En el período estudiado se observa un aumento del consumo regular de tabaco, una disminución del consumo de alcohol y una estabilización del consumo de cannabis. Las diferencias entre ambos sexos tienden a desaparecer. Abstract in english Objective: To describe trends in tobacco, alcohol, and cannabis consumption among secondary school pupils in Barcelona between 1987 and 1999. Methods: Cross-sectional surveys administered to representative samples of pupils in the second year of secondary school between 1987 and 1999. The questionna [...] ires were anonymous and self-completed. We present data from 5013 secondary school pupils from Barcelona who participated in one of the five surveys. Results: Regular smoking (daily and weekly) showed a uniform decrease between 1987 and 1996. The results of the last survey (1999) showed an increase over those the 1996 survey, ranging from 13.4% for regular smoking to 38.7% for experimental smoking. Between 1987 and 1999, the percentage of schoolchildren who reported drinking at least half a glass of alcohol at some time showed an overall decrease of 14.0%. No differences in sex were found in problematic alcohol consumption, while a higher proportion of girls (14.0%) than boys (10.5%) reported getting drunk at some time. Whereas in 1996, 6.9% of the population studied had smoked cannabis at some time, in 1999 this proportion was 7.3%, with no differences between sexes. Conclusions: During the study period regular smoking increased, alcohol consumption decreased and cannabis consumption tended to level-off. Differences between boys and girls tended to disappear.

C., Ariza; M., Nebot; J.R., Villalbí; E., Díez; Z., Tomás; S., Valmayor.

2003-06-01

384

Peer environment mediates parental history and individual risk in the etiology of cannabis use disorder in boys: a 10-year prospective study.  

Science.gov (United States)

Previous research has shown that a trait termed neurobehavior disinhibition (ND) measured in childhood predicts substance use disorder by young adulthood. The present investigation extends these findings by determining the degree to which peer environment mediates the association between ND and development of cannabis use disorder (CUD). ND was measured in a sample of 216 boys 10-12 years of age. The peer environment was assessed at age 16. Current CUD was determined at age 22. Paternal and maternal SUD predicted son's ND which, in turn, predicted son's peer environment and, subsequently, son's cannabis use frequency and CUD. Peer environment mediated the association between ND and cannabis use and ND and CUD. Maternal and paternal SUD predicted the peer environment. Parental SUD, son's ND, and son's peer environment predicted CUD at age 22 with 84% accuracy. PMID:18428073

Feske, Ulrike; Tarter, Ralph E; Kirisci, Levent; Gao, Zhongcui; Reynolds, Maureen; Vanyukov, Michael

2008-01-01

385

Evaluation of Phytocannabinoids from High Potency Cannabis sativa using In Vitro Bioassays to Determine Structure-Activity Relationships for Cannabinoid Receptor 1 and Cannabinoid Receptor 2.  

Science.gov (United States)

Cannabis has been around for thousands of years and has been used recreationally, medicinally, and for fiber. Over 500 compounds have been isolated from Cannabis sativa with approximately 105 being cannabinoids. Of those 105 compounds, ?(9)-tetrahydrocannabinol has been determined as the primary constituent, which is also responsible for the psychoactivity associated with Cannabis. Cannabinoid receptors belong to the large superfamily of G protein-coupled receptors. Targeting the cannabinoid receptors has the potential to treat a variety of conditions such as pain, neurodegeneration, appetite, immune function, anxiety, cancer, and others. Developing in vitro bioassays to determine binding and functional activity of compounds has the ability to lead researchers to develop a safe and effective drug that may target the cannabinoid receptors. Using radioligand binding and functional bioassays, a structure-activity relationship for major and minor cannabinoids was developed. PMID:25419092

Husni, Afeef S; McCurdy, Christopher R; Radwan, Mohamed M; Ahmed, Safwat A; Slade, Desmond; Ross, Samir A; ElSohly, Mahmoud A; Cutler, Stephen J

2014-09-01

386

Análise forense: pesquisa de drogas vegetais interferentes de testes colorimétricos para identificação dos canabinoides da maconha (Cannabis Sativa L. Forensic analysis: evaluation of interfering vegetable drugs in colorimetric tests for identifying marijuana cannabinoids (Cannabis sativa L.  

Directory of Open Access Journals (Sweden)

Full Text Available Marijuana (Cannabis sativa L. is the most cultivated, trafficked and consumed illicit drug worldwide. Estimates indicate 10% of individuals experiencing marijuana become daily users, and 20-30% use it weekly. Around 489 natural compounds have been identified in this plant, of which 70 are cannabinoids, responsible for psychic effects. The most relevant cannabinoid is ?9-THC, recognized as the main chemical substance with psychoactive effects. The aims of this work was to investigate whether other drugs interfere with the colorimetric tests Fast Blue B and Duquenois-Levine, widely used for marijuana screening in forensic chemistry laboratories.

Dayanne Cristiane Bordin

2012-01-01

387

Detection of Herb-Symptom Associations from Traditional Chinese Medicine Clinical Data  

Science.gov (United States)

Background. Traditional Chinese medicine (TCM) is an individualized medicine by observing the symptoms and signs (symptoms in brief) of patients. We aim to extract the meaningful herb-symptom relationships from large scale TCM clinical data. Methods. To investigate the correlations between symptoms and herbs held for patients, we use four clinical data sets collected from TCM outpatient clinical settings and calculate the similarities between patient pairs in terms of the herb constituents of their prescriptions and their manifesting symptoms by cosine measure. To address the large-scale multiple testing problems for the detection of herb-symptom associations and the dependence between herbs involving similar efficacies, we propose a network-based correlation analysis (NetCorrA) method to detect the herb-symptom associations. Results. The results show that there are strong positive correlations between symptom similarity and herb similarity, which indicates that herb-symptom correspondence is a clinical principle adhered to by most TCM physicians. Furthermore, the NetCorrA method obtains meaningful herb-symptom associations and performs better than the chi-square correlation method by filtering the false positive associations. Conclusions. Symptoms play significant roles for the prescriptions of herb treatment. The herb-symptom correspondence principle indicates that clinical phenotypic targets (i.e., symptoms) of herbs exist and would be valuable for further investigations. PMID:25650023

Li, Yu-Bing; Zhou, Xue-Zhong; Zhang, Run-Shun; Wang, Ying-Hui; Peng, Yonghong; Hu, Jing-Qing; Xie, Qi; Xue, Yan-Xing; Xu, Li-Li; Liu, Xiao-Fang; Liu, Bao-Yan

2015-01-01

388

Determination of the Antimicrobial Effects of Hydro-Alcoholic Extract of Cannabis Sativa on Multiple Drug Resistant Bacteria Isolated from Nosocomial Infections  

OpenAIRE

Background: The science of identification and employment of medicinal plants dates back to the early days of man on earth. Cannabis (hashish) is the most common illegal substance used in the United States and was subjected to extensive research as a powerful local disinfecting agent for mouth cavity and skin and an anti-tubercular agent in 1950. Methods: Clinical strains were isolated from hospitalized patients in Vali-e-Asr Hospital of Arak. The hydro-alcoholic extract of cannabis (5 g) w...

Hossein Sarmadyan; Hassan Solhi; Tahereh Hajimir; Negin Najarian-Araghi; Ehsanollah Ghaznavi-Rad

2014-01-01

389

Novel Phenotype Issues Raised in Cross-National Epidemiological Research on Drug Dependence  

OpenAIRE

Stage-transition models based on the American Diagnostic and Statistical Manual (DSM) generally are applied in epidemiology and genetics research on drug dependence syndromes associated with cannabis, cocaine, and other internationally regulated drugs (IRD). Difficulties with DSM stage-transition models have surfaced during cross-national research intended to provide a truly global perspective, such as the work of the World Mental Health Surveys (WMHS) Consortium. Alternative simpler dependen...

Anthony, James C.

2010-01-01

390

A pilot study of an online universal school-based intervention to prevent alcohol and cannabis use in the UK  

Science.gov (United States)

Objectives The online universal Climate Schools intervention has been found to be effective in reducing the use of alcohol and cannabis among Australian adolescents. The aim of the current study was to examine the feasibility of implementing this prevention programme in the UK. Design A pilot study examining the feasibility of the Climate Schools programme in the UK was conducted with teachers and students from Year 9 classes at two secondary schools in southeast London. Teachers were asked to implement the evidence-based Climate Schools programme over the school year with their students. The intervention consisted of two modules (each with six lessons) delivered approximately 6?months apart. Following completion of the intervention, students and teachers were asked to evaluate the programme. Results 11 teachers and 222 students from two secondary schools evaluated the programme. Overall, the evaluations were extremely positive. Specifically, 85% of students said the information on alcohol and cannabis and how to stay safe was easy to understand, 84% said it was easy to learn and 80% said the online cartoon-based format was an enjoyable way to learn health theory topics. All teachers said the students were able to recall the information taught, 82% said the computer component was easy to implement and all teachers said the teacher's manual was easy to use to prepare class activities. Importantly, 82% of teachers said it was likely that they would use the programme in the future and recommend it to others. Conclusions The Internet-based universal Climate Schools prevention programme to be both feasible and acceptable to students and teachers in the UK. A full evaluation trial of the intervention is now required to examine its effectiveness in reducing alcohol and cannabis use among adolescents in the UK before implementation in the UK school system. PMID:24840248

Newton, Nicola C; Conrod, Patricia J; Rodriguez, Daniel M; Teesson, Maree

2014-01-01

391

CURRENT SYMPTOMS AND NEWS MANNERS OF JOUISSANCE  

Directory of Open Access Journals (Sweden)

Full Text Available This paper presents a discussion about the so called current symptoms and its relations with ways of jouissance. It begins with a definition of what might be the current symptoms before exploring the actual notion of the term and its unfolding about the symptom. In a second moment, it articulates the symptom with ways of jouissance, demonstrating how much jouissance is connected to the symptom. More specifically, it is in the symptom’s meaning that jouissance is found, since it is through meaning that jouissance is connected to the symptom. It is not about reducing jouissance due to the search of pleasure or to search in pleasure the relief of the jouissance’s tension. It is about, in psychoanalysis, to potentialize the jouissance no more connected to the symptom’s meaning, but to articulate it to the sinthome, so the subject can jouir life and not the symptom anymore.

Maurício Eugênio Maliska

2010-12-01

392

Chemataxonomic researches in higher plants. XV Carotenoid and chlorophyll pigments in the leaves of Cannabis sativa L.  

Directory of Open Access Journals (Sweden)

Full Text Available In the leaves of Cannabis sativa L. were found the following carotenoid pigments: ?-carotene, lutein, zeaxanthin, violaxanthin, neoxanthin and ?-cryptoxanthin. The ratio between the content of ?-carotene and lutein - which are the principal foliar carotenoids - was supraunitary, a feature that might be used as a chemotaxonomic criterion. It is worth to be mentioned the relatively high content of zeaxanthin and ?-cryptoxanthin in comparison with the level of these pigments in the leaves of most higher plants. The ratio between the content of chlorophyll a and b was of 2,17.

Ecaterina POP

1981-08-01

393

Evidence That Environmental and Genetic Risks for Psychotic Disorder May Operate by Impacting on Connections Between Core Symptoms of Perceptual Alteration and Delusional Ideation.  

Science.gov (United States)

Background: Relational models of psychopathology propose that symptoms are dynamically connected and hypothesize that genetic and environmental influences moderate the strength of these symptom connections. Previous findings suggest that the interplay between hallucinations and delusions may play a crucial role in the development of psychotic disorder. The current study examined whether the connection between hallucinations and delusions is impacted by proxy genetic and environmental risk factors. Methods: Hallucinations and delusions at baseline and at 3-year follow-up were assessed in a sample of 1054 healthy siblings and 918 parents of 1109 patients with psychosis, and in 589 healthy controls (no familial psychosis risk). Environmental factors assessed were cannabis use, childhood trauma, and urbanicity during childhood. Logistic regression analyses tested whether familial psychosis risk predicted increased risk of delusions, given presence of hallucinations. Moderating effects of environmental factors on the hallucination-delusion association were tested in a similar fashion, restricted to the control and sibling groups. Results: The risk of delusions, given hallucinations, was associated with proxy genetic risk: 53% in parents, 47% in siblings, and 36% in controls. The hallucination-delusion association was stronger in those reporting cannabis use (risk difference: 32%) and childhood trauma (risk difference: 15%) although not all associations were statistically conclusive (respectively: p = .037; p = .054). A directionally similar but nonsignificant effect was found for urb anicity during childhood (risk difference: 14%, p =.357). Conclusion: The strength of the connection between delusions and hallucinations is associated with familial and environmental risks for psychotic disorder, suggesting that specific symptom connections in the early psychosis psychopathology network are informative of underlying mechanisms. PMID:25217481

Smeets, Feikje; Lataster, Tineke; Viechtbauer, Wolfgang; Delespaul, Philippe

2014-09-12

394

Dimensions of depressive symptoms and smoking cessation.  

Science.gov (United States)

Because different psychopathologic components of depressive symptoms may have distinct etiologies, examining their differential effects on smoking cessation may elucidate mechanisms underlying the smoking-depression relationship. Negative affect (NA), somatic features (SF), low positive affect/anhedonia (PA), and interpersonal disturbance (IP) have been identified as unique dimensions of depression that can be measured using the Center for Epidemiologic Studies Depression Scale (CESD). This study examined common and unique associations between CESD subscales and baseline smoking characteristics, nicotine withdrawal, and relapse in 157 participants enrolled in a smoking cessation trial for heavy social drinkers. Each dimension was univariately associated with negative and positive reinforcement smoking motives. Only SF had unique relations with tolerance smoking motives and univariate associations with nicotine dependence severity. Only PA predicted cessation-related changes in withdrawal symptoms on quit day. Analyses predicting abstinence at 8, 16, and 26 weeks post quit date showed that NA, SF, and PA each univariately predicted relapse, ps< or =.0083. Only low PA predicted poorer outcomes incrementally to the other dimensions, even when controlling for level of nicotine dependence, smoking frequency, and history of major depression, p = .0018. Interventions targeting anhedonia and low positive affect may be useful for smokers trying to quit. PMID:18324570

Leventhal, Adam M; Ramsey, Susan E; Brown, Richard A; LaChance, Heather R; Kahler, Christopher W

2008-03-01

395

Menopausal Symptoms in Urban Women  

OpenAIRE

The present observational, cross sectional study was carried out in urban women (n=117) from Jammu withnatural menopause to evaluate menopausal symptoms in women above the age of 40 belonging to the middlesocioeconomic strata from Jammu (extreme northern India) as well as to evaluate the correlation of age onthese symptoms by interviewing regarding their menopausal complaints in the following 40-44(n=27), 45-50(n=30) and above 50 (n =60) years age groups. Mean age at menopause was 47.35 years...

Sudhaa Sharma, Vishal R. Tandon

2007-01-01

396

Los productos de Cannabis sativa: situación actual y perspectivas en medicina  

Directory of Open Access Journals (Sweden)

Full Text Available Los productos psicoactivos de la Cannabis sativa, como marihuana y hachís, se han usado desde hace varios siglos con fines medicinales, religiosos y recreativos. Ahora, la marihuana es la droga ilegal de mayor consumo en el mundo, particularmente por adolescentes y adultos jóvenes. La adolescencia es una etapa crítica en el desarrollo y maduración del Sistema Nervioso Central. La marihuana está constituida por un gran número y variedad de substancias químicas que pueden interactuar entre sí. Sus efectos agudos se caracterizan por euforia, relajación e intensificación de las experiencias sensoriales ordinarias. Su consumo crónico induce tolerancia, dependencia, síndrome de carencia, déficit cognitivo y aumenta el riesgo de enfermedades psiquiátricas. El descubrimiento de un sistema cannabinoide endógeno renovó el interés médico por la marihuana y los datos de los últimos 20 años indican que el sistema endocannabinoide regula la función de diversos tipos de sinapsis y juega un papel importante en el desarrollo cerebral extrauterino. Recientemente el interés sobre la marihuana se centró en sus propiedades medicinales y existe un buen número de ensayos clínicos controlados que apoyan su uso en ciertas condiciones médicas; sin embargo, su eficacia y seguridad siguen siendo motivo de controversia. En este artículo se analizan los conocimientos farmacológicos sobre la marihuana, se establecen los riesgos de su consumo, la información sobre sus propiedades medicinales y, con base en la evidencia disponible, se opina contra su legalización. Finalmente, aquí se postula que la marihuana en su forma herbaria, por vía enteral, puede ser de gran valor para mitigar el sufrimiento de pacientes con enfermedad terminal.

Rodolfo Rodr\\u00EDguez Carranza

2012-01-01

397

Elemental characterization of marijuana (cannabis sativa) as a stride in the isolation of its active ingredients  

International Nuclear Information System (INIS)

Seed, stem and leaves samples of Marijuana (Cannabis sativa) popularly called Indian Hemp available in northern Nigeria were analyzed for trace amounts of Mg, Al, Ca, Ti, Mn, Na, Br, La, Yb, Cr, Fe, Zn, and Ba using Instrumental Neutron Activation Analysis. Sample sizes of roughly 300mg irradiated for five minutes (short irradiation) and six hours (long irradiation), with decay times of 7 minutes, 10,000 minutes and 26,000 minutes for short, medium and long-lived nuclides respectively. Counting times for ten minutes (short-lived nuclides), 1,800 minutes (medium-lived nuclides) and 36,000 minutes (long-lived nuclides) yielded detection limits between 0.05 - 0.09?g/g. For comparative study, refined tobacco produced by a tobacco company operating in northern Nigeria were characterized together with the marijuana-which is usually smoked raw with leaves stem and seed packed together. The results obtained shows that both the refined tobacco and the raw marijuana have high c oncentration of Ca, Mg, Al and Mn and low values of Na, Br and La. However, marijuana was found to have heavy elements in abundance compared to the refined tobacco, with Zn = 20.5 ?g/g and Cr = 14.3?g/g recording the highest values among the heavy elements detected. This is a sharp difference between the two since the values of heavy elements obtained for the refined tobacco are even below detection limits. Quality Control and Quality Assurance was tested using certified reference material obtained frertified reference material obtained from NIST (Tomato Leaves).

398

[Epidemiology of drug abuse and dependence].  

Science.gov (United States)

Drug abuse or dependence in Japan has been characterized by three epidemics of methamphetamine abuse. In addition, solvent abuse has been predominant for a long time. Since 1995, with the start of the third epidemic of methamphetamine abuse, drug abuse or dependence in Japan has obviously changed, with an obvious decrease in solvent abuse; the stabilization of methamphetamine abuse; an increase in the abuse of such drugs as cannabis or MDMA, which do not have high potential to cause drug-induced psychosis; and the emergence of designer drugs. These changes imply a shift from conduct that leads to arrest to conduct that does not lead to arrest. Therefore, Japan is urged to deal with drug abuse and dependence using both a criminal model and a medical model. PMID:20715473

Wada, Kiyoshi

2010-08-01

399

Autism and ADHD Symptoms in Patients with OCD: Are They Associated with Specific OC Symptom Dimensions or OC Symptom Severity?  

OpenAIRE

In obsessive-compulsive disorder (OCD), the relationship between autism spectrum disorders (ASD), attention-deficit/hyperactivity disorder (ADHD) symptom, and obsessive-compulsive (OC) symptom dimensions and severity has scarcely been studied. Therefore, 109 adult outpatients with primary OCD were compared to 87 healthy controls on OC, ADHD and ASD symptoms. OCD patients showed increased ADHD and autism symptom frequencies, OCD + ADHD patients reporting more autism symptoms (particularly at...

Anholt, G. E.; Cath, D. C.; Oppen, P. C.; Eikelenboom, M.; Smit, J. H.; Megen, H.; Balkom, A. J. L. M.

2010-01-01

400

Novel time-dependent vascular actions of ?9-tetrahydrocannabinol mediated by peroxisome proliferator-activated receptor gamma  

International Nuclear Information System (INIS)

Cannabinoids have widespread effects on the cardiovascular system, only some of which are mediated via G-protein-coupled cell surface receptors. The active ingredient of cannabis, ?9-tetrahydrocannabinol (THC), causes acute vasorelaxation in various arteries. Here we show for the first time that THC also causes slowly developing vasorelaxation through activation of peroxisome proliferator-activated receptors gamma (PPAR?). In vitro, THC (10 ?M) caused time-dependent vasorelaxation of rat isolated arteries. Time-dependent vasorelaxation to THC was similar to that produced by the PPAR? agonist rosiglitazone and was inhibited by the PPAR? antagonist GW9662 (1 ?M), but not the cannabinoid CB1 receptor antagonist AM251 (1 ?M). Time-dependent vasorelaxation to THC requires an intact endothelium, nitric oxide, production of hydrogen peroxide, and de novo protein synthesis. In transactivation assays in cultured HEK293 cells, THC-activated PPAR?, transiently expressed in combination with retinoid X receptor ? and a luciferase reporter gene, in a concentration-dependent manner (100 nM-10 ?M). In vitro incubation with THC (1 or 10 ?M, 8 days) stimulated adipocyte differentiation in cultured 3T3L1 cells, a well-accepted property of PPAR? ligands. The present results provide strong evidence that THC is a PPAR? ligand, stimulation of which causes time-dependent vasorelaxation, implying some of the pleiotropic effects of cannabis may be mediated byf cannabis may be mediated by nuclear receptors

401

Schizophrenia and gastroesophageal reflux symptoms  

Science.gov (United States)

Background: Psychological factors and psychiatric disorders play a role in a variety of gastrointestinal illnesses, including esophageal diseases. Aim: The aim of the present study was to evaluate the frequency of gastroesophageal reflux disease symptoms in patients with schizophrenia in Turkey. Patients and Methods: Ninety-eight patients with schizophrenia and one hundred control individuals were enrolled in the study, which was undertaken at the Manisa State Hospital for Mental Health and Neurological Disorders and Celal Bayar University Gastroenterology Department. Case and control subjects alike underwent 30–45 min oral interviews conducted by a designated study coordinator (E.K.). The coordinator gathered information about demographic characteristics, social habits, and a large variety of symptoms suggestive of reflux disease or other gastrointestinal conditions. Results: In terms of reflux symptoms, cough was the only significant association in schizophrenic patients than controls. Heartburn and regurgitation were more frequent in schizophrenic patients who smoked than in controls who were smokers. However, the prevalence of reflux symptoms in cigarette smokers versus nonsmoker patients with schizophrenia was similar. Heartburn and/or regurgitation occurred more frequently in patients with schizophrenic than controls with alcohol use. Conclusions: Psychiatric disorders might indirectly affect esophageal physiology through increased consumption of alcohol and nicotine.

Kasap, Elmas; Ayer, Ahmet; Bozo?lan, Hümeyra; Ozen, Cigdem; Eslek, Ilhan; Yüceyar, Hakan

2015-01-01

402

Perfectionism, Shame, and Depressive Symptoms  

Science.gov (United States)

The authors examined the relationship between depression, maladaptive perfectionism, and shame. Regression analyses were used to replicate a model in which maladaptive perfectionism was negatively associated with self-esteem and positively associated with symptoms of depression, with self-esteem mediating the effects of maladaptive perfectionism…

Ashby, Jeffrey S.; Rice, Kenneth G.; Martin, James L.

2006-01-01

403

Symptoms and Treatment of Depression  

Medline Plus

Full Text Available ... the road to recovery. Depression treatment can take time to work, so don't give up. Read more about depression on this Web page. If the symptoms fit, get help now. Share More Video and Audio about: Depression Contact the Press Office 301-443-4536 NIMHpress@mail. ...

404

10 Symptoms of Kidney Disease  

Science.gov (United States)

10 Symptoms of Kidney Disease Many people who have chronic kidney disease don't know it because the early signs can be very subtle. ... the same side as the affected kidney. Polycystic kidney disease (PKD) , which causes large, fluid-filled cysts on ...

405

Women and Heart Attack Symptoms  

Medline Plus

Full Text Available ... the heart doesn’t receive enough oxygen-rich blood. They looked at their symptoms and what prompted them to seek medical care. The team then questioned another group of men and women in an attempt to ...

406

Symptoms and Treatment of Depression  

Medline Plus

Full Text Available ... up. Read more about depression on this Web page. If the symptoms fit, get help now. Share More Video and Audio about: Depression Contact the Press Office 301-443-4536 NIMHpress@mail.nih.gov Press Resources Mental Health Information Summaries of Scientific Meetings Information about NIMH RePORTER : ...

407

Tetrahydrocannabinol Induces Brain Mitochondrial Respiratory Chain Dysfunction and Increases Oxidative Stress: A Potential Mechanism Involved in Cannabis-Related Stroke  

Science.gov (United States)

Cannabis has potential therapeutic use but tetrahydrocannabinol (THC), its main psychoactive component, appears as a risk factor for ischemic stroke in young adults. We therefore evaluate the effects of THC on brain mitochondrial function and oxidative stress, key factors involved in stroke. Maximal oxidative capacities Vmax (complexes I, III, and IV activities), Vsucc (complexes II, III, and IV activities), Vtmpd (complex IV activity), together with mitochondrial coupling (Vmax/V0), were determined in control conditions and after exposure to THC in isolated mitochondria extracted from rat brain, using differential centrifugations. Oxidative stress was also assessed through hydrogen peroxide (H2O2) production, measured with Amplex Red. THC significantly decreased Vmax (?71%; P < 0.0001), Vsucc (?65%; P < 0.0001), and Vtmpd (?3.5%; P < 0.001). Mitochondrial coupling (Vmax/V0) was also significantly decreased after THC exposure (1.8±0.2 versus 6.3±0.7; P < 0.001). Furthermore, THC significantly enhanced H2O2 production by cerebral mitochondria (+171%; P < 0.05) and mitochondrial free radical leak was increased from 0.01±0.01 to 0.10±0.01% (P < 0.001). Thus, THC increases oxidative stress and induces cerebral mitochondrial dysfunction. This mechanism may be involved in young cannabis users who develop ischemic stroke since THC might increase patient's vulnerability to stroke. PMID:25654095

Wolff, Valérie; Schlagowski, Anna-Isabel; Rouyer, Olivier; Charles, Anne-Laure; Singh, François; Auger, Cyril; Schini-Kerth, Valérie; Marescaux, Christian; Raul, Jean-Sébastien; Zoll, Joffrey; Geny, Bernard

2015-01-01

408

Demographic and Social Correlates of Tobacco, Alcohol and Cannabis Use Among 15-16-Year-Old Students in Albania: Results of the ESPAD Survey  

Directory of Open Access Journals (Sweden)

Full Text Available AIMS – Our aim was to assess the demographic and social factors associated with lifetime use of tobacco, alcohol and cannabis among school students aged 15–16 in Albania in order to make information and knowledge available for health promotion specialists working on substance use prevention. DESIGN – This cross-sectional study was conducted in March–May 2011 in the framework of the European School Survey Project on Alcohol and Other Drugs (ESPAD. In total, 3189 students born in 1995 participated in the survey. The standardised ESPAD questionnaire was used to collect data about substance use. RESULTS – Our multivariable adjustment analysis showed that being a male and having easy access to cigarettes were the only universal factors significantly increasing the likelihood of ever using tobacco, alcohol or cannabis. Own smoking was strongly and significantly associated with alcohol and cannabis use. The associations of own substance use with peer substance consumption were weak to moderate. CONCLUSIONS – Own smoking seems to be the most important single independent risk factor which strongly and significantly predicted alcohol and cannabis use among Albanian school students. Policy makers need to strengthen the rule of law whereas health promotion professionals should firmly address smoking in adolescence through target interventions.

Toçi Ervin

2014-10-01

409

The hemp russet mite Aculops cannabicola (Farkas, 1960 (Acari: Eriophyoidea found on Cannabis sativa L. in Serbia: Supplement to the description  

Directory of Open Access Journals (Sweden)

Full Text Available The description of Aculops cannabicola (Farkas, 1960, a new species for the fauna of Serbia, is supplemented. The male and juveniles are described for the first time. This species was found as vagrants on leaves of hemp, Cannabis sativa L. A comparison of characters of the population from Serbia and the originally described samples from Hungary is given.

Petanovi? Radmila

2007-01-01

410

Symptoms  

Science.gov (United States)

... Support Legal Assistance Success Stories Complications Hypoglycemia Hyperglycemia Skin Complications Eye Complications Neuropathy Foot Complications DKA (Ketoacidosis) & Ketones Kidney Disease (Nephropathy) Gastroparesis Mental Health Treatment & Care Blood Glucose ...

411

Symptoms  

Science.gov (United States)

... of the following: Obstructive swelling of the lips, tongue, and/or throat Trouble swallowing Shortness of breath or wheezing Turning blue Drop in blood pressure (feeling faint, confused, weak, ...

412

Predictive model accuracy in estimating last ?9-tetrahydrocannabinol (THC) intake from plasma and whole blood cannabinoid concentrations in chronic, daily cannabis smokers administered subchronic oral THC*  

Science.gov (United States)

Background Determining time since last cannabis/?9-tetrahydrocannabinol (THC) exposure is important in clinical, workplace, and forensic settings. Mathematical models calculating time of last exposure from whole blood concentrations typically employ a theoretical 0.5 whole blood-to-plasma (WB/P) ratio. No studies previously evaluated predictive models utilizing empirically-derived WB/P ratios, or whole blood cannabinoid pharmacokinetics after subchronic THC dosing. Methods Ten male chronic, daily cannabis smokers received escalating around-the-clock oral THC (40-120 mg daily) for 8 days. Cannabinoids were quantified in whole blood and plasma by two-dimensional gas chromatography-mass spectrometry. Results Maximum whole blood THC occurred 3.0 h after the first oral THC dose and 103.5 h (4.3 days) during multiple THC dosing. Median WB/P ratios were THC 0.63 (n=196), 11-hydroxy-THC 0.60 (n=189), and 11-nor-9-carboxy-THC (THCCOOH) 0.55 (n=200). Predictive models utilizing these WB/P ratios accurately estimated last cannabis exposure in 96% and 100% of specimens collected within 1-5 h after a single oral THC dose and throughout multiple dosing, respectively. Models were only 60% and 12.5% accurate 12.5 and 22.5 h after the last THC dose, respectively. Conclusions Predictive models estimating time since last cannabis intake from whole blood and plasma cannabinoid concentrations were inaccurate during abstinence, but highly accurate during active THC dosing. THC redistribution from large cannabinoid body stores and high circulating THCCOOH concentrations create different pharmacokinetic profiles than those in less than daily cannabis smokers that were used to derive the models. Thus, the models do not accurately predict time of last THC intake in individuals consuming THC daily. PMID:22464363

Karschner, Erin L.; Schwope, David M.; Schwilke, Eugene W.; Goodwin, Robert S.; Kelly, Deanna L.; Gorelick, David A.; Huestis, Marilyn A.

2012-01-01

413

Diurnal variation of depressive symptoms  

OpenAIRE

Diurnal variation of depressive symptoms appears to be part of the core of depression. Yet longitudinal investigation of an individual's pattern regularity, relation to clinical state, and clinical improvement reveals little homogeneity. Morning lows, afternoon slump, evening worsening - all can occur during a single depressive episode. Mood variability, or the propensity to produce mood swings, appears to be the characteristic that most predicts capacity to respond to treatment. Laboratory s...

Wirz-justice, Anna

2008-01-01

414

The puzzling symptom of paranoia  

OpenAIRE

Paranoia can present as a symptom, a syndrome or as a personality trait. We present a series of cases, in adults, adolescents and children, where paranoia is the most prominent feature in the clinical presentation, with the objective of discussing difficulties encountered in diagnosis. A total of nine cases are presented where the initial diagnosis needed subsequent revision. The possible reasons for this are inadequacy of diagnostic classification systems leading to false positive diagnosis,...

Hemamali Perera; Ayodya Malalagama; Sayuri Perera

2010-01-01

415

Cholecystic fistula with atypical symptoms  

DEFF Research Database (Denmark)

We report a patient with spontaneous cholecystocolonis fistula secondary to cholelithiasis. A 93 year-old woman was admitted because of weight loss, diarrhoea and upper abdominal pain. Ultrasound examination revealed air in the biliary tract and cholescientigraphy revealed a fistula between the gallbladder and right colon. Using endoscopic retrograde cholangiopancreatography a calculus was extracted from the bile duct and the symptoms disappeared Udgivelsesdato: 2008/1/14

Bang, U.C.; Hasbak, P.

2008-01-01

416

Functional bowel symptoms and diet.  

Science.gov (United States)

It is well recognised that ingestion of food is a trigger for functional bowel symptoms, particularly those associated with irritable bowel syndrome (IBS). Patients often use manipulation of diet as a means of controlling symptoms. Despite description of multiple dietary methods, few have scientific backing or quality evidence of efficacy. One approach is to define how specific food components influence the pathophysiology of IBS and then rationally design dietary approaches. For example, short-chain poorly absorbed carbohydrates (fermentable oligo-, di- and mono-saccharides and polyols (FODMAP)) cause luminal distension, which is a major stimulus for the development of symptoms in patients with visceral hypersensitivity. By determining food content of FODMAP, a diet in which foods low in FODMAP are favoured over those high in FODMAP can be designed. Observational, comparative and randomised controlled treatment and rechallenge studies have shown that such an approach is efficacious in the majority of patients with IBS. The low FODMAP diet is now the primary dietary therapy for such patients. Similar approaches can be applied to other food components, including proteins (such as gluten), fats and natural bioactive food chemicals. Such approaches have suggestions of efficacy, but the evidence base remains underdeveloped. An additional and important consideration for any dietary therapy is its nutritional adequacy and potential adverse health effects. Dietary manipulation is now a key management strategy in patients with functional bowel symptoms. Future well-designed interventional studies will lead to refinement of dietary approaches taken and to a better understanding of their long-term safety. PMID:24134168

Gibson, P R; Barrett, J S; Muir, J G

2013-10-01

417

[Symptoms and diagnosis of auditory processing disorder].  

Science.gov (United States)

The definition of an auditory processing disorder (APD) is based on impairments of auditory functions. APDs are disturbances in processes central to hearing that cannot be explained by comorbidities such as attention deficit or language comprehension disorders. Symptoms include difficulties in differentiation and identification of changes in time, structure, frequency and intensity of sounds; problems with sound localization and lateralization, as well as poor speech comprehension in adverse listening environments and dichotic situations. According to the German definition of APD (as opposed to central auditory processing disorder, CAPD), peripheral hearing loss or cognitive impairment also exclude APD. The diagnostic methodology comprises auditory function tests and the required diagnosis of exclusion. APD is diagnosed if a patient's performance is two standard deviations below the normal mean in at least two areas of auditory processing. The treatment approach for an APD depends on the patient's particular deficits. Tra